<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>mds_16oct2006-borealismatdoc.htm
<DESCRIPTION>MDS INC. AND BOREALIS INFRASTRUCTURE MANAGEMENT INC. ASSET PURCHASE AGREEMENT DATED OCTOBER 4, 2006
<TEXT>
<html>
  <head>
    <title>
      MDS Inc. and Borealis Infrastructure Management Inc. Asset Purchase Agreement
      dated October 4, 2006
</title>
<!-- Licensed to: zd8426-->
<!-- Document Created using EDGARizer HTML 3.0.4.0 -->
<!-- Copyright 2006 EDGARfilings, Ltd., an IEC company.-->
<!-- All rights reserved EDGARfilings.com -->
</head>
  <body bgcolor="#ffffff"><br>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><strong>MDS
      INC.</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><strong>-
      AND -</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><strong>BOREALIS
      INFRASTRUCTURE MANAGEMENT INC.</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td valign="top" width="44%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><strong>ASSET
                PURCHASE AGREEMENT</strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dated
      this 4th day of October, 2006</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Prepared
      by:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><img src="fasken.jpg" alt=""></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Fasken
      Martineau DuMoulin LLP</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Toronto,
      Ontario</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div><br>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
        <div style="WIDTH: 100%" align="left">
        </div>
      </div>
    </div><br><br>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -90pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ARTICLE&#160;1<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;</font></strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>INTERPRETATION</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Definitions</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Interpretation</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.3</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Entire
      Agreement</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Amendment</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.5</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Waiver
      of
      Rights</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.6</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Schedules</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.7</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Applicable
      Law</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.8</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Currency</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.9</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Performance
      on Holidays</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.10</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Calculation
      of Time</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.11</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Severability</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.12</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">No
      Third
      Party Beneficiaries</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -90pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ARTICLE&#160;2</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>PURCHASE
      AND SALE OF PURCHASED ASSETS</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Purchase
      and Sale of Purchased Assets</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Excluded
      Assets</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.3</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Non-Assignable
      Contracts</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Place
      of
      Closing</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.5</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Closing
      Time</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -90pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ARTICLE&#160;3</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>CONSIDERATION
      FOR PURCHASED ASSETS</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Purchase
      Price; Holdback Amount</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Post-Closing
      Audit</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.3</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Determination
      of Value of Inventory, Accounts Receivable</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Working
      Capital Adjustment</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.5</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">General
      Adjustments</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.6</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Long-Term
      Liability and Other Adjustments</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.7</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Interest</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.8</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Allocation
      of Purchase Price</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.9</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Payment
      of Purchase Price</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.10</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Transfer
      Taxes and Tax Elections</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.11</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Excluded
      Liabilities</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -90pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ARTICLE&#160;4</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>REPRESENTATIONS
      AND WARRANTIES</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Representations
      and Warranties of MDS</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Representations
      and Warranties of Buyer</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.3</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Commission</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Qualification
      of Representations and Warranties</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.5</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Survival
      of Representations and Warranties of MDS</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.6</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Survival
      of Representations and Warranties of Buyer</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.7</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Knowledge
      of MDS</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.8</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">No
      Breach</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -90pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ARTICLE&#160;5</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>OTHER
      COVENANTS OF THE PARTIES</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Conduct
      Prior to Closing</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Regulatory
      Consents</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.3</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Bulk
      Sales</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer&#8217;s
      Covenants</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.5</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Benefit
      Plans</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.6</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Limited
      Trade Mark Licence</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.7</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Migration
      Agreement</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.8</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Non-Competition
      Agreement</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.9</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Support
      Services Agreement</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.10</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Shared
      Contracts</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.11</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Designated
      Buyer Affiliates</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.12</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Confidentiality</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.13</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Transaction
      Structure</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.14</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Replacement
      Material Contracts</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -90pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ARTICLE&#160;6</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>CONDITIONS
      PRECEDENT</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer&#8217;s
      Conditions</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Conditions
      of MDS</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.3</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Waiver</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Failure
      to Satisfy Conditions</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -90pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ARTICLE&#160;7</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>POST-CLOSING
      PROVISIONS</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Insurance
      and Risk of Loss</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Litigation</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.3</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Post-Closing
      Access</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Excluded
      Asset Adjustment</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.5</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Tax
      Matters</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.6</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Privacy
      Notification</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.7</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Other
      Confidentiality Agreements</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.8</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Post-Closing
      Reimbursements</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.9</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">No
      MDS
      Guarantees on Lease Renewals</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.10</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Post-Closing
      Conveyance of Migrating Assets</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.11</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Survival
      of Covenants</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.12</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">U.S.
      Non-Competition and Non-Solicitation Agreements</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -90pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ARTICLE&#160;8</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>INDEMNIFICATION</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Definitions</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indemnification
      by MDS</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.3</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indemnification
      by Buyer</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Agency
      for Representatives</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.5</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notice
      of
      the Defence of Third Party Claims</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.6</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Assistance
      for Third Party Claims</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.7</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Settlement
      of Third Party Claims</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.8</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Direct
      Claims</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.9</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Failure
      to Give Timely Notice</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.10</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Limitation</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.11</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Reductions
      and Subrogation</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.12</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Exclusive
      Remedy</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.13</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Duty
      to
      Mitigate</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.14</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">General
      Limitations</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.15</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Adjustment
      to the Purchase Price</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -90pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ARTICLE&#160;9</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ARBITRATION</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Arbitration</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Laws
      of
      Ontario</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9.3</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Arbitration
      Act</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -90pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ARTICLE&#160;10</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>GENERAL</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Expenses</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Time</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10.3</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notices</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Assignment,
      Successors</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10.5</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Further
      Assurances</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10.6</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Public
      Announcements</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10.7</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Counterparts</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10.8</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Facsimile
      Execution</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10.9</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">No
      Partnership</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -54pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10.10</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Survival</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -90pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>SCHEDULE
      2.5<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>TRANSACTION
      STRUCTURE AND CLOSING SEQUENCE</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -90pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>SCHEDULE
      3.1<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>HOLDBACK
      AMOUNT</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -90pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>SCHEDULE
      3.8<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>PURCHASE
      PRICE ALLOCATION</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -90pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>SCHEDULE
      5.6<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>FORM
      OF LIMITED TRADE MARK LICENCE</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -90pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>SCHEDULE
      5.7<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>FORM
      OF CBS LICENSE AGREEMENT</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -90pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>SCHEDULE
      5.8<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>FORM
      OF NON-COMPETITION AGREEMENT</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -90pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>SCHEDULE
      5.9<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>SUPPORT
      SERVICES AGREEMENT TERM SHEET</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -90pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>SCHEDULE
      5.12<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>FORM OF
      MDS CONFIDENTIALITY AGREEMENT</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -90pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>SCHEDULE
      6.1.5(B)<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;CLOSING CONDITIONS IN
      FAVOUR OF BUYER</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -90pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>SCHEDULE
      6.2.4(B)<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;CLOSING CONDITIONS IN
      FAVOUR OF MDS</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 90pt; TEXT-INDENT: -90pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>SCHEDULE
      9.3<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>RULES
      OF PROCEDURE FOR ARBITRATION</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div><br><br><br>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ASSET
      PURCHASE AGREEMENT</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
      agreement is made this 4th day of October, 2006</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>B
      E T W E E N:</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 72pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>MDS
      INC.</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 72pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a
      corporation incorporated under the laws of Canada</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 72pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>MDS</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 72pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">-
      and
      -</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 72pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>BOREALIS
      INFRASTRUCTURE MANAGEMENT INC.</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 72pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a
      corporation incorporated under the laws of Canada</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 72pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Buyer</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>RECITALS:</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MDS
                has agreed to sell and to cause the Sellers to sell to Buyer the
                diagnostics services business in Canada carried out by MDS, the Operators
                and the BC Operators. The parties have agreed to enter into separate
                purchase agreements in respect of the Diagnostics Business and the
                BC
                Diagnostics Business.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Contemporaneously
                with and conditional upon the execution of this Agreement by the
                Parties,
                MDS, Mether Properties Limited Partnership and Buyer shall execute
                and
                deliver a purchase agreement with respect to the BC Diagnostics Business
                (the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>BC
                Purchase Agreement</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
                and MDS, Dr. Donald B. Rix and Rix Clinical Laboratories Ltd. shall
                execute and deliver a purchase agreement with respect to certain
                assets
                owned by Rix and Rixco (as such terms are defined below) in the BC
                Diagnostics Business on the terms and subject to the conditions set
                forth
                in such agreement.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant
                to this Agreement, MDS has agreed to sell and to cause the Sellers
                to sell
                to Buyer the Purchased Assets owned by them and the Replacement Contracts
                and the Migrating Assets to be acquired by them as provided herein
                and in
                the Migration Agreement and the Buyer has agreed to purchase the
                Purchased
                Assets, the Replacement Contracts and the Migrating Assets and assume
                the
                Assumed Liabilities on the terms and subject to the conditions set
                forth
                in this Agreement.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
                boards of directors of MDS and Buyer have each approved the execution
                and
                delivery of this Agreement, the performance of their respective
                obligations hereunder and the transactions contemplated by this
                Agreement.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Certain
                of the Purchased Assets, the Replacement Contracts and Migrating
                Assets
                may be acquired by Designated Buyer Affiliates pursuant to the terms
                of
                this Agreement.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>IN
      CONSIDERATION </strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">of
      the
      premises and the respective agreements in this Agreement, and of other
      consideration (the receipt and sufficiency of which are acknowledged by each
      Party), the Parties agree as follows:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ARTICLE&#160;1</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>INTERPRETATION</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>1.1</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Definitions</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
      this
      Agreement including the Recitals,</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Accounts
      Receivable</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means,
      with respect to any Person at a given time, all accounts receivable of the
      Person as at that time;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Accrual
      Adjustment Date</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.6(b)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;
      </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Affiliate</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means,
      with respect to any Person,</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">any
                other Person who directly or indirectly controls, is controlled by,
                or is
                under direct or indirect common control with, such Person;
                or</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">any
                other Person that directly or indirectly owns all of the participating
                equity of such Person or for which all of the participating equity
                is
                directly or indirectly owned by such Person;
                and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a
      Person
      shall be deemed to &#8220;control&#8221; a Person if such Person possesses directly or
      indirectly the power to direct or cause the direction of the management and
      policies of such Person, whether through the ownership of voting securities,
      by
      contract or otherwise, and &#8220;controlled&#8221; shall have a similar
      meaning;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Agreement</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      this asset purchase agreement and all attached schedules, in each case as
      supplemented, amended, restated or replaced from time to time;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Applicable
      Law</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      any domestic or foreign statute, law (including the common law), ordinance,
      rule, regulation, or Order, or the terms of any consent, exemption, approval
      or
      Licence of any Governmental Authority, that applies in whole or in part to
      MDS,
      Buyer, a Designated Buyer Affiliate, an Operator, the Diagnostics Business
      or
      the way the Diagnostics Business is carried on or to any of the Purchased
      Assets;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Assignment
      and Assumption Agreement</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.1.8(d)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Assumed
      Liabilities</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means,
      subject to Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      the
      Quebec Liabilities, the Ontario Liabilities and any Liabilities associated
      with
      the Migrating Assets;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Assumed
      Long-Term Liabilities</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the Liabilities of the Diagnostics Business reflected on the Closing Balance
      Sheet other than those included in Working Capital;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>AutoLabs
      Assets</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      all assets owned, leased or otherwise held by MDS and its Affiliates exclusively
      in respect of the operation of the AutoLabs Business;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>AutoLabs
      Business</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the business carried on by MDS and its Affiliates relating to the hardware
      system and related software known as APX (AutoLab Process eXpert) that provides
      specimen management, storage, results and instrument interfacing capabilities
      at
      testing locations, consisting of the licensing, maintenance and support of
      such
      system; </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>AutoLabs
      Contracts</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Schedule </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.9</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>AutoLabs
      Liabilities</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      all Liabilities of MDS and its Affiliates relating exclusively to the AutoLabs
      Business;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>BC
      Closing</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning attributed thereto in the BC Purchase Agreement;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>BC
      Diagnostics Business</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the specimen collection and diagnostic services businesses carried on directly
      by MDS, in British Columbia, and the BC Operators consisting of the provision
      of
      clinical laboratory testing for physicians, hospitals, non-hospital health
      care
      institutions, employers or insurance companies, management of hospital
      laboratories and other support services for clinical diagnostics but excluding,
      for avoidance of doubt, the businesses carried on by any Person in which MDS
      does not directly or indirectly have a greater than 50% interest;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>BC
      Documents</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the BC Purchase Agreement, the Regional Purchase Agreements (as defined in
      and
      entered into pursuant to the BC Purchase Agreement), and any document delivered
      contemporaneously with the execution of the BC Purchase Agreement by the Parties
      or prior to or at the BC Closing as contemplated by or pursuant to the BC
      Purchase Agreement;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>BC
      Operators</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      Metro LP, Metro-McNair Clinical Laboratories Ltd., Mether LP, Mether Management
      Ltd., Mether Properties Ltd., Metropolitan Laboratories of Victoria Ltd., Prince
      George Medical Laboratory Partnership, Dawson Creek Medical Laboratory and
      Stirrat Laboratories Ltd.;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>BC
      Purchase Agreement</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in the recitals to this Agreement;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>BC
      Purchased Assets</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Purchased
      Assets</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
as
      that
      term is defined in the BC Purchase Agreement;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Benefit
      Plans</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      all bonus, deferred compensation, incentive compensation, share purchase, share
      appreciation, phantom share, restricted stock unit, deferred stock unit, share
      option, severance or termination pay, hospitalization or other medical benefits,
      life or other insurance, dental, disability, salary continuation, vacation,
      supplemental unemployment benefits, profit-sharing, mortgage assistance, legal
      benefits, change of control, retention, employee loan, employee assistance,
      pension, retirement or supplemental retirement plan or agreement (including
      any
      defined benefit or defined contribution Pension Plan and any group registered
      retirement savings plan), and each other employee benefit plan or agreement
      sponsored, maintained or contributed to or required to be contributed to by
      MDS
      or one or more Operators for the benefit of any Employees or former employees,
      officers or directors of the Diagnostics Business or their dependants or
      beneficiaries, whether written or unwritten, formal or informal, funded or
      unfunded, insured or uninsured, registered or unregistered and whether or not
      subject to any Applicable Law except that the term &#8220;Benefit Plans&#8221; shall not
      include any statutory plans with which MDS or an Operator is required to comply,
      including the Canada/Quebec Pension Plan and plans administered pursuant to
      applicable provincial health Tax, workers&#8217; compensation and workers&#8217; safety and
      employment insurance legislation;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Books
      and Records</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      all books, records, books of account, sales and purchase records, lists of
      suppliers and customers, credit and pricing information, formulae, business,
      engineering and consulting reports, research and development information, plans
      and projections, personnel records, operating guides, test data, health records,
      manuals, records, reports and information or documents of the Diagnostics
      Business maintained by or on behalf of MDS or an Operator pursuant to, or to
      demonstrate compliance with, Applicable Law and all other documents, files,
      records, correspondence, and all other data and information, financial or
      otherwise, of the Diagnostics Business held by or on behalf of MDS or an
      Operator including all service level reports, metrics and performance data
      (including raw data) relating to the provision of all services to the
      Diagnostics Business (whether by MDS or third parties) and all data and
      information stored electronically or on computer-related media (or in any other
      form or format);</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Building</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      a
      plant, warehouse, building, structure, erection, improvement, appurtenance
      or
      fixture (including fixed machinery and fixed equipment) situate on or forming
      part of the Land and includes without limitation all heating, ventilating,
      air
      conditioning, plumbing, sprinkler, life safety, electrical, mechanical,
      drainage, elevating and security systems and infrastructure incorporated in
      or
      situate on the Building, together with all floor coverings and window coverings
      incorporated within such Building;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Business
      Day</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      a
      day other than a Saturday or Sunday, on which Canadian chartered banks are
      open
      for the transaction of domestic business in the City of Toronto;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Buyer&#8217;s
      Benefit Plans</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.5(b)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Buyer&#8217;s
      Pension Plans</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.5(a)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Buyer
      Purchase Structure</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.13(a)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>CBS
      IP</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the technology, information, materials, data, components and elements
      proprietary to MDS that form a part of or are included in the Oracle based
      common back office system solution known internally by MDS as &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>CBS</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>CBS
      License Agreement</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.7</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Closing</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the completion of the sale to, and the purchase by, Buyer of the Purchased
      Assets, the Replacement Contracts and the Migrating Assets, the assumption
      of
      the Assumed Liabilities by Buyer and the completion of all other transactions
      contemplated by this Agreement that are to occur contemporaneously with or
      prior
      to the purchase and sale of the Purchased Assets, the Replacement Contracts
      and
      the Migrating Assets and the assumption of the Assumed Liabilities;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Closing
      Balance Sheet</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      an audited combined balance sheet of the MDS Diagnostics Division as at the
      Closing Time as prepared in accordance with Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Closing
      Cash Amount</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the portion of the Purchase Price paid to Sellers by wire transfer at the
      Closing as described in Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.1(a)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Closing
      Date</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      (i) the later of: (A) November 29, 2006, and (B) if any of the conditions set
      forth in Section 6.1 or 6.2 is not satisfied or waived on any date, the second
      Business Day following the date the last of such conditions is satisfied or
      waived; or (ii) such later date as the Parties may agree in writing as the
      date
      the Closing shall take place; </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Closing
      Documents</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the Regional Purchase Agreement, Migration Agreement, Limited Trade Mark
      Licence, Non-Competition Agreement, CBS License Agreement, Support Services
      Agreement, MDS Confidentiality Agreement and, if required, the International
      Boulevard Licenses and the Post-Closing Services Agreement, and any document
      delivered contemporaneously with the execution of this Agreement by the Parties
      or prior to or at the Closing Time as contemplated by or pursuant to this
      Agreement but excluding, for greater certainty, the BC Documents;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Closing
      Regional Balance Sheet</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      an unaudited supplementary schedule to the Closing Balance Sheet consisting
      of a
      balance sheet of the MDS Diagnostics Division in Ontario and Quebec and the
      head
      office of the MDS Diagnostics Division as at the Closing Date; </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Closing
      Time</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      2:00 p.m. (Toronto time) on the Closing Date, or such other time on that date
      as
      the Parties agree in writing that the Closing shall take place; </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Commissioner</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the Commissioner of Competition under the Competition Act or any person duly
      authorized to exercise the powers of the Commissioner of
      Competition;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Competition
      Act</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Competition
      Act</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      (Canada);</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Competition
      Act Clearance</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      either of the following:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                issuance of an advance ruling certificate by the Commissioner under
                section 102(1) of the Competition Act, which advance ruling certificate
                remains in force at the Closing; or</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                applicable waiting period, if any, under section 123 of the Competition
                Act</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>&#160;</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">shall
                have expired or been earlier terminated or waived and the Commissioner
                shall have issued a No-Action Letter, in form and substance satisfactory
                to the Buyer, acting reasonably, to the effect that the Commissioner
                is
                satisfied that the Commissioner would not have sufficient grounds
                upon
                which to apply to the Competition Tribunal for an order under section
                92
                of the Competition Act with respect to the transactions contemplated
                herein, which letter remains in force at the Closing;
                </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Competition
      Tribunal</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the Competition Tribunal established under the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Competition
      Tribunal Act</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      (Canada);</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Confidentiality
      Agreement</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.3</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Consent
      Exclusion</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.2(b)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Contracts</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the contracts, agreements, licence agreements and other legally binding
      instruments entered into by a Person or to which a Person is bound or entitled
      including restrictive agreements and negative covenant agreements, the full
      benefit of all unfilled supplier purchase orders, quotations, tenders for
      contracts which remain open for acceptance, and entitlements and engagements,
      to
      which such Person is entitled including any deposits made in connection
      therewith, and forward commitments of any Person for supplies or materials,
      in
      all cases, whether written or oral;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Corporate
      Operator</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.1(a)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Designated
      Buyer Affiliate</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Section 5.11;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Diagnostics
      Business</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the specimen collection and diagnostic services businesses carried on in Ontario
      and Quebec directly by MDS and the Operators consisting of the provision of
      clinical laboratory testing for physicians, hospitals, non-hospital health
      care
      institutions, employers or insurance companies, management of hospital
      laboratories and other support services for clinical diagnostics and the
      AutoLabs Business as well as the US Support Service Assets but excluding, for
      avoidance of doubt, the businesses carried on by any Person in which MDS does
      not directly or indirectly have a greater than 50% interest;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Disclosed
      Matter</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Section 8.2(d);</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Disclosed
      Personal Information</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.1.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Disclosure
      Letter</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the letter of MDS to Buyer dated the date hereof which sets forth, or refers
      to
      documents which set forth, certain information, including information to qualify
      the representations and warranties of MDS contained in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Employees</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means,
      collectively, the Quebec Employees and the Ontario Employees;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Encumbrance</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      any encumbrance, security interest, mortgage, lien, hypothec, pledge,
      hypothecation, title retention agreement, reservation of title, easement,
      servitude, right of occupation, executions, judgments, assignment, charge,
      trust
      or deemed trust affecting an asset; </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Environmental
      Laws</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      all Applicable Laws relating to environmental matters or occupational health
      and
      safety including but not limited to pollution, contamination or protection
      of
      the environment, the prevention or reduction to acceptable levels of pollution
      and further including those relating to Releases of Hazardous Material into
      the
      environment (including ambient air, soil, surface water, ground water and
      subsurface strata) or otherwise relating to the manufacture, processing,
      distribution, use, treatment, storage, disposal, transport or handling of
      Hazardous Material;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Environmental
      Permit</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      any Licence required by or pursuant to any applicable Environmental Law in
      connection with the Diagnostics Business or connected to the Diagnostics
      Business;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Equipment</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means,
      in respect of a Person, all equipment, machines, machinery, motor vehicles,
      trucks and other mobile equipment, fixtures, gauges, furniture, furnishings,
      material handling, data processing equipment, laboratory equipment, collection
      centre equipment, typewriters, computers, servers, telecom equipment, data
      bases, photocopiers, office equipment, implements, tools and spare parts,
      wherever located and similar tangible personal property;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Equipment
      Leases</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means,
      in respect of a Person, the leases, subleases and conditional sales contracts
      of
      Equipment to which such Person is a party;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Estimated
      Long-Term Liabilities</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      an estimate of the Assumed Long-Term Liabilities as at the Closing
      Time;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Excluded
      Asset Event</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.2(b)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Excluded
      Assets</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means,
      subject to Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      the
      following:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                cash, bank balances, moneys in possession of banks and other depositories,
                term deposits and similar cash property and bank accounts and trust
                accounts of, owned or held by or for the account of any Seller in
                the
                Diagnostics Business, at the Closing Time but excluding for greater
                certainty any Petty Cash;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">any
                interest of MDS, directly or indirectly, in MDS Quebec or the Ontario
                GP
                and any interest of the Ontario GP in MDS ONT
                LP;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">any
                interest of MDS Quebec, directly or indirectly, in MDS (Canada)
                Inc.;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                non-transferable Licences of a Seller listed in Section 1.1 of the
                Disclosure Letter;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                property, rights, assets and undertaking of a Seller which are not
                used
                Primarily in the Diagnostics Business (including, for avoidance of
                doubt,
                all furniture, fixtures and equipment located at 75 International
                Boulevard, Toronto, Ontario other than that listed at Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                of
                the Disclosure Letter under the heading &#8220;Ontario Assets&#8221; and the
                furniture, fixtures, artwork and equipment located at 100 International
                Boulevard, Toronto, Ontario listed at Section 1.1 of the Disclosure
                Letter) and those assets, contracts, trade marks and computer software
                listed in Section 1.1 of the Disclosure Letter;
</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                information and that part of any Books and Records of a Seller relating
                thereto which must not be disclosed by the Seller to Buyer pursuant
                to the
                provisions of Applicable Law or which would be libellous if
                disclosed;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">any
                confidential documents, data, information or records prepared by
                or on
                behalf of a Seller or an Operator and undisclosed to Buyer specifically
                in
                connection with the proposed sale of the Diagnostics Business and
                the
                Purchased Assets;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(h)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                corporate and Tax records of
                Sellers;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">any
                information or records related to an Employee who does not accept
                Buyer&#8217;s
                offer of employment or to other businesses of Sellers or to MDS and
                its
                Affiliates as a whole, and not reasonably required in connection
                with the
                Purchased Assets or the Diagnostics Business or its
                operations;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(j)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Intentionally
                deleted;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(k)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                insurance policies of Sellers and benefits for claims thereunder
                relating
                to occurrences in the Diagnostics Business prior to the Closing
                Time;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(l)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                amounts due from one Seller to another Seller or an Affiliate
                thereof;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(m)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                Tax and GST credits, losses, rebates and refunds of Sellers including
                any
                rebate, refund or credit relating to a real estate assessment in
                respect
                of the Real Property included in the Purchased Assets earned or otherwise
                arising from or relating to the operation of the Diagnostics Business
                prior to the Closing Time or relating to a period of time prior to
                the
                Closing Time which become payable after the Closing Time and are
                not
                reflected on the balance sheet included in the Quarterly
                Statements;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(n)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                right, title and interest of Sellers in, to or under, and the full
                benefit
                of, the Shared Contracts and the U.S. Support Services Contracts
                other
                than the AutoLabs Contracts; and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(o)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">any
                Ontario Asset or Quebec Asset for which a replacement asset or contract
                will be created or entered into (or sourced from a third party) in
                accordance with the provisions of (x) the Migration Agreement, which
                replacement asset or contract will be conveyed or assigned to the
                Buyer as
                a Migrating Asset; or (y) Sections </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.10</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                and </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.14</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
                which Replacement Contracts will be assigned to the Buyer pursuant
                to this
                Agreement;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Excluded
      Liabilities</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.11</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Excluded
      Refund</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Field</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the collection, testing, monitoring and/or reporting of test results of bodily,
      cytological and other specimens from a patient at the request of any other
      Person, including a patient, health care professional, employer or insurance
      company; </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Financial
      Statements</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the audited combined financial statements for the MDS Diagnostics Division
      as at
      October 31, 2005, including the notes thereto, copies of which financial
      statements are annexed to the Disclosure Letter as Schedule A;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>General
      Conveyance</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.1.8(c)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Generally
      Accepted Accounting Principles</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
or
      &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>GAAP</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      generally accepted accounting principles of Canada, applicable as at the date
      on
      which any calculation or determination is required to be made in accordance
      with
      generally accepted accounting principles, and where the Canadian Institute
      of
      Chartered Accountants includes a recommendation in its Handbook concerning
      the
      treatment of any accounting matter, such recommendation shall be regarded as
      the
      only generally accepted accounting principle applicable to the circumstances
      that it covers;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Governmental
      Authority</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      any domestic or foreign government whether federal, provincial, state or
      municipal and any governmental agency, governmental authority, governmental
      tribunal or governmental commission of any kind whatsoever;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>GST</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      all goods and service Taxes, sales Taxes levied by the federal government of
      Canada, value added Taxes or multi-stage Taxes and all provincial sales Taxes
      integrated with such federal Taxes;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Hazardous
      Material</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      any substance, pollutant, contaminant, material or waste that could reasonably
      be expected to impair the quality of the environment or that causes or could
      reasonably be expected to cause an adverse effect on the environment for any
      use
      which can be made of it and which is regulated under any Environmental Law,
      including any such material regulated as hazardous, toxic, deleterious, caustic,
      dangerous, a contaminant, hazardous waste, a source of contaminant and including
      but not limited to any pathogen, bacteria, microbe, virus, parasite, nuclear
      substance as defined in the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Nuclear
      Safety and Control Act</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      or any
      related regulations, asbestos, petroleum products, urea formaldehyde, chemical
      and biochemical waste;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Holdback
      Amount</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the amount determined as set forth in Schedule 3.1, which shall not exceed
      $78,750,000;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Inscyte
      Assets</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      a
      33 1/3% interest in Inscyte (Information System for Cytology, etc.) Corporation
      held by MDS; </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Intellectual
      Property Rights</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      all trade or brand names, business names, trade-marks (including logos), trade
      mark registrations and applications, service marks, service mark registrations
      and applications, copyrights (registered or otherwise), moral rights, copyright
      registrations and applications, issued patents and pending applications and
      other patent rights (including divisions, reissues, renewals, re-examinations,
      continuations, continuations in part and extensions) applied for or registered
      in any and all jurisdictions and all rights of priority, rights to file
      applications for inventions and derivative applications and patents in any
      and
      all jurisdictions, industrial design registrations, pending applications for
      industrial design rights and other industrial design rights, integrated circuit
      topographies, internet domain names (including Internet protocol addresses)
      and
      rights in and to e-mail addresses and Software;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Interim
      Period</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the period between the date of this Agreement and the Closing Time;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>International
      Boulevard Licenses</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Section&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.1.7</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>International
      Survey</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the survey of that portion of the Real Property municipally known as 100
      International Boulevard, Toronto dated August 2, 2006 prepared by K.S. Thom
      of
      Lloyd &amp; Purcell Ltd., Ontario Land Surveyors;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Inventory</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means,
      in respect of a Person, all inventories of replacements, laboratory supplies,
      spare and component parts, supplies, packaging and advertising and publicity
      materials, wherever located, and whether on consignment or not;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Investment
      Canada Act</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Investment
      Canada Act</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      (Canada);</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ITA</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Income
      Tax Act</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      (Canada);</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Land</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the lands and Buildings owned by MDS at 100 International Boulevard, Toronto,
      Ontario and the lands and Buildings owned by an Operator, or, to the extent
      owned and used exclusively in the Diagnostics Business, MDS, as described in
      Section 4.1.20 of the Disclosure Letter and all rights of way, easements,
      licences, benefits, covenants and privileges and other rights relating
      thereto;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Leased
      Premises</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the premises or portions thereof which are subject to the Leases;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Leases</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means,
      in respect of a Person, the leases, licenses, occupancy agreements or agreements
      or arrangements in the nature of a lease, license or occupancy agreement of
      real
      property to which such Person is a party, whether as lessor or
      lessee;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Liabilities</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      all debts, obligations and liabilities, of any nature or kind whatsoever,
      whether accrued or fixed, absolute or contingent, matured or unmatured, secured
      or unsecured, liquidated or unliquidated and whether or not reflected or
      required to be reflected in a balance sheet in accordance with
      GAAP;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Licence</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      any licence, permit, approval, right, privilege, concession or franchise issued,
      granted, conferred or otherwise created by a Governmental
      Authority;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Licensed
      IP</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Subsection 4.1.18(b);</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Limited
      Trade Mark Licence</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.6</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>LPBP
      Consent</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the consent of the limited partner of MDS ONT LP to the sale by MDS ONT LP
      of
      its Ontario Assets in accordance with the terms of the limited partnership
      agreement governing MDS ONT LP;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Material
      Adverse Effect</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      any circumstance, state of facts or matter, either alone or in combination,
      which is materially adverse to, or could reasonably be expected to have a
      material adverse effect on, the financial condition, results of operations,
      prospects or value of the Diagnostics Business or the Purchased Assets, the
      Replacement Contracts and the Migrating Assets taken as a whole, provided,
      however, that any adverse circumstance, state of facts or matter directly or
      indirectly:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">arising
                out of or resulting in the ordinary course of business or from actions
                taken by MDS, Rix, Buyer, a Designated Buyer Affiliate or an Operator
                pursuant to, or as contemplated by, this Agreement, the BC Purchase
                Agreement or the Rix Agreement;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">resulting
                from the announcement or performance of this Agreement, the BC Purchase
                Agreement or the Rix Agreement or the transactions contemplated hereby
                or
                thereby;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">resulting
                from economic factors affecting the Canadian economy as a
                whole;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">resulting
                from factors generally affecting the specific markets in which the
                Diagnostics Business operates, including any adjustment to the insured
                laboratory services fee rates or the provincial insured laboratory
                services payment cap imposed by a Governmental Authority;
                </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">resulting
                from any change in Applicable Laws or
                GAAP;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">arising
                from a material worsening of current conditions caused by acts of
                God,
                terrorism or war (whether or not declared);
                or</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">resulting
                from any failure of the Diagnostics Business to meet projections
                and
                estimates;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">shall
      not
      be deemed in themselves, either alone or in combination, to constitute a
      Material Adverse Effect;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>MDS
      Confidentiality Agreement</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the confidentiality agreement to be entered into on the Closing Date
      substantially in the form attached hereto as Schedule </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.12</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>MDS
      Contracting Party</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Schedule </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.9</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>MDS
      Diagnostics Division</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the combined operations, assets and Liabilities of the Diagnostics Business
      and
      the BC Diagnostics Business and including MDS&#8217; proportionate consolidated
      interest in Toronto Labs and MDS&#8217; equity interest in Windsor Labs;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>MDS
      ESOP</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the employee share ownership plan of MDS as amended and restated as of September
      8, 2004;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>MDS
      ONT LP</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      MDS Laboratory Services Limited Partnership, a limited partnership governed
      by
      the laws of Ontario;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>MDS
      Option Plan</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the MDS Inc. Stock Option Plan as amended and restated on December 5,
      2005;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>MDS
      Quebec</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      Laboratoires MDS Qu&#233;bec Lt&#233;e., a wholly-owned subsidiary of MDS incorporated
      under the laws of Qu&#233;bec;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Mether
      LP</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      Mether Properties Limited Partnership, a limited partnership governed by the
      laws of British Columbia;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Metro
      LP</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      Metro-McNair Clinical Laboratories Limited Partnership, a limited partnership
      governed by the laws of British Columbia;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Migrating
      Assets</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning attributed thereto in the Migration Agreement;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Migration
      Agreement</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.7</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Minimum
      Required Consents</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Schedule </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>No-Action
      Letter</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      a
      letter wherein the Commissioner advises the Parties, and whether or not subject
      to any conditions or qualifications, that the Commissioner is of the view that
      there are not sufficient grounds at that time to initiate proceedings before
      the
      Competition Tribunal under the merger provisions of the Competition Act in
      respect of the transactions contemplated herein and in the BC Purchase
      Agreement;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Non-Assignable
      Contract</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      any of the Contracts, Leases, Equipment Leases, Shared Contracts, Warranty
      Rights or Transferable Licences included in the Purchased Assets:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 108pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">an
                assignment or attempted assignment of which would constitute a breach
                thereof without the consent of a third party if such consent has
                not been
                obtained; or</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 108pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">an
                assignment of which would contravene any Applicable
                Law,</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">including
      those set forth in Section 1.1 of the Disclosure Letter;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Non-Assigned
      Leases</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Section&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.3(c)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Non-Competition
      Agreement</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.8</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Non-Controlled
      Corporate Operator</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.1(a)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Non-Controlled
      Operators</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means,
      collectively, the Non-Controlled Corporate Operator and the Non-Controlled
      Partnership Operator;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Non-Controlled
      Partnership Operator</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.1(a)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Ontario
      Assets</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the AutoLabs Assets and all of the assets, property and undertaking of every
      kind and nature and wherever located, owned, leased, used or otherwise held
      by
      MDS ONT LP, Ontario GP or MDS Primarily in respect of the operation of the
      Diagnostics Business carried on in Ontario, excluding the Excluded Assets,
      but
      including the following: </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                Ontario Premises and the Building, Equipment and Inventory located
                in, on
                or about the Ontario Premises, in each case to the extent they relate
                Primarily to the Diagnostics Business carried on in Ontario including,
                for
                greater certainty, the furniture, fixtures and equipment at 100
                International Boulevard, Toronto, Ontario, except as set forth in
                Section
                </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                of
                the Disclosure Letter under the heading &#8220;Excluded Assets&#8221;, and the
                furniture, fixtures and equipment at 75 International Boulevard,
                Toronto,
                Ontario set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                of
                the Disclosure Letter;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                right, title and interest of MDS ONT LP, Ontario GP or MDS in, to
                and
                under the Leases and the Leased Premises as described under the subheading
                Ontario in Schedule C annexed to the Disclosure Letter, all leasehold
                improvements pertaining to the Leases and Leased Premises, all Equipment
                and Inventory located in, on or about the Leased Premises and all
                appurtenances thereto, in each case to the extent they relate Primarily
                to
                the Diagnostics Business carried on in
                Ontario;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                right, title and interest of MDS ONT LP, Ontario GP or MDS in, to
                and
                under, and the full benefit of, the Contracts and the Equipment Leases
                relating Primarily to the Diagnostics Business carried on in Ontario
                including those listed in Schedule D annexed to the Disclosure
                Letter;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                Intellectual Property Rights of MDS ONT LP, Ontario GP and MDS relating
                Primarily to the Diagnostics Business carried on in Ontario, including
                the
                Intellectual Property Rights set forth in Schedule E annexed to the
                Disclosure Letter;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                Accounts Receivable (save and except for any Accounts Receivable
                of MDS
                ONT LP or Ontario GP owing by MDS or any of its Affiliates), Books
                and
                Records, Petty Cash, Prepaid Expenses, Technical Information, Warranty
                Rights and Transferable Licences of MDS ONT LP, Ontario GP or MDS,
                in each
                case relating Primarily to the Diagnostics Business carried on in
                Ontario;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                claims of MDS, Ontario GP or MDS ONT LP relating to the Diagnostics
                Business carried on in Ontario (except to the extent such claims
                relate to
                any Excluded Assets) or the Purchased Assets or the Replacement Contracts
                in Ontario, whether choate or inchoate, known or unknown, contingent
                or
                otherwise; </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                goodwill of the Diagnostics Business carried on in Ontario, including
                the
                exclusive right to the Buyer to represent itself as carrying on the
                Diagnostics Business in Ontario in continuation of and in succession
                to
                MDS, Ontario GP and MDS ONT LP, subject to the provisions of the
                Limited
                Trade Mark Licence; and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(h)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                Toronto Assets, the Windsor Assets and the Inscyte
                Assets;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Ontario
      Employees</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      all of the employees of MDS working exclusively in the Diagnostics Business
      carried on in Ontario as at the Closing Time, which are, as at August 28, 2006,
      those Employees identified in Schedule F annexed to the Disclosure Letter under
      the subheading Ontario Employees and all of the employees of the Ontario GP
      as
      at the Closing Time, which are, as at August 28, 2006, those Employees
      identified in Schedule F annexed to the Disclosure Letter under the subheading
      Ontario GP Employees;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Ontario
      GP</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      MDS Laboratory Services Inc., a wholly-owned subsidiary of MDS incorporated
      under the laws of Ontario;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Ontario
      Liabilities</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means,
      without duplication,</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                Liabilities of MDS ONT LP, Ontario GP or MDS relating to the Diagnostics
                Business carried on in Ontario or the Ontario Assets in each case
                included
                in or provided for in, or required to be included in or provided
                for in,
                the Closing Balance Sheet in accordance with GAAP (including those
                Liabilities included in or provided for in the Financial Statements
                that
                remain outstanding at the Closing Time) but excluding payables owed
                by MDS
                ONT LP or Ontario GP to MDS or any of its
                Affiliates;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                AutoLab Liabilities arising after the Closing
                Time;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                Liabilities of MDS ONT LP, Ontario GP or MDS under the Contracts,
                Leases
                and Equipment Leases included in the Purchased Assets and the Replacement
                Contracts, in each case arising after the Closing Time and not related
                to
                any default of MDS ONT LP, Ontario GP or MDS existing prior to (and
                remaining unremedied at the Closing Time) or as a consequence of
                Closing;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                Liabilities of MDS ONT LP, Ontario GP or MDS relating to the Ontario
                Employees who accept the Buyer&#8217;s or Designated Buyer Affiliate&#8217;s offer of
                employment as contemplated by Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.4.1(a)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                and which arise or become payable on or after the Closing Time, including
                wages and any other form of compensation, remuneration or benefits
                under
                any Benefit Plan including bonuses, termination and severance pay,
                pensions and all other post-retirement benefits and employee health
                and
                welfare obligations and including any claims by any such Employee
                arising
                on or after the Closing Time other than any Liabilities arising under
                or
                with respect to the MDS Option Plan or MDS ESOP or the lack of such
                plans
                or any retention, change of control or deal bonus pertaining to the
                sale
                of the Diagnostics Business;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                Liabilities of MDS and its Affiliates arising in respect of the
                Replacement Contracts to the extent same relate directly to the
                Diagnostics Business carried on in Ontario or the Ontario Assets
                and arise
                after the Closing Time and are not related to any default of MDS
                or its
                Affiliates existing prior to (and remaining unremedied at the Closing
                Time) or as a consequence of
                Closing;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                other Liabilities of MDS, Ontario GP and MDS ONT LP not otherwise
                provided
                for herein relating directly to the Diagnostics Business carried
                on in
                Ontario arising, accruing or relating to periods on or after the
                Closing
                Time; </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                Liabilities of MDS, Ontario GP and MDS ONT LP relating to the claims
                referred to in clause (f) of the definition of Ontario Assets arising
                after the Closing Time; and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(h)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                Toronto Liabilities and Windsor
                Liabilities.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Ontario
      Licensing Act</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Laboratory
      and Specimen Collection Centre Licensing Act </em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Ontario)
      and the related </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Specimen
      Collection Centres</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      Regulation, and </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Laboratories</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      Regulation; </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Ontario
      Premises</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the Lands described in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.20</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      of the
      Disclosure Letter;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Operators</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means,
      collectively, MDS ONT LP, Ontario GP and MDS Quebec, and &#8220;Operator&#8221; means any
      one of them;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Order</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      any order, judgment, injunction, decree, award or writ of any court, arbitrator
      or Governmental Authority;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ordinary
      course</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
or
      &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>normal
      course</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;,
      when
      used in relation to the conduct by a Person, means any transaction or conduct
      which constitutes an ordinary day-to-day business activity of the Person
      conducted in a commercially reasonable and businesslike manner consistent with
      such Person&#8217;s past customs and practices;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Other
      Confidentiality Agreements</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      all of the confidentiality agreements between MDS and each party (other than
      the
      Buyer and Rix) that was in discussions with MDS to purchase the Purchased Assets
      and/or the BC Purchased Assets;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Parties</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      MDS and Buyer, and upon a Designated Buyer Affiliate signing a contract of
      adhesion as required by Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.11</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      such
      Designated Buyer Affiliate, collectively, and &#8220;Party&#8221; means either (or, as
      applicable, any) one of them;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Partnership
      Interest</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
in
      respect of a partner in a partnership, means all the units and/or other interest
      held by such partner in such partnership, if any, and all right, title and
      interest of such partner under the partnership agreement governing such
      partnership and Applicable Law including all rights, benefits and entitlement
      to
      profits and losses, insurance proceeds, current account, capital account, return
      of capital, repayment of indebtedness and any other benefit in connection with
      the business, sale or dissolution of such partnership whether as a general
      or
      limited partner and whether of a general or limited partnership;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Partnership
      Operator</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.1(a)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Pension
      Plan</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      each of the Benefit Plans that is a &#8220;Registered Pension Plan&#8221; as that term is
      defined in subsection 248(1) of the ITA;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Permitted
      Encumbrances</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
      means:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">inchoate
                or statutory liens for Taxes and assessments, both general and special,
                and other governmental charges not yet due and payable as of the
                Closing
                Time;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">statutory
                liens incurred or deposits made by an Operator or MDS in connection
                with
                workers&#8217; compensation, unemployment insurance and similar legislation;
                </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">any
                reservations or exceptions contained in the original grants from
                the Crown
                as amended by statute;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                encroachments, overlaps, overhangs, unrecorded servitudes and easements,
                variations in area or measurement, rights of parties in possession
                or any
                other matters not of record which would be disclosed by an accurate
                survey
                or physical inspection of the Real Property, provided that same are
                not of
                such nature as to, individually or in aggregate, have a material
                adverse
                effect on the use or value of the Real Property subject
                thereto;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                encroachments, overlaps, overhangs, servitudes and easements, variations
                in area or measurement, rights of parties in possession, discrepancies
                in
                the legal description of that portion of the Real Property municipally
                known as 100 International Boulevard, Toronto or any other matters
                disclosed by the International Survey;
</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">minor
                discrepancies in the legal description of the Land or any adjoining
                real
                property which would be disclosed in an up to date
                survey;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                servitudes and easements (including conservation easements and public
                trust easements, rights-of-way, road use agreements, covenants,
                conditions, restrictions, reservations, licences, agreements and
                other
                matters of record) and zoning by-laws, ordinances and other restrictions
                as to the use of real property, provided that same are not of such
                nature
                as to, individually or in aggregate, have a material adverse effect
                on the
                use or value of the Real Property subject thereto and provided the
                same
                have been complied with by MDS or the Operators, as the case may
                be, in
                all material respects to the Closing
                Date;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(h)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                registered and unregistered municipal agreements and agreements with
                public and private utilities, provided the same have been complied
                with by
                MDS or the Operators, as the case may be, in all material respects
                to the
                Closing Date; </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                rights of third parties under the Contracts, Equipment Leases, Leases,
                Shared Contracts, the Replacement Contracts and the Migrating Assets
                including the partnership agreements and shareholders&#8217; agreements included
                in the Purchased Assets including the consent rights and rights of
                first
                refusal of third parties triggered upon the transfer of Partnership
                Interests or shares included in the Purchased Assets but excluding
                rights
                against Sellers arising in respect of indebtedness; and
                </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(j)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">in
                respect of MDS or any Operator, the Encumbrances set forth in Section
                1.1
                of the Disclosure Letter;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Permitted
      Proposal</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.1.1(e)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Person</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
shall
      be broadly interpreted and includes an individual, body corporate, partnership,
      joint venture, trust, association, unincorporated organization, the Crown,
      any
      Governmental Authority or any other entity recognized by law;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Personal
      Information</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      personal information in each case as defined by the applicable Privacy Laws
      and
      collected, used, disclosed or retained by MDS or an Operator in connection
      with
      the Diagnostics Business;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Petty
      Cash</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the petty cash of the MDS Diagnostics Division in Ontario and Quebec for use
      in
      the business at the premises at which the business is carried on;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Post-Closing
      Services Agreement</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in the Migration Agreement;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Prepaid
      Expenses</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means,
      in respect of a Person, all deposits and prepaid expenses of such Person
      including those with any public utility or any municipal, governmental or other
      public authority, to the extent the same are transferable;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Primarily</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">means
      in
      respect of any asset of a Person, each asset that has been used by such Person
      during the previous 12</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">months
      not less than 70% of the time, in the aggregate in the ordinary course of the
      Diagnostics Business;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Prime
      Rate</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
for
      any
      day means the rate of interest expressed as a rate per annum that Canadian
      Imperial Bank of Commerce establishes at its head office in Toronto as the
      reference rate of interest that it will charge on that day for Canadian dollar
      demand loans to its customers in Canada and which at present it refers to as
      its
      prime rate;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Privacy
      Laws</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      all applicable federal and provincial laws governing the collection, use,
      disclosure and retention of Personal Information, including, the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Personal
      Information Protection and Electronic Documents Act</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      (Canada), the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Personal
      Health Information Protection Act</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      (Ontario) and </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>An
      Act Respecting the Protection of Personal Information in the Private
      Sector</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      (Quebec);</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Proprietary
      IP</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Subsection 4.1.18(a);</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Purchase
      Price</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.1(a)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Purchased
      Assets</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means,
      subject to Section&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      the
      Quebec Assets and the Ontario Assets;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Quarterly
      Statements</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the unaudited combined financial statements prepared by MDS for the MDS
      Diagnostics Division for the three (3), six (6) and nine (9) month periods
      ended
      January 31, 2006, April 30, 2006 and July 31, 2006, respectively, a copy of
      which financial statements are annexed to the Disclosure Letter as Schedule
      B;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Quebec
      Assets</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      all of the assets, property and undertaking of every kind and nature and
      wherever located, owned, leased, used or otherwise held by MDS Quebec or MDS
      Primarily in respect of the operation of the Diagnostics Business carried on
      in
      Quebec, excluding the Excluded Assets, but including the following:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                right, title and interest of MDS Quebec or MDS in, to and under the
                Leases
                and the Leased Premises as described under the subheading Quebec
                in
                Schedule C annexed to the Disclosure Letter, all leasehold improvements
                pertaining to the Leases and Leased Premises, all Equipment and Inventory
                located in, on or about the Leased Premises and all appurtenances
                thereto,
                in each case to the extent they relate Primarily to the Diagnostics
                Business carried on in Quebec;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                right, title and interest of MDS Quebec or MDS in, to and under,
                and the
                full benefit of, the Contracts and the Equipment Leases relating
                Primarily
                to the Diagnostics Business carried on in Quebec including those
                listed in
                Schedule D annexed to the Disclosure
                Letter;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                Intellectual Property Rights of MDS Quebec or MDS relating Primarily
                to
                the Diagnostics Business in Quebec, including the Intellectual Property
                Rights set forth in Schedule E annexed to the Disclosure
                Letter;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                Accounts Receivable (save and except for any Accounts Receivable
                of MDS
                Quebec owing by MDS or any of its Affiliates), Books and Records,
                Petty
                Cash, Prepaid Expenses, Technical Information, Warranty Rights and
                Transferable Licences of MDS Quebec or MDS, in each case relating
                Primarily to the Diagnostics Business carried on in
                Quebec;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                claims of MDS or MDS Quebec relating to the Diagnostics Business
                carried
                on in Quebec (except to the extent such claims relate to any Excluded
                Assets) or the Purchased Assets or the Replacement Contracts in Quebec,
                whether choate or inchoate, known or unknown, contingent or otherwise;
                and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                goodwill of the Diagnostics Business carried on in Quebec, including
                the
                exclusive right to the Buyer to represent itself as carrying on the
                Diagnostics Business in Quebec in continuation of and in succession
                to MDS
                and MDS Quebec, subject to the provisions of the Limited Trade Mark
                Licence;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Quebec
      Employees</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      all of the employees of MDS Quebec or MDS working exclusively in the Diagnostics
      Business carried on in Quebec as at the Closing Time, which are, as at August
      28, 2006, those Employees identified in Schedule F annexed to the Disclosure
      Letter under the subheading Quebec Employees;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Quebec
      Liabilities</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means,
      without duplication, </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                Liabilities of MDS Quebec or MDS relating to the Diagnostics Business
                carried on in Quebec or the Quebec Assets in each case included in
                or
                provided for in, or required to be included in or provided for in,
                the
                Closing Balance Sheet in accordance with GAAP (including those Liabilities
                included in or provided for in the Financial Statements that remain
                outstanding at the Closing Time) but excluding payables owed by MDS
                Quebec
                to MDS or any of its Affiliates;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                Liabilities of MDS Quebec or MDS under the Contracts, Leases and
                Equipment
                Leases included in the Purchased Assets and the Replacement Contracts,
                in
                each case arising after the Closing Time and not related to any default
                of
                MDS Quebec or MDS existing prior to (and remaining unremedied at
                the
                Closing Time) or as a consequence of
                Closing;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                Liabilities of MDS Quebec or MDS relating to the Quebec Employees
                who
                accept the Buyer&#8217;s or Designated Buyer Affiliate&#8217;s offer of employment as
                contemplated by Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.4.1(a)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                and which arise or become payable on or after the Closing Time, including
                wages and any other form of compensation, remuneration or benefits
                under
                any Benefit Plan including bonuses, termination and severance pay,
                pensions and all other post-retirement benefits and employee health
                and
                welfare obligations and including any claims by any such Employee
                arising
                on or after the Closing Time other than any Liabilities arising under
                or
                with respect to the MDS Option Plan or MDS ESOP or the lack of such
                plans
                or any retention, change of control or deal bonus pertaining to the
                sale
                of the Diagnostics Business; </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                Liabilities of MDS and its Affiliates arising in respect of the
                Replacement Contracts to the extent same relate directly to the
                Diagnostics Business carried on in Quebec or the Quebec Assets and
                arise
                after the Closing Time and are not related to any default of MDS
                or its
                Affiliates existing prior to (and remaining unremedied at the Closing
                Time) or as a consequence of Closing;
</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                other Liabilities of MDS Quebec not otherwise provided for herein
                relating
                directly to the Diagnostics Business carried on in Quebec arising,
                accruing or relating to periods on or after the Closing Time;
                and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                Liabilities of MDS and MDS Quebec relating to the claims referred
                to in
                clause (e) of the definition of the Quebec Assets arising after the
                Closing Time;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Quebec
      Licensing Act</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>an
      act respecting medical laboratories, organ, tissue, gamete and embryo
      conservation and the disposal of human bodies</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      (Quebec)
      and its regulation entitled </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Regulation
      respecting the application of the public health protection act</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Quebec
      Personal Information</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      &#8220;personal information&#8221; as defined in Section 2 of </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>An
      Act Respecting the Protection of Personal Information in the Private
      Sector</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      (Quebec)
      that has been collected and used by MDS Quebec in Quebec;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Real
      Property</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the Land and the Buildings thereon;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Regional
      Assets</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.1(b)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Regional
      Financial Statements</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the unaudited supplementary schedule to the Quarterly Statements for the period
      ended July 31, 2006 for the MDS Diagnostics Division in Ontario and Quebec
      and
      the head office of the MDS Diagnostic Division consisting of a balance sheet
      as
      at July 31, 2006 and an income statement for the nine-month period ending July
      31, 2006;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Regional
      Purchase Agreement</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.1(b)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Regulatory
      Consents</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the Competition Act Clearance and all approvals and consents of Governmental
      Authorities required by reason of the transactions contemplated herein in
      relation to the specimen collection and laboratory testing Licences required
      under the Ontario Licensing Act and Quebec Licensing Act for the diagnostic
      testing facilities of MDS and the Operators in Ontario and Quebec, respectively,
      relating exclusively to the Diagnostics Business and the specimen collection
      Licences for the patient service centers of MDS and the Operators in Ontario
      and
      Quebec, respectively, relating exclusively to the Diagnostics Business including
      those set forth in Section 1.1 of the Disclosure Letter;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Release</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      releasing, spilling, seeping, leaking, pumping, pouring, emitting, emptying,
      discharging, depositing, injecting, escaping, leaching, disposing or dumping
      into the environment of any Hazardous Materials or any consequent release,
      spill, leak, emission, discharge, deposit, seepage, and/or exhaust of any
      Hazardous Material;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Replacement
      Contracts</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means,
      collectively, each of the Contracts relating to the Diagnostics Business entered
      into pursuant to (i) Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.10</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      in
      respect of Shared Contracts, or (ii) Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.14</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      in
      respect of a Subject Contract, which are transferred and assigned to Buyer
      or a
      Designated Buyer Affiliate as contemplated herein;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Representative</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means,
      in respect of a Person, each director, officer, employee, agent, solicitor,
      accountant, professional advisor and other representative of the
      Person;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Rix</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      Donald B. Rix, a resident of Vancouver, British Columbia;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Rix
      Agreement</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the agreement dated the date hereof between MDS, Rixco and Rix pursuant to
      which, among other things, Rixco agrees to sell to MDS the Rix Partnership
      Interests (as defined in the Rix Agreement) and MDS agrees to purchase the
      Rix
      Partnership Interests and assume the Rix Liabilities (as defined in the Rix
      Agreement) on the terms and subject to the conditions set forth in such
      agreement, as such agreement may be supplemented, amended, restated or replaced
      from time to time;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Rixco</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      Rix Clinical Laboratories Ltd., a corporation incorporated under the laws of
      British Columbia controlled by Rix;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ROFR
      Exclusion</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.2(b)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Rules</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Section 9.3;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Sellers</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means,
      collectively, MDS, Ontario GP, MDS ONT LP and MDS Quebec, and &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Seller</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      any one of them;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Shared
      Contract</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      each Contract listed on Schedule H annexed to the Disclosure Letter pursuant
      to
      which MDS and one or more Operators is a party and whereby such parties share
      the rights, interests, benefits and Liabilities thereunder in accordance with
      the terms of each such Contract; </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Software</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      all computer software (in all forms and formats, including source code and
      object code) owned by the Operators or, to the extent owned for use Primarily
      in
      the Diagnostics Business, MDS, including the computer programs known by the
      names as set forth in Schedule E to the Disclosure Letter, including all
      versions thereof, and all related documentation (of any kind or nature),
      development tools, diagnostic tools, manuals, program files, data files (to
      the
      extent required to execute and operate the Software), specifications, data
      model
      structures, program and system logic, technical interfaces, program modules,
      routines, sub-routines, algorithms, program architecture, design concepts,
      system designs, program structure, sequence and organization, graphical user
      interfaces (including screen displays and so called &#8220;look &amp; feel&#8221; but
      excluding all logos and trade marks other than to the extent set forth in
      Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.18</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      of the
      Disclosure Letter) and report layouts;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Subject
      Contract</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.14</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Support
      Services Agreement</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.9</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Support
      Services Agreement Term Sheet</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.9</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Target
      Working Capital</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the targeted amount of Working Capital of the MDS Diagnostics Division in
      Ontario and Quebec and the head office of the MDS Diagnostics Division being
      $8,000,000;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Tax
      Returns</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      any return, declaration, report, schedule, information statement or return
      with
      respect to Taxes required to be filed with a Governmental
      Authority;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Taxes</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means,
      in respect of a Person, any and all taxes and related governmental charges
      (including assessments, charges, duties, rates, fees, imposts, levies or other
      governmental charges and interest, penalties or additions associated therewith)
      including Canadian federal, provincial, municipal and local, foreign or other
      income, franchise, capital, real property, personal property, tangible,
      withholding, payroll, employer health, social security, transfer, sales, use,
      consumption, GST, excise, anti-dumping, stamp, countervail and value added
      taxes, all other taxes of any kind for which the Person may have any Liability
      whether disputed or not and all Canada Pension Plan contributions and employment
      insurance premiums; </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Technical
      Information</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means,
      in respect of a Person, all right, title and interest in and to all trade
      secrets, confidential information and proprietary know-how, in each case used
      Primarily in the Diagnostics Business and to the extent not subject to an
      Intellectual Property Right, whether developed or acquired by or on behalf
      of
      such Person including:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                confidential information of a scientific, technical or business nature
                whether in written, graphic, machine readable, electronic or physical
                form;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                patterns, plans, designs, research data, research plans, processes,
                formulae, drawings, unpatented blue prints, flow sheets, equipment
                and
                parts lists, instructions, manuals, records and procedures;
                and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                inventions other than as embodied in any issued patents and pending
                patent
                applications;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Threshold
      Adjustment</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.5</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Toronto
      Assets</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the following:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1,000
                common shares of Toronto GP held by
                MDS;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">49.995%
                Partnership Interest in Toronto Labs held by MDS, as a limited partner
                or,
                at the option of MDS, all of the issued and outstanding shares of
                a newly
                incorporated corporation holding such 49.995% Partnership Interest
                of
                Toronto Labs, as a limited partner and no other assets;
                </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                right, title and interest of MDS in, to and under the shareholders&#8217;
                agreement governing Toronto GP; and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                right, title and interest of MDS in, to and under the [REDACTED]
                agreement
                dated November 29, 1996 between The Toronto Hospital, MDS, Toronto
                Labs
                and Toronto GP;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Toronto
      GP</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      Toronto Medical Laboratories Limited, a corporation incorporated under the
      laws
      of Ontario;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Toronto
      Labs</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      Toronto Medical Laboratories Limited Partnership, a limited partnership governed
      by the laws of Ontario;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Toronto
      Liabilities</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      all Liabilities of MDS and its Affiliates:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">under
                the shareholders&#8217; agreement governing Toronto GP arising after the Closing
                Time and not related to any default of MDS existing prior to (and
                remaining unremedied at the Closing Time) or as a consequence of
                Closing;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">in
                respect of the Partnership Interest of Toronto Labs held by MDS or
                an
                Affiliate, as a limited partner;
                and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">under
                the [REDACTED] agreement dated November 29, 1996 between The Toronto
                Hospital, MDS, Toronto Labs and Toronto GP arising after the Closing
                Time
                and not related to any default of MDS existing prior to (and remaining
                unremedied at the Closing Time) or as a consequence of
                Closing;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Transferable
      Licences</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means,
      in respect of a Person, all rights and interest in and to all Licences issued
      to
      such Person which are transferable, with or without the consent of a
      Governmental Authority;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Unaccounted
      Excluded Refund</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>U.S.
      Non-Competition Agreements</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.12</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>U.S.
      Support Services Contracts</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the support, transition and related services agreements between MDS and/or
      certain of MDS&#8217; U.S. Affiliates and purchasers of certain diagnostics businesses
      formerly operated by any Seller or its Affiliates as listed in Section 1.1
      of
      the Disclosure Letter:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>U.S.
      Transition Services Contracts</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Schedule </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.9</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Warranty
      Rights</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means,
      in respect of a Person, the full benefit of all warranties, warranty rights,
      guarantees, indemnities, undertakings and similar covenants (implied, express
      or
      otherwise) against manufacturers or sellers held by such Person or to which
      such
      Person is entitled;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Windsor
      Assets</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the following:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">40
                common shares of Windsor Labs held by MDS;
                and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                right, title and interest of MDS in, to and under the Windsor
                Shareholders&#8217; Agreement;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Windsor
      Labs</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      Medical Laboratories of Windsor Limited, a corporation incorporated under the
      laws of Ontario;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Windsor
      Liabilities</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      all Liabilities of MDS under the Windsor Shareholders&#8217; Agreement arising after
      the Closing Time and not related to any default of MDS existing prior to (and
      remaining unremedied at the Closing Time) or as a consequence of
      Closing;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Windsor
      Shareholders&#8217; Agreement</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      the shareholders&#8217; agreement governing Windsor Labs dated as of November 1,
      2002;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Working
      Capital</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means,
      as at any time, the sum of Petty Cash, Accounts Receivable, Inventory, Prepaid
      Expenses and instalments, refunds or other recoverables in respect of Taxes
      (other than income Taxes) of the MDS Diagnostics Division in Ontario and Quebec
      and the head office of the MDS Diagnostics Division at that time, determined
      in
      accordance with Sections </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      and
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.3</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      less
      the amount of accounts payable or accrued current Liabilities of the MDS
      Diagnostics Division in Ontario and Quebec and the head office of the MDS
      Diagnostics Division that would be included in or provided in a balance sheet
      under GAAP at that time but excluding any provision for income Taxes under
      GAAP
      and the current portion of long term debt; and</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Working
      Capital Adjustment Date</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
has
      the
      meaning set forth in Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.2(d)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>1.2</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Interpretation</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Unless
                specified otherwise, reference in this Agreement to a statute refers
                to
                that statute as it may be amended, or to any restated or successor
                legislation of comparable effect.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
                accounting and financial terms used herein, unless specifically provided
                to the contrary, shall be interpreted and applied in accordance with
                GAAP.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
                division of this Agreement into articles, sections, subsections and
                schedules and the insertion of headings are for convenience of reference
                only and shall not affect the construction or interpretation of this
                Agreement. The article, section, subsection and schedule headings
                in this
                Agreement are not intended to be full or precise descriptions of
                the text
                to which they refer and are not to be considered part of this Agreement.
                All uses of the words &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>hereto</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;,
                &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>herein</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;,
                &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>hereof</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;,
                &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>hereby</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
                and &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>hereunder</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
                and similar expressions refer to this Agreement and not to any particular
                section or portion of it. References to an Article, Section, Subsection
                or
                Schedule refer to the applicable article, section, subsection or
                schedule
                of this Agreement.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
                this Agreement, words in the singular include the plural and vice-versa
                and words in one gender include all
                genders.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
                Agreement is the joint product of MDS and Buyer, has been subject
                to
                mutual consultation, negotiation and agreement of the Parties and
                shall
                not be construed for or against any
                Party.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Reference
                in this Agreement to the term &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>including</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
                shall mean &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>including</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>without
                limitation</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
                and shall not be construed to limit any general statement which it
                follows
                to the specific or similar items or matters immediately following
                it.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MDS
                shall cause MDS Quebec and, subject to the LPBP Consent, Ontario
                GP, as
                general partner of, MDS ONT LP, to perform their respective obligations
                as
                Sellers under this Agreement subject to and in accordance with this
                Agreement. References in this Agreement to Seller agreeing or otherwise
                covenanting to take some action or to MDS causing the other Sellers
                to
                take some action shall, in the case of MDS ONT LP mean that Ontario
                GP, as
                general partner, will cause MDS ONT LP to perform such action, subject
                to
                LPBP Consent.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(h)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If
                there is any conflict or inconsistency between the provisions of
                this
                Agreement and the provisions of any Regional Purchase Agreement,
                the
                provisions of this Agreement shall govern.
</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Reference
                in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.2.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                to
                the Buyer using &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>best
                efforts</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
                to obtain one or more Regulatory Consents, in the time stipulated
                in this
                Agreement, shall mean that the Buyer shall, if necessary or advantageous
                to securing such Regulatory Consents within such time period and
                without
                limiting its general obligations to use best efforts, (i) agree to
                such
                undertakings as may be required by the applicable Governmental Authority
                as a condition of granting its consent, approval or non-disapproval;
                and
                (ii) propose to the applicable Governmental Authority, and negotiate,
                offer to take, and, if such offer is accepted, effect by consent
                order,
                undertaking and/or otherwise to:</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">restructure
                the transaction as now contemplated in this Agreement prior to or
                at
                Closing to the satisfaction of the Governmental Authority (such as
                the
                sale of some of the assets, shares and/or other ownership interests
                that
                are the subject of this Agreement to a third party), but only with
                the
                consent of MDS, acting reasonably;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">divest
                post-Closing certain assets, shares and/or other ownership interests;
                and/or</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">agree
                to abide by post-Closing conduct requirements as specified by the
                Governmental Authority.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(j)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For
                greater certainty, each reference in this Agreement to the term
                &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Primarily</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;,
                notwithstanding any reference to the &#8220;Diagnostics Business&#8221; as it is being
                carried on in Ontario or Quebec immediately following, is intended
                by the
                Parties to relate to the Diagnostics Business alone or together with
                any
                part or portion of the BC Diagnostics Business, with the intention
                that
                any applicable Purchased Asset that meets the test set forth in the
                definition of &#8220;Primarily&#8221;, either excluding its use in the BC Diagnostics
                Business or as a result of the inclusion of its use in the BC Diagnostics
                Business where its use as at the Closing Date is predominantly in
                the
                Diagnostics Business in Ontario or Quebec, as the case may be, such
                Purchased Asset shall be conveyed to the Buyer pursuant to this
                Agreement.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>1.3</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Entire
      Agreement</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
      Agreement, the confidentiality agreement between MDS and Buyer, dated December
      6, 2005, as amended by agreement of even date herewith (the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Confidentiality
      Agreement</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;),
      a
      letter of even date from Buyer or an Affiliate thereof to MDS, the Closing
      Documents and the BC Documents constitute the entire agreement between the
      Parties pertaining to the subject matter hereof and thereof, respectively,
      and
      supersede all prior agreements, negotiations, discussions and understandings,
      written or oral, between the Parties. There are no representations, warranties,
      conditions, other agreements or acknowledgements, whether direct or collateral,
      express or implied, that form part of or affect this Agreement, or which induced
      any Party to enter into this Agreement or on which reliance is placed by any
      Party, except as specifically set forth in this Agreement, the Confidentiality
      Agreement and the Closing Documents.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>1.4</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Amendment</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject
      to Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      this
      Agreement may be amended, modified or supplemented only by a written agreement
      signed by MDS and Buyer.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>1.5</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Waiver
      of Rights</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any
      waiver of, or consent to depart from, the requirements of any provision of
      this
      Agreement shall be effective only if it is in writing and signed by the Party
      giving it, and only in the specific instance and for the specific purpose for
      which it has been given. No failure on the part of any Party to exercise, and
      no
      delay in exercising, any right under this Agreement shall operate as a waiver
      of
      such right. No single or partial exercise of any such right shall preclude
      any
      other or further exercise of such right or the exercise of any other
      right.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>1.6</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Schedules</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      following Schedules are incorporated by reference into and form part of this
      Agreement: </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div align="left">
      <table border="1" bordercolor="black" cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td align="justify" valign="top" width="21%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Schedule</strong></font></div>
            </td>
            <td align="justify" valign="top" width="46%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Description
                of Schedule</strong></font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="21%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Schedule
                .5<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;</font></div>
            </td>
            <td align="left" valign="top" width="46%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Transaction
                Structure and Closing Sequence</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="21%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Schedule
                3.1</font></div>
            </td>
            <td align="left" valign="top" width="46%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Holdback
                Amount</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="21%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Schedule
                3.8</font></div>
            </td>
            <td align="left" valign="top" width="46%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Purchase
                Price Allocation</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="21%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Schedule
                5.6</font></div>
            </td>
            <td align="left" valign="top" width="46%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Form
                of Limited Trade Mark Licence</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="21%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Schedule
                5.7(a)</font></div>
            </td>
            <td align="left" valign="top" width="46%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Form
                of Migration Agreement </font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="21%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Schedule
                5.7(b)</font></div>
            </td>
            <td align="left" valign="top" width="46%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Form
                of CBS License Agreement</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="21%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Schedule
                5.8</font></div>
            </td>
            <td align="left" valign="top" width="46%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Form
                of Non-Competition Agreement</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="21%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Schedule
                5.9</font></div>
            </td>
            <td align="left" valign="top" width="46%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Support
                Services Agreement Term Sheet</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="21%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Schedule
                5.12</font></div>
            </td>
            <td align="left" valign="top" width="46%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Form
                of MDS Confidentiality Agreement</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="21%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Schedule
                6.1.5(b)</font></div>
            </td>
            <td align="left" valign="top" width="46%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Closing
                Conditions in favour of Buyer</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="21%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Schedule
                6.2.4(b)</font></div>
            </td>
            <td align="left" valign="top" width="46%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Closing
                Conditions in favour of MDS</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="21%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Schedule
                9.3</font></div>
            </td>
            <td align="left" valign="top" width="46%" style="border-bottom: black thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Rules
                of Procedure for Arbitration</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>1.7</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Applicable
      La</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">w</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
      Agreement shall be governed by, and interpreted and enforced in accordance
      with,
      the laws in force in the Province of Ontario (excluding any rule or principle
      of
      the conflict of laws which might refer such interpretation to the laws of
      another jurisdiction). Subject to </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Article&#160;9</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      each
      Party irrevocably submits to the non-exclusive jurisdiction of the courts of
      Ontario with respect to any matter arising hereunder or related hereto. The
      Parties expressly exclude the application of the United Nations Convention
      on
      Contracts for the International Sale of Goods.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>1.8</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Currency</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Unless
      specified otherwise, all statements of or references to dollar amounts in this
      Agreement are to Canadian currency.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>1.9</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Performance
      on Holidays</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If
      any
      action is required to be taken pursuant to this Agreement on or by a specified
      date which is not a Business Day, then such action shall be valid if taken
      on or
      by the next succeeding Business Day.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>1.10</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Calculation
      of Time</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
      this
      Agreement, a period of days shall be deemed to begin on the first day after
      the
      event which began the period and to end at 6:00 p.m. (Toronto time) on the
      last
      day of the period. If, however, the last day of the period does not fall on
      a
      Business Day, the period shall terminate at 6:00 p.m. (Toronto time) on the
      next
      Business Day.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>1.11</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Severability</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If
      any
      provision of this Agreement is determined by a court of competent jurisdiction
      to be invalid, illegal or unenforceable in any respect, such determination
      shall
      not impair or affect the validity, legality or enforceability of the remaining
      provisions hereof, and each provision is hereby declared to be separate,
      severable and distinct.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>1.12</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>No
      Third Party Beneficiaries</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Nothing
      in this Agreement is intended expressly or by implication to, or shall, confer
      upon any Person other than Sellers, Buyer, Designated Buyer Affiliates, as
      applicable, and, solely in respect of </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Article&#160;8</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      and
      Section&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.13</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      their
      respective Representatives, respectively, and, solely in respect of Section
      </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.12</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      the MDS
      Contracting Parties (other than MDS), any rights or remedies of any kind. MDS
      accepts each covenant in favour of the other Sellers, the Representatives of
      Sellers and the MDS Contracting Parties as agent and trustee of that Seller,
      the
      Representative and MDS Contracting Party, as applicable, and MDS shall be
      responsible for and liable for such covenants and may enforce such covenant
      on
      behalf of such Seller, the Representatives of Sellers and the MDS Contracting
      Parties.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ARTICLE&#160;2</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>PURCHASE
      AND SALE OF PURCHASED ASSETS</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>2.1</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Purchase
      and Sale of Purchased Assets</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject
                to Section 2.2, MDS agrees to sell and transfer and to cause the
                other
                Sellers to sell and transfer the Purchased Assets owned by them and
                the
                Replacement Contracts and the Migrating Assets to be acquired by
                them
                under this Agreement and the Migration Agreement, respectively, to
                Buyer
                (and, as applicable, one or more Designated Buyer Affiliates), and
                Buyer
                agrees to acquire and pay for (and/or, as applicable, to cause one
                or more
                Designated Buyer Affiliates to acquire and pay for) the Purchased
                Assets,
                the Replacement Contracts and the Migrating Assets and assume the
                Assumed
                Liabilities, on the terms and subject to the conditions contained
                in this
                Agreement.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
                acknowledges that any one or both of (i) the entering into of this
                Agreement by MDS, and (ii) the transfer of the [REDACTED] (each a
                &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Regional
                Asset</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
                and collectively, the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Regional
                Assets</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
                and the associated Assumed Liabilities to Buyer and/or any Designated
                Buyer Affiliate may require certain consents or approvals (including,
                in
                certain cases, consent or approval to enter into this Agreement,
                and, in
                certain cases, such consents or approvals may be unreasonably or
                arbitrarily withheld) and/or trigger rights of certain third parties.
                To
                facilitate the Closing, seek to obtain the required consents or approvals
                of such third parties and where applicable, trigger the third party
                rights
                with respect to such Regional Assets (and the associated Assumed
                Liabilities), the Parties shall take commercially reasonable efforts
                to
                comply with the agreements and constating documents governing each
                Regional Asset, including, as required to trigger the third party
                rights,
                execution and delivery on October 27, 2006 (or such earlier date
                as
                mutually agreed between the Parties, acting reasonably) of a purchase
                and
                sale agreement with respect to one or more of the Regional Assets
                on terms
                mutually agreed to between Buyer and MDS, acting reasonably (each
                a
                &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Regional
                Purchase Agreement</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;).</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
                agrees that the transfer of the Purchased Assets, the Replacement
                Contracts and the Migrating Assets shall be on an &#8220;as is, where is basis&#8221;
                and none of Sellers makes or will make any representation or warranty
                and
                there are no conditions, including as to title, merchantability,
                fitness
                for purpose, value or condition, except as expressly set forth herein
                and
                in the Regional Purchase
                Agreements.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>2.2</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Excluded
      Assets</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Neither
                Buyer nor any Designated Buyer Affiliate will purchase or acquire
                any of
                the Excluded Assets. </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notwithstanding
                anything else herein contained, but subject to Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.2(c)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
                (A)&#160;should Sellers be unable to obtain any required third party
                consent or approval (or waiver thereto) to the transfer of a Regional
                Asset to Buyer (or, as applicable, any Designated Buyer Affiliate)
                on or
                before the Closing Time (a &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Consent
                Exclusion</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;),
                (B) should any third party exercise its right to acquire and acquires
                a
                Regional Asset, or</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(C)
                should the period in which the right of any third party to exercise
                a
                right to acquire a Regional Asset not have expired on or before the
                Closing Time and such right has not prior to that time been waived
                by all
                applicable Persons (a &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ROFR
                Exclusion</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
                (any event referred to in (A), (B) or (C) being an &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Excluded
                Asset Event</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;),
                the following shall and shall be deemed to occur automatically and
                without
                any further act or formality and this Agreement shall be deemed to
                be
                amended accordingly in respect of an Excluded Asset Event: (i) the
                Regional Assets, the Books and Records and the Assumed Liabilities
                relating thereto shall not be transferred to or assumed by Buyer
                or any
                Designated Buyer Affiliate, as applicable, on the Closing Date and
                shall
                be excluded from the definition of Diagnostics Business, MDS Diagnostics
                Division, Purchased Assets and Assumed Liabilities, and shall be
                deemed
                removed from the Disclosure Letter and applicable Schedules thereto
                and
                elsewhere in the Agreement where the context so requires, (ii) such
                Regional Assets shall be an Excluded Asset, (iii) the amount of each
                of
                the Purchase Price and the Closing Cash Amount shall be reduced by,
                in the
                event of an Excluded Asset Event under (B) or (C) above, the last
                price
                offered within the range, or, in the event of a Consent Exclusion,
                the
                highest value in the range for the amount of the Purchase Price allocated
                to each such Excluded Asset under Section 3.8, and, in each case,
                the
                definition of Purchase Price and Closing Cash Amount shall be amended
                accordingly, (iv) the Closing Balance Sheet and Working Capital as
                at the
                Closing Time shall be calculated without regard to such Excluded
                Assets
                and Assumed Liabilities related thereto; and (v) neither Buyer (nor
                any
                Designated Buyer Affiliate) nor any of the Sellers shall have any
                further
                obligation or Liability under this Agreement or the applicable Regional
                Purchase Agreement with respect to such Regional Asset and Assumed
                Liabilities relating thereto. The representations and warranties
                of MDS
                provided in this Agreement shall be deemed to have been given as
                of the
                date of this Agreement and as required in respect of the Closing
                Date only
                with respect to the Diagnostics Business, MDS Diagnostics Division,
                the
                Purchased Assets and the Assumed Liabilities as such terms may be
                amended
                in accordance with this Subsection.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notwithstanding
                Subsection</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.2(b)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
                if following the Closing Time, in respect of a Consent Exclusion,
                the
                required third party consent or approval (or waiver thereto) to the
                transfer of the applicable Regional Asset to Buyer is obtained or
                waived
                or, in respect of a ROFR Exclusion, the rights of all applicable
                third
                parties to acquire the applicable Regional Asset are waived, no longer
                apply or expire without having been exercised, Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.2(b)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                shall no longer apply in respect of such Regional Asset, such Regional
                Asset shall no longer be an Excluded Asset and Buyer shall, as soon
                as
                practicable, purchase such Regional Asset on the terms and conditions
                hereof applicable to such Regional
                Asset.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>2.3</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Non-Assignable
      Contracts</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Neither
                this Agreement nor any Closing Document shall constitute an assignment
                or
                an attempted assignment of any Non-Assignable Contract. MDS agrees
                to
                assign and to cause each other Seller to assign any Non-Assignable
                Contracts to Buyer or the applicable Designated Buyer Affiliate when
                such
                assignment is permitted and as Buyer or the applicable Designated
                Buyer
                Affiliate may from time to time direct. MDS shall, and shall cause
                each
                other Seller to, use commercially reasonable efforts to obtain all
                consents required for the assignment to Buyer or the applicable Designated
                Buyer Affiliate of the Contracts, the Equipment Leases, the Warranty
                Rights and Transferable Licences included in the Purchased Assets
                of such
                Seller. No Seller shall, however, be obliged to commence arbitration
                or
                any other legal proceeding or make any payments to third parties
                other
                than any administrative, processing or similar fee or any other amounts
                contemplated by the particular Contract, Equipment Lease, Warranty
                Rights
                or Transferable Licence to be payable in connection with the assignment
                thereof to the Buyer pursuant hereto. Buyer and each Designated Buyer
                Affiliate shall co-operate with and assist each Seller in such Seller&#8217;s
                efforts to obtain such consents.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
                respect of Non-Assignable Contracts other than Leases, to the extent
                permitted by Applicable Law and the provisions of such Non-Assignable
                Contract: (i) if any of the Non-Assignable Contracts are not assignable
                by
                the terms thereof or consents to the assignment thereof have not
                been
                obtained prior to the Closing Time, such Non-Assignable Contracts
                shall be
                held by the applicable Seller (without any additional expense to
                the
                Seller whatsoever) in trust for Buyer or the applicable Designated
                Buyer
                Affiliate and the covenants and obligations thereunder shall be performed
                by Buyer or the applicable Designated Buyer Affiliate in the name
                of the
                applicable Seller and all benefits and obligations existing thereunder
                shall be for the account of Buyer or the applicable Designated Buyer
                Affiliate (without any additional expense to Sellers whatsoever);
                and (ii)
                MDS shall take, and shall cause the applicable Seller (if other than
                MDS)
                to take or cause to be taken such reasonable action in the Seller&#8217;s name
                or otherwise as Buyer or the applicable Designated Buyer Affiliate
                may
                reasonably require so as to provide Buyer or the applicable Designated
                Buyer Affiliate with the benefits thereof and each Seller shall promptly
                pay over or deliver to Buyer or the applicable Designated Buyer Affiliate
                all money or other consideration, if any, received by such Seller
                in
                respect of all such Non-Assignable Contracts. Upon the Closing, MDS
                shall
                and shall cause each other Seller to authorize Buyer or the applicable
                Designated Buyer Affiliate, to the extent permitted by Applicable
                Law and
                the terms of such Non-Assignable Contracts, at the expense of Buyer
                or the
                applicable Designated Buyer Affiliate, to perform all of such Seller&#8217;s
                obligations arising under such applicable Non-Assignable Contracts
                after
                the Closing Time. MDS shall continue to use and cause the Sellers
                to
                continue to use commercially reasonable efforts to obtain and deliver
                all
                remaining consents required for the assignment to Buyer or the applicable
                Designated Buyer Affiliate of the remaining Non-Assignable Contracts
                after
                the Closing Time. If a Non-Assignable Contract is not validly assigned
                to
                Buyer or the applicable Designated Buyer Affiliate within twelve
                (12)
                months after the Closing Date, such Non-Assignable Contract shall
                be
                deemed to be an Excluded Asset and all obligations of Sellers to
                Buyer or
                the applicable Designated Buyer Affiliate and all obligations hereunder
                of
                Buyer and the applicable Designated Buyer Affiliate to Sellers with
                respect to such Non-Assignable Contract shall
                terminate.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
                respect of those Non-Assignable Contracts which are Leases included
                in the
                Purchased Assets (the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Non-Assigned
                Leases</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;),
                the following provisions shall
                apply:</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">if
                the landlord&#8217;s consent to the assignment of the Non-Assigned Lease has not
                been obtained prior to the Closing Time, the applicable Lease shall
                remain
                in the name of MDS or the applicable Seller, and such party shall
                continue
                to pay the rents and otherwise observe and perform the covenants
                and
                obligations of the tenant under the provisions of the applicable
                Non-Assigned Lease (including without limitation, maintenance and
                repair
                obligations and insurance
                requirements);</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">on
                the Closing, to the extent permitted by Applicable Law and the provisions
                of such Non-Assigned Lease, the applicable Seller and the Buyer or
                the
                applicable Designated Buyer Affiliate shall enter into a sublease,
                licence
                or other occupancy agreement relating to such premises on terms and
                conditions mutually acceptable to the Parties, acting reasonably,
                pending
                the delivery of the landlord&#8217;s consent to the assignment of the applicable
                Non-Assigned Lease, and the applicable Seller shall take or cause
                to be
                taken such reasonable action in its name or otherwise as Buyer or
                the
                applicable Designated Buyer Affiliate shall reasonably require so
                as to
                provide Buyer or the applicable Designated Buyer Affiliate with,
                and/or
                not deprive, Buyer or the applicable Designated Buyer Affiliate of,
                the
                benefit of quiet and uninterrupted use and possession of the applicable
                premises for its conduct of the Diagnostics
                Business;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">on
                the Closing, to the extent permitted by Applicable Law and the provisions
                of such Non-Assigned Lease, the Buyer or the applicable Designated
                Buyer
                Affiliate shall access and occupy the applicable premises under such
                sublease, licence or other form of occupancy agreement, shall comply
                with
                the obligations of the occupant of the applicable premises under
                the
                provisions of the applicable Non-Assigned Lease (including without
                limitation, repair of any damage to the premises caused by the Buyer
                or
                the applicable Designated Buyer Affiliate, and insurance for its
                own
                operations) and shall, provided access and occupancy is obtained
                and
                during the period that the Buyer or the applicable Designated Buyer
                Affiliate enjoys and/or is not deprived of the benefit of quiet and
                uninterrupted use and possession of the applicable Leased Premises
                (other
                than as a result of force majeure or a default by the Buyer or Designated
                Buyer Affiliate under the applicable sublease, licence or other form
                of
                occupancy agreement or the applicable landlord under the Non-Assigned
                Lease) for the conduct of the Diagnostics Business from such premise,
                promptly reimburse the applicable Seller for or, at the written direction
                of such Seller pay directly to the landlord, the rents (including
                any
                applicable Taxes) and all other amounts payable by the tenant under
                the
                Non-Assigned Lease, including utility costs, realty Taxes and common
                area
                charges, in respect of the applicable premises accruing from and
                after the
                Closing Time, but for greater certainty shall not be responsible
                for the
                payment of any amount due by the tenant prior to the Closing Time,
                or in
                respect of obtaining the consent, or the consequences of the failure
                to
                obtain the consent of the landlord to the assignment of the Non-Assigned
                Lease; </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iv)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MDS
                shall, or shall cause the applicable Seller (if other than MDS),
                as may be
                the case, to and Buyer shall, continue to use commercially reasonable
                efforts to obtain and deliver the applicable landlord&#8217;s consent to the
                assignment to the Buyer or the applicable Designated Buyer Affiliate
                of
                the applicable Non-Assigned Lease, and in the event that such consent
                is
                not obtained and delivered within eighteen (18) months after the
                Closing
                Date, then, at the option of the Buyer or the applicable Designated
                Buyer
                Affiliate, the foregoing interim occupancy arrangement shall come
                to an
                end on the last day of the eighteenth (18</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><sup>th</sup></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">)
                month following the Closing Date, the Buyer or the applicable Designated
                Buyer Affiliate shall remove all of the Purchased Assets from the
                applicable premises, the applicable Non-Assigned Lease shall be deemed
                to
                be an Excluded Asset, and all obligations of the Buyer or the applicable
                Designated Buyer Affiliate with respect to such Non-Assigned Lease
                shall
                terminate; and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(v)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
                shall have reasonable access to all MDS personnel, information and
                data as
                may be reasonably required or requested by Buyer in connection with
                the
                obligations of MDS to obtain and deliver the applicable landlord&#8217;s consent
                to the assignment of the applicable Non-Assigned Lease to the Buyer
                or the
                applicable Designated Buyer Affiliate. From and after this date,
                MDS shall
                keep Buyer apprised of its activities concerning its obtaining and
                delivering such applicable landlord consents including, without limitation
                providing the Buyer with monthly reports identifying which additional
                consents have been obtained, whether there were any changes in the
                status
                of discussions with the landlords, and identifying the parties contacted
                and the statements made in connection with all outstanding consents.
                MDS
                shall consult with and provide Buyer with all reasonable opportunities
                to
                assist MDS in such activities and agrees to consider, in good faith,
                all
                Buyer input and requests provided in the course of the aforementioned
                activities of MDS in respect of such applicable landlord consents
                and not
                to unreasonably refuse to take into account and/or implement any
                reasonable Buyer requests or input
                received.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>2.4</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Place
      of Closing</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      Closing shall take place at the Closing Time at the offices of Fasken Martineau
      DuMoulin LLP, Toronto, Ontario, or at such other place as may be agreed upon
      by
      the Parties.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>2.5</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Closing
      Time</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notwithstanding
      any provision herein to the contrary, the transactions comprising the Closing
      shall be effective in the sequence contemplated in Schedule 2.5.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ARTICLE&#160;3</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>CONSIDERATION
      FOR PURCHASED ASSETS</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>3.1</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Purchase
      Price</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>;
      Holdback Amount</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject
                to Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                and to the adjustments set forth in Sections </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.1(a)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iv),
                </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
                </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.5</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                and </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.6</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                and Schedule </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
                the purchase price (the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Purchase
                Price</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
                payable to MDS or as MDS directs for all of the Purchased Assets,
                the
                Replacement Contracts and the Migrating Assets is $801,000,000. The
                cash
                amount payable on Closing (the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Closing
                Cash Amount</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
                is equal to the Purchase Price less (i) the amount of the Estimated
                Long-Term Liabilities; (ii) a contribution of capital of $7,000,000
                being
                the amount of cash, which together with the Target Working Capital
                will
                permit Buyer immediately after the Closing Time to carry on the
                Diagnostics Business in the ordinary course of business; (iii) the
                Holdback Amount; and (iv) the aggregate amount of the net proceeds
                received by MDS or any Operators from the sale of any assets Primarily
                related to the Diagnostics Business since April 30, 2006 to the extent
                that, in respect of any sale completed, such net proceeds are not
                less
                than $100,000 and have been distributed to MDS or the partners of
                MDS ONT
                LP, as applicable. Buyer acknowledges that the Purchase Price does
                not
                include any amount payable by Buyer as contemplated under Subsection
                </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.10(c)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
                MDS shall provide a statement of the Estimated Long-Term Liabilities
                to
                the Buyer three Business Days prior to the Closing Date. MDS acknowledges
                that the Purchase Price is inclusive of the purchase price consideration
                payable by Buyer or the applicable Designated Buyer Affiliate to
                MDS under
                a Regional Purchase Agreement. Consequently, appropriate adjustments
                shall
                be made to the Closing Cash Amount to reflect the actual purchase
                price
                paid under all Regional Purchase
                Agreements.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
                Parties covenant and agree that the Holdback Amount shall be calculated
                under, governed by the principles set forth in, and released and
                paid to
                MDS subject to the terms and conditions prescribed by, Schedule
                </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>3.2</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Post-Closing
      Audit</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Forthwith
                following the Closing Time, MDS shall cause its auditor, Ernst &amp; Young
                LLP, to conduct an audit of the MDS Diagnostics Division in order
                to
                prepare the Closing Balance Sheet. Based on the Closing Balance Sheet,
                MDS
                shall prepare the unaudited Closing Regional Balance Sheet and the
                calculation of the Working Capital of the MDS Diagnostics Division
                in
                Ontario and Quebec and the head office of the MDS Diagnostics Division
                as
                at the Closing Time. The Closing Balance Sheet, the Closing Regional
                Balance Sheet and such calculation of Working Capital shall be prepared
                on
                a combined basis in accordance with GAAP, applied on a basis consistent
                with the Financial Statements. Buyer shall co-operate with MDS and
                Ernst
                &amp; Young LLP and shall provide to such Persons copies of all financial
                and other records and access to all necessary personnel required
                to
                conduct the audit and prepare the Closing Balance Sheet, the Closing
                Regional Balance Sheet and calculation of Working Capital. At the
                request
                of MDS, Buyer shall provide assistance in the preparation of the
                Closing
                Balance Sheet, the Closing Regional Balance Sheet and the calculation
                of
                Working Capital.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MDS
                shall co-operate with Buyer in conducting such audit and will provide
                to
                Buyer and its auditor copies of all working papers prepared by MDS
                for
                review. Representatives of Buyer or Buyer&#8217;s auditor are permitted to be
                present at, and to participate in, any inventory counts and any other
                procedures used in preparing the Closing Balance Sheet, Closing Regional
                Balance Sheet and calculation of Working Capital. A copy of the Closing
                Balance Sheet, Closing Regional Balance Sheet and Working Capital
                calculation shall be delivered to each Party within seventy-five
                (75) days
                of the Closing Date.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If
                Buyer objects to any of the Closing Balance Sheet, the Closing Regional
                Balance Sheet and the calculation of Working Capital, then Buyer
                shall
                prepare and deliver to MDS a statement (an &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Objection
                Notice</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
                setting forth the matters that are the subject of Buyer&#8217;s objection and
                Buyer&#8217;s position including reasonable details of calculations on or before
                the thirtieth (30th) day after the delivery of such statements and
                calculation. The Parties shall then use reasonable efforts to resolve
                such
                objection for a period of twenty (20) days following the delivery
                of the
                Objection Notice. If the matter is not resolved by the end of such
                twenty
                (20) day period, then the matters remaining in dispute will be referred
                to
                the CEO of each Party to attempt to resolve within ten (10) days
                after the
                date of referral. If the matter is not resolved within such ten (10)
                day
                period, then the items remaining in dispute shall be submitted by
                the
                Parties to arbitration in accordance with </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Article&#160;9</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
                If Buyer fails to deliver an Objection Notice within the thirty (30)
                day
                period, it shall be deemed to have agreed to the Closing Balance
                Sheet,
                the Closing Regional Balance Sheet and Working Capital calculation
                which
                shall then be final and binding upon the
                Parties.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
                &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Working
                Capital Adjustment Date</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
                shall be the date that is three (3) Business Days after (i) the date
                Buyer
                agrees in writing or is deemed under clause (c) above to agree to
                the
                Closing Balance Sheet, the Closing Regional Balance Sheet and Working
                Capital calculation, whichever is earlier or (ii) if Buyer issues
                an
                Objection Notice in accordance with the foregoing, the date the Parties
                agree to the Closing Balance Sheet, the Closing Regional Balance
                Sheet and
                the calculation of Working Capital or the date the Closing Balance
                Sheet,
                the Closing Regional Balance Sheet and Working Capital calculation
                are
                finally determined by arbitration as contemplated by this Section,
                whichever is earlier.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>3.3</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Determination
      of Value of Inventory, Accounts Receivable</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For
      the
      purposes of Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      (a)
      Inventory shall be valued at the lower of actual cost or market value determined
      in accordance with GAAP, applied on a basis consistent with the Financial
      Statements; and (b) the value of the Accounts Receivable at the Closing Time
      shall be the amount included in the Closing Balance Sheet (and the Closing
      Regional Balance Sheet) less an amount equal to the balance of Accounts
      Receivable owed by Persons other than a Governmental Authority or hospital
      that
      are older than 90 days and for which no provision has been made in the Closing
      Balance Sheet (and the Closing Regional Balance Sheet) and less the amount
      of
      any Accounts Receivable excluded as an asset in the definition of Ontario Assets
      and Quebec Assets. For greater certainty, in determining Working Capital, any
      liability for Taxes arising from or in connection with the implementation of
      the
      Buyer Purchase Structure shall be valued at zero.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>3.4</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Working
      Capital Adjustment</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On
      the
      Working Capital Adjustment Date, the Purchase Price shall be adjusted in
      accordance with Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.5</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      and as
      follows:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                amount of any decrease in Working Capital of the MDS Diagnostics
                Division
                in Ontario and Quebec and the head office of the MDS Diagnostics
                Division
                as at the Closing Time from the Target Working Capital shall be deducted
                from the Purchase Price and the amount of any increase in Working
                Capital
                of the MDS Diagnostics Division in Ontario and Quebec and the head
                office
                of the MDS Diagnostics Division as at the Closing Time from the Target
                Working Capital shall be added to the Purchase Price, each on a dollar
                for
                dollar basis; and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                Purchase Price shall be increased, on a dollar for dollar basis,
                by the
                amount that the cash, marketable securities and other cash equivalents
                as
                set forth on the Closing Balance Sheet (and the Closing Regional
                Balance
                Sheet) exceeds the Petty Cash included in the Working Capital of
                the MDS
                Diagnostics Division in Ontario and Quebec and the head office of
                the MDS
                Diagnostics Division,</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">and
      the
      aggregate or net payment required under this Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      shall be
      made by the appropriate Party to the other Party on the Working Capital
      Adjustment Date. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>3.5</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>General
      Adjustments</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      Parties shall make, without duplication, and provided that such adjustments
      are
      not already provided for on the Closing Balance Sheet and the Closing Regional
      Balance Sheet, the usual adjustments relating to the sale of the Purchased
      Assets as of the Closing Time and such adjustments shall be readjusted, if
      necessary, on the Working Capital Adjustment Date. Adjustments shall
      include:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Realty
                Taxes, etc. </strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
                amounts paid or payable with respect to realty Taxes, local improvements
                and other amounts usually adjusted with respect to the Real Property
                included in the Purchased Assets;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Charges
                Under Leases. </strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
                amounts paid or payable to or by MDS or an Operator under the Leases
                included in the Purchased Assets including, without limitation, rental
                (including percentage rental, prepaid rent and security deposits),
                Taxes
                (including contributions by lessees to real estate Taxes), common
                area
                maintenance charges or contributions towards operating expenses,
                utilities
                charges, business Taxes, merchant&#8217;s association and advertising fees and
                occupancy costs;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Adjustments
                Under Contracts and Equipment Leases</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
                All amounts paid or payable by, or in the case of amounts such as
                rebates
                or royalties, payable to, any Seller under the Contracts and Equipment
                Leases (including any deposits) included in the Purchased
                Assets;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Employee
                Remuneration and Benefits</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
                Wages, bonuses, commissions, sick pay, vacation pay, contributions
                to
                Benefit Plans and other remuneration and health, welfare or other
                benefits
                accrued, paid or payable by any Seller to or in respect of the Ontario
                Employees and Quebec Employees who accept the offer of employment
                of Buyer
                or a Designated Buyer Affiliate;
                and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Fuel,
                Utilities, etc.</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                All fuel, water, telephone and other utility charges paid or payable
                by
                any Seller in respect of the Real Property included in the Purchased
                Assets.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notwithstanding
      the foregoing, no adjustment shall be made in respect of any one of the
      aforementioned class of items specified in Subsections </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.5(a)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      through
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      and
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      unless
      the particular adjustment amount (the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Threshold
      Adjustment</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
      in
      respect of an item in such class is at least $25,000. Any readjustments and
      payment therefor shall be made by the appropriate Party on the Working Capital
      Adjustment Date. Without limiting the foregoing in respect of Leases, the
      Parties acknowledge that certain adjustments and payments therefor under each
      Lease included in the Purchased Assets such as common area charges, realty
      Taxes
      and contributions towards operating expenses, shall be made when the lessor
      under that Lease provides to Buyer or the applicable Designated Buyer Affiliate
      a final adjustment amount in respect of such Lease for the lease years for
      which
      no such adjustment has been given to Sellers at the Working Capital Adjustment
      Date. Once the Threshold Adjustment is obtained in respect of any one of the
      aforementioned items, Buyer or the applicable Designated Buyer Affiliate shall
      provide to MDS a copy of the adjustment(s) received from the applicable third
      party within ten (10) days of receipt of same and the payment of any
      readjustment between the Parties based upon the information contained in such
      third party&#8217;s adjustments shall be made by the appropriate Party promptly
      thereafter. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>3.6</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Long-Term
      Liability and Other Adjustments</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On
                the Working Capital Adjustment Date, the Closing Cash Amount and
                Assumed
                Liabilities shall be adjusted as follows: (i) the Assumed Liabilities
                shall be decreased and the Closing Cash Amount shall be increased
                by the
                amount that the Assumed Long-Term Liabilities of the MDS Diagnostics
                Division in Ontario and Quebec and the head office of the MDS Diagnostics
                Division as at the Closing Time is less than the Estimated Long-Term
                Liabilities and (ii) the Assumed Liabilities shall be increased and
                the
                Closing Cash Amount shall be decreased by the amount that the Assumed
                Long-Term Liabilities of the MDS Diagnostics Division in Ontario
                and
                Quebec and the head office of the MDS Diagnostics Division as at
                the
                Closing Time exceeds the Estimated Long-Term Liabilities, each on
                a dollar
                for dollar basis and the aggregate or net payment required under
                this
                Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.6</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                shall be made by the appropriate Party to the other Party on the
                Working
                Capital Adjustment Date. </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notwithstanding
                the provisions of Sections 3.2 and 3.4,</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">if,
                prior to the date that is eighteen (18) months</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">after
                the Closing Time (the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Accrual
                Adjustment Date</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;),
                it is determined that a Liability provided for on the Closing Balance
                Sheet which is based on an estimate made in accordance with GAAP
                (including in respect of claims reported but not incurred under applicable
                health and dental Benefit Plans of the Employees) is less than or
                more
                than the actual amount paid by MDS or an Affiliate thereof in respect
                of
                such Liability, provided the difference between the accrual and the
                actual
                Liability is at least $25,000, the Purchase Price shall be reduced
                or
                increased, respectively, each on a dollar for dollar basis and Buyer
                or
                MDS shall pay the other party, as appropriate, the amount of such
                difference within ten (10) Business Days of the Accrual Adjustment
                Date.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>3.7</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Interest</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any
      adjustments to the Purchase Price payable in accordance with Sections
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      and
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.5</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      and any
      amount payable pursuant to Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.6</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      shall
      bear interest at the Prime Rate calculated from the earlier of the date the
      adjustment is due or 120 days after the Closing Date to the date of payment
      of
      the adjustment.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>3.8</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Allocation
      of Purchase Price</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      Parties shall allocate $1,000 to the Non-Competition Agreement and the balance
      of the Purchase Price among the Purchased Assets, the Replacement Contracts
      and
      the Migrating Assets as mutually agreed and as set forth in Schedule 3.8 -
      Purchase Price Allocation. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      Parties agree that the amount of the Purchase Price allocated to each Purchased
      Asset, Replacement Contract, Migrating Asset and the Non-Competition Agreement
      is the fair market value thereof and agree to file all returns and forms, and
      provide all information, under the ITA and any applicable taxing statute or
      regulation, on the basis of the agreed allocation.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If
      the
      Purchase Price is adjusted pursuant to the terms of this Agreement, appropriate
      adjustments shall be made by the Parties jointly to the allocations set forth
      in
      this Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.8</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      The
      Parties shall file their respective Tax Returns in a manner that reflects and
      is
      consistent with the foregoing. The Parties agree to amend any Tax filings or
      elections as may be required or as may be reasonable to reflect any revisions
      to
      the allocations under this Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.8</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>3.9</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Payment
      of Purchase Price</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At
      the
      Closing Time, Buyer or the applicable Designated Buyer Affiliate shall pay
      and
      satisfy the Purchase Price as follows:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
                or the applicable Designated Buyer Affiliate shall assume, pay, perform
                and discharge the Assumed Liabilities in accordance with their
                terms;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
                or the applicable Designated Buyer Affiliate shall pay the Closing
                Cash
                Amount to or to the order or at the direction of the Sellers in accordance
                with Schedule 3.8 - Purchase Price Allocation by wire transfer of
                immediately available funds to one or more bank accounts as directed
                by
                the Sellers prior to the Closing Time</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;
                and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">as
                to the Holdback Amount, by release and payment of all or such portions
                thereof in accordance with Schedule </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                to
                or to the order or at the direction of the applicable Seller in accordance
                with Schedule 3.1,</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">in
      full
      satisfaction thereof, subject to the adjustments to be made pursuant to Sections
      </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.1(a)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iv),
      </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.5</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      and
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.6</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      and
      Schedule </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>3.10</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Transfer
      Taxes and Tax Elections</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Where
                permitted by Applicable Law, Buyer or the applicable Designated Buyer
                Affiliate and the applicable Seller of the Ontario Assets and Quebec
                Assets shall each execute on Closing and file a joint election under
                section 22 of the ITA and the corresponding provisions of any other
                applicable taxing statute or regulation, within the prescribed time
                periods, in respect of the Accounts Receivable of the applicable
                Seller
                included in the Purchased Assets and shall designate in such election
                an
                amount equal to the portion of the Purchase Price allocated to such
                Accounts Receivable as the consideration paid by Buyer
                therefor.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To
                the extent that a Seller has received an amount in respect of services
                not
                rendered or goods not delivered and has an Assumed Liability arising
                therefrom and Purchased Assets having a fair market value equal to
                such
                amounts are transferred to Buyer or the applicable Designated Buyer
                Affiliate as payment for such Assumed Liabilities, the applicable
                Seller
                and Buyer or the applicable Designated Buyer Affiliate shall execute
                on
                Closing and file an election pursuant to the provisions of subsection
                20(24) of the ITA and the corresponding provisions of any applicable
                taxing statute or regulation within the prescribed time
                periods.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
                or the applicable Designated Buyer Affiliate shall remit direct to
                the
                appropriate Governmental Authority, all sales and transfer Taxes,
                registration charges and transfer fees payable by it in respect of
                the
                purchase and sale of the Purchased Assets, the Replacement Contracts
                and
                the Migrating Assets under this Agreement, and upon the request of
                MDS or
                a Seller, the payor shall furnish proof of such payment except that
                all
                Taxes properly collectable by a Seller on the sale of the Purchased
                Assets, the Replacement Contracts and the Migrating Assets (including
                any
                GST) shall be paid by Buyer or the applicable Designated Buyer Affiliate
                to the Seller on Closing in addition to the Purchase
                Price.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Where
                permitted by Applicable Law, the applicable Seller and Buyer or the
                applicable Designated Buyer Affiliate shall, at the Closing, elect
                jointly
                pursuant to the provisions of subsection 167(1) of the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Excise
                Tax Act </em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Canada)
                and under any similar provision of any applicable provincial legislation
                in the form prescribed for the purposes of that provision, in respect
                of
                the sale and transfer of the Purchased Assets and Migrating Assets
                of the
                applicable Seller hereunder, that for purposes of such legislation
                no GST
                (and any comparable provincial Taxes) is payable on the purchase
                of such
                Purchased Assets and Migrating Assets, provided, however, that Buyer
                or
                the applicable Designated Buyer Affiliate shall be responsible and
                indemnify and hold harmless Sellers for any GST (and any comparable
                provincial Taxes) to the extent payable notwithstanding this election
                plus
                any interest and/or penalties payable as a consequence
                thereof.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>3.11</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Excluded
      Liabilities</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Neither
      Buyer nor any Designated Buyer Affiliate shall assume or have any obligation
      to
      discharge, perform or fulfill any Liabilities of Sellers of any kind whatsoever
      other than the Assumed Liabilities (collectively, the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Excluded
      Liabilities</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;),
      all
      of which shall remain obligations of Sellers. For greater certainty, Excluded
      Liabilities shall include any Liabilities of Sellers or Operators arising,
      directly or indirectly, from the claims or causes of action of any third party
      with an interest in any of the Operators or their Affiliates, Toronto Labs
      and
      Windsor Labs and any Liabilities of the Sellers or Operators arising from their
      failure to obtain prior to Closing the consent of [REDACTED] to the Buyer or
      a
      Designated Buyer Affiliate.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ARTICLE&#160;4</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>REPRESENTATIONS
      AND WARRANTIES</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Representations
      and Warranties of MDS</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MDS
      represents and warrants to Buyer and Designated Buyer Affiliates as set forth
      in
      the following Subsections of this Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
      Buyer
      acknowledges that all representations and warranties made by MDS in this
      Agreement are qualified in their entirety by the information and exceptions
      disclosed in the Disclosure Letter and the schedules thereto. Without limiting
      the foregoing, all representations and warranties of MDS with respect to the
      assets, the Liabilities, employees, Benefit Plans and other labour matters,
      Taxes and business and operations of the Operators are qualified to the extent
      of any action taken or omitted to be taken or Liability incurred in connection
      with or in any way related to the implementation of the Buyer Purchase
      Structure.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.1</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Corporate
      Matters</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each
                of the Ontario GP and MDS Quebec (each a &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Corporate
                Operator</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
                and MDS is a corporation duly incorporated and validly existing under
                the
                laws of its jurisdiction of incorporation. MDS ONT LP (the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Partnership
                Operator</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
                is a limited partnership duly formed and validly existing under the
                laws
                of its jurisdiction of formation. No proceedings have been taken
                or
                authorized by MDS or an Operator or, to the best of MDS&#8217; knowledge, by any
                other Person, with respect to the bankruptcy, insolvency, liquidation,
                dissolution or winding up of MDS or an Operator. To the knowledge
                of MDS,
                Toronto GP (the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Non-Controlled
                Corporate Operator</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
                is a corporation duly incorporated and validly existing under the
                laws of
                its jurisdiction. To the knowledge of MDS, Toronto Labs (a &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Non-Controlled
                Partnership Operator</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
                is a limited partnership duly formed and validly existing under the
                laws
                of its jurisdiction of formation. To the knowledge of MDS, no proceedings
                have been taken or authorized by MDS or a Non-Controlled Operator
                or by
                any other Person with respect to the bankruptcy, insolvency, liquidation,
                dissolution or winding up of a Non-Controlled
                Operator.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MDS
                has all necessary corporate power and capacity to execute and deliver,
                and
                to observe and perform its covenants and obligations under, this
                Agreement
                and the Closing Documents to which it is a party. MDS has taken all
                corporate action necessary to authorize its execution and delivery
                of, and
                the observance and performance of its covenants and obligations under,
                this Agreement and the Closing Documents to which it is a party.
                </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)
                MDS Quebec has all necessary corporate power and capacity and, subject
                to
                the LPBP Consent, MDS ONT LP has all necessary power and capacity
                under
                the partnership agreement governing it to execute and deliver and
                perform
                its covenants and obligations under the Closing Documents to which
                it will
                be a party; and (ii) MDS Quebec has taken all corporate action necessary
                and, subject to the LPBP Consent, MDS ONT LP has taken all action
                necessary under the partnership agreement governing it to authorize
                the
                execution and delivery of, and the observance and performance of
                its
                covenants and obligations under the Closing Documents to which it
                will be
                a party.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MDS,
                each Corporate Operator and, to the knowledge of MDS, the Non-Controlled
                Corporate Operator has all necessary corporate power and capacity,
                and the
                Partnership Operator and, to the knowledge of MDS, the Non-Controlled
                Partnership Operator has all necessary power and capacity under the
                partnership agreement governing it, to own or lease the Purchased
                Assets
                owned or leased by it and to carry on the Diagnostics Business as
                presently carried on by it. Neither the nature of the Diagnostics
                Business
                nor the location or character of any of the Purchased Assets requires
                MDS
                or any Operator to be registered, licensed or otherwise qualified
                as an
                extra-provincial or foreign corporation or partnership or to be in
                good
                standing in any jurisdiction other than (i) jurisdictions where it
                is duly
                registered, licensed or otherwise qualified and in good standing
                for such
                purpose or (ii) to the extent that any failure to be so qualified
                either
                individually or in the aggregate, would not have a Material Adverse
                Effect. </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
                Agreement has been duly executed and delivered by MDS and, subject
                to the
                LPBP Consent, the Closing Documents to be entered into by a Seller
                will be
                duly executed and delivered by such Seller. This Agreement constitutes
                a
                valid and binding obligation of MDS enforceable against MDS in accordance
                with its terms and, subject to the LPBP Consent, each such Closing
                Document will constitute a valid and binding obligation of the applicable
                Seller enforceable against such Seller in accordance with its
                terms.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.2</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Absence
      of Conflicting Agreements</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">None
      of
      the execution and delivery of, or the observance and performance by any Seller
      of, any covenant or obligation under this Agreement or any Closing Document
      to
      which such Seller is or will be a party:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">contravenes
                or results in, or will contravene or result in, a violation of or
                a
                default under (with or without the giving of notice or lapse of time,
                or
                both) or in the acceleration of any obligation
                under:</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">subject
                to the consents to the within transactions and the rights of the
                third
                parties contemplated in Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.1(b)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                and the LPBP Consent, the articles or by-laws of MDS or each Corporate
                Operator or the partnership agreement governing the Partnership
                Operator;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">except
                for the Leases, the Equipment Leases and the Contracts included in
                the
                Purchased Assets and the Shared Contracts, the consent to the assignment
                or transfer of which or a change of control of the party thereto
                which may
                be required from landlords or other third parties thereunder in connection
                with the Closing, the consents to the within transactions and the
                rights
                of the third parties contemplated in Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.1(b)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                and the LPBP Consent as set forth in, and in addition to the others
                set
                forth in, Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                of
                the Disclosure Letter, the provisions of any material agreement,
                lease,
                mortgage or security document to which MDS or any Operator is a party;
                except, in each case any contravention, violation, default under
                or
                acceleration of any obligations under any such agreement, lease,
                mortgage
                or security document that would not have a Material Adverse Effect
                individually or in the aggregate;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">subject
                to Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.1.4(d)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
                Applicable Law; or</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">will
                result in the creation or imposition of any material Encumbrance
                on an
                Operator or any of the Purchased Assets except as set forth in Section
                </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                of
                the Disclosure Letter.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.3</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Regulatory
      Approvals</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except
      as
      set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.3</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      of the
      Disclosure Letter, no consent, approval, or authorization of, or registration
      or
      filing with, any Governmental Authority is required by MDS, any Operator or,
      to
      the knowledge of MDS, any Non-Controlled Operator in connection with the
      execution and delivery by MDS of this Agreement or by any Seller of any Closing
      Document to which it will be a party or the observance and performance by a
      Seller of its obligations under this Agreement or such Closing Documents to
      which it will be a party other than the Regulatory Consents and other than
      those
      consents, approvals, authorizations, registrations, declarations or filings
      with
      any Governmental Authority which are routine post-closing notifications or
      filings or those the absence of which will not have a Material Adverse
      Effect.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.4</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Title
      to Assets</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
                Persons set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                of
                the Disclosure Letter are the registered and beneficial owners of
                the Real
                Property, with good and marketable title thereto and the Sellers
                collectively are the legal and beneficial owners of the remaining
                Purchased Assets, and on completion of the applicable Migration Project
                (as defined in the Migration Agreement) under the Migration Agreement
                pertaining to a Migrating Asset and, upon a Seller and the applicable
                third party entering into a Replacement Contract, MDS or the applicable
                Seller will be the legal and beneficial owner or authorized licensor
                of
                such Migrating Assets and Replacement Contracts, in each case with
                good
                and valid title thereto, in each case free and clear of any Encumbrances,
                except for Permitted Encumbrances.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notwithstanding
                subsection (a), the Sellers collectively, in respect of each of the
                Purchased Assets comprising Technical Information, are the legal
                and
                beneficial owners of the Technical Information with good and valid
                title
                thereto, free and clear of any Encumbrances, except for Permitted
                Encumbrances, and the applicable Seller has a valid and legally
                enforceable right in Canada and the United States to use (inclusive
                of the
                right to commercially exploit and further license and convey) the
                Technical Information free from third party
                interference.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notwithstanding
                subsection (a), the Sellers collectively, in respect of each of the
                Purchased Assets comprising Proprietary IP, are the sole and exclusive
                owner in Canada and the United States of all Proprietary IP included
                in
                the Purchased Assets, free and clear of all Encumbrances, except
                for
                Permitted Encumbrances.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.5</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>No
      Options</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except
      as
      set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.5</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      of the
      Disclosure Letter, no Person other than Buyer has any written agreement, option,
      warrant, privilege or right, or any right capable of becoming any of the
      foregoing for the purchase from a Seller of any of the Purchased Assets or
      the
      Replacement Contracts. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.6</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Litigation</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except
      as
      set forth in Section 4.1.6 of the Disclosure Letter, there is no claim, demand,
      suit, action, cause of action, dispute, proceeding, investigation, inquiry,
      litigation, grievance, arbitration, governmental proceeding or other proceeding
      including appeals and applications for review, in progress against, by or
      relating to or affecting the Purchased Assets, the Replacement Contracts or
      the
      Diagnostics Business, nor, to the knowledge of MDS are any of the same
      threatened, which if decided adversely to MDS or an Operator would have a
      Material Adverse Effect. There is no Order outstanding against MDS or any
      Operator that affects the Diagnostics Business or any of the Purchased Assets
      except those that would not have a Material Adverse Effect.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.7</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>The
      Financial Statements</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
                Financial Statements and Quarterly
                Statements:</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">have
                been prepared in accordance with Generally Accepted Accounting Principles,
                applied on a basis consistent with that of the preceding periods;
                and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">present
                fairly, in all material respects, the assets, Liabilities (whether
                accrued, absolute or contingent) and the financial position of the
                MDS
                Diagnostics Division and the results of the operations of the MDS
                Diagnostics Division as at the dates thereof and for the periods
                covered
                thereby in accordance with GAAP. </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
                Regional Financial Statements:</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">have
                been prepared in accordance with Generally Accepted Accounting Principles,
                applied on a basis consistent with that of the Financial Statements;
                and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">present
                fairly, in all material respects, the assets, Liabilities and the
                financial position of the MDS Diagnostics Division in Ontario and
                Quebec
                and the head office of the MDS Diagnostics Division and the results
                of the
                operations of the MDS Diagnostics Division in Ontario and Quebec
                and the
                head office of the MDS Diagnostics Division as at the dates thereof
                and
                for the period covered thereby in accordance with
                GAAP.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.8</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Absence
      of Changes</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except
      as
      set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.8</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      of the
      Disclosure Letter or as contemplated by this Agreement, since the date of the
      Financial Statements:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">each
                Operator and, to the knowledge of MDS, each Non-Controlled Operator
                has
                conducted the Diagnostics Business carried on by it in the ordinary
                course;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">there
                has not been any material change in the condition of the Diagnostics
                Business, the Purchased Assets, the Replacement Contracts or the
                financial
                position or results of operations of MDS Diagnostics Division in
                Ontario
                and Quebec other than changes reflected in the Quarterly Statements
                and
                changes in the ordinary course of business, and such changes have
                not,
                either individually or in the aggregate, had a Material Adverse Effect;
                </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">there
                has not been any damage, destruction, loss, technology failure, labour
                dispute, organizing drive, application for certification or other
                event,
                development or condition of any character (whether or not covered
                by
                insurance) which has had or would reasonably be expected to
                have</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a
                Material Adverse Effect. </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.9</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Absence
      of Unusual Transactions</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except
      as
      set forth in Section 4.1.9 of the Disclosure Letter or as contemplated by this
      Agreement, since the date of the Financial Statements:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">neither
                MDS nor any Operator has increased (or offered to increase) the
                compensation paid or payable to the Employees or increased (or offered
                to
                increase) the benefits to which the Employees are entitled under
                any
                benefit or pension plan of such Person or created (or offered to
                create)
                any new benefit or pension plan for the Employees or entered into
                any
                Contract with an Employee, in each case other than in the ordinary
                course
                of business;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">no
                Seller has created any Encumbrance on any of the Purchased Assets
                or the
                Replacement Contracts or suffered or permitted any such Encumbrance
                that
                has arisen on the Purchased Assets or the Replacement Contracts since
                that
                date to remain, other than Permitted
                Encumbrances;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">no
                Operator has:</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">changed
                its accounting practices or policies in any material respect;
                </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">modified,
                amended or terminated any Contract to which it is or was a party,
                or
                waived or released any right which it has or had, other than in the
                ordinary course of its business or that has not individually or in
                the
                aggregate had or would reasonably be expected to have</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a
                Material Adverse Effect; </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">incurred
                any material debt, liability or obligation for borrowed money, or
                incurred
                any other material debt, liability or obligation, except in the ordinary
                course of its business;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iv)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">nor
                MDS relating to the Diagnostics Business, suffered an operating loss
                or
                any unusual or extraordinary loss, or entered into any commitment
                or
                transaction not in the ordinary course where such loss, commitment
                or
                transaction is or would be material in relation to the Purchased
                Assets or
                the Diagnostics Business;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(v)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">except
                as set forth in Section 4.1.9 of the Disclosure Letter, nor MDS relating
                to the Diagnostics Business, hired or dismissed any senior
                Employees;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(vi)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">except
                as set forth in Section 4.1.9 of the Disclosure Letter, nor MDS relating
                to the Diagnostics Business, directly or indirectly, engaged in any
                transaction, made any loan or entered into any arrangement with any
                officer, director, partner, shareholder, Employee (whether current
                or
                former or retired), consultant, independent contractor or agent of
                MDS or
                an Operator, except in the ordinary course and consistent with past
                practice; and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(vii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">except
                as set forth in Section 4.1.9 of the Disclosure Letter, nor MDS relating
                to the Diagnostics Business, deferred any capital expenditures or
                commitments therefor which were budgeted for in the capital expenditure
                budgets of the Diagnostics Business for the current fiscal year or
                would
                have been made in the ordinary
                course;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">no
                Corporate Operator nor, to the knowledge of MDS, any Non-Controlled
                Corporate Operator, has issued or sold any shares, bonds or other
                securities of any type whatsoever; </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">no
                Partnership Operator nor, to the knowledge of MDS, any Non-Controlled
                Partnership Operator, has issued or sold any units, partnership interests
                or other securities of any type whatsoever;
</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">neither
                MDS nor the Operators have authorized, agreed or otherwise become
                committed to do any of the matters set forth in paragraphs (c), (d)
                and
                (e) above; and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">to
                the knowledge of MDS, no Non-Controlled Operator has authorized,
                agreed or
                otherwise become committed to do any of the matters set forth in
                paragraphs (d) and (e) above.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.10</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Compliance
      with Applicable Law</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MDS,
      each
      Operator and, to the knowledge of MDS, each Non-Controlled Operator has operated
      that part of the Diagnostics Business presently operated by it and currently
      operates such Diagnostics Business in compliance with all Applicable Laws in
      all
      material respects.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.11</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Sufficiency
      of Purchased Assets</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      Purchased Assets owned, leased or otherwise held by the Sellers are, together
      with the Migrating Assets, the Replacement Contracts and the Limited Trade
      Mark
      Licence, sufficient to carry on the Diagnostics Business as presently conducted
      by the Sellers, subject to clauses (a), (d), (k), (o) and, to the extent used
      in
      the Diagnostics Business, (e) of the definition of the Excluded Assets, all
      Employees, and any services to be provided by MDS or a third party to the Buyer
      and/or any Designated Buyer Affiliates after the BC Closing under the Migration
      Agreement. It being acknowledged that the Parties have agreed to the Migrating
      Assets and the Replacement Contracts under Sections </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.10</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      and
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.14</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      and MDS
      makes no representation or warranty as to the sufficiency of the Migrating
      Assets and the Replacement Contracts and shall have no liability therefor.
      Except as set forth in Schedule F1 to the Disclosure Letter, Schedule F to
      the
      Disclosure Letter lists all employees necessary to carry on the Diagnostics
      Business as presently conducted by each such Seller.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.12</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Licences</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except
      as
      set forth in Section 4.1.12 of the Disclosure Letter, each Operator and, to
      the
      knowledge of MDS, each Non-Controlled Operator, possesses all Licences material
      to the conduct of the Diagnostics Business carried on by it and each such
      Licence of any Operator and, to the knowledge of MDS, a Non-Controlled Operator
      is in full force and effect and each Operator and, to the knowledge of MDS,
      each
      Non-Controlled Operator is in compliance with the terms and conditions of such
      Licences in all material respects and, to the knowledge of MDS, no proceeding
      is
      pending or threatened to revoke or limit any such Licence. Each Licence of
      an
      Operator material to the conduct of the Diagnostics Business carried on by
      it is
      listed in Section 4.1.12 of the Disclosure Letter.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.13</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Employees,
      Labour Matters</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Schedule
                F annexed to the Disclosure Letter contains as at August 28,
                2006:</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                employee identification number and titles of all Employees together
                with
                the location of their employment;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                date each Employee was hired;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a
                list of all employment offers made by MDS or an Operator to an executive
                Employee or an Employee with a total annual salary which exceeds
                $150,000;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iv)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                rate of annual remuneration or hourly wage of each Employee at the
                date
                hereof and all bonuses, incentive schemes, benefits and other compensation
                to which such Employee is entitled;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(v)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                amount of vacation pay to which each Employee is entitled on the
                date
                hereof; and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(vi)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                contractor identification letter of all independent contractors that
                regularly provide material services to an Operator (or, to the extent
                the
                services relate exclusively to the Diagnostics Business, MDS) pursuant
                to
                a consulting arrangement and their annual
                remuneration.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except
                as disclosed in Section 4.1.13 of the Disclosure Letter, no Employee
                is
                employed under a contract which cannot be terminated by his or her
                employer with appropriate notice and there are no retention, change
                of
                control or deal bonuses or other compensation or benefits payable
                by the
                Buyer or the Operators pertaining to the sale of the Diagnostics
                Business.
                MDS and each Operator has withheld and remitted or paid to the relevant
                Governmental Authority all income Taxes, employment insurance
                contributions, Canada Pension Plan contributions and any Taxes or
                other
                amounts which it is required by statute to withhold and remit or
                pay to
                any Governmental Authority in respect of its
                Employees.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except
                as disclosed in Section 4.1.13 of the Disclosure Letter, there are
                no
                outstanding charges or inspection Orders made under the Occupational
                Health and Safety Act (Ontario) or similar legislation of any jurisdiction
                in which the Diagnostics Business is carried on by an Operator in
                respect
                of the Diagnostics Business carried on by such Operator nor, to the
                knowledge of MDS, are any charges pending or threatened in writing
                under
                such legislation.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There
                are no outstanding notices of assessment, provisional assessment,
                reassessment, supplementary assessment, penalty assessment or increased
                assessment (collectively, &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>assessments</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
                which any Operator has received from any workers&#8217; compensation board or
                similar authority and there are no material assessments which are
                unpaid
                on the date hereof or which will be unpaid at the Closing
                Time.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.14</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Collective
      Agreements</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">No
      Operator, or to the knowledge of MDS, any Non-Controlled Operator, is a party
      to
      a collective agreement. No trade union, council of trade unions, employee
      bargaining agency or affiliated bargaining agent holds bargaining rights with
      respect to any Employees by way of certification, interim certification,
      voluntary recognition, or successor rights, or, to the knowledge of MDS, has
      applied or threatened to apply to be certified as the bargaining agent of any
      of
      such employees. To the knowledge of MDS, no material work stoppage or other
      material labour dispute in respect of the Diagnostics Business is pending or
      threatened.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.15</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Benefit
      Plans</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Section
                4.1.15 of the Disclosure Letter contains a true and complete list
                of all
                Benefit Plans of the Diagnostics Business and identifies which of
                such
                Benefit Plans is a Pension Plan. Except as disclosed at Section 4.1.15
                of
                the Disclosure Letter, neither MDS nor any Operator has a formal
                plan or
                commitment to create any additional Benefit Plan or to modify, amend
                or
                change any existing Benefit Plan that would affect any Employee or
                former
                employee of the Diagnostics Business, except such modification, amendment
                or change as may be required to be made to secure the continued
                registration of any existing Benefit Plan with any applicable Governmental
                Authority or to reflect annual premium changes in the ordinary course
                of
                business. </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">With
                respect to each of the Benefit Plans, MDS has made available to Buyer
                true, correct and complete copies of each of the following
                documents:</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a
                copy of the current terms of the Benefit
                Plan;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">if
                the Benefit Plan is funded through a trust or any third party funding
                arrangement, a copy of the current trust or other funding agreement
                (including all amendments thereto) and the most recent financial
                statements thereof;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                current material Contracts relating to the Benefit Plan with respect
                to
                which MDS or an Operator may have any Liability, including insurance
                contracts, investment management agreements, subscription and
                participation agreements and record keeping
                agreements;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iv)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                most recent financial, accounting, actuarial valuation or other report,
                as
                applicable, of each Benefit Plan whether or not such report is required
                by
                Applicable Law; and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(v)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                most recent annual information returns filed with Governmental Authorities
                in respect of each Benefit Plan for which such filing is required
                by
                Applicable Law.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except
                as disclosed in Section 4.1.15 of the Disclosure Letter, no material
                changes have occurred in respect of any Benefit Plan since the date
                of the
                most recent financial, accounting, actuarial or other report, as
                applicable, issued in connection with any Benefit Plan, which could
                reasonably be expected to adversely affect the relevant report (including
                rendering it misleading in any material respect), other than changes
                arising as a result of the experience of the Benefit Plan or changes
                in
                the assumptions or methods used in the most recent
                report.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">None
                of the Sellers has received, or applied for, any payment of surplus
                out of
                any Benefit Plan or any payment in respect of the demutualization
                of the
                insurer of any Benefit Plan.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
                Employee data necessary to administer each Benefit Plan is in the
                possession of the Sellers or the Operators, will be included in the
                Purchased Assets and is complete, correct and in a form which is
                sufficient for the proper administration of the Benefit Plan in accordance
                with its terms and all Applicable
                Laws.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">None
                of the Benefit Plans require or permit a retroactive increase in
                premium
                or payments or require additional premiums or payments upon termination
                of
                the Benefit Plan or any insurance contract relating thereto, and
                the level
                of insurance reserves, if any, under any insured Benefit Plan is
                reasonable and sufficient to provide for all incurred but unreported
                claims.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
                Liabilities of the Diagnostics Business in respect of all Benefit
                Plans
                are properly reflected in the Financial Statements according to GAAP,
                other than Liabilities related to the MDS Option Plan which Liabilities
                are not reflected on the Financial
                Statements.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(h)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except
                as disclosed at Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.15</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                of
                the Disclosure Letter, no Benefit Plan provides benefits, including
                death
                or medical benefits (whether or not insured), with respect to Employees
                or
                former employees of the Diagnostics Business beyond retirement or
                other
                termination of service, other than:</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">coverage
                required by Applicable Law,</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">death
                or retirement benefits under any Pension
                Plan,</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">deferred
                compensation benefits accrued as Liabilities in the Financial Statements,
                or</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iv)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">benefits
                the full cost of which is borne by the Employee or former employee
                (or his
                beneficiary).</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
                employer contributions required to be made by an Operator that are
                due
                under Applicable Law to the Pension Plans as of the date hereof have
                been
                made or properly accrued. All employee contributions to such Pension
                Plans
                required to be contributed prior to the most recent pay period ending
                prior to the date hereof have been properly withheld by the applicable
                Operator and have been fully paid into the funding arrangements for
                the
                respective Pension Plan. </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(j)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Neither
                MDS nor, to the knowledge of MDS, any Operator has received any written
                notice of any material claims or proceedings involving MDS or any
                Operator
                or, to the knowledge of MDS, any of the Employees before any Governmental
                Authority relating to any Benefit
                Plan.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.16</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Residence
      of Sellers</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each
      Seller is not a non-resident of Canada within the meaning of the ITA and MDS
      ONT
      LP is a &#8220;Canadian partnership&#8221; for the purposes of the ITA.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.17</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Insurance</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      Purchased Assets owned or used by the Operators in the operation of the
      Diagnostics Business are insured pursuant to the insurance policies listed
      at
      Section 4.1.17 of the Disclosure Letter. All such policies of insurance are
      in
      full force and effect and MDS is not in material default, whether as to the
      payment of premium or otherwise, under the terms of any such policy. All claims
      of MDS or any Operator relating to the Diagnostics Business under such insurance
      policies and other policies held over the past three (3) years and all losses
      covered by any insurance policy deductible or self insurance are listed at
      Section 4.1.17 of the Disclosure Letter.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.18</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Intellectual
      Property Rights and Information Systems</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Other
                than any (i) unregistered copyrights and unregistered trade marks
                and
                common law rights in trade marks; (ii) moral rights, all rights of
                priority, rights to file applications for inventions and derivative
                applications and patents in any and all jurisdictions; and (iii)
                industrial design rights other than industrial design registrations
                and
                pending applications for same (all of which for greater certainty
                are
                included in the Purchased Assets in accordance with the terms and
                conditions hereof), Schedule E annexed to the Disclosure Letter sets
                forth
                a true and complete list of all Intellectual Property Rights which
                are
                proprietary to the Operators or MDS and which are included in the
                Purchased Assets including all Software which is proprietary to the
                Operators or MDS and which is included in the Purchased Assets (such
                Intellectual Property Rights including such Software collectively
                the
                &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Proprietary
                IP</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;).</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Schedule
                E annexed to the Disclosure Letter sets forth a true and complete
                list of
                all Intellectual Property Rights licensed from third parties that
                is used
                in whole or in part in the Diagnostics Business (the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Licensed
                IP</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;).</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except
                pursuant to the license agreements disclosed on Schedule D to the
                Disclosure Letter, neither MDS nor the Operators have licensed or
                granted
                any material interest in or right to use, access or exploit all or
                any
                portion of any Proprietary IP to any other
                Person.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
                registrations and filings necessary to preserve the rights of MDS
                or such
                Operator in and to such Proprietary IP, in each case federally in
                Canada
                and in the United States, as at the date hereof have been made other
                than
                those that the failure to make has not had and would not reasonably
                be
                expected to have a Material Adverse Effect. Except as set forth in
                Schedule E to the Disclosure Letter there have been no patents applied
                for
                and no other intellectual property registrations of any nature made,
                by
                MDS or an Operator, in any jurisdiction concerning all or any part
                of the
                Proprietary IP.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To
                the knowledge of MDS, none of: (i) the Proprietary IP; (ii) MDS&#8217; or an
                Operator&#8217;s ownership, use, operation, copying, licensing or other
                commercial exploitation of the Proprietary IP; and (iii) the carrying
                on
                of the Diagnostics Business infringes, violates or breaches the
                intellectual property or other proprietary rights in Canada or the
                United
                States of any other Person. MDS is not aware of any misappropriation,
                breach, violation or material interference with such Proprietary
                IP by any
                third parties and neither MDS nor any Operator has received any written
                notice expressly claiming that any Proprietary IP is, or may be,
                invalid
                or unenforceable other than where such claim, if decided adversely
                to any
                of MDS or an Operator, would not have a Material Adverse
                Effect.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except
                as disclosed in Schedule E to the Disclosure
                Letter:</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                of the Proprietary IP are in full force and effect and have not been
                used
                or enforced or failed to be used or enforced in a manner that would
                result
                in their abandonment, cancellation or unenforceability;
                and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                of the Proprietary IP consisting of issued registrations, or in the
                case
                of inventions, issued patents, are valid and enforceable (with respect
                to
                Canadian registrations and issued patents, in Canada, and, with respect
                to
                U.S. registrations and issued patents, in the United
                States).</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
                Proprietary IP was developed either by contractors retained by MDS
                or an
                Operator or by employees of MDS or an Operator and, to the knowledge
                of
                MDS, does not: (i) contain any third party software, technology or
                third
                party intellectual property or other proprietary rights or property;
                and
                (ii) require any other Person&#8217;s license, authorization, consent or waiver
                of any kind in connection with the use or commercial exploitation
                of the
                Proprietary IP by Buyer (or any transferee of all or substantially
                all of
                the MDS Diagnostics Division) in the carrying on of the diagnostics
                business after the Closing Time.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(h)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Intentionally
                deleted.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Neither
                MDS nor any Operator is a party to any claim (i) for trade mark,
                trade
                name, industrial design, patent or copyright, trade secret or other
                intellectual property right infringements as to any services provided,
                or
                any products produced or sold by, or concerning the Software of,
                MDS or an
                Operator in the Diagnostics Business; or (ii) relating to trade marks,
                trade names, industrial designs, patents or copyrights, trade secret
                or
                other intellectual property right owned or licensed by any of MDS
                or an
                Operator exclusively in connection with the Diagnostics
                Business.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(j)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MDS
                and the applicable Operators have:</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">not
                intentionally incorporated, and the Software does not to the knowledge
                of
                MDS, contain any disabling mechanisms or protection features, including
                computer viruses, time locks or any code, instruction or device which
                are
                designed to or may disrupt or prevent the use of the Software or
                computer
                hardware or render any data inaccessible or that may be used without
                authority to access, modify or delete or damage any of the Software
                or
                computer hardware data in the Software;
                and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">implemented
                industry standard software to detect computer viruses.
                </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(k)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MDS
                and the applicable Operators have taken commercially reasonable steps
                to
                safeguard and maintain the proprietary rights of MDS and the Operators
                in
                and to the Proprietary IP and the trade secrets and confidential
                information of the Diagnostics
                Business.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(l)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To
                the knowledge of MDS, the Software is free from defects or deficiencies
                that would materially interfere with the ordinary course operation
                of the
                Software.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(m)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MDS
                or the applicable Operators have registered each of the domain names
                set
                forth in Schedule E to the Disclosure Letter and have paid all fees
                required to maintain each registration, and there are no other domain
                names used in the Diagnostics Business except as set forth in Schedule
                E.
                None of such domain names have been placed &#8220;on
                hold&#8221;.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(n)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
                will not suffer or incur any Liability to the applicable third party
                under
                any AutoLabs Contract as a direct result of an MDS Contracting Party&#8217;s
                misrepresentation or breach of any covenant, agreement or representation
                made by the MDS Contracting Party under the applicable AutoLabs Contract
                (i) in respect of the intellectual property rights related to the
                APX
                (AutoLab Process eXpert), and (ii) that the APX (AutoLab Process
                eXpert)
                system complies with or conforms to the requirements, specifications
                or
                documentation as set out in the applicable AutoLabs Contract.
                </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.19</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Environmental
      Matters</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each
                of the Operators possesses all material environmental licences, permits
                and other governmental approvals and authorizations (collectively
                the
                &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Environmental
                Permits</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
                necessary to conduct the Diagnostics Business carried on by it and
                is in
                compliance with the Environmental Permits and applicable Environmental
                Laws except for non-compliance which either individually or in the
                aggregate has not had and would not reasonably be expected to
                have</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a
                Material Adverse Effect. The Environmental Permits are listed in
                Section
                4.1.19 of the Disclosure Letter, are in full force and effect and,
                subject
                to receipt of any approval, consent or authorization of any Governmental
                Authority required by Applicable Law in respect of the transfer of
                such
                Environmental Permits to Buyer, will not become void or voidable
                as a
                result of the Closing. To the knowledge of MDS, there are no material
                proceedings or investigations in progress or threatened in writing,
                which
                may result in the cancellation, revocation, suspension, or modification
                of
                any Environmental Permit of the
                Operators.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Neither
                MDS nor any Operator has used or, since the date of ownership by
                the
                applicable Operator or MDS, permitted to be used, except in material
                compliance with all Environmental Laws, the Real Property and the
                Leased
                Premises included in the Purchased Assets to generate, manufacture,
                process, distribute, use, treat, store, dispose of, transport or
                handle
                any Hazardous Materials except for any non-compliance that has not
                had and
                would not reasonably be expected to have</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">any
                Material Adverse Effect. Except as set forth in Section 4.1.19 of
                the
                Disclosure Letter, to the knowledge of MDS, no underground storage
                tanks
                are located on the Real Property included in the Purchased Assets
                and the
                Leased Premises. </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Within
                the last 36 months, neither MDS nor any Operator has received any
                written
                notice of, or been prosecuted for, non-compliance of any Environmental
                Law
                in respect of the Diagnostics Business or the Purchased Assets owned
                or
                used by it. There are no outstanding written notices, orders or directions
                relating to environmental matters requiring, or notifying MDS or
                any
                Operator that it is or may be responsible for, any containment, clean-up,
                remediation or corrective action to be made under Environmental Laws
                with
                respect to the Diagnostics Business or the Purchased Assets owned
                or used
                by it in the Diagnostics Business. To the knowledge of MDS, there
                are no
                material proceedings or investigations in progress or threatened
                relating
                to environmental matters in respect of the Diagnostics Business,
                the Real
                Property or the Leased Premises.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Neither
                MDS nor any of the Operators has caused, nor to the knowledge of
                MDS, has
                there been, any Release in contravention of any Environmental Law
                on, in,
                or from the Real Property or the Leased Premises included in the
                Purchased
                Assets that has resulted in or would reasonably be expected to result
                in</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a
                Material Adverse Effect. All Hazardous Materials used in whole or
                in part
                by MDS or any Operator in connection with the Diagnostics Business
                or
                resulting from the Diagnostics Business have been disposed of, treated
                and
                stored by such Person in material compliance with all Environmental
                Laws
                except for any non-compliance that has not had and would not reasonably
                be
                expected to have</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">any
                Material Adverse Effect.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Sellers
                have provided to the Buyer a copy of all environmental audits, studies
                or
                reports on the Real Property and, to the knowledge of MDS, the Leased
                Premises included in the Purchased Assets in the possession of
                Sellers.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.20</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Real
      Property</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
                Land included in the Purchased Assets is listed in Section 4.1.20
                of the
                Disclosure Letter including the legal description
                thereof.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To
                the knowledge of MDS, there are no work orders outstanding against
                the
                Real Property included in the Purchased Assets and neither MDS nor
                any
                Operator has received any written deficiency notices of any material
                breach of any Applicable Law in respect of the foregoing which could,
                if
                not corrected, become a work order.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To
                the knowledge of MDS, the Buildings included in the Purchased Assets
                have
                not been insulated with urea formaldehyde foam insulation, nor have
                they
                been fireproofed or insulated with any asbestos fibre product nor
                are
                there PCB&#8217;s stored on any such Real
                Property.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">With
                respect to the Real Property included in the Purchased Assets:
                </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                applicable owner of the Land holds no registered and/or beneficial
                interest in any lands adjoining the Land, as contemplated in the
                </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Planning
                Act</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                (Ontario);</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">to
                the knowledge of MDS, the Land has unobstructed access to and from
                adjoining public highways, streets and/or roads;
                </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                Land is adequately serviced by public or private utilities or its
                own
                services to permit the Diagnostics Business operated at the Lands
                to be
                carried on substantially as currently carried on;
                and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iv)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">save
                as set forth in Section 4.1.20 of the Disclosure Letter, there are
                no
                leases, subleases, licenses, concessions, or other agreements, written
                or
                oral, granting to any Person other than an Operator the right of
                use or
                occupancy of any portion of such Real
                Property.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except
                as may be disclosed by the International Survey, the Building at
                100
                International Boulevard, Toronto is erected within the boundaries
                of the
                Land municipally known as 100 International Boulevard, Toronto, no
                part of
                such Building encroaches upon any adjoining lands, and to the knowledge
                of
                MDS there are no encroachments of any buildings, structures or
                improvements situate on any adjoining lands onto such
                Land.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.21</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>No
      Expropriation</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">No
      Operator or MDS has received any written notice of expropriation of all or
      any
      material part of the Purchased Assets and MDS is not aware of any expropriation
      proceeding pending or threatened in respect of any of the Purchased
      Assets.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.22</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Leases</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except
      as
      set forth in Section 4.1.22 of the Disclosure Letter, each of the Leases
      included in the Purchased Assets is listed in Schedule C annexed to the
      Disclosure Letter and is in full force and effect. No Operator or MDS nor,
      to
      the knowledge of MDS, the lessor, is currently in breach of any material
      provision of any such Lease and each such Lease is otherwise in good standing.
      MDS has made available to Buyer true, complete and correct copies of all such
      Leases. The possession and quiet enjoyment by the applicable Seller or Operator
      of the Leased Premises has not been disturbed in any material respect and there
      are no material disputes with the lessors under any of the Leases included
      in
      the Purchased Assets. Except as set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.22</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      of the
      Disclosure Letter, there are no subleases, licenses or other rights of
      occupation which have been granted by any Operator to any Person other than
      an
      Operator the right to use or occupy any such Leased Premises or any portion
      thereof.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.23</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Material
      Contracts</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each
                of the material Contracts of MDS pertaining exclusively to the Diagnostics
                Business, including for greater certainty the partnership agreements
                that
                govern MDS ONT LP and Toronto Labs and the shareholders&#8217; agreements of
                Windsor Labs and Toronto GP and each of the material Contracts to
                which
                the Operators are party included in the Purchased Assets is listed
                in
                Schedule D annexed to the Disclosure Letter. Neither MDS nor any
                Operator
                is currently in breach of any material provision of such material
                Contract</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">and
                each such material Contract is otherwise in good standing. To the
                knowledge of MDS, there exists no condition, event or fact that,
                with
                giving of notice or lapse of time or both, would constitute a material
                default of any such material Contract. MDS has made available to
                Buyer
                true, complete and correct copies of all such material Contracts.
                Except
                as set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.23</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                of
                the Disclosure Letter, no Seller is a party to or bound by any guarantee,
                surety or similar obligation which pertains to or affects the Diagnostics
                Business or the Purchased Assets. </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
                respect of each of the AutoLabs Contracts that involves the installation
                and implementation of an APX (AutoLab Process eXpert) system, MDS
                or the
                applicable MDS Contracting Party has installed and implemented such
                APX
                (AutoLab Process eXpert) system such that it complies in all material
                respects with, and it has been accepted by the applicable customer
                as
                being in compliance with, the terms and conditions of the applicable
                AutoLabs Contract.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except
                in respect of the specified project work remaining to be completed
                pursuant to the U.S. Transition Services Contract as set out in Subsection
                </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.23(c)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                of
                the Disclosure Letter, MDS does not have knowledge of, and does not
                anticipate that, the applicable third party requires or will require
                the
                applicable MDS Contracting Party to perform any other services under
                any
                of the U.S. Transition Services Contracts.
</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
                respect of certain of the U.S. Non-Competition Agreements: (i) neither
                MDS
                nor MDS Laboratories Georgia Inc. are in violation of the Non-Competition
                Agreement dated March 15, 2004 between MDS and MDS Laboratories Georgia,
                Inc. for the benefit of Laboratory Corporation of America Holdings;
                and
                (ii) neither MDS nor MDS Hudson Valley Laboratories, Inc. are in
                violation
                of the Non-Competition Agreement dated March 15, 2004 between MDS
                and MDS
                Hudson Valley Laboratories Inc. for the benefit of Laboratory Corporation
                of America Holdings.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.24</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Books
      and Records</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      Books
      and Records of the Sellers included in the Purchased Assets fairly and correctly
      set out and disclose the financial position of the MDS Diagnostics Division
      of
      the Sellers as at the date hereof in all material respects, and all material
      financial transactions of MDS Quebec and MDS ONT LP relating exclusively to
      the
      Diagnostics Business have been accurately recorded in such Books and Records.
      The Books and Records of the Ontario GP fairly and correctly set out and
      disclose the financial position of the Diagnostics Business carried on by the
      Ontario GP as at the date hereof in all material respects, and all material
      financial transactions of the Ontario GP have been accurately recorded in such
      Books and Records.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.25</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Accounts
      Receivable</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each
      Seller has the full right and authority to assign to Buyer the Accounts
      Receivable of the Seller included in the Purchased Assets. The Accounts
      Receivable reflected in the Quarterly Statements are bona fide, enforceable
      and
      fully collectible (subject to a reasonable allowance, consistent with past
      practice, for doubtful accounts as reflected in the Quarterly Statements in
      accordance with GAAP). Except as set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.25</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      of the
      Disclosure Letter, such Accounts Receivable are not subject to any defence,
      set-off or counterclaim.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.26</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Tax
      Matters</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There
                are no Encumbrances, other than Permitted Encumbrances, on account
                of
                Taxes on the Purchased Assets. </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There
                are no proceedings, investigations, audits or claims now pending
                or
                threatened against the Sellers or Operators in respect of any Taxes
                in
                respect of the Diagnostics Business or Operators, and there are no
                matters
                under discussion, audit or appeal with any Governmental Authority
                relating
                to Taxes in respect of the Diagnostics Business or Operators, which
                will
                result in an Encumbrance on any of the Purchased Assets or Replacement
                Contracts other than Permitted Encumbrances.
</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.27</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>GST
      Registration</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Ontario
      GP is registered for purposes of Part IX of the Excise Tax Act (Canada). Ontario
      GP&#8217;s GST Registration Number is [REDACTED]. MDS Quebec is registered under
      Division I of Chapter VIII of Title I of the Quebec Sales Tax Act with respect
      to Quebec sales Tax and its registration number is [REDACTED].</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.28</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Share
      Capital</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To
      the
      knowledge of MDS, the authorized and issued capital of Toronto GP is as set
      forth in Section 4.1.28 of the Disclosure Letter.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.29</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Subsidiaries
      and Joint Venture Interests</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except
      as
      set forth in Section 4.1.29 of the Disclosure Letter, no Operator owns any
      shares in or securities of any other body corporate nor is any Operator a
      partner, member, owner, proprietor or equity investor of or in any partnership,
      joint venture, co-tenancy or other similar jointly-owned business undertaking
      nor has it agreed to become any of the foregoing.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.30</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Privacy
      Matters</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except
      as
      set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.30</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      of the
      Disclosure Letter, neither MDS nor any Operator has received any written
      complaint or notice of any complaint, breach or violation of any Privacy Law
      in
      respect of the Diagnostics Business carried on by it which has had a Material
      Adverse Effect.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.31</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Condition
      of Purchased Assets</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To
      the
      knowledge of MDS, except as set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.31</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      of the
      Disclosure Letter, the Buildings included in the Purchased Assets are free
      from
      significant mechanical, electrical or</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">structural
      defects and the material Equipment and other tangible personal property included
      in the Purchased Assets are in good working order, subject to reasonable wear
      and tear. To the knowledge of MDS, except as set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.31</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      of the
      Disclosure Letter, none of such Buildings or Equipment or other tangible
      personal property material to the operation of the Diagnostics Business are
      in
      need of maintenance or repairs except for maintenance and repairs in the
      ordinary course of business.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.1.32</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Related
      Party Transactions</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except
      as
      set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.32</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      of the
      Disclosure Letter, all Contracts included in the Purchased Assets have been
      entered into on arm&#8217;s length terms (within the meaning of the ITA). Any accounts
      due and payable by the Operators to MDS or any Affiliate of MDS or by MDS or
      any
      Affiliate of MDS to any Operator, are recorded on the Books and Records of
      the
      Operators at their fair market value. Since the date of the Financial
      Statements, there has been no forgiveness or similar release or, except in
      the
      ordinary course of business, repayment of a debt owed by or to a Person not
      at
      arms-length with the Operators or the Sellers. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.2</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Representations
      and Warranties of Buyer</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
      represents and warrants to MDS and the other Sellers as set forth in the
      following Subsections of this Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.2.1</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Incorporation</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
      is
      a corporation duly incorporated and validly existing under the laws of its
      jurisdiction of incorporation. No proceedings have been taken or authorized
      by
      Buyer or, to the best of Buyer&#8217;s knowledge, by any other Person, with respect to
      the bankruptcy, insolvency, liquidation, dissolution or winding up of
      Buyer.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.2.2</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Corporate
      Power and Due Authorization</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
      has
      all necessary corporate power and capacity to execute and deliver, and to
      observe and perform its covenants and obligations under, this Agreement and
      the
      Closing Documents to which it will be a party. Buyer has taken all corporate
      action necessary to authorize the execution and delivery of, and the observance
      and performance of its covenants and obligations under, this Agreement and
      such
      Closing Documents.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.2.3</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Absence
      of Conflicting Agreements</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">None
      of
      the execution and delivery of, or the observance and performance by Buyer of
      any
      covenant or obligation under, this Agreement or any Closing Document to which
      it
      will be a party contravenes or results in or will contravene or result in a
      violation of or a default under (with or without the giving of notice or lapse
      of time, or both) or in the acceleration of any material obligation
      under:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                articles or by-laws of Buyer; </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">any
                agreement, lease, mortgage, security document, obligation or instrument
                to
                which Buyer is a party or by which Buyer or its assets is affected
                or
                bound; or</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Applicable
                Law.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.2.4</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Enforceability
      of Obligations</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
      Agreement has been, and the Closing Documents to be entered into by Buyer will
      be, duly executed and delivered by Buyer and this Agreement constitutes and
      each
      such Closing Document will constitute a valid and binding obligation of Buyer
      enforceable against Buyer in accordance with its terms.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.2.5</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Investment
      Canada Act</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
      is
      not a &#8220;non-Canadian&#8221; for the purposes of the Investment Canada Act and no
      approval or consent is required under such Act in connection with the execution,
      delivery and performance of this Agreement by Buyer.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.2.6</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Status
      of Buyer</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">None
      of
      the Buyer or any Designated Buyer Affiliate is or will be a Person the taxable
      income of which is exempt from income Tax under Part I of the ITA by virtue
      of
      subsection 149(1) of the ITA (a &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>149
      Person</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;),
      and
      where a Designated Buyer Affiliate is a partnership, its partners will be (i)
      entities other than 149 Persons or (ii) partnership, the partners of which
      are
      persons other than 149 Persons.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.2.7</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>GST
      Registration</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
      is
      registered for purposes of Part IX of the Excise Tax Act (Canada). Buyer&#8217;s GST
      Registration Number is [REDACTED]. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.2.8</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Consents
      and Approvals</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Other
      than the Regulatory Consents, no consent, approval, or authorization of or
      registration or filing with any Governmental Authority is required by Buyer
      in
      connection with the execution and delivery by Buyer of this Agreement or any
      of
      the Closing Documents to be entered into by Buyer, or the observance and
      performance by Buyer of its obligations under this Agreement or such Closing
      Documents.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.2.9</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Financing</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
      is
      able to finance the entire Purchase Price from its existing cash on hand, liquid
      assets, credit facilities and other binding financial commitments. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.2.10</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Eligibility</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
      is
      able to satisfy each of the representations and warranties required to be given
      by it in order to become a limited partner or shareholder, as applicable, of
      Toronto Labs, Toronto GP and Windsor Labs as set forth in the partnership
      agreement, shareholders&#8217; agreement or constating documents governing each such
      Operator.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.3</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Commission</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each
      Party represents and warrants to the other Party that the other Party will
      not
      be liable for any brokerage commission, finder&#8217;s fee or other like payment in
      connection with the transactions contemplated hereby because of any action
      taken
      by, or agreement or understanding reached by, that Party.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.4</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Qualification
      of Representations and Warranties</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any
      representation or warranty made by a Party as to the enforceability of this
      Agreement or any Closing Document against a Person is subject to the following
      qualifications:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">specific
                performance, injunction and other equitable remedies are discretionary
                and, in particular, may not be available where damages are considered
                an
                adequate remedy; and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">enforcement
                may be limited by bankruptcy, insolvency, liquidation, reorganization,
                reconstruction and other laws generally affecting enforceability
                of
                creditors&#8217; rights.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.5</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Survival
      of Representations and Warranties of MDS</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
      representations and warranties made by MDS in this Agreement and in any Closing
      Document shall survive the Closing for a period of eighteen (18) months after
      the Closing Date other than representations and warranties of MDS set forth
      in
      Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      regarding title of Purchased Assets which representations and warranties shall
      survive Closing for a period of six years after the Closing Date. The
      representations and warranties of MDS set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.26</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      shall,
      to the extent it relates to a particular Tax Liability of a Person or a Seller,
      survive closing until 90 days after the expiration of the limitation period
      contained in the applicable Tax laws subsequent to the expiry of which an
      assessment or reassessment or other form or recognized document assessing such
      Tax Liability cannot be issued. After each such period, MDS shall have no
      further liability hereunder with respect to such representations and warranties
      except with respect to claims properly made pursuant to </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Article&#160;8</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      hereof
      within such period.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.6</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Survival
      of Representations and Warranties of Buyer</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
      representations and warranties made by Buyer in this Agreement and in any
      Closing Document shall survive for a period of eighteen (18) months after the
      Closing Date. After such period, Buyer shall have no further liability hereunder
      with respect to such representations and warranties except with respect to
      claims properly made pursuant to </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Article&#160;8</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      hereof
      within such period.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.7</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Knowledge
      of MDS</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Where
      any
      representation or warranty contained in this Agreement, other than one regarding
      a Non-Controlled Operator, is expressly qualified by reference to the
&#8220;knowledge&#8221; or &#8220;awareness&#8221; of MDS, it shall be deemed to refer to the actual
      knowledge or awareness of any one of (i) Kenneth L. Horton, Executive
      Vice-President, Corporate Development and General Counsel, James A.H. Garner,
      Executive Vice-President and Chief Financial Officer, Peter Winkley,
      Vice-President, Finance and Global Controller, Rob Breckon, Senior
      Vice-President, Corporate Development, William Chung, Director, Strategic
      Initiatives, Corporate Development, Hans K. Thunem, President, MDS Diagnostics
      Services, Michael McTeague, Senior Vice-President, Legal, MDS Diagnostics and
      Frank Amodeo, Senior Vice-President, Finance, MDS Diagnostics Services, in
      each
      case without any enquiry other than reasonable enquiry of appropriate senior
      officers of the Sellers in respect of the Diagnostics Business and the Purchased
      Assets; (ii) Anne Louise Aboud, General Manager, Ontario and Quebec, MDS
      Diagnostic Services, Anna Filipopoulos, Senior Vice-President, Human Resources,
      MDS Diagnostic Services, Craig Taylor, Leasing Manager, Nigel Terrett,
      Vice-President, BC Operations, Maurizio Laudisa, Senior Vice-President,
      Information Technology and Richard Goddard, Director, Facility Operations in
      respect of that portion of the operations of the Diagnostics Business that
      such
      individual is responsible for, without any enquiry. Where any representation
      or
      warranty contained in this Agreement regarding a Non-Controlled Operator is
      expressly qualified by reference to the &#8220;knowledge&#8221; or &#8220;awareness&#8221; of MDS, it
      shall be deemed to refer to the actual knowledge or awareness of Frank Amodeo
      after reasonable enquiry and Anne Louise Aboud and Hans K. Thunem without any
      enquiry.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>4.8</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>No
      Breach</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any
      matter or thing done or omitted to be done prior to the Closing by MDS or any
      Operator in substantial compliance with the request of or with the
      informed</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">approval
      of Buyer or any of its Representatives or as contemplated by this Agreement
      or
      the BC Agreement, shall not constitute a breach of any representation, warranty,
      covenant or other provision of this Agreement.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ARTICLE&#160;5</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>OTHER
      COVENANTS OF THE PARTIES</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.1</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Conduct
      Prior to Closing</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During
      the Interim Period, the Parties shall act as set forth in this Section
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.1.1</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Conduct
      Business in Ordinary Course</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except
      as
      otherwise contemplated or permitted by this Agreement, the BC Agreement, the
      Rix
      Agreement or the Migration Agreement or set forth in the Disclosure Letter,
      MDS
      shall and shall cause the other Sellers to:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">use
                commercially reasonable efforts to:</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">preserve
                and protect the Diagnostics Business and its income and the goodwill and
                reputation of the Diagnostics
                Business;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">retain
                or cause to be retained the Employees necessary for the operation
                of the
                Diagnostics Business in the manner it is currently being
                operated;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">maintain
                its and the Operators&#8217; material business relationships with its and the
                Operators&#8217; respective customers, suppliers, landlords and governments, and
                promote and preserve for Buyer such
                relationships;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iv)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ensure
                that any material</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Contracts
                entered into or amended by the Sellers or the Operators with respect
                to
                the Diagnostics Business shall include provisions permitting the
                assignment of such Contracts to the Buyer or a Designated Buyer Affiliate
                and a change of control of the Diagnostics Business as a result of
                the
                transactions contemplated hereunder, as applicable, without having
                to
                obtain the consent of any other party to such Contracts, the payment
                of
                any fee, penalty or liquidated damages or any other limitation or
                restriction;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">carry
                on the Diagnostics Business with reasonable diligence and in the
                ordinary
                course and not make any material modification in its accounting or
                management practices;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">confer
                with Buyer concerning operational matters of a material nature relating
                to
                the Diagnostics Business; </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">promptly
                inform Buyer in writing of (i) any material change in the Purchased
                Assets, the Replacement Contracts, the Migrating Assets, Assumed
                Liabilities, business, affairs, operations, financial condition,
                or
                capital of the Diagnostics Business, and (ii) any fact, change, condition,
                circumstance or occurrence of any event that MDS believes will, or
                is
                reasonably likely to, result in a failure to satisfy the conditions
                in
                favour of Buyer hereunder to be complied with or satisfied by Sellers;
                provided, however, that the delivery of any such notice pursuant
                to this
                paragraph shall not limit or otherwise affect the remedies available
                hereunder to Buyer;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">not,
                directly or indirectly, through any officer, director, Employee,
                representative (including, without limitation and for greater certainty,
                any investment banker, financial advisor, lawyer or accountant) or
                agent
                of the Sellers, a Seller or other Affiliate (excluding the BC Operators)
                (i) solicit, initiate, encourage or otherwise facilitate (including
                by way
                of furnishing information or entering into any form of agreement,
                arrangement or understanding) the initiation of any inquiries or
                proposals
                regarding (A) any sale of all or a substantial part of the Diagnostics
                Business or the Purchased Assets to any Person other than Buyer and
                its
                permitted assigns; or (B) any business combination, reorganization,
                recapitalization, amalgamation, merger or consolidation of a Seller
                (other
                than MDS) or an Operator or, only to the extent it materially adversely
                affects the ability of MDS to perform its material obligations under
                this
                Agreement, MDS, including the sale of any securities of a Seller
                (other
                than MDS) or an Operator or, only to the extent it materially adversely
                affects the ability of MDS to perform its material obligations under
                this
                Agreement, MDS to any Person other than Buyer and its permitted assigns
                (each an &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Acquisition
                Proposal</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;),
                (ii) participate in any discussions or negotiations regarding any
                Acquisition Proposal, (iii) approve or recommend any Acquisition
                Proposal,
                (iv) publicly disclose in any manner any Acquisition Proposal, or
                (v)
                enter into any agreement, arrangement or understanding related to
                any
                Acquisition Proposal, except as contemplated by this Agreement. For
                greater certainty, (a) an Acquisition Proposal does not include (i)
                the
                furnishing of information to Rix, entities controlled by him, his
                agents
                and representatives to the extent necessary to facilitate the transactions
                contemplated in the BC Purchase Agreement or (ii) any action required
                by a
                partnership or shareholder agreement or constating document of an
                Operator, Toronto Labs, Toronto GP or Windsor Labs or any action
                contemplated or permitted by this Agreement (each, a &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Permitted
                Proposal</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;);
                (b) MDS may continue to provide such information and enter into
                discussions and negotiations with other Persons regarding a Permitted
                Proposal; (c) MDS may enter into a binding agreement in respect of
                a
                Permitted Proposal including a Regional Purchase Agreement and any
                other
                agreements contemplated by either such agreement provided that it
                does not
                materially adversely affect the ability of MDS to perform its material
                obligations under this Agreement, and may approve, recommend and
                publicly
                announce same, in each case without violating this
                Agreement;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">except
                for any Permitted Proposals, MDS shall, and shall use commercially
                reasonable efforts to cause the officers, directors, employees,
                representatives and agents of the Sellers to, cease immediately all
                discussions and negotiations regarding any proposal that constitutes,
                or
                may reasonably be expected to lead to, an Acquisition Proposal;
                </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ensure
                that its officers, directors, Employees, representatives and agents
                and
                those of the other Sellers are aware of the provisions of Subsection
                </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.1.1(e)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
                and it shall be responsible for any breach of Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.1.1(e)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                by
                its and the other Sellers&#8217; and Operators&#8217; officers, directors, Employees,
                representatives or agents other than Rix or Rixco or any nominees,
                representatives or agents of Rix or
                Rixco;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(h)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">not
                enter into any new Leases or offers to lease in respect of the Diagnostics
                Business or any renewal or extension of an existing Lease or prepay
                any
                rent in respect of a Lease without the prior written consent of Buyer,
                which shall not be unreasonably withheld or
                delayed.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notwithstanding
      the foregoing, Buyer acknowledges and agrees that on or prior to the Closing
      Time, MDS may, whether conditional upon the Closing or not, terminate certain
      related party agreements as set forth at Section 5.1.1 of the Disclosure Letter.
      </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.1.2</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Action
      to Satisfy Closing Conditions</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each
      Party shall take all such commercially reasonable action as is within its power
      to control, and shall use its commercially reasonable efforts to cause other
      actions to be taken which are not within its power to control, so as to ensure
      compliance with all conditions which are for the benefit of any Party. Subject
      to and in compliance with Applicable Law, including the Competition Act, and
      the
      Confidentiality Agreement, the Parties will co-operate in exchanging such
      information and providing such assistance as may be reasonably required in
      connection with the foregoing.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.1.3</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>MDS
      Consents and Waivers</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MDS
      shall, and shall cause the other Sellers to, at their own expense, subject
      to
      obtaining all commercially reasonable co-operation and assistance of Buyer,
      use
      all commercially reasonable efforts to obtain by the Closing Time the LPBP
      Consent, all consents or waivers of applicable third parties, including other
      shareholders and partners, required to transfer the Regional Assets owned by
      them and all material consents or waivers of the landlords and other third
      parties in respect of the Non-Assignable Contracts and the Non-Assigned Leases,
      and shall provide and deliver all notices, if any, required by the terms of
      the
      Contracts, the Leases, the Equipment Leases, the Warranty Rights and the
      Transferable Licences included in the Purchased Assets in connection with the
      transactions contemplated herein. For greater certainty, this Section shall
      not
      obligate any Seller to make payment to any such shareholder, partner or other
      third party nor any payment, other than to cover administrative, processing
      or
      similar fees or any other amounts contemplated in any Non-Assignable Contracts
      in connection with the assignment thereof, to any landlord or other third party
      or to institute legal or arbitration or other proceedings to obtain such
      consents or waivers.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.1.4</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Privacy</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MDS
      and
      Buyer acknowledge and agree that certain information provided to Buyer or any
      Designated Buyer Affiliate in connection with the transactions contemplated
      hereunder constitutes Personal Information (the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Disclosed
      Personal Information</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
      the
      disclosure of which is necessary for the purposes (the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Purposes</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
      of
      both determining if Buyer or the Designated Buyer Affiliate shall proceed with,
      and completing, the transactions, and thereafter for carrying on the Diagnostics
      Business and that:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                Disclosed Personal Information may not be used or disclosed by Buyer
                or
                the Designated Buyer Affiliate for any purpose other than the
                Purposes;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                Disclosed Personal Information must be kept strictly confidential
                and
                Buyer or the Designated Buyer Affiliate shall ensure that access
                to the
                Disclosed Personal Information shall be restricted to those
                representatives of Buyer who have a bona fide need for access to
                the
                Disclosed Personal Information for the Purposes and shall instruct
                those
                representatives to protect the confidentiality of such information
                in a
                manner consistent with the obligations of Buyer and or the Designated
                Buyer Affiliate hereunder and under the Confidentiality Agreement;
                </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">if
                the transactions contemplated hereby do not proceed or are not completed,
                Buyer and the Designated Buyer Affiliate shall destroy or return
                to MDS,
                as directed by MDS, the Disclosed Personal Information;
                and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">if
                the transactions contemplated hereby are completed, (i) Buyer and
                the
                Designated Buyer Affiliate shall only use or disclose the Disclosed
                Personal Information for the same purposes for which it was collected,
                used or disclosed by MDS or the Operators; and (ii) Buyer and the
                Designated Buyer Affiliate shall (A) not use or communicate the Quebec
                Personal Information to a third party unless and until, and to the
                extent,
                the Buyer obtains the consent of such individual to do so, and (B)
                develop
                and implement such policies and procedures as Buyer considers appropriate
                to ensure that the Buyer meets the commitment set forth in (A) of
                this
                Subsection</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.1.4(d)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.1.5</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Injunctions</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If
      any
      court having jurisdiction over the Parties or any Seller issues any injunction,
      decree or similar order before the Closing Time which would prohibit or
      materially restrict or hinder the Closing, the Parties shall use their
      respective commercially reasonable efforts to have such injunction, decree
      or
      order dissolved or otherwise eliminated as promptly as possible and, in any
      event, prior to the Closing Time.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.1.6</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Access
      for Investigation</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject
                to and in compliance with Applicable Law, including the Competition
                Act,
                and the Confidentiality Agreement during the Interim Period, MDS
                shall
                permit Buyer and its Representatives to have access during normal
                business
                hours to the Purchased Assets, such portions of the Shared Contracts
                as
                relate to the Diagnostics Business, the Replacement Contracts and
                the
                Migrating Assets, in each case, once acquired, and the Books and
                Records
                over which it or an Operator exercises control on condition that
                no Person
                given access interferes with the ordinary conduct of the Diagnostics
                Business by MDS or any Operator and MDS shall furnish to Buyer such
                operating data and other information with respect to the Diagnostics
                Business, the Purchased Assets, such portions of the Shared Contracts
                as
                relate to the Diagnostics Business, to the extent related to the
                Diagnostics Business, the Replacement Contracts and the Migrating
                Assets
                in the possession or control of MDS as Buyer shall from time to time
                reasonably request. MDS agrees that Buyer may conduct such environmental
                investigations and tests on the Real Property included in the Purchased
                Assets as Buyer, acting reasonably, considers necessary, at Buyer&#8217;s
                expense and provided that no damage is caused to such Real Property
                and
                the condition of the Real Property is restored substantially to its
                pre-investigation condition and that such investigations and tests
                do not
                interfere with the ordinary conduct of the Diagnostics Business.
                Buyer
                shall indemnify and hold harmless MDS and the Operators of and from
                and
                against all actions, causes of actions, suits, claims, demands, damages,
                losses, costs or expenses suffered or incurred by any of them to
                the
                extent Buyer does not comply with the foregoing obligations with
                respect
                to the conduct of any such investigations and tests. Buyer shall
                forthwith
                provide to MDS a copy of the results of such investigations and tests
                and
                shall not disclose and shall cause any Person who prepared a report
                based
                on such investigations and tests not to disclose, any information
                relating
                to such investigations and tests or contained in any such report
                to any
                Person unless compelled to do so by Applicable Law. Except as set
                forth in
                this Agreement, the exercise of any rights of access or inspection
                by or
                on behalf of Buyer under this Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.1.6</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                will not affect or mitigate the covenants, representations and warranties
                of MDS in this Agreement which will continue in full force and effect
                as
                provided in this Agreement.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject
                to the terms of the Confidentiality Agreement and Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.1.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
                both prior to the Closing Date and, if the sale and purchase of the
                Purchased Assets hereunder fails to occur for whatever reason, thereafter
                Buyer will not disclose to anyone or use for its own or for any purpose
                other than the purpose contemplated by this Agreement any confidential
                information concerning MDS or an Operator or the Diagnostics Business
                obtained by Buyer pursuant hereto, will hold all such information
                in the
                strictest confidence and, if the sale and purchase of the Purchased
                Assets
                hereunder fails to occur for whatever reason, will return to MDS
                or, at
                the request of MDS, destroy all documents, records and all other
                information or data relating to MDS or the Operators or to the Diagnostics
                Business which Buyer obtained pursuant to this
                Agreement.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">From
                and after the Closing Date, Sellers will not disclose to anyone or
                use for
                any purpose any confidential information concerning the Purchased
                Assets,
                the Replacement Contracts, the Migrating Assets or the Diagnostics
                Business purchased by Buyer pursuant to this Agreement and will hold
                all
                such information in the strictest confidence, in each case, except,
                upon
                prior notice to Buyer, to defend any claim or other proceeding as
                contemplated in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
                the filing of Tax Returns or dealing with any other matters contemplated
                in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                or
                </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.5</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
                or as required by Applicable Law. </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.1.7</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>75
      and 100 International Blvd.</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At
      the
      Closing Time and conditional upon Closing, MDS and Buyer and/or the applicable
      Designated Buyer Affiliates shall execute and deliver a license of certain
      premises at each of 75 and 100 International Boulevard (collectively, the
&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>International
      Boulevard Licenses</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
      on
      mutually acceptable terms to the extent the applicable real estate Migration
      Projects are not completed by the Closing Time.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.2</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Regulatory
      Consents</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.2.1</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Competition
      Act Filings</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
      shall use its best efforts to obtain Competition Act Clearance. Buyer shall
      co-operate with MDS and keep MDS informed as to the status of the proceedings
      related to all applications, notifications and filings relating to Competition
      Act Clearance. MDS will co-operate with Buyer and provide reasonable assistance
      to Buyer in obtaining Competition Act Clearance.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Without
      limiting the generality of the foregoing, as soon as practicable and in any
      event within ten (10) Business Days after the date of this Agreement (or within
      such other period of time as the Parties may agree), on the written election
      of
      Buyer, the Parties will prepare and file with the Commissioner:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">an
                application for an advance ruling certificate under section 102 of
                the
                </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Competition
                Act</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                in
                respect of the transactions contemplated by this Agreement, together
                with
                a request that a No-Action Letter be issued and a waiver under subsection
                113(c) of the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Competition
                Act</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                be
                granted if an advance ruling certificate is not issued. Where a waiver
                under subsection 113(c) of the Competition Act is not granted, on
                the
                written election of Buyer given at any time, Buyer and the Sellers
                shall
                promptly prepare and file a short-form pre-merger notification (and
                if the
                Commissioner requests a long-form, they shall prepare and file a
                long-form
                in addition to or in lieu of a short-form) pursuant to Part IX of
                the
                Competition Act in respect of the transactions contemplated by this
                Agreement; or</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a
                short-form pre-merger notification (and if the Commissioner requests
                a
                long-form, they shall file a long-form in addition to or in lieu
                of a
                short-form) pursuant to Part IX of the Competition Act in respect
                of the
                transactions contemplated by this Agreement, together with a competitive
                impact submission and a request that an advance ruling certificate
                or
                No-Action Letter be issued.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.2.2</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Competition
      Act Clearance Process</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
      and
      MDS shall promptly furnish to the Commissioner, or her authorized representative
      under the Competition Act, any additional information required or reasonably
      requested under the Competition Act. All requests and enquiries from the
      Commissioner or her authorized representative under the Competition Act will
      be
      dealt with by MDS and Buyer in consultation with the other. MDS and Buyer
      will:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">not
                extend or consent to any extension of any waiting period under the
                Competition Act or enter into any agreement with the Commissioner,
                or her
                authorized representative under the Competition Act, to not consummate
                any
                of the transactions contemplated in this Agreement, including under
                any
                Regional Purchase Agreement, except with the consent of the
                other;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">promptly
                notify the other of written communications of any nature from the
                Commissioner, or her authorized representative under the Competition
                Act,
                relating to such transactions and provide the other with copies thereof,
                except to the extent of competitively sensitive information, which
                competitively sensitive information will be provided only to the
                external
                legal counsel and/or external expert of the other and will not be
                shared
                by such counsel or expert with any other
                Person;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">permit
                the other to review in advance any proposed written communications
                of any
                nature with the Commissioner, or her authorized representative under
                the
                Competition Act, relating to such transactions, and provide the other
                with
                final copies thereof, except to the extent of competitively sensitive
                information, which competitively sensitive information will be provided
                only to the external legal counsel and/or external expert of the
                other and
                will not be shared by such counsel with any other Person;
                and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">not
                participate in any substantive meeting or discussion (whether in
                person,
                by telephone or otherwise) with the Commissioner, or her authorized
                representative under the Competition Act, in respect of any filings,
                investigation or inquiry concerning such transactions unless it consults
                with the other in advance and gives the other the opportunity to
                attend
                and participate thereat (except where the Commissioner, or her authorized
                representative under the Competition Act, expressly requests that
                the
                other should not be present at the meeting or discussion or part
                or parts
                of the meeting or discussion).</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.2.3</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Filing
      Fees</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      responsibility for payment of the required filing fees and applicable Taxes
      thereon payable in connection with the Competition Act Clearance will be for
      the
      account of Buyer and such expenses will include any fines, penalties and other
      costs resulting from the failure to make any such filings as a result of the
      Buyer&#8217;s actions or failure to act. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.2.4</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Other
      Regulatory Consents</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
      addition to its obligations in respect of Regulatory Consents under the
      Competition Act, Buyer shall, at its own expense, subject to obtaining the
      reasonable cooperation and assistance of MDS, use all commercially reasonable
      efforts to obtain by the Closing Time all other Regulatory Consents in respect
      of the Diagnostics Business in Ontario and Quebec. MDS shall cause the Sellers
      to reasonably co-operate with and assist Buyer during the Interim Period in
      order to permit Buyer to obtain such Regulatory Consents. Subject to Applicable
      Law and the Confidentiality Agreement, the Parties will coordinate and
      co-operate with one another in exchanging such information and supplying such
      assistance as may be reasonably requested by each in connection with the
      foregoing including providing each other with all notices and information
      supplied or filed with any Governmental Authority after the date hereof (except
      for notices and information which MDS or Buyer in each case acting reasonably,
      considers confidential and competitively sensitive which may be filed on a
      confidential basis) and all notices or correspondence received from any
      Governmental Authority.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.3</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Bulk
      Sales</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
      waives compliance with the provisions of the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Bulk
      Sales Act</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      (Ontario) and any other applicable bulk sales legislation in connection with
      the
      purchase and sale of the Purchased Assets contemplated in this
      Agreement.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.4</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Buyer&#8217;s
      Covenants</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.4.1</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Employees</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Prior
                to the Closing Time, but conditional upon the completion of the Closing,
                Buyer or the applicable Designated Buyer Affiliate shall offer employment
                to all the Ontario Employees and Quebec Employees on terms and conditions
                which are substantially comparable in the aggregate to those upon
                which
                such Employees are employed by the relevant Seller at the Closing
                Time
                including under the short-term incentive plan applicable to each
                such
                Employee provided that it is agreed that such offer by Buyer will
                not
                include any stock option or stock purchase plan entitlement. Buyer
                will
                develop and implement a long-term performance based incentive plan
                or
                other compensation scheme to be effective on or about January 1,
                2007, for
                senior management of the Diagnostics Business in recognition that
                Buyer is
                not able to offer a stock option or stock purchase plan. Buyer neither
                represents nor warrants that such long-term performance based incentive
                plan or other compensation scheme will be equivalent to any stock
                option
                or stock purchase plan currently provided by MDS. In making such
                offer,
                Buyer or the applicable Designated Buyer Affiliate shall take into
                account
                the aggregate compensation and benefits (including, as applicable,
                the
                short term incentive plan) enjoyed by the Ontario Employees and Quebec
                Employees and the existing seniority and length of service of the
                Ontario
                Employees and Quebec Employees.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Until
                the Closing Time, each Seller shall be responsible for all wages,
                bonuses,
                earned vacations, sick leave, termination and severance pay, and
                other
                remuneration and benefits for all of their Employees. On and after
                the
                Closing Time, Buyer or the applicable Designated Buyer Affiliate
                shall be
                responsible for all wages, bonuses, earned vacations, sick leave,
                termination and severance pay and other remuneration and benefits
                under
                Buyer&#8217;s Benefits Plans with respect to the Employees who accept Buyer&#8217;s or
                the applicable Designated Buyer Affiliate&#8217;s offer of employment. For
                greater certainty, each Seller shall be responsible for all termination
                and severance costs related to the termination by such Seller of
                any
                Ontario Employee or Quebec Employee who refuses the offer of employment
                made in accordance with Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.4.1(a)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If
                Buyer, a Designated Buyer Affiliate or an Operator acquired by Buyer
                or a
                Designated Buyer Affiliate terminates any Employee within six (6)
                months
                of the Closing Time, Buyer shall, or shall cause the applicable Designated
                Buyer Affiliate or Operator to, provide such Employee with termination
                and
                severance pay at least as favourable as that for which such Employee
                would
                have been entitled to receive under the severance policy or employment
                contract applicable to such Employee immediately prior to the Closing
                Time
                other than with respect to any entitlement under an employee stock
                option
                plan or employee share purchase plan or any retention, change of
                control
                or deal bonus pertaining to the sale of the Diagnostics
                Business.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.4.2</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Cooperation</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
      shall co-operate with and assist Sellers during the Interim Period in order
      to
      permit the Closing to be consummated. In particular, Buyer shall provide to
      the
      applicable third party partners and shareholders in respect of the Regional
      Assets and the lessors and other third parties under the Leases, Equipment
      Leases and Contracts included in the Purchased Assets all such information
      relating to Buyer and the applicable Designated Buyer Affiliate including
      financial information, information relating to its business experience and
      the
      business experience of the individuals who ultimately control and operate Buyer
      and the applicable Designated Buyer Affiliate and with respect to their ability
      to perform their obligations under the applicable partnership agreement and
      shareholders&#8217; agreement relating to such Purchased Assets and such Leases,
      Equipment Leases and Contracts and operate the Diagnostics Business, as may
      be
      reasonably required by such Persons in order to obtain the consents of such
      Persons to the transfer of such Purchased Assets to Buyer or the applicable
      Designated Buyer Affiliate.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.5</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Benefit
      Plans</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As
                soon as practicable after the Closing Date, but effective as of the
                Closing Time, Buyer or the applicable Designated Buyer Affiliate
                shall
                establish and register with the applicable Governmental Authorities,
                or
                shall otherwise cause to be provided, one or more pension plans or
                other
                retirement savings arrangements for those Ontario Employees and Quebec
                Employees who accepted the Buyer&#8217;s or the Designated Buyer Affiliate&#8217;s, as
                the case may be, offer of employment who participated in a Pension
                Plan
                immediately prior to the Closing Time (the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Buyer&#8217;s
                Pension Plans</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
                each of which shall contain benefit provisions which are substantially
                comparable, in the aggregate, to those provided under the Pension
                Plan in
                which the Ontario Employees and Quebec Employees who accepted the
                Buyer&#8217;s
                or Designated Buyer Affiliate&#8217;s, as the case may be, offer of employment,
                respectively, participated immediately prior to the Closing Time.
                Buyer or
                the applicable Designated Buyer Affiliate shall also establish or
                otherwise provide a pension fund or other funding arrangement for
                each
                Buyer&#8217;s Pension Plan. Buyer&#8217;s Pension Plans shall provide that for the
                purposes of eligibility for membership, vesting and continued benefit
                accrual, service by Ontario Employees and Quebec Employees who accepted
                the Buyer&#8217;s or Designated Buyer Affiliate&#8217;s, as the case may be, offer of
                employment recognized under a Pension Plan shall be recognized as
                continuous unbroken service with Buyer or the applicable Designated
                Buyer
                Affiliate. Buyer or the applicable Designated Buyer Affiliate further
                agrees to provide the applicable Seller with such documentation and
                information as it may reasonably require to satisfy itself that the
                Buyer&#8217;s Pension Plans and the pension funds therefor have been properly
                established or otherwise provided, as applicable, in accordance with
                this
                Section. For those Ontario Employees and Quebec Employees who join
                a
                Buyer&#8217;s Pension Plan that is a &#8220;registered pension plan&#8221; as that term is
                defined in subsection 248(1) of the ITA, MDS shall cause the Pension
                Plans
                in which such employees participated immediately prior to the Closing
                Time
                to recognize service of such employees with Buyer or the applicable
                Designated Buyer Affiliate after the Closing Time for purposes of
                vesting
                and eligibility for benefits.</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At
                the Closing Time, Buyer or the applicable Designated Buyer Affiliate
                shall
                make available to the Ontario Employees and Quebec Employees who
                accepted
                the Buyer&#8217;s or the applicable Designated Buyer Affiliate&#8217;s, as the case
                may be, offer of employment benefits, in addition to those provided
                under
                the Buyer&#8217;s Pension Plans, which are substantially comparable, in the
                aggregate to those provided under the Benefit Plans which currently
                are
                applicable to such Employees (&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Buyer&#8217;s
                Benefit Plans</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;).
                For the purposes of Buyer&#8217;s Benefit Plans, Buyer or the applicable
                Designated Buyer Affiliate agrees to credit the Employees who accepted
                the
                Buyer&#8217;s or the applicable Designated Buyer Affiliate&#8217;s offer of employment
                with eligibility and vesting service on and after the Closing Time
                for
                such Employees&#8217; service prior to the Closing Time recognized by the
                applicable Benefit Plans. Buyer or the applicable Designated Buyer
                Affiliate agrees to waive any pre-existing medical condition or similar
                restriction in any Buyer&#8217;s Benefit Plans only to the extent an Employee
                has coverage on the Closing Date under the Benefit Plans which currently
                are applicable to such Employee notwithstanding such pre-existing
                medical
                condition or similar restriction. Buyer or the applicable Designated
                Buyer
                Affiliate will credit amounts paid by such Employees during the 2006
                plan
                year as deductibles or co-payments under the applicable Benefit Plan
                toward the total deductible and/or co-payment requirements under
                the
                applicable Buyer&#8217;s Benefit Plan after the Closing Time. With respect to
                any flexible benefit arrangements, Buyer or the applicable Designated
                Buyer Affiliate will provide credit under the applicable Buyer&#8217;s Benefit
                Plan after the Closing Time for the net unused benefits remaining
                including, for greater certainty, the balance in the health spending
                account of any such Employee. MDS or the applicable Seller shall
                remain
                responsible for those Liabilities under any Benefit Plan in connection
                with claims incurred with respect to Employees before the Closing
                Time. No
                Seller shall be responsible for any Liabilities under any Benefit
                Plan in
                connection with claims incurred at or after the Closing Time with
                respect
                to any Ontario Employees or Quebec Employees who accepted the offer
                of
                employment of the Buyer or applicable Designated Buyer
                Affiliate.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Effective
                as of the Closing Time, each Employee who is a participant in any
                Benefit
                Plan shall cease to be an active participant in such Benefit Plan
                and the
                applicable Seller shall be responsible for any benefits accrued by
                or
                payable to any Employee under such Benefit Plan up to the Closing
                Time.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Effective
                as of the Closing Time, each Seller shall assign to Buyer or the
                applicable Designated Buyer Affiliate, and Buyer or the applicable
                Designated Buyer Affiliate shall assume all of Sellers&#8217; Liabilities and
                responsibilities with respect to death or medical benefits (whether
                or not
                insured), with respect to Ontario Employees and Quebec Employees
                who
                accepted the Buyer&#8217;s or applicable Designated Buyer Affiliate&#8217;s, as the
                case may be, offer of employment beyond retirement or other termination
                of
                service.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For
                greater certainty, effective as of the Closing Time, each Seller
                shall
                cease to have any Liabilities or obligations in respect of those
                Benefit
                Plans to which it did not contribute or was not required to contribute
                and
                for which its obligations were limited to providing administrative
                services in respect thereto, provided that nothing in this Subsection
                </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.5(e)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                shall relieve any obligation of a Seller to provide benefits after
                the
                Closing Time as provided by this Agreement to Ontario Employees and
                Quebec
                Employees who do not accept Buyer&#8217;s or the applicable Designated Buyer
                Affiliate&#8217;s, as the case may be, offer of
                employment.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.6</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Limited
      Trade Mark Licence</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At
      the
      Closing Time and conditional upon Closing, MDS and Buyer and/or the Designated
      Buyer Affiliates shall execute and deliver a limited trade mark licence
      agreement (the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Limited
      Trade Mark Licence</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
      in the
      form of agreement attached as Schedule 5.6 hereto.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.7</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Migration
      Agreement</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Contemporaneously
      with the execution of this Agreement by the Parties, MDS and Buyer and/or the
      Designated Buyer Affiliates have executed and delivered a migration agreement
      (the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Migration
      Agreement</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
      in the
      form of agreement attached as Schedule 5.7(a) hereto. At the Closing Time and
      conditional upon Closing, MDS and Buyer and/or the Designated Buyer Affiliates
      shall execute and deliver a licence agreement in respect of the CBS IP (the
      &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>CBS
      License Agreement</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
      in the
      form of agreement attached as Schedule </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.7</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)
      hereto.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.8</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Non-Competition
      Agreement</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At
      the
      Closing Time and conditional upon Closing, MDS and Buyer and/or the Designated
      Buyer Affiliates shall execute and deliver a non-competition and
      non-solicitation agreement (the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Non-Competition
      Agreement</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
      in the
      form of agreement attached as Schedule 5.8 hereto. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.9</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Support
      Services Agreement</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At
      the
      Closing Time and conditional upon Closing, MDS and Buyer and/or the Designated
      Buyer Affiliates shall execute and deliver a support services agreement (the
      &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Support
      Services Agreement</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;),
      which
      agreement shall be consistent with the term sheet attached hereto at Schedule
      </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.9</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      (the
&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Support
      Services Agreement Term Sheet</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
      and on
      terms and conditions mutually agreed to by the Parties. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.10</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Shared
      Contracts</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
      and
      MDS shall use commercially reasonable efforts to cause each of the Shared
      Contracts to be split into two contracts, one with respect to the rights
      relating to the Diagnostics Business in Ontario and Quebec and, as applicable
      British Columbia, in favour of Buyer or the applicable Designated Buyer
      Affiliate and the other with respect to the rights not relating to such
      Diagnostics Business in favour of MDS. Each Shared Contract will only be split
      upon the mutual agreement of MDS, Buyer (or, as applicable, the Designated
      Buyer
      Affiliate) and the applicable third party as to the terms of each of the
      contracts resulting from the split thereof. Subject to the foregoing, the
      Parties acknowledge and agree that: (i) each of the Parties (and in the case
      of
      Buyer, any Designated Buyer Affiliate, as applicable) shall co-operate and
      work
      together with the other Party and the applicable third party to achieve such
      splitting; (ii) no Seller shall be obliged to commence arbitration or any other
      legal proceeding or make any payments to third parties other than any
      administrative, processing or similar fee in connection with such splitting;
      (iii) for any Shared Contract, the Parties may not be able to obtain terms
      and
      conditions in each of the contracts resulting from a split thereof that are
      identical to or as favourable as the terms and conditions of such Shared
      Contract prior to the split; and (iv) MDS shall not be obligated to amend,
      terminate, extend, renew or replace any Shared Contract to effect any split
      of
      such Shared Contract until such time as it is satisfied as to the terms and
      conditions of such amendment or new, extended, renewed or replacement contract,
      if any, as the case may be. Each reference in this Agreement relating to the
      assignment or non-assignment of Non-Assignable Contracts shall, as it pertains
      to Shared Contracts, be deemed to be a reference to the intended splitting
      of
      such Shared Contracts as described in this Section. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.11</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Designated
      Buyer Affiliates</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MDS
      acknowledges that Buyer shall, prior to Closing, designate in writing one or
      more Affiliates of Buyer or OMERS Administration Corporation, acceptable to
      MDS,
      acting reasonably or as set forth in Schedule 2.5</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(each
      a
&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Designated
      Buyer Affiliate</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
      to
      become party to this Agreement so as to acquire certain of the Purchased Assets,
      Replacement Contracts and Migrating Assets as contemplated under Schedule 2.5.
      Each Designated Buyer Affiliate shall execute a contract of adhesion agreeing
      to
      be bound by this Agreement as if an original party hereto, containing
      representations and warranties of the Designated Buyer Affiliate in favour
      of
      MDS and the Operators the same as those of Buyer set forth in Section
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>mutatis
      mutandis</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      and
      otherwise in form and substance satisfactory to the Parties. Upon such
      Designated Buyer Affiliate executing and delivering to MDS such contract of
      adhesion, such Designated Buyer Affiliate shall be a Party and all references
      herein to Buyer (other than in Sections </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.5</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.6</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      and
      6.2.1) shall include such Designated Buyer Affiliate as the context requires.
      Notwithstanding the foregoing, Buyer shall remain jointly and severally liable
      with such designated Affiliates of Buyer and shall cause all of its covenants
      and obligations hereunder to be observed and performed by such
      Affiliates.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.12</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Confidentiality
      </strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Prior
                to the Closing Time, MDS shall request that the other parties to
                the Other
                Confidentiality Agreements return and destroy all Confidential Information
                (as defined in the Other Confidentiality Agreements) and provide
                evidence
                of having done so to Buyer at Closing.
</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Prior
                to the Closing Time, the Sellers and Buyer shall enter into a
                confidentiality agreement in the form of agreement attached as Schedule
                </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.12</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.13</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Transaction</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Structure</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Prior
      to
      the Closing, the Parties agree to co-operate in structuring the sale of the
      Purchased Assets as set forth in Schedule 2.5 and, to the extent necessary,
      any
      amendments made thereto with the consent of the Parties prior to the Closing
      Time, subject to the following:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                Buyer will structure the implementation of steps 2 and 13 (the
                &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Buyer
                Purchase Structure</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
                as set forth in Schedule 2.5 in a manner so that no costs and expenses
                (including, without limitation, legal fees and disbursements) will
                be
                borne by MDS or any of the other Sellers and Buyer will be solely
                responsible for any and all Taxes actually incurred by MDS in connection
                with or in any way related to the implementation of the Buyer Purchase
                Structure and any costs and expenses (including, without limitation,
                legal
                fees and disbursements) actually incurred by MDS or the Sellers in
                the
                event of the termination or unwinding of such steps of the Buyer
                Purchase
                Structure should Closing not occur (unless Closing does not occur
                as a
                result of the failure of MDS to satisfy any conditions precedent
                within
                its control), and the Buyer shall indemnify and reimburse MDS and
                the
                Sellers forthwith, on an as incurred basis, for any and all such
                Taxes,
                costs and expenses;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">without
                restricting the application of paragraph (a) above, MDS agrees to
                reasonably cooperate with Buyer in respect of any required or desired
                amendment to Schedule 2.5 following the date of this Agreement; provided,
                however, that (i) if MDS or any of the Operators incurs
                incremental</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Taxes
                in connection with or in any way related to the subject matter of
                the
                amendment, or (ii) if such amendment materially increases the risk
                for
                liability to Tax to MDS or any of the Operators, and MDS or any of
                the
                Operators incurs Taxes in connection with or in any way related to
                the
                subject matter of such amendment, in both (i) and (ii) as determined
                by
                MDS, acting reasonably, Buyer shall be solely responsible for any
                and all
                such Taxes. In the event of any such amendment, Buyer shall be responsible
                for all costs and expenses (including, without limitation, all legal
                fees
                and disbursements) actually incurred by MDS or any of the Operators
                in
                connection with or in any way related to implementation of the subject
                matter of any such amendment to Schedule 2.5. Buyer shall indemnify
                and
                reimburse each of MDS and the Operators forthwith, on an as incurred
                basis, for any and all such Taxes, costs and expenses so incurred;
                </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">without
                restricting the application of paragraph (a) above, Buyer agrees
                to
                reasonably cooperate with MDS in respect of any required or desired
                amendment to Schedule 2.5 following the date of this Agreement; provided,
                however, that (i) if Buyer or any Designated Buyer Affiliate incurs
                incremental</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Taxes
                in connection with or in any way related to the subject matter of
                the
                amendment, or (ii) if such amendment materially increases the risk
                for
                liability to Tax to Buyer or any Designated Buyer Affiliate, and
                Buyer or
                any Designated Buyer Affiliate incurs Taxes in connection with or
                in any
                way related to the subject matter of such amendment, in both (i)
                and (ii)
                as determined by Buyer, acting reasonably, MDS shall be solely responsible
                for any and all such Taxes. In the event of any such amendment, MDS
                shall
                be responsible for all costs and expenses (including, without limitation,
                all legal fees and disbursements) actually incurred by Buyer or any
                Designated Buyer Affiliate in connection with or in any way related
                to
                implementation of the subject matter of any such amendment to Schedule
                2.5. MDS shall indemnify and reimburse each of Buyer or any Designated
                Buyer Affiliate forthwith, on an as incurred basis, for any and all
                such
                Taxes, costs and expenses so incurred;
                and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                obligation of the Parties set forth in this Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.13</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                shall, notwithstanding any other provision of this Agreement to the
                contrary, survive completion or termination of this Agreement and
                the
                transactions contemplated hereby and shall continue in full force
                and
                effect for the benefit of the other Party until 60 days after the
                expiration of the period during which, in the absence of any waiver
                or
                other document extending such period, an assessment, reassessment
                or other
                form of recognized document assessing liability for Taxes could be
                issued
                under applicable Tax laws.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>5.14</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Replacement</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Material</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Contracts</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notwithstanding
      anything in this Agreement, including Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.1.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      in
      proceeding to seek any necessary consent to the assignment of any Contracts
      contemplated in Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.1.5(b)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      if, in
      MDS&#8217; reasonable estimation, after having made commercially reasonable efforts to
      do so (which efforts shall not include commencing arbitration or any other
      legal
      proceeding), the applicable third party to any particular Contract other than,
      for the avoidance of doubt, a Lease (a &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Subject
      Contract</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
      will
      not, on or prior to the Closing Time, provide its consent to the assignment
      of
      the Subject Contract to Buyer or the applicable Designated Buyer Affiliate
      or
      will not provide such consent without requiring MDS to pay any amount other
      than
      an amount contemplated to be payable by MDS under Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.3</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      then
      MDS may satisfy the condition in Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.1.5(b)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      by
      securing on or prior to the Closing an equivalent substitute for such Subject
      Contract and assigning such equivalent substitute Contract to the Buyer or
      the
      applicable Designated Buyer Affiliate on the Closing and the provisions of
      Subsection&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.3(b)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      shall
      not apply to such Subject Contract. Whether MDS shall have secured, on or before
      the BC Closing, an equivalent substitute for a Subject Contract shall be (i)
      determined by the President, Senior Vice-President, Finance and, in respect
      of a
      Subject Contract pertaining to information technology, by the Senior
      Vice-President, Information Technology of the management team of the MDS
      Diagnostics Division, and (ii) evidenced by the delivery to Buyer on or before
      the BC Closing of an officers&#8217; certificate executed by each of such Persons
      certifying such determination in their respective view. Each such Person shall
      act reasonably in his determination under this Section.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ARTICLE&#160;6</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>CONDITIONS
      PRECEDENT</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>6.1</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Buyer&#8217;s
      Conditions</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject
      to Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      Buyer
      shall be obliged to complete the Closing only if each of the conditions
      precedent set forth in the following Subsections of this Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      have
      been satisfied in full at or before the Closing Time and the Closing is
      completed on or before March 15, 2007. Each of such conditions precedent is
      for
      the exclusive benefit of Buyer and Buyer may waive any of them in whole or
      in
      part in writing.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>6.1.1</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Accuracy
      of Representations and Performance of Covenants</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At
      the
      Closing Time, all of the representations and warranties of MDS made in or
      pursuant to this Agreement shall be true and correct in all material respects
      as
      if made at and as of the Closing Time, except: (i) with respect to Subsection
      </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.19(a)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      only, to
      the extent that any inaccuracy thereof does not individually or in the aggregate
      have a Material Adverse Effect; (ii)&#160;as such representations and warranties
      may be affected by events or transactions expressly permitted by this Agreement
      or the BC Purchase Agreement or by Buyer, including, for greater certainty,
      the
      implementation of the Buyer Purchase Structure; and (iii) that the
      representations and warranties of MDS made in Subsections </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.13(c)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.15(j)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.20(b)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      and
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1.26</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      shall be
      true and correct as if made at and as of the Closing Time subject to any changes
      in the disclosure contained in the Disclosure Letter with respect to such
      representations which shall have been disclosed in writing to the Buyer prior
      to
      the Closing. At the Closing Time, MDS and its Affiliates shall have observed
      or
      performed in all material respects all of the obligations, covenants and
      agreements that they must perform at or before the Closing Time. Buyer shall
      have received immediately prior to Closing Time a certificate from a senior
      officer of MDS (without personal liability) certifying, to the best of such
      officer&#8217;s knowledge, information and belief that the conditions in this Section
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.1.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      have
      been satisfied.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>6.1.2</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Receipt
      of Closing Documentation</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
      documentation relating to the due authorization of the sale of the Purchased
      Assets, the Replacement Contracts and the Migrating Assets by the applicable
      Seller under this Agreement and the Closing Documents to which it is a party
      shall be mutually satisfactory to the Parties, acting reasonably.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>6.1.3</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Transfer
      of Real Property</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      transfers of the Real Property included in the Purchased Assets shall be in
      such
      forms as are customary for conveyances of real property on an &#8220;as is, where is&#8221;
basis, but in Ontario shall contain the statements contemplated in clauses
      50(22)(a) and (b) of the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Planning
      Act </em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Ontario).
      Buyer shall pay the cost of registration of the transfers to it and any land
      transfer Taxes payable with respect thereto. This Agreement is subject to
      compliance with the subdivision control provisions of the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Planning
      Act </em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Ontario)
      and any similar provisions under Applicable Law, and the Sellers covenant to
      comply with such provisions and obtain at their own expense any consents
      required in that regard prior to Closing. The Sellers and Buyer acknowledge
      and
      agree that in Ontario the transfer of real property will be completed by
      electronic registration pursuant to Part III of the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Land
      Registration Reform Act</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      R.S.O.
      1990, c.L4, as amended, and that the delivery of documents and the release
      thereof to the Buyer and Sellers shall be governed by a &#8220;Document Registration
      Agreement&#8221; to be entered into between the respective solicitors for the Buyer
      and the Sellers substantially in the current form prescribed by the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Law
      Society of Upper Canada</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>6.1.4</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>BC
      Closing</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
      conditions precedent to the BC Closing shall have been satisfied or waived,
      as
      applicable, save and except for the release from escrow of all BC Documents
      delivered in connection with the BC Closing, the [REDACTED] prior to the BC
      Closing as contemplated in Step 19 of Schedule 2.5 and the payment of the Cash
      Closing Amount (as defined in and under the BC Purchase Agreement).</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>6.1.5</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Consents
      and Other Conditions</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
                Regulatory Consents shall have been obtained or made on or before
                the
                Closing Time.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject
                to Section&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.14</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
                the Sellers shall have given or obtained, as the case may be, all
                of the
                notices, consents and approvals described in Schedule </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.1.5(b)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
                in all cases in form and substance satisfactory to the Buyer, acting
                reasonably.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each
                of the transactions included in Schedule 2.5 that are to have occurred
                prior to the Closing Time shall have been completed in the sequence
                contemplated therein to the satisfaction of the Buyer, acting
                reasonably.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>6.1.6</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Litigation</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There
      shall not be in force any Applicable Law or Order, and there shall not have
      been
      any action taken under any Applicable Law or by any Governmental Authority,
      that
      makes it illegal or otherwise restrains, enjoins or prohibits the Closing
      contemplated herein in accordance with the terms hereof in any material
      respect.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>6.1.7</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Material
      Adverse Change</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">No
      change
      which would constitute a Material Adverse Effect shall have occurred since
      the
      date hereof and Buyer shall have received immediately prior to the Closing
      Time
      a certificate from a senior officer of MDS (without personal liability)
      confirming to the best of his knowledge, information and belief that no Material
      Adverse Effect has occurred. For avoidance of doubt, the failure to obtain
      the
      necessary consent from the applicable third parties in respect of the transfer
      to Buyer of any of the Regional Assets or the exercise by any such third party
      of any right of first refusal shall not constitute a Material Adverse
      Effect.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>6.1.8</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Deliveries
      of MDS</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At
      the
      Closing Time, MDS shall, and shall cause MDS Quebec and subject to LPBP Consent,
      MDS ONT LP as applicable to, execute and deliver to Buyer in form and substance
      mutually satisfactory to the Parties, acting reasonably, all certificates,
      agreements, documents and instruments as required under this Agreement including
      the following:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a
                statutory declaration of each Seller that it is not a non-resident
                of
                Canada within the meaning of the
                ITA;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                Land transfers, Document Registration Agreements and Acknowledgements
                and
                Directions permitting electronic registration contemplated by Section
                </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.1.3</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
                together with all duplicate keys, combinations and codes in the possession
                or control of the Sellers to the locks in the buildings, offices,
                security
                devices and storage facilities relating to the Real Property and
                all
                permits, licences, contracts, agreements, records, drawings, plans,
                drawings, operating manuals, reports, studies, warranties and all
                other
                documents and information relating to the operation, maintenance
                and
                repair of the Real Property in the possession or control of the
                Sellers;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a
                general conveyance or bill of sale duly executed by each Seller,
                conveying
                to Buyer all of such Seller&#8217;s right, title, and interest in the Quebec
                Assets, the Ontario Assets, the Replacement Contracts and the Migrating
                Assets relating to or arising from each Migration Project that has
                been
                completed in accordance with the Migration Agreement, respectively
                (&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>General
                Conveyance</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;);</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">an
                assignment and assumption agreement duly executed by each Seller
                under
                which such Seller assigns its right, title and interest in and to
                the
                Leases, Contracts and Equipment Leases included in the Purchased
                Assets,
                the Replacement Contracts and the Migrating Assets relating to or
                arising
                from each Migration Project that has been completed in accordance
                with the
                Migration Agreement to Buyer and Buyer assumes the Assumed Liabilities
                (each an &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Assignment
                and Assumption Agreement</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;),
                together with all lessor consents to the assignments of the Leases
                obtained by the Closing Time, and an assignment of such Seller&#8217;s right,
                title and interest in any warranties relating to the Real
                Property;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">assignments
                duly executed by each Seller for the Intellectual Property Rights
                and
                Transferable Licences of such Seller included in the Purchased Assets
                or
                Migrating Assets in appropriate form for
                registration;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">an
                application for transfer of the motor vehicle registration permit
                duly
                executed by a Seller, as applicable, for each motor vehicle used
                exclusively in the Diagnostics Business and registered in the name
                of the
                Seller;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                Limited Trade Mark Licence;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(h)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                CBS License Agreement;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                Non-Competition Agreement;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(j)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                Support Services Agreement; </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(k)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">subject
                to Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.1(b)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                and Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
                the stock transfers, Partnership Interest transfers, resignations,
                releases and other documents to be delivered to Buyer on the Closing
                Date
                under the Regional Purchase
                Agreements;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(l)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">an
                opinion of counsel to MDS customary for a transaction of this nature;
                </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(m)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">if
                required under Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.1.7</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                or
                the Migration Agreement, the International Boulevard Licenses and
                Post-Closing Services Agreement, respectively;
                and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(n)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">such
                other certificates, instruments of conveyance and documents as may
                be
                reasonably requested by Buyer prior to the Closing Date to carry
                out the
                intent and purposes of this Agreement.
</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>6.1.9</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>LPBP
      Consent</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      LPBP
      Consent shall have been obtained on or before the Closing Time.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>6.1.10</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Migration
      Condition</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      condition set forth in Section 9.1 of the Migration Agreement shall have been
      satisfied or waived by the Buyer on or before the Closing Time. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>6.2</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Conditions</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>
      of MDS</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject
      to Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      MDS
      shall be obliged to complete the Closing only if each of the conditions
      precedent set forth in the following Subsections of this Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      has been
      satisfied in full at or before the Closing Time and the Closing is completed
      on
      or before March 15, 2007. Each of such conditions precedent is for the exclusive
      benefit of MDS and MDS may waive any of them in whole or in part in writing.
      </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>6.2.1</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Accuracy
      of Representations and Performance of Covenants</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At
      the
      Closing Time, all of the representations and warranties of Buyer and each
      Designated Buyer Affiliate made in or pursuant to this Agreement shall be true
      and correct in all material respects as if made at and as of the Closing Time,
      except as such representations and warranties may be affected by events or
      transactions expressly permitted by this Agreement. At the Closing Time, Buyer
      and each Designated Buyer Affiliate shall have observed or performed in all
      material respects all of the obligations, covenants and agreements that it
      must
      perform at or before the Closing Time. MDS shall have received immediately
      prior
      to Closing Time a certificate from a senior officer of Buyer certifying, to
      the
      best of such officer&#8217;s knowledge, information and belief, and without personal
      liability, that the conditions in this Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.2.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      have
      been satisfied.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>6.2.2</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Receipt
      of Closing Documentation</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
      documentation relating to the due authorization of the purchase of the Purchased
      Assets, the Replacement Contracts and the Migrating Assets by the Buyer and
      each
      Designated Buyer Affiliate under this Agreement and the Closing Documents to
      which it is a party shall be mutually satisfactory to the Parties, acting
      reasonably.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>6.2.3</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Litigation</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There
      shall not be in force any Applicable Law or Order, and there shall not have
      been
      any action taken under any Applicable Law or by any Governmental Authority,
      that
      makes it illegal or otherwise restrains, enjoins or prohibits the Closing
      contemplated herein in accordance with the terms hereof in any material
      respect.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>6.2.4</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Consents
      and Other Conditions</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
                Regulatory Consents</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">shall
                have been obtained or made on or before the Closing
                Time.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
                conditions set forth in Schedule</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.2.4(b)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                shall have been satisfied.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each
                of the transactions included in Schedule 2.5 that are to have occurred
                prior to the Closing Time shall have been completed in the sequence
                contemplated therein to the satisfaction of MDS, acting
                reasonably.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
                Buyer Purchase Structure shall not have resulted in any incremental
                Taxes
                for MDS or any Operator as a result of any change effective on or
                before
                11:59 p.m. on the day prior to the Closing in any applicable Tax
                law or
                the interpretation thereof by any applicable Governmental
                Authority.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>6.2.5</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Deliveries
      of Buyer</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At
      the
      Closing Time, Buyer and each Designated Buyer Affiliate as applicable shall
      execute and/or deliver to the applicable Seller in form and substance mutually
      satisfactory to the Parties, acting reasonably, all certificates, agreements,
      documents and instruments as required under this Agreement including the
      following:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">payment
                of the Closing Cash Amount in accordance with Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.9(b)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                General Conveyance, the Document Registration Agreements and
                Acknowledgements and Directions permitting electronic registration
                in
                respect of the transfer of the
                Lands;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a
                GST undertaking and indemnity regarding the self-assessment and remittance
                of GST applicable to the purchase of the Lands, as applicable, in
                lieu of
                the payment of GST on the Lands to the applicable Seller;
                </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                Assignment and Assumption Agreements, together, if requested by a
                party to
                any Lease, Contract or Equipment Lease, the agreement of Buyer directly
                with such party to assume all obligations thereunder from the Closing
                Time;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                Limited Trade Mark Licence;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                CBS License Agreement;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                Non-Competition Agreement; </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(h)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                Support Services Agreement;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">subject
                to Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.1(b)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                and Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
                the assumption agreements in respect of the partnership agreements
                and
                shareholders&#8217; agreements and other documents to be delivered by Buyer to
                the applicable Seller on Closing under the Regional Purchase
                Agreements;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(j)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                opinion of counsel to Buyer and any Designated Buyer Affiliates,
                as
                applicable; </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(k)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">if
                required under Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.1.7</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                or
                the Migration Agreement, the International Boulevard Licenses and
                Post-Closing Services Agreement, respectively;
</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(l)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">any
                costs payable by Buyer to MDS pursuant to Sections&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                and </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                of
                the Migration Agreement; and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(m)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">such
                other certificates, instruments of conveyance and documents as may
                be
                reasonably requested by MDS prior to the Closing Date to carry out
                the
                intent and purposes of this
                Agreement.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>6.2.6</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>LPBP
      Consent</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      LPBP
      Consent shall have been obtained on or before the Closing Time.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>6.2.7</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>BC
      Closing</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
      conditions precedent to the BC Closing shall have been satisfied or waived,
      as
      applicable, save and except for the release from escrow of all BC Documents
      delivered in connection with the BC Closing, [REDACTED] prior to the BC Closing
      as contemplated in Step 19 of Schedule 2.5 and the payment of the Cash Closing
      Amount (as defined in and under the BC Purchase Agreement).</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>6.3</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Waiver</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Either
      Party may waive, by written notice to the other Party, any condition set forth
      in this </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Article&#160;6</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      which is
      for its sole benefit. No waiver by a Party of any condition, in whole or in
      part, shall operate as a waiver of any other condition.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>6.4</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Failure
      to Satisfy Conditions</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject
      to Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      if any
      condition set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.1</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      or
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      is not
      satisfied at the Closing Time, or if it becomes apparent that any such condition
      cannot be satisfied at the Closing Time, the Party entitled to the benefit
      of
      such condition (the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>First
      Party</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
      may
      terminate this Agreement by notice in writing to the other Party and in such
      event:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">unless
                the other Party can show that the condition or conditions which have
                not
                been satisfied and for which the First Party has terminated this
                Agreement
                are reasonably capable of being performed or caused to be performed
                by the
                First Party or have not been satisfied by reason of a default by
                the First
                Party hereunder, the First Party shall be released from all obligations
                hereunder, except as contemplated in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10.10</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;
                and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">unless
                the First Party can show that the condition or conditions which have
                not
                been satisfied and for which the First Party has terminated this
                Agreement
                are reasonably capable of being performed or caused to be performed
                by the
                other Party or have not been satisfied by reason of a default by
                the other
                Party hereunder, then the other Party shall also be released from
                all
                obligations hereunder, except as contemplated in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10.10</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ARTICLE&#160;7</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>POST-CLOSING
      PROVISIONS</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      provisions of this Article 7 shall apply conditional upon Closing.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>7.1</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Insurance
      and Risk of Loss</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">From
                and after the Closing Time, Buyer shall place its own insurance on
                the
                Purchased Assets, the Replacement Contracts conveyed at that time
                and the
                Migrating Assets and the Diagnostics Business and none of MDS or
                the
                Operators shall have any obligation or Liabilities in respect of
                the
                Purchased Assets, the Replacement Contracts, the Migrating Assets,
                the
                Diagnostics Business or the Assumed Liabilities thereafter except
                as
                otherwise expressly provided in this Agreement.
</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MDS
                shall use commercially reasonably efforts to recover any Losses in
                respect
                of the Disclosed Matter under its policies of insurance. To the extent
                that such Losses are not covered by MDS&#8217; insurance policies, it shall
                notify Buyer and Buyer shall use commercially reasonable efforts
                to seek
                coverage for any such Loss under applicable workers&#8217; compensation
                legislation.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>7.2</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Litigation</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
      and
      the applicable Designated Buyer Affiliate shall reasonably co-operate with
      each
      Seller but, subject to the terms of </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Article&#160;8</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      at the
      expense of such Seller in order that such Seller may properly defend any claim,
      demand, suit, action, cause of action, dispute, proceeding, litigation,
      investigation, grievance, arbitration, governmental proceeding or other
      proceeding including appeals and applications for review, in progress against,
      by or relating to such Seller with respect to the Purchased Assets, the
      Replacement Contracts, the Migrating Assets, the Diagnostics Business or the
      Excluded Liabilities (including with respect to the partnerships and
      corporations in which the Seller holds an interest directly or indirectly)
      or
      any diagnostics business formerly operated by any Seller or any of its
      Affiliates or in which any Seller or an Affiliate thereof had any equity
      interest prior to the Closing Time in respect of a period of time prior to
      the
      Closing Time, whether brought before or after the Closing Time. In this
      connection, Buyer shall make reasonably available to Sellers those Employees
      knowledgeable about the matter in question and all books and records relating
      thereto and shall permit such employees to testify in all proceedings with
      respect thereto.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>7.3</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Post-Closing
      Access</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">After
      the
      Closing, upon reasonable notice, Buyer and the applicable Designated Buyer
      Affiliate and MDS and the other Sellers will give, or cause to be given, to
      the
      Representatives of the other, access, during normal business hours, to the
      books
      and records which relate exclusively to the Diagnostics Business (including
      with
      respect to the underlying partnerships and corporations of the Diagnostics
      Business) for the periods prior to the Closing Time, and will permit such
      persons to examine and copy such books and records to the extent reasonably
      requested by the other Party in connection with the preparation of Tax and
      financial reporting matters, audits, legal proceedings, governmental
      investigations and other business purposes. Each of Buyer and the applicable
      Designated Buyer Affiliate and MDS and the other Sellers will preserve such
      books and records for a period of seven years from Closing Date, or such longer
      period as is required by Applicable Law or a Governmental Authority in
      connection with a Licence or related audit, including an Ontario Health
      Insurance Plan audit. However, none of such Persons shall be obligated to take
      any action pursuant to this Section that would unreasonably disrupt the normal
      course of its business, violate the terms of any contract to which it is a
      party
      or to which it or any of its assets is subject or grant access to any of its
      proprietary, confidential or classified information. MDS, Buyer and any
      Designated Buyer Affiliate will co-operate with one another in the conduct
      of
      any Tax audit or similar proceedings involving or otherwise relating to the
      Diagnostics Business (or the income therefrom or assets thereof).</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>7.4</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Excluded
      Asset Adjustment</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To
      the
      extent a rebate, refund, royalty, credit or other amount contemplated by
      subsection (m) of the definition of &#8220;Excluded Assets&#8221; (each a &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Excluded
      Refund</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
      is
      paid to Buyer, a Designated Buyer Affiliate or an Operator and such Excluded
      Refund is not included in the Accounts Receivable on the Closing Balance Sheet
      and has not been received by MDS or Operator</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">prior
      to
      the Closing Time (an &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Unaccounted
      Excluded Refund</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;),
      and
      the Buyer, applicable Designated Buyer Affiliate or an Operator, or other Person
      to which the applicable Diagnostics Business has been transferred receives
      the
      Unaccounted Excluded Refund, directly or indirectly, after the Closing Time,
      Buyer, the applicable Designated Buyer Affiliate, Operator or other Person
      shall
      receive such Unaccounted Excluded Refund in trust for MDS, to the extent of
      the
      interest of MDS therein, and shall promptly notify MDS of such payment, provide
      to MDS an accounting of such Unaccounted Excluded Refund and pay to MDS all
      money received by such Person in respect of such Unaccounted Excluded Refund
      without any deduction, withholding or off set. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>7.5</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Tax
      Matters</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">After
                the Closing, Buyer or the applicable Designated Buyer Affiliate shall
                provide to MDS such information and assistance as is reasonably requested
                by MDS for the purposes of preparing any Tax Returns of Ontario GP,
                MDS
                ONT LP and MDS Quebec in respect of periods ending on or before the
                Closing Date and determining MDS&#8217; (or its Affiliates) liability for Taxes.
                </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">After
                the Closing Date, each Party shall provide to the other Party, at
                such
                other Party&#8217;s expense, such information and assistance as is reasonably
                requested by the other Party for the purpose of completing and filing
                any
                Tax Returns, claiming any refunds or credits and responding to, defending
                against or conducting any action, suit, proceeding, audit, investigation
                or claim in respect of Taxes. </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>7.6</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Privacy
      Notification</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
      and
      each Designated Buyer Affiliate shall notify the employees, customers, patients,
      directors, officers, securityholders and other Persons whose Personal
      Information is included within the Disclosed Personal Information that the
      Closing has taken place and Personal Information about them has been disclosed
      to Buyer and each Designated Buyer Affiliate to the extent and in the manner
      required by Applicable Law.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>7.7</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Other
      Confidentiality Agreements</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MDS
      shall, at the expense and reasonable request of Buyer, diligently enforce any
      and all rights and remedies available to it under the terms of the Other
      Confidentiality Agreements in respect of confidential information of the
      Diagnostics Business purchased by Buyer hereunder including by injunction or
      specific performance.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>7.8</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Post-Closing
      Reimbursements</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">After
      the
      Closing Time, should a Seller receive payment of any amount on account of any
      Accounts Receivable or Prepaid Expenses of the MDS Diagnostics Division
      reflected on the Closing Balance Sheet, such Seller shall receive such payment
      in trust for Buyer or the applicable Designated Buyer Affiliate and shall,
      within fifteen (15) Business Days after the end of each month in which any
      such
      payment was received, notify the Buyer or the applicable Designated Buyer
      Affiliate of such payment and pay to the Buyer or the applicable Designated
      Buyer Affiliate an amount equal to the money received by such Seller in respect
      of such payment without any deduction, withholding or off set. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">After
      the
      Closing Time, should a Seller make a payment of any amount on account of any
      Assumed Liability</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>&#160;</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">reflected
      on the Closing Balance Sheet, including for greater certainty any Employee
      wages, health, dental or other benefits and other remuneration, the Seller
      shall
      provide Buyer or the applicable Designated Buyer Affiliate with evidence of
      the
      payment and Buyer or the applicable Designated Buyer Affiliate shall, within
      fifteen (15) Business Days of receipt of such evidence, reimburse the Seller
      an
      amount equal to the amount paid without any deduction, withholding or off set.
      </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>7.9</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>No
      MDS Guarantees on Lease Renewals</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
      and
      the applicable Designated Buyer Affiliate shall not extend the term of any
      Lease
      or renew any Lease included in the Purchased Assets or the Replacement Contracts
      acquired in connection with this Agreement without the prior written consent
      of
      MDS unless no Seller shall have any Liability thereunder surviving beyond a
      period of twelve (12) months following Closing.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>7.10</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Post-Closing
      Conveyance of Migrating Assets</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MDS
      shall
      as soon as reasonably practicable after any Migrating Project is completed
      after
      Closing in accordance with the Migration Agreement, transfer and convey to
      the
      Buyer or a Designated Buyer Affiliate all of MDS&#8217; right, title and interest in
      and to the Migrating Assets relating to or arising from such Migration Project
      pursuant to a general conveyance or bill of sale, in form and substance mutually
      satisfactory to the Parties, acting reasonably.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>7.11</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Survival
      of Covenants</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All
      covenants and agreements of the Parties set forth in this Agreement to be
      performed after the Closing Date shall survive the Closing and remain in full
      force and effect indefinitely until fully performed.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>7.12</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>U.S.
      Non-Competition and Non-Solicitation Agreements</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      Buyer
      and each Designated Buyer Affiliate hereby agrees to (and to cause their
      respective Affiliates to) adhere to and be bound by each non-competition
      covenant and non-solicitation covenant, the waivers of defences relating thereto
      and the remedies for breach thereof, to which the applicable MDS Contracting
      Party (and its Affiliates) is subject pursuant to the agreements executed in
      connection with the sale of the MDS diagnostics business in the United States,
      as such agreements are listed in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.12</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      of the
      Disclosure Letter (the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>U.S.
      Non-Competition Agreements</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;),
      to
      the same extent (including for the periods of time) as the applicable MDS
      Contracting Party (and its Affiliates), as if Buyer and the Designated Buyer
      Affiliates were the original MDS Contracting Party under such U.S.
      Non-Competition Agreements. For certainty, such non-competition covenants,
      non-solicitation covenants, the waivers of defences relating thereto and the
      remedies for breach thereof consist of those provisions set out opposite the
      applicable U.S. Non-Competition Agreements in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.12</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      of the
      Disclosure Letter. The Buyer and its Designated Buyer Affiliates acknowledge
      and
      agree that the covenants set forth in this Section are reasonable, properly
      required in the circumstances and are necessary in connection with the purchase
      of the Purchased Assets and assumption of the Assumed Liabilities by Buyer
      and
      its Designated Buyer Affiliates pursuant to this Agreement and the BC Purchase
      Agreement.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ARTICLE&#160;8</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>INDEMNIFICATION</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>8.1</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Definitions</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As
      used
      in this </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Article&#160;8</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Claim</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      any act, omission or state of facts and any demand, action, investigation,
      inquiry, suit, proceeding, claim, assessment, judgment or settlement or
      compromise relating thereto which may give rise to a right to indemnification
      under Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      or
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.3</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Direct
      Claim</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      any Claim by an Indemnified Party against an Indemnifier which does not result
      from a Third Party Claim;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Indemnifier</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      any Party obligated to provide indemnification under this
      Agreement;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Indemnified
      Party</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      any Person entitled to indemnification under this Agreement;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Indemnity
      Payment</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      any amount of Loss required to be paid pursuant to Sections </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      or
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.3</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Loss</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      any and all loss, Liability, damage, cost, expense, charge, fine, penalty or
      assessment, suffered or incurred by the Person seeking indemnification directly
      resulting from or arising out of any Claim, including the costs and expenses
      of
      any action, suit, proceeding, investigation, inquiry, arbitration award,
      grievance, demand, assessment, judgment, settlement or compromise relating
      thereto, but (i) excluding loss of profits, indirect, incidental, special,
      punitive and consequential damages (which, for greater certainty, are deemed
      to
      include any Taxes payable by the Indemnified Party as a consequence of the
      receipt of an amount pursuant to </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Article&#160;8</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      hereof
      and provided that a Loss shall not be deemed an indirect Loss solely because
      the
      Loss is incurred by Buyer through a diminution in the value of its direct or
      indirect investment in an Operator); (ii) excluding any contingent Liability
      until it becomes actual; (iii) reduced by any net Tax benefit; and (iv) reduced
      by any recovery, settlement or otherwise under or pursuant to any insurance
      coverage, or pursuant to any claim, recovery, settlement or payment by or
      against any other Person; and</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Third
      Party Claim</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;
means
      any Claim asserted against an Indemnified Party by any Person who is not a
      Party
      or a Seller or an Affiliate of such a Person.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>8.2</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Indemnification
      by MDS</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject
      to the limits set forth in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.10</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      MDS
      shall indemnify, defend and save harmless Buyer, each Designated Buyer Affiliate
      and the Representatives of the Buyer and Designated Buyer Affiliate from and
      against any and all Loss suffered or incurred by any of them, as a result of,
      or
      arising in connection with:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">subject
                to Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.5</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
                any misrepresentation or breach of any warranty made or given by
                MDS in
                this Agreement or in any Closing
                Document;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">any
                failure by any Seller to observe or perform any covenant, agreement
                or
                obligation of such Seller contained in this Agreement or in any Closing
                Document; or</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">any
                Excluded Liability including for greater certainty, (i) all claims
                for
                severance or termination pay made by any Ontario Employee or Quebec
                Employee who does not accept Buyer&#8217;s offer of employment made in
                accordance with Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.4.1(a)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                and (ii) any Liability incurred by Buyer, a Designated Buyer Affiliate
                or
                the Operator of the Diagnostics Business [REDACTED] arising from
                the
                failure of the Sellers or Operators to obtain the consent of [REDACTED]
                to
                the Buyer or a Designated Buyer Affiliate prior to Closing;
                or</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">subject
                to compliance by Buyer with Subsection 7.1(b), any Claim related
                to the
                matter set forth in Section 4.1.6(3)(g) of the Disclosure Letter
                (the
                &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Disclosed
                Matter</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;).</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>8.3</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Indemnification
      by Buyer</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
      shall indemnify, defend and save harmless each Seller and the Representatives
      of
      each Seller from and against any and all Loss suffered or incurred by any of
      them, as a result of, or arising in connection with:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">subject
                to Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.6</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
                any misrepresentation or breach of any warranty made or given by
                Buyer or
                any Designated Buyer Affiliate in this Agreement or in any Closing
                Document;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">any
                failure by Buyer or any Designated Buyer Affiliate to observe or
                perform
                any covenant, agreement or obligation of Buyer or such Designated
                Buyer
                Affiliate contained in this Agreement or in any Closing Document;
                or</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">any
                Assumed Liability, including for greater certainty, those resulting
                from
                any Claim, which may be asserted by any Ontario Employee or Quebec
                Employee who accepts Buyer&#8217;s or the applicable Designated Buyer
                Affiliate&#8217;s offer of employment against any Seller in respect of the
                employment or termination of employment of such Employee by Buyer
                or the
                applicable Designated Buyer Affiliate or an Operator or any changes
                to the
                duties, terms and conditions of their employment at or after the
                Closing
                Time. </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>8.4</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Agency
      for Representatives</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each
      Party agrees that it accepts each indemnity in favour of any of its
      Representatives as agent and trustee of that Representative and MDS accepts
      each
      indemnity in favour of the other Sellers and their Representatives as agent
      and
      trustee of that Seller and Representative. Each Party agrees that a Party may
      enforce an indemnity in favour of any of that Party&#8217;s Representatives on behalf
      of that Representative (and in the case of MDS, on behalf of the other Sellers
      and their Representatives). </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>8.5</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Notice
      of the Defence of Third Party Claims</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If
      an
      Indemnified Party receives notice of the commencement or assertion of any Third
      Party Claim, the Indemnified Party shall give the Indemnifier reasonably prompt
      written notice thereof, but in any event no later than 30 days after receipt
      of
      such notice of such Third Party Claim. Such notice to the Indemnifier shall
      describe the Third Party Claim in reasonable detail and shall indicate, if
      reasonably practicable, the estimated amount of the Loss that has been or may
      be
      sustained by the Indemnified Party. The Indemnifier shall have the right to
      participate in or, by giving notice to that effect to the Indemnified Party
      not
      later than 30 days after receipt of such notice of such Third Party Claim and
      subject to the rights of any insurer or other third party having potential
      liability therefor, to elect to assume the defence of any Third Party Claim
      at
      the Indemnifier&#8217;s own expense and by such Indemnifier&#8217;s own counsel, and the
      Indemnified Party shall co-operate in good faith in such defence. The
      Indemnified Party shall have the right to participate in the defence of any
      Third Party Claim assisted by counsel of its own choosing at the Indemnified
      Party&#8217;s expense. The Indemnified Party shall not settle or compromise any Third
      Party Claim without the prior written consent of the Indemnifier.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>8.6</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Assistance
      for Third Party Claims</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      Indemnifier and the Indemnified Party will use all reasonable efforts to make
      available to the Party which is undertaking and controlling the defence of
      any
      Third Party Claim,</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">those
                employees whose assistance, testimony or presence is necessary to
                assist
                such Party in evaluating and in defending any Third Party Claim;
                and
                </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all
                documents, records and other materials in the possession of such
                Party
                reasonably required by such Party for its use in defending any Third
                Party
                Claim,</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">and
      shall
      otherwise co-operate with the Party defending such Third Party Claim. The
      Indemnifier shall be responsible for all reasonable expenses associated with
      making such documents, records and materials available and for all reasonable
      expenses of any employees made available by the Indemnified Party to the
      Indemnifier hereunder, which expense shall be equal to an amount to be mutually
      agreed upon per person per hour or per day for each day or portion thereof
      that
      such employees are assisting the Indemnifier but such expenses shall not exceed
      the actual direct out-of pocket cost to the Indemnified Party associated with
      such employees.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>8.7</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Settlement
      of Third Party Claims</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If
      an
      Indemnifier elects to assume the defence of any Third Party Claim as provided
      in
      Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.5</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      the
      Indemnifier shall not be liable for any legal expenses subsequently incurred
      by
      the Indemnified Party in connection with the defence of such Third Party Claim.
      However, if the Indemnifier fails to take reasonable steps necessary to defend
      diligently such Third Party Claim within 15 days after receiving notice from
      the
      Indemnified Party that the Indemnified Party bona fide believes on reasonable
      grounds that the Indemnifier has failed to take such steps, the Indemnified
      Party may, at its option, elect to assume the defence of and to compromise
      or
      settle the Third Party Claim assisted by counsel of its own choosing and the
      Indemnifier shall be liable for all reasonable costs and expenses paid or
      incurred in connection therewith; provided that the Indemnified Party shall
      not
      enter into any compromise or settlement of any Third Party Claim without the
      prior written consent of the Indemnifier, which shall not be unreasonably
      withheld, delayed or conditioned.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>8.8</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Direct
      Claims</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any
      Direct Claim shall be asserted by giving the Indemnifier reasonably prompt
      written notice thereof, but in any event not later than 30 days after the
      Indemnified Party becomes aware of such Direct Claim. The Indemnifier shall
      then
      have a period of 15 days within which to respond in writing to such Direct
      Claim. If the Indemnifier does not so respond within such 15 day period, the
      Indemnifier shall be deemed to have rejected such Claim, and in such event
      the
      Indemnified Party shall be free to pursue such remedies as may be available
      to
      the Indemnified Party.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>8.9</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Failure
      to Give Timely Notice</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A
      failure
      to give timely notice as provided in this </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Article&#160;8</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      shall
      not affect the rights or obligations of the Indemnifier or Indemnified Party
      except and only to the extent that, as a result of such failure, any such party
      which was entitled to receive such notice was deprived of its right to recover
      any payment under its applicable insurance coverage or was otherwise directly
      and materially damaged as a result of such failure or whose rights were
      materially prejudiced by such failure.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>8.10</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Limitation</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Claims
      for indemnification made by Buyer, any Designated Buyer Affiliate or the
      Representative of Buyer or a Designated Buyer Affiliate against any Seller
      shall
      be limited as follows:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">in
                respect of Claims made under Subsection </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.2(a)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                (other than a Claim resulting from a misrepresentation or breach
                of
                warranty in respect of a representation or warranty in Subsection
                4.1.26)
                no Losses shall be recoverable until the aggregate of all Losses
                suffered
                or incurred by Buyer, any Designated Buyer Affiliate or the Representative
                of Buyer or a Designated Buyer Affiliate in respect of all
                misrepresentations or breaches of warranty made or given by MDS in
                this
                Agreement or in any Closing Document exceeds 0.5% of the Purchase
                Price in
                the aggregate in which event the amount of all such Losses in excess
                of
                such amount may be recovered by Buyer or the applicable Designated
                Buyer
                Affiliate or Representative, as applicable;
</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
                maximum aggregate liability of Sellers to Buyer, any Designated Buyer
                Affiliate and their Representatives for Losses pursuant to Section
                </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                shall not exceed 30% of the Purchase Price other than Losses resulting
                directly from the intentional breach of this Agreement or any Closing
                Document by a Seller or a Seller&#8217;s fraudulent or deceitful act;
                and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">if
                any Applicable Law would give Buyer, any Designated Buyer Affiliate
                or the
                Representative of Buyer or a Designated Buyer Affiliate the right,
                notwithstanding the express terms of Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.5</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                or
                </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.2</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                to
                the contrary, to make a claim in respect of a breach of a representation
                or warranty made or given by a Seller in this Agreement or in any
                Closing
                Document after the expiry of the survival period set forth in Section
                </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.5</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                with respect to such representation and warranty, the Parties agree
                that
                the aggregate Losses suffered or incurred by Buyer, any Designated
                Buyer
                Affiliate or the Representative of Buyer or a Designated Buyer Affiliate
                as a result of, or arising in connection with, any such Claim shall
                be
                deemed to be limited to $1.00 and Buyer and each Designated Buyer
                Affiliate hereby forever waives, releases and discharges each Seller
                from
                any Loss in excess of such deemed
                amount.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>8.11</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Reductions
      and Subrogation</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If
      the
      amount of any Loss incurred by an Indemnified Party at any time subsequent
      to
      the making of an Indemnity Payment is reduced by </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">any
                net Tax benefit to the Indemnified Party;
                or</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">any
                recovery, settlement or otherwise under or pursuant to any insurance
                coverage, or pursuant to any claim, recovery, settlement or payment
                by or
                against any other Person,</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
      Indemnified Party shall promptly notify the Indemnifier in writing of the nature
      and amount of such reduction (and any costs, expenses (including Taxes) or
      premiums incurred in connection therewith), and the amount of such reduction
      (less any such costs, expenses (including Taxes) or premiums) shall promptly
      be
      repaid by the Indemnified Party to the Indemnifier. Upon making an Indemnity
      Payment, the Indemnifier shall, to the extent of such Indemnity Payment, be
      subrogated to all rights of the Indemnified Party against any third party in
      respect of the Loss to which the Indemnity Payment relates. Until the
      Indemnified Party recovers full payment of its Loss, any and all claims of
      the
      Indemnifier against any such third party on account of such Indemnity Payment
      shall be postponed and subordinated in right of payment to the Indemnified
      Party&#8217;s rights against such third party.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>8.12</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Exclusive
      Remedy</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      rights of indemnity set forth in this </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Article&#160;8</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      are the
      sole and exclusive remedy of Buyer and each Designated Buyer Affiliate on the
      one hand and the Sellers on the other in respect of any misrepresentation,
      breach of warranty or breach of covenant by the other hereunder or under any
      Closing Document (other than the rights of termination in Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      or a
      claim for specific performance or injunctive relief).</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>8.13</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Duty
      to Mitigate</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Nothing
      in this Agreement shall in any way restrict or limit the general obligation
      at
      law of an Indemnified Party to mitigate any Loss which it may suffer or incur
      by
      reason of the breach by an Indemnifier of any representation, warranty or
      covenant of the Indemnifier hereunder or under any Closing Document. If any
      Loss
      can be reduced by any recovery, settlement or otherwise under or pursuant to
      any
      insurance coverage, or pursuant to any claim, recovery, settlement or payment
      by
      or against any other Person, the Indemnified Party shall take all appropriate
      steps to enforce such recovery, settlement or payment.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>8.14</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>General
      Limitations</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">An
      Indemnifier shall have no liability to an Indemnified Party hereunder or under
      any Closing Document:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">for
                any Liability which arises solely by reason of a proposed or actual
                enactment or change of any applicable Tax legislation or any proposed
                or
                actual change in the interpretation or administration of such legislation
                after the date hereof;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">for
                any Liability that arises as a result of any legislation not in force
                on
                the date hereof which takes effect retrospectively or occurs as a
                consequence of a change in the interpretation of the law after the
                date
                hereof;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">in
                respect of any matter or thing done or omitted to be done by or at
                the
                direction or with the consent of the Indemnified
                Party;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">in
                respect of any Claim arising in connection with or in any way related
                to
                the implementation by the Indemnifier of the Indemnified Party&#8217;s
                structuring of the purchase and sale of the Purchased Assets as
                contemplated herein;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">in
                respect of more than one representation, warranty or covenant that
                relates
                to the same matter or thing in this Agreement or a Closing
                Document;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">for
                any Loss or matter to the extent arising from a change in the accounting
                policies or practices of the Operator after the Closing;
                </font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">to
                the extent that a Seller is unable to challenge or dispute any Claim
                due
                to the loss or destruction, in each case by Buyer, a Designated Buyer
                Affiliate or an Operator, of any relevant Books and
                Records;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(h)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">for
                any Loss or matter to the extent accrued, provided for or reserved
                for, or
                otherwise taken into account in the Closing Balance Sheet or an adjustment
                to the Purchase Price (otherwise than under Section </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.15</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">);
                and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">for
                any Loss for a breach of or inaccuracy in any representation or warranty
                if the Indemnified Party was aware, at or before the Closing Date,
                of the
                facts as a result of which such representation or warranty was breached
                or
                inaccurate.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>8.15</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Adjustment
      to the Purchase Price</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For
      greater certainty, the amount of any payment required to be made by an
      Indemnifier to an Indemnified Party shall be deemed to constitute an adjustment
      to the Purchase Price and the Parties agree to allocate the adjustment to the
      appropriate Purchased Asset, acting reasonably.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ARTICLE&#160;9</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ARBITRATION</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>9.1</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Arbitration</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any
      dispute between the Parties concerning any matter arising under or in connection
      with Sections </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.5</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      and
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.6</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      and
      Schedule 3.1 of this Agreement shall be submitted to arbitration in accordance
      with the provisions of this Article.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>9.2</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Laws
      of Ontario</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      law
      to be applied in connection with the arbitration shall be the law of Ontario,
      including its conflict of law rules.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>9.3</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Arbitration
      Act</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      arbitration shall be governed by the Rules of Procedure (the &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Rules</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
      set
      forth in Schedule 9.3. The rules and procedures of the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>Arbitration
      Act, 1991</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      (Ontario) shall apply except to the extent that they are modified by the express
      provisions of this Article or such Rules. The decision of the arbitrator shall
      be conclusive, final and binding on the Parties and no appeal shall lie
      therefrom.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>ARTICLE&#160;10</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>GENERAL</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>10.1</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Expenses</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except
      as
      set forth in this Agreement, each Party shall pay all expenses it incurs (and
      in
      the case of MDS, any expenses that MDS Quebec incurs) in authorizing, preparing,
      executing and performing this Agreement and the Closing Documents and the
      transactions contemplated under this Agreement and the Closing Documents,
      whether or not the Closing occurs, including all fees and expenses of its legal
      counsel, bankers, investment bankers, brokers, accountants or other
      representatives or consultants.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>10.2</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Time</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Time
      is
      of the essence of each provision of this Agreement.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>10.3</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Notices</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any
      notice, demand or other communication (in this Section, a &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>notice</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
      required or permitted to be given or made hereunder shall be in writing and
      shall be sufficiently given or made if:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">delivered
                in person during normal business hours of the recipient on a Business
                Day
                and left with a receptionist or other responsible employee of the
                recipient at the applicable address set forth below;
                or</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">sent
                by any electronic means of sending messages, including facsimile
                transmission (excluding e-mail), which produces a paper record
                (&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Transmission</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8221;)
                during normal business hours on a Business Day;
</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">in
      the
      case of a notice to MDS, addressed to it at:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MDS
      Inc.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">100
      International Blvd.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Toronto,
      Ontario</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">M9W
      6J6</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Attention:</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Executive
      Vice-President,</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font id="TAB1" style="MARGIN-LEFT: 72pt"></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Corporate
      Development and General Counsel</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Fax
      No.:</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(416)
      213-4222</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">with
      a
      copy to (which shall not constitute notice):</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Fasken
      Martineau DuMoulin LLP</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">66
      Wellington Street West</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Suite
      4200, Toronto Dominion Bank Tower</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Box
      20,
      Toronto-Dominion Centre</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Toronto,
      Ontario</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">M5K
      1N6</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Attention:
      </font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Scott
      Conover</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Fax
      No.:
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(416)
      364-7813</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">and
      in
      the case of a notice to Buyer or any applicable Designated Buyer Affiliate,
      addressed to it at:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">200
      Bay
      Street</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">P.O.
      Box
      56</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Suite
      2100</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Royal
      Bank Plaza, South Tower</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Toronto,
      ON</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">M5J
      2J2</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Attention:
      </font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">President
      and Chief Executive Officer</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Fax
      No.:
</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(416)
      361-6075</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">with
      a
      copy to (which shall not constitute notice):</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Ogilvy
      Renault LLP</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">200
      Bay
      Street</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Royal
      Bank Plaza, South Tower</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Suite
      3800</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">P.O.
      Box
      84</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Toronto,
      ON</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">M5J
      2Z4</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Attention:
      Jacques Demers</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Fax
      No.:
      (416) 216-3930</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each
      notice sent in accordance with this Section shall be deemed to have been
      received:</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">on
                the day it was delivered in person as
                aforesaid;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">on
                the same day that it was sent by Transmission, or on the first Business
                Day thereafter if the day on which it was sent by Transmission was
                not a
                Business Day or if it was sent after normal business hours on a Business
                Day.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any
      Party
      may change its address for notice by giving notice to the other
      Parties.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>10.4</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Assignment,
      Successors</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Buyer
                (and, as applicable, any Designated Buyer Affiliate) may, without
                the
                consent of MDS but upon prior written notice to MDS, assign this
                Agreement
                and its rights and obligations hereunder, in whole or in part, to
                one or
                more Affiliates of Buyer or OMERS Administration Corporation. Upon
                notification to MDS of any such assignment by Buyer (or, as applicable,
                any Designated Buyer Affiliate), the applicable Affiliate (to which
                such
                assignment is made) shall become liable for the performance of the
                obligations assigned by Buyer (or, as applicable, any Designated
                Buyer
                Affiliate) to it. Notwithstanding the foregoing, Buyer shall remain
                jointly and severally liable with such designated Affiliates of Buyer
                or
                OMERS Administration Corporation (or, as applicable, any Designated
                Buyer
                Affiliate) and shall cause all of its covenants and obligations hereunder
                to be observed and performed by such Affiliates. Notwithstanding
                the
                foregoing, any assignee which will acquire property pursuant to Section
                2.1 must satisfy the conditions in Section
                5.11.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MDS
                may, without the consent of Buyer (and, as applicable, any Designated
                Buyer Affiliate), but upon prior written notice to Buyer, assign
                this
                Agreement and its rights and obligations hereunder, in whole or in
                part,
                to one or more direct or indirect subsidiaries of MDS. Upon notification
                to Buyer (and, as applicable, any Designated Buyer Affiliate) of
                any such
                assignment by MDS, the designated subsidiary of MDS shall become
                liable
                for the performance of the obligations assigned to them. Notwithstanding
                the foregoing, MDS shall remain jointly and severally liable with
                such
                designated subsidiaries of MDS and shall cause all of its covenants
                and
                obligations hereunder to be observed and performed by such
                subsidiaries.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject
                to paragraphs (a) and (b),</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">no
                Party may assign any rights or benefits under this Agreement to any
                Person;</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">each
                Party agrees to perform its obligations under this Agreement itself,
                and
                not to arrange in any way for any other Person to perform those
                obligations; and</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iii)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">no
                assignment of benefits or arrangement for substituted performance
                by one
                Party shall be of any effect against the other Party except to the
                extent
                that the other Party has consented to it in
                writing.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div>
      <table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%">

          <tr valign="top" style="line-height: 1.25;">
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt;">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)</font></div>
            </td>
            <td>
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
                Agreement shall enure to the benefit of and be binding upon the Parties
                and their respective successors (including any successor by reason
                of
                amalgamation or statutory arrangement of any Party) and permitted
                assigns.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>10.5</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Further
      Assurances</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each
      Party shall do such acts and shall execute such further documents, conveyances,
      deeds, assignments, transfers, elections and the like, and will cause the doing
      of such acts and will cause the execution, filing and registration of such
      further documents as are within its power, as the other Party may in writing
      at
      any time and from time to time reasonably request be done and or executed,
      in
      order to give full effect to the provisions of this Agreement and each Closing
      Document.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>10.6</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Public
      Announcements</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject
      to Applicable Law, no Party shall make or cause to be made, any public statement
      or public announcement or issue any press release or otherwise communicate
      with
      any news media concerning this Agreement or the transactions contemplated by
      this Agreement without the prior written consent of the other Party, and the
      Parties shall co-operate as to the timing and content of any such press release,
      public announcement or communication. Notwithstanding the foregoing, Buyer
      acknowledges that MDS is a reporting issuer under Applicable Laws and is
      obligated to make immediate public disclosure of the entering into of this
      Agreement and the material terms hereof and will be required to file a copy
      of
      this Agreement on the System for Electronic Document Analysis and Retrieval
      (SEDAR) and EDGAR, and Buyer consents to the making of such disclosure and
      such
      filing and any related communications (including in connection with analyst
      conference calls) and shall co-operate in the content of such disclosure
      provided, however, that Buyer has a reasonable opportunity to comment on the
      disclosure related to such filing.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>10.7</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Counterparts</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
      Agreement may be executed in any number of counterparts. Each executed
      counterpart shall be deemed to be an original. All executed counterparts taken
      together shall constitute one agreement.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>10.8</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Facsimile
      Execution</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To
      evidence the fact that it has executed this Agreement, a Party may send a copy
      of its executed counterpart to the other Party by Transmission. That Party
      shall
      be deemed to have executed this Agreement on the date it sent such Transmission.
      In such event, such Party shall forthwith deliver to the other Party the
      counterpart of this Agreement executed by such Party.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>10.9</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>No
      Partnership</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Nothing
      contained in this Agreement shall be deemed in any way or for any purpose to
      constitute any Party a partner or agent or legal representative of the other
      Party in the conduct of any business or otherwise or a member of a joint venture
      or joint enterprise with the other, or to authorize one Party to bind the other
      or to create any fiduciary relationship between them.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>10.10</strong></font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 63pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Survival</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notwithstanding
      any provision herein to the contrary, Sections </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.1.4</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.1.6(a)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.1.6(b)</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      and&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.13</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      and
      Articles 1, 8 and 10 shall survive the termination of this
      Agreement.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font size="2">[THE
      REMAINDER OF THIS PAGE HAS BEEN INTENTIONALLY
      LEFT BLANK]</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>TO
      WITNESS THEIR AGREEMENT</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
      the
      Parties have duly executed this Agreement.</font></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td align="left" colspan="2" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>MDS
                INC.</strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="7%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Per:</font></div>
            </td>
            <td align="left" valign="top" width="32%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em><u>/s/
                Stephen P. DeFalco</u></em></font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="7%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Name:</font></div>
            </td>
            <td align="left" valign="top" width="32%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Stephen
                P. DeFalco</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="7%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Title:</font></div>
            </td>
            <td align="left" valign="top" width="32%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Chief
                Executive Officer</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="7%">&#160;</td>
            <td align="left" valign="top" width="32%">&#160;</td>
          </tr>
          <tr>
            <td align="left" valign="top" width="7%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Per:</font></div>
            </td>
            <td align="left" valign="top" width="32%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em><u>/s/
                Jim Garner</u></em></font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="7%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Name:</font></div>
            </td>
            <td align="left" valign="top" width="32%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Jim
                Garner</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="7%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Title:</font></div>
            </td>
            <td align="left" valign="top" width="32%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Executive
                Vice President and Chief Financial Officer</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" colspan="2" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We
                have authority to bind the
                Corporation</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td align="left" colspan="2" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>BOREALIS
                INFRASTRUCTURE MANAGEMENT INC.</strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="7%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Per:</font></div>
            </td>
            <td align="left" valign="top" width="32%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em><u>/s/J.
                Michael Rolland</u></em></font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="7%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Name:</font></div>
            </td>
            <td align="left" valign="top" width="32%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">J.
                Michael Rolland</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="7%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Title:</font></div>
            </td>
            <td align="left" valign="top" width="32%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Senior
                Vice President</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="7%">&#160;</td>
            <td align="left" valign="top" width="32%">&#160;</td>
          </tr>
          <tr>
            <td align="left" valign="top" width="7%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Per:</font></div>
            </td>
            <td align="left" valign="top" width="32%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em><u>/s/John
                Knowlton</u></em></font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="7%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Name:</font></div>
            </td>
            <td align="left" valign="top" width="32%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">John
                Knowlton</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="7%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Title:</font></div>
            </td>
            <td align="left" valign="top" width="32%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Secretary</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" colspan="2" valign="top" width="39%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We
                have authority to bind the
                Corporation</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div>
      <hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
      <hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
      <div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong>Schedule
          2.5<br>Transaction Structure and Closing
          Sequence</strong></div>
        <div style="MARGIN: 12pt 0pt 0pt"><strong>[REDACTED]</strong></div>
      </div><br clear="all">
      <div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong>Schedule
          3.1<br>Holdback Amount</strong></div>
        <div style="MARGIN: 12pt 0pt 0pt"><strong>[REDACTED]</strong></div>
      </div><br clear="all">
      <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong>Schedule
        3.8<br>Purchase Price Allocation</strong></div>
      <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center">&#160;</div><strong>[REDACTED]</strong><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div>
      <hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
      <hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br>&#160;</div>
    <div>
      <div>
        <div style="MARGIN: 0pt; PAGE-BREAK-AFTER: auto; TEXT-INDENT: 0pt" align="center"><a name="DocsID"><strong>Schedule
          5.6</strong></a></div>
        <div style="MARGIN: 50pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong>M</strong><a name="_Ref127365466"><strong>DS
          INC.</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center">&#160;</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong>-
          AND
          -</strong></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center">&#160;</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong>BOREALIS
          INFRASTRUCTURE MANAGEMENT INC.</strong></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center">&#160;</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong>-
          AND
          -</strong></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center">&#160;</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong>[DESIGNATED
          BUYER AFFILIATES]</strong></div>
        <div style="MARGIN: 12pt 0pt 0pt">&#160;</div>
        <div style="MARGIN: 12pt 0pt 0pt">&#160;</div>
        <table border="1" cellpadding="0" cellspacing="0" style="BORDER-RIGHT: medium none; BORDER-TOP: medium none; MARGIN-LEFT: 88.05pt; BORDER-LEFT: medium none; BORDER-BOTTOM: medium none; BORDER-COLLAPSE: collapse; mso-table-layout-alt: fixed; mso-border-top-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; mso-padding-alt: 0pt 5.4pt 0pt 5.4pt">

            <tr>
              <td valign="top" width="418" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: windowtext 0.5pt solid; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 313.5pt; padding-top: 0pt; border-bottom: windowtext 0.5pt solid;">
                <div style="MARGIN: 12pt 0pt 0pt; TEXT-ALIGN: center" align="center"><strong>LIMITED
                  TRADE-MARK LICENCE
                  AGREEMENT<br><br></strong></div>
              </td>
            </tr>

        </table>
        <div style="MARGIN: 60pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong>Dated
          this &lt;*&gt; day of &lt;*&gt;, 2006</strong></div>
        <div style="MARGIN: 50pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong>Prepared
          by:</strong></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-ALIGN: center" align="center"><img src="fasken.jpg" alt=""></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-ALIGN: center" align="center">Fasken
          Martineau DuMoulin LLP</div>
        <div style="MARGIN: 0pt; TEXT-ALIGN: center" align="center">Toronto, Ontario</div>
        <div style="MARGIN: 12pt 0pt 0pt">&#160;</div>
      </div><br clear="all">
      <div style="MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
        <div style="MARGIN: 0pt 36pt 0pt 90pt"><strong>Article&#160;1.........
          INTERPRETATION</strong></div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">1.1.......... Definitions</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">1.2.......... Headings, etc</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">1.3.......... Plurality and Gender</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">1.4.......... Including, etc.</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">1.5.......... Construction</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">1.6.......... Severability</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">1.7.......... Time of the Essence</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">1.8.......... No Third Party
          Beneficiaries.</div>
        <div style="MARGIN: 12pt 36pt 0pt 90pt"><strong>Article&#160;2......... GRANT OF
          LICENCE</strong></div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">2.1.......... Grant</div>
        <div style="MARGIN: 12pt 36pt 0pt 90pt"><strong>Article&#160;3......... QUALITY
          CONTROL</strong></div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">3.1.......... Compliance with Quality
          Control Guidelines</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">3.2.......... Preserve Goodwill</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">3.3.......... Access for Inspection</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">3.4.......... Compliance with Applicable
          Laws</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">3.5.......... Notice of Default</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">3.6.......... Remedy</div>
        <div style="MARGIN: 12pt 36pt 0pt 90pt"><strong>Article&#160;4.........
          AGREEMENT NOT ASSIGNABLE</strong></div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">4.1.......... Not Assignable</div>
        <div style="MARGIN: 12pt 36pt 0pt 90pt"><strong>Article&#160;5.........
          TRADE-MARK OWNERSHIP</strong></div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">5.1.......... MDS Owner of MDS
          Marks</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">5.2.......... Negative Covenant</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">5.3.......... No Challenge</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">5.4.......... Defending the MDS
          Marks</div>
        <div style="MARGIN: 12pt 36pt 0pt 90pt"><strong>Article&#160;6......... TERM AND
          TERMINATION</strong></div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">6.1.......... Term and Termination</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">6.2.......... Termination with Respect
          to
          a Licensee</div>
        <div style="MARGIN: 12pt 36pt 0pt 90pt"><strong>Article&#160;7......... EFFECT
          OF TERMINATION</strong></div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">7.1.......... Discontinue Use on
          Termination</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">7.2.......... Destruction of
          Materials</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">7.3.......... Survival</div>
        <div style="MARGIN: 12pt 36pt 0pt 90pt"><strong>Article&#160;8.........
          SUB-LICENSING</strong></div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">8.1.......... Permitted
          Sub-Licensees</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">8.2.......... Sub-Licenses</div>
        <div style="MARGIN: 12pt 36pt 0pt 90pt"><strong>Article&#160;9.........
          INDEMNITY</strong></div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">9.1.......... Indemnity</div>
        <div style="MARGIN: 12pt 36pt 0pt 90pt"><strong>Article&#160;10.......
          REMEDIES</strong></div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">10.1........ Remedies</div>
        <div style="MARGIN: 12pt 36pt 0pt 90pt"><strong>Article&#160;11.......
          GENERAL</strong></div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">11.1........ Notices</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">11.2........ Waiver of Rights</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">11.3........ Amendments</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">11.4........ Governing Law</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">11.5........ Entire Agreement</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">11.6........ Further Assurances</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">11.7........ Counterparts</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">11.8........ Facsimile Execution</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">11.9........ Binding Agreement</div>
        <div style="MARGIN: 0pt 36pt 0pt 90pt">11.10...... No Partnership</div>
        <div style="MARGIN: 12pt 36pt 6pt 90pt"><strong>SCHEDULE &#8220;A&#8221;MDS
          Marks</strong></div><strong><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;SCHEDULE
&#8220;B&#8221;Form
        of
        Sub-License</strong></div><br clear="all">
      <div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong>TRADE-MARK
          LICENSE AGREEMENT</strong></div>
        <div style="MARGIN: 12pt 0pt 0pt"><strong>THIS LIMITED TRADE-MARK LICENSE
          AGREEMENT </strong>(&#8220;<strong>Agreement</strong>&#8221;) is made and entered into as of
&lt;*&gt;, 2006, by and between MDS Inc., a corporation
          incorporated under the
          laws of Canada (the &#8220;<strong>Licensor</strong>&#8221;) and Borealis Infrastructure
          Management Inc., a corporation incorporated under the laws of Canada (the
          &#8220;<strong>Buyer</strong>&#8221;) <strong>[NTD:&#160; The Designated Buyer Affiliates
          will be added as Licensees.]</strong> (the Buyer and <font style="DISPLAY: inline; FONT-FAMILY: Wingdings">l</font>,
<font color="#0000ff"><font style="DISPLAY: inline; FONT-FAMILY: Wingdings">l</font></font>and
<font color="#0000ff"><font style="DISPLAY: inline; FONT-FAMILY: Wingdings">l</font></font>
          are collectively
          referred to herein as the &#8220;<strong>Licensees</strong>&#8221;)&#160; </div>
        <div style="MARGIN: 12pt 0pt 0pt"><strong>RECITALS:</strong></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><strong>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</strong>Licensor
          is the owner of all right, title and interest in and to the
          registered trade-marks in Canada, shown in Schedule &#8220;A&#8221; attached hereto.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><strong>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</strong>Licensor
          and Buyer have entered into an asset purchase agreement with
          respect to the portion of the Diagnostics Business conducted in Ontario
          and
          Quebec dated <font color="#0000ff"><font style="DISPLAY: inline; FONT-FAMILY: Wingdings">l</font></font>,
          2006 (as such
          agreement may be amended from time to time, the &#8220;<strong>Ontario Purchase
          Agreement</strong>&#8221;), as well as an asset purchase agreement with respect to the
          portion of the Diagnostics Business conducted in British Columbia dated
<font color="#0000ff"><font style="DISPLAY: inline; FONT-FAMILY: Wingdings">l</font></font>,
          2006 (as such
          agreement may be amended from time to time, the &#8220;<strong>BC Purchase
          Agreement</strong>&#8221;) (the Ontario Purchase Agreement and the BC Purchase
          Agreement are collectively referred to herein as the &#8220;<strong>Purchase
          Agreements</strong>&#8221;), pursuant to which, among other things, Buyer is
          purchasing from Licensor and the other Sellers the Purchased Assets (as
          defined
          in both of the Purchase Agreements) on the terms and subject to the conditions
          set forth in each of the Purchase Agreements.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><strong>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</strong>The
          MDS Marks are used by Licensor and its Affiliates in connection
          with its Pharma Services, Nordion and Sciex businesses and, prior to the
          Closing, the MDS Marks have been used by Licensor and its Affiliates in
          connection with the Diagnostics Business.&#160; The goodwill associated with the
          MDS Marks is extremely valuable to Licensor and its Affiliates and all
          right,
          title and interest in and to the MDS Marks shall remain with Licensor and
          shall
          not be transferred to Buyer pursuant to or in connection with the Purchase
          Agreements.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><strong>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</strong>Buyer
          requires a transition period to re-brand and adopt new marks in
          connection with the operation of the Diagnostics Business by the Licensees
          and
          their Affiliates after Closing.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><strong>E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</strong>It
          is a condition of Closing under the Ontario Purchase Agreement that
          the Parties enter into this Agreement on the Closing Date.</div>
        <div style="MARGIN: 12pt 0pt 0pt"><strong>IN CONSIDERATION</strong> of the
          premises, the Purchase Price paid by Buyer to the Sellers pursuant to the
          Purchase Agreements, the respective covenants and agreements contained
          herein
          and of other consideration (the receipt and sufficiency of which are hereby
          acknowledged by each Party) the Parties agree as follows:</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><a name="_Toc145994488"><strong>Article&#160;1</strong><strong><br>INTERPRETATION</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994489"><strong>1.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Definitions</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">As used in this Agreement, unless the
          context
          otherwise requires capitalized terms not expressly defined in this Agreement
          shall have the meanings ascribed thereto in the Ontario Purchase Agreement,
          and
          the following terms shall have the following meanings:</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Affiliate</strong>&#8221; means, with respect
          to any Person,</div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
any other Person who directly or
          indirectly controls, is controlled by, or is
          under direct or indirect common control with, such Person; or </div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
any other Person that directly or
          indirectly owns all of the participating
          equity of such Person or for which all of the participating equity is directly
          or indirectly owned by such Person; and</div>
        <div style="MARGIN: 12pt 0pt 0pt 74.1pt; TEXT-INDENT: -2.1pt; tab-stops: 36.0pt; mso-list: none">a
          Person shall be deemed to &#8220;control&#8221; a Person if such Person possesses directly
          or indirectly the power to direct or cause the direction of the management
          and
          policies of such Person, whether through the ownership of voting securities,
          by
          contract or otherwise, and &#8220;controlled&#8221; shall have a similar meaning;</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Agreement</strong>&#8221; has the meaning
          ascribed thereto in the preamble
          hereof and includes all attached schedules;</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>AutoLabs Business</strong>&#8221; means the business
          carried on by the
          Licensor and its Affiliates prior to Closing and by Licensees and their
          Affiliates after Closing relating to the hardware system and related software
          known as APX (AutoLab Process eXpert) that provides specimen management,
          storage, results and instrument interfacing capabilities at testing locations,
          consisting of the licensing, maintenance and support of such system;&#160;
</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>BC Purchase Agreement</strong>&#8221; has the meaning
          ascribed thereto in the
          recitals;</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Defaulting Licensee</strong>&#8221; has the meaning
          ascribed thereto in
          Section 6.2;</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Diagnostics Business</strong>&#8221; means the specimen
          collection and
          diagnostic services businesses carried on, prior to the date hereof, by
          Licensor
          and the BC Operators, the Operators and the Non-Controlled Operators as
          defined
          in both of the Purchase Agreements and after Closing by Licensees and their
          Sub-Licensees, consisting of the provision of clinical laboratory testing
          for
          physicians, hospitals, non-hospital health care institutions, employers
          or
          insurance companies, management of hospital laboratories and other support
          services for clinical diagnostics and the Auto Labs Business;</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>MDS Marks</strong>&#8221; means the registered
          trade-marks in Canada set out
          in Schedule&#160;&#8220;A&#8221; attached hereto, including any and all common law rights
          and goodwill attaching thereto;</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>notice</strong>&#8221; has the meaning
          ascribed thereto in Section
          11.1;</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Ontario Purchase Agreement</strong>&#8221; has the meaning
          ascribed thereto
          in the recitals;</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Parties</strong>&#8221; means, collectively
          Licensor and Licensees and
&#8220;<strong>Party</strong>&#8221; means any one of them;</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Permitted Assignee</strong>&#8221; has the meaning
          ascribed thereto in
          Section 4.1;</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Permitted Sub-Licensee</strong>&#8221; has the meaning
          ascribed thereto in
          Section 8.1;</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Person</strong>&#8221; shall be broadly
          interpreted and includes an
          individual, body corporate, partnership, joint venture, trust, association,
          unincorporated organization, the Crown, any Governmental Authority or any
          other
          entity recognized by law;</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Purchase Agreements</strong>&#8221; has the meaning
          ascribed thereto in the
          recitals;</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Representative</strong>&#8221; has the meaning
          ascribed thereto in Section
          9.1;</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(p)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Sub-License</strong>&#8221; has the meaning
          ascribed thereto in Section
          8.2;</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(q)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Territory</strong>&#8221; means (a) Canada,
          (b) and, to the extent required
          to perform the obligations of the Licensees under the US Support Services
          Contracts as contemplated by the Ontario Purchase Agreement, the U.S.A.
          ;</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(r)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Transition Period</strong>&#8221; means the period
          commencing on the date
          hereof and ending on the date that is 12 months after the date of this
          Agreement; and</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(s)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Transmission</strong>&#8221; has the meaning
          ascribed thereto in Section
          11.1(b).</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994490"><strong>1.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Headings, etc</strong>.</a></div>
        <div style="MARGIN: 12pt 0pt 0pt">The division of this Agreement into articles,
          sections, subsections and schedules and the insertion of headings are for
          convenience of reference only and shall not affect the construction or
          interpretation of this Agreement.&#160; The article, section, subsection and
          schedule headings in this Agreement are not intended to be full or precise
          descriptions of the text to which they refer and are not to be considered
          part
          of this Agreement.&#160; All uses of the words &#8220;hereto&#8221;, &#8220;herein&#8221;, &#8220;hereof&#8221;,
&#8220;hereby&#8221; and &#8220;hereunder&#8221; and similar expressions refer to this Agreement and not
          to any particular section or portion of it.&#160; References to an Article,
          Section, Subsection or Schedule refer to the applicable article, section,
          subsection or schedule of this Agreement.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994491"><strong>1.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Plurality and Gender</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">In this Agreement, words in the singular
          include the plural and vice-versa and words in one gender include all
          genders.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994492"><strong>1.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Including, etc</strong>.</a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Reference in this Agreement to the term
          &#8220;including&#8221; shall mean &#8220;including without limitation&#8221; and shall not be construed
          to limit any general statement which it follows to the specific or similar
          items
          or matters immediately following it.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994493"><strong>1.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Construction</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">This Agreement is the joint product of
          Licensor and Licensees, has been subject to mutual consultation, negotiation
          and
          agreement of the Parties and shall not be construed for or against any
          Party.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994494"><strong>1.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Severability</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">If any provision of this Agreement is
          determined by a court of competent jurisdiction to be invalid, illegal
          or
          unenforceable in any respect, such determination shall not impair or affect
          the
          validity, legality or enforceability of the remaining provisions hereof,
          and
          each provision is hereby declared to be separate, severable and distinct.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994495"><strong>1.7&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Time of the Essence</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Time shall be of the essence of this Agreement
          and each provision hereof.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994496"><strong>1.8&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>No Third Party Beneficiaries</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Nothing in this Agreement is intended
          expressly or by implication to, or shall, confer upon any Person other
          than
          Licensor and Licensees and, solely in respect of Article&#160;9, Licensor&#8217;s
          Representatives, any rights or remedies of any kind.&#160; Licensor accepts each
          covenant in favour of each Representative as agent and trustee of such
          Representative, and Licensor may enforce such covenants on behalf of each
          Representative.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><a name="_Toc145994497"><strong>Article&#160;2</strong><strong><br>GRANT
          OF
          LICENCE</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994498"><strong>2.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Grant</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Subject to the terms and conditions of
          this
          Agreement, Licensor grants to Licensees a non-exclusive, non-transferable,
          royalty-free licence to use the MDS Marks solely in association with the
          Diagnostics Business for the Transition Period in the Territory (provided
          that,
          notwithstanding any other statement in this Agreement, Licensees may only
          use
          the MDS Marks in the U.S.A to the extent required to perform the obligations
          of
          the Licensees under the US Support Services Contracts as contemplated by
          the
          Ontario Purchase Agreement).</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><a name="_Toc145994499"><strong>Article&#160;3</strong><strong><br>QUALITY
          CONTROL</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994500"><strong>3.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Compliance with Quality Control Guidelines</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Licensees shall use the MDS Marks only
          in
          connection with the Diagnostics Business and only in the Territory.&#160;
Licensees shall operate the Diagnostics Business and provide diagnostic
          services
          of substantially the same character and quality as the Licensor prior to
          Closing
          and shall ensure that the use of the MDS Marks conforms to and complies
          with a
          character and quality substantially the same as the character and quality
          standards of Licensor prior to Closing.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994501"><strong>3.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Preserve Goodwill</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Licensees shall ensure that all
          representations of the MDS Marks shall be used in a manner so as to ensure
          the
          preservation and enhancement of the goodwill attaching to the MDS Marks.&#160;
Licensees shall not advertise, exploit, promote, market or otherwise operate
          the
          Diagnostics Business using the MDS Marks in any manner which will or is
          reasonably likely to adversely affect the reputation of Licensor or the
          validity
          or distinctiveness of the MDS Marks.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994502"><strong>3.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Access for Inspection</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Licensees will permit Licensor and its
          authorized representatives access to Licensees&#8217; operating facilities during
          normal business hours upon Licensor providing a Licensee with two (2) Business
          Days prior written notice of its request for such access, for the purpose
          of
          inspecting the Diagnostics Business operated in association with the MDS
          Marks
          and full disclosure of all uses of the MDS Marks by such Licensee.&#160;
Licensees shall provide samples of all proposed uses of the MDS Marks including
          with any trade-marks of Licensees, in each case together with reasonable
          details
          as to the proposed usage, and shall not use the MDS Marks in any advertising,
          promotional or other materials, including without limitation in any press
          release, prepared by or on behalf of a Licensee after the date hereof,
          without
          the prior written approval of Licensor, which approval shall not be unreasonably
          withheld.&#160; Approval or non-approval shall be given within three (3)
          Business Days of a request for approval having been made.&#160;&#160; </div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994503"><strong>3.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Compliance with Applicable Laws</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Licensees shall operate the Diagnostics
          Business and use the MDS Marks in compliance with all Applicable Laws and
          shall
          obtain and at all times maintain any and all Licences necessary for the
          operation of the Diagnostics Business in the Territory.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994504"><strong>3.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Notice of Default</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Each Licensee shall give prompt notice
          to
          Licensor of (i) any violation of this Agreement by such Licensee or violation
          of
          any Sub-License by any Sub-Licensee; (ii) any unauthorized use of the MDS
          Marks
          in the Territory or any confusingly similar marks or names adopted by third
          parties of which a Licensee becomes aware and (iii) the occurrence of any
          of the
          matters or events described in Section 6.1(b) or Section&#160; 6.2(a), (b), (c)
          or (d) with respect to such Licensee.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994505"><strong>3.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Remedy</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Upon notice to or other discovery by a
          Licensee of any misuse of the MDS Marks or non-compliance by such Licensee
          or a
          Permitted Sub-Licensee with the provisions of this Agreement or the applicable
          Sub-License, such Licensee shall (and shall cause the applicable Sub-Licensee
          to, as the case may be) promptly notify Licensor and remedy such misuse
          or
          non-compliance and notify Licensor of the remedial steps taken.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><a name="_Toc145994506"><strong>Article&#160;4</strong><strong><br>AGREEMENT
          NOT
          ASSIGNABLE</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Ref131933673"/><a name="_Toc145994507"><strong>4.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Not Assignable</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">No Licensee shall have the right to assign,
          divide, mortgage, pledge, charge or otherwise encumber this Agreement in
          whole
          or in any part, or any licensed right granted herein, to any Person, other
          than
          the right to assign this Agreement to an Operator or BC Operator (each,
          a
&#8220;<strong>Permitted Assignee</strong>&#8221;), provided that (a) the Licensee shall
          provide reasonable prior written notice of such assignment to Licensor,
          the
          Licensees shall remain jointly and severally liable with such Permitted
          Assignee, and shall cause all of its covenants and obligations hereunder
          to be
          observed and performed by such Permitted Assignee, and (b) such Licensee
          shall,
          promptly upon the Permitted Assignee ceasing to be an Affiliate of such
          Licensee
          or OMERS Administration Corporation or ceasing to operate the applicable
          part of
          the Diagnostics Business within the Territory, (i) provide Licensor with
          written
          notice of same, and (ii) cause such Permitted Assignee to assign this Agreement
          to another Permitted Assignee, such assignment to be subject to this Section
          4.1.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><a name="_Toc145994508"><strong>Article&#160;5</strong><strong><br>TRADE-MARK
          OWNERSHIP</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994509"><strong>5.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>MDS Owner of MDS Marks</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Licensees recognize the significant value
          of
          the goodwill associated with the MDS Marks and acknowledge that the MDS
          Marks
          and all rights therein, including the goodwill, belong exclusively to
          Licensor.&#160; Licensees agree not to commit any act or omission adverse or
          injurious to Licensor&#8217;s rights in the MDS Marks.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994510"><strong>5.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Negative Covenant</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Licensees shall not associate intellectual
          property belonging to third parties with the MDS Marks (other than the
          intellectual property of Affiliates of Licensees, to the extent such association
          is reasonably required in connection with the use of the MDS Marks permitted
          to
          such Affiliates by this Agreement) except with the prior written consent
          of
          Licensor, such consent not to be unreasonably withheld.&#160; Licensees shall
          not (and shall cause each Affiliate of Licensees not to) use any of the
          MDS
          Marks as, or as part of, its corporate, partnership, business or trade-name
          or
          style.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994511"><strong>5.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>No Challenge</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Neither during the term of this Agreement,
          nor
          at any time after termination hereof, shall any Licensee, either directly
          or
          indirectly, (i) dispute, challenge or contest the ownership, validity,
          distinctiveness or enforceability of the MDS Marks, (ii) attempt any
          registration thereof or of any other mark or name that is similar phonetically
          or visually to the MDS Marks or is so similar thereto as to suggest association
          with, confusion with or sponsorship by Licensor, or (iii) depreciate, impair,
          dilute or otherwise adversely affect or attempt to depreciate, impair,
          dilute or
          otherwise adversely affect the value of the goodwill attaching to the MDS
          Marks.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994512"><strong>5.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Defending the MDS Marks</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Licensor shall have the sole and exclusive
          right and discretion to determine whether or not any action shall be taken
          by
          itself on account of any infringements of, use of, imitations of or interference
          with the MDS Marks or any right confusingly similar thereto.&#160; Licensor may
          at any time commence proceedings in respect of the MDS Marks.&#160; Licensees
          shall assist Licensor in the proof and enforcement of the rights of Licensor
          at
          Licensor&#8217;s expense as required by Licensor.&#160; In no event shall a Licensee
          have any recourse against Licensor for costs or damages as a result of
          Licensor&#8217;s failure to act or as a result of any action brought by
          Licensor.&#160; Licensor may at its sole discretion assume the defense of any
          action or proceeding of any kind brought against a Licensee which relates
          to the
          use, distinctiveness or validity of, or otherwise to, the MDS Marks.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><a name="_Toc145994513"><strong>Article&#160;6</strong><strong><br>TERM
          AND
          TERMINATION</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994514"><strong>6.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Term and Termination </strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">This Agreement shall expire and terminate
          upon
          the expiry of the Transition Period as defined in this Agreement.&#160; However,
          in addition to and without limiting or prejudicing any rights or remedies
          of
          Licensor hereunder, at law or in equity, this Agreement shall automatically
          terminate before the expiry of the Transition Period, upon the happening
          of any
          of the following events:</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
A Licensee or any of its Sub-Licensees
          commits a breach of this Agreement or the
          applicable Sub-License and the Licensee or Sub-Licensee, as the case may
          be, is
          so notified in writing by Licensor of such breach occurring and, in the
          case of
          a breach capable of remedy, fails to remedy the same within ten (10) days
          after
          receipt of such notice from Licensor; or</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt"><a name="_Ref145992751">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          A Licensee or any of its Sub-Licensees disputes, contests or challenges
          (i)&#160;the validity or enforceability of any MDS Marks, (ii) the ownership of
          any MDS Marks by Licensor, its successors and assigns, (iii) the entitlement
          of
          Licensor or any of its Affiliates or licensees to use or licence any MDS
          Marks
          or (iv) opposes any application by Licensor or any of its Affiliates for
          any MDS
          Marks or any associated or similar trade-marks.</a></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Ref145992612"/><a name="_Toc145994515"><strong>6.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Termination with Respect to a Licensee</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">This Agreement shall automatically terminate
          before the expiry of the Transaction Period with respect to a Licensee
          (a
&#8220;<strong>Defaulting Licensee</strong>&#8221;) upon the happening of any of the
          following events:</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt"><a name="_Ref131933267">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          A change of control of such Licensee occurs.&#160; For the purpose hereof, a
          change of control shall occur if (i) all or substantially all of the assets
          of
          such Licensee are sold, distributed or otherwise disposed or in one or
          more
          transactions to a Person other than an Affiliate of the Licensee or OMERS
          Administration Corporation or (i</a>i) a Licensee ceases to be an Affiliate of
          either Borealis Capital Corporation or OMERS Administration Corporation;</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt"><a name="_Ref131933274">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Such Licensee ceases or threatens to cease to carry on business or takes
          any
          action to dissolve, wind-up or liquidate;</a></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt"><a name="_Ref131933276">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Such Licensee stops making payments in the normal course of business, makes
          a
          general assignment for the benefit of creditors, makes a bulk sale of its
          assets, institutes any proceedings relating to insolvency or bankruptcy,
          or such
          proceedings are instituted against such Licensee; or</a></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt"><a name="_Ref131933279">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          A custodian, receiver, manager, receiver-manager, lessor, encumbrancer
          or any
          other entity is appointed to take charge of or takes possession of any
          material
          part of such Licensee&#8217;s business, property or assets, or a distress or execution
          is levied against such Licensee.</a></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><a name="_Toc145994516"><strong>Article&#160;7</strong><br></a><a name="_Ref131925758"><strong>EFFECT
          OF TERMINATION</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Ref144360098"/><a name="_Toc145994517"><strong>7.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Discontinue Use on Termination</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Upon expiry or termination of this
          Agreement pursuant to Section 6.1, the
          licensed rights granted herein shall immediately cease and be null and
          void,
          Licensees shall immediately discontinue any and all use, display or
          advertisement of any kind in any medium or manner of the MDS Marks, or
          any
          confusingly similar names or marks including any brochures, pamphlets,
          signs
          (including, appearing on, in or around any building or any vehicle), business
          cards, letterhead, internet sites or web pages and Licensee shall not adopt
          any
          other mark, name, logo, acronym or any other identification of source that
          may
          be considered confusingly similar with the MDS Marks or suggest a relationship,
          association or affiliation with Licensor or the MDS Marks.</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Upon termination of this Agreement
          pursuant to Section 6.2, the licensed rights
          granted herein to the Defaulting Licensee shall immediately cease and be
          null
          and void, the Defaulting Licensees shall immediately discontinue any and
          all
          use, display or advertisement of any kind in any medium or manner of the
          MDS
          Marks, or any confusingly similar names or marks including any brochures,
          pamphlets, signs (including, appearing on, in or around any building or
          any
          vehicle), business cards, letterhead, internet sites or web pages and the
          Defaulting Licensee shall not adopt any other mark, name, logo, acronym
          or any
          other identification of source that may be considered confusingly similar
          with
          the MDS Marks or suggest a relationship, association or affiliation with
          Licensor or the MDS Marks.</div>
        <div style="MARGIN: 12pt 0pt 0pt"><a name="_Toc145994518"><strong>7.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Destruction of Materials</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Notwithstanding Section&#160;7.1 hereof, upon
          the expiry or termination of this Agreement pursuant to either Sections
          6.1 or
          6.2, all Licensees or the Defaulting Licensee, as the case may be, will:
          (i)&#160;use commercially reasonable efforts to remove any embedded software
          codes that contain any MDS Marks in such Licensee&#8217;s internal business systems,
          to the extent that such removal may be conducted without disruption, other
          than
          minor disruption, to such Licensee&#8217;s internal business systems; and
          (ii)&#160;ensure that any public documents containing a MDS Mark within such
          Licensee&#8217;s custody or control are destroyed, or where such destruction is
          impracticable, discontinued and shall ensure that such discontinued documents
          remain subject to such Licensee&#8217;s obligations of confidentiality; and the Chief
          Information Officer of such Licensee shall deliver to Licensor a certificate
          certifying that such Licensee and all Permitted Sub-Licensees of such Licensee
          have complied with this Section.&#160; <strong>&#160;</strong></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994519"><strong>7.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Survival</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Notwithstanding the expiration or termination
          of this Agreement, all covenants and acts to be performed and/or observed
          by a
          Licensee under this Agreement or which by their nature survive the expiration
          or
          termination of this Agreement including this Article&#160;7 and Article&#160;9,
          shall survive any such expiration or termination.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><a name="_Toc145994520"><strong>Article&#160;8</strong><strong><br>SUB-LICENSING</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Ref130798751"/><a name="_Toc145994521"><strong>8.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Permitted Sub-Licensees</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Licensees shall not grant or purport to
          grant
          any sub-licence of its rights or obligations under this Agreement, except
          that a
          Licensee may sub-license its rights and obligations to any Affiliate, Operator
          or BC Operator within the Territory as long as such Affiliate, Operator
          or BC
          Operator is and remains throughout the Transition Period an Affiliate of
          Buyer
          or OMERS Administration Corporation, operates any part of the Diagnostics
          Business within the Territory and exercises the sublicensed rights only
          in
          connection with such operation as permitted by this Agreement (a
&#8220;<strong>Permitted Sub-Licensee</strong>&#8221;).&#160;&#160;&#160; </div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Ref130818710"/><a name="_Toc145994522"><strong>8.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Sub-Licenses</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Any sub-license granted under Section
          8.1
          (each a &#8220;<strong>Sub-License</strong>&#8221;) shall be on the following terms:</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
The sub-license shall not be effective
          until a Licensee and the Permitted
          Sub-Licensee have entered into an agreement in writing which is in all
          material
          respects the same as this Agreement (save that there will be no further
          right to
          sub-license by a Permitted Sub-Licensee) and shall be executed and delivered
          by
          the Licensee, the applicable Permitted Sub-Licensee and Licensor, in the
          form
          attached hereto as Schedule&#160;&#8220;B&#8221; attached hereto;</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
The Licensees shall be fully responsible
          and jointly and severally liable with
          each Permitted Sub-Licensee for the acts and omissions of each Permitted
          Sub-Licensee;</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
The Licensee shall at all times and
          solely at its own cost diligently enforce
          the terms and conditions of such Sub-Licenses; and</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
The permission to sub-licence and
          all Sub-Licenses granted pursuant hereto, will
          terminate automatically without any further act or formality upon the earliest
          of (i) expiry of the Transition Period; (ii) termination of this Agreement;
          or
          (iii)&#160;in the case of any Permitted Sub-Licensee, if it is no longer an
          Affiliate of Buyer or OMERS Administration Corporation.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><a name="_Ref130818857"/><a name="_Toc145994523"><strong>Article&#160;9</strong><br></a><a name="_Ref130976135"><strong>INDEMNITY</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Ref130818680"/><a name="_Toc145994524"><strong>9.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Indemnity</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Licensees shall jointly and severally
          indemnify and hold harmless Licensor, its Affiliates and their respective
          directors, shareholders, officers, employees, agents and other representatives
          (each such Person other than Licensor being a
&#8220;<strong>Representative</strong>&#8221;), from any and all liabilities, losses, suits,
          claims, demands, damages, expenses, costs (including all legal costs),
          fines and
          actions of any kind or nature whatsoever to which they shall or may become
          liable for, or suffer by reason of, arising in connection with or relating
          to
          any breach, violation or non-performance on the part of a Licensee or a
          Permitted Sub-Licensee of any provision of this Agreement or applicable
          Sub-License.&#160; The maximum aggregate liability of Licensees to Licensor, its
          Affiliates and their Representatives pursuant to this Section 9.1 shall
          be one
          million dollars ($1,000,000),provided that this limitation shall not apply
          in
          the case of any gross negligence or wilful misconduct by a Licensee, a
          Permitted
          Sublicensee and/or any of their respective Affiliates. </div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><a name="_Toc145994525"><strong>Article&#160;10</strong><strong><br>REMEDIES</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994526"><strong>10.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Remedies</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Licensees acknowledge that the goodwill
          associated with the MDS Marks is extremely valuable as it has been used
          by
          Licensor in connection with its businesses for over thirty years, Licensor
          intends to continue to use the MDS Marks in its businesses other than the
          Diagnostics Business after the date hereof and monetary damages may not
          be a
          sufficient remedy for, and Licensor may suffer irreparable harm as a result
          of,
          a breach by a Licensee of this Agreement or by any Permitted Sub-Licensee
          of the
          applicable Sub-License.&#160; Accordingly, in the event of any breach of this
          Agreement by a Licensee or any Sub-License by any Permitted Sub-Licensee,
          in
          addition to any other remedy provided for at law or in equity, Licensor
          shall be
          entitled to equitable relief, including an injunction or specific performance
          or
          both.&#160; The remedies of Licensor under this Agreement are cumulative and
          shall not exclude any other remedies to which Licensor may be lawfully
          entitled.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><a name="_Toc145994527"><strong>Article&#160;11</strong><strong><br>GENERAL</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Ref144359159"/><a name="_Toc145994528"><strong>11.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Notices</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Any notice, demand or other communication
          (in
          this Section, a &#8220;<strong>notice</strong>&#8221;) required or permitted to be given or
          made hereunder shall be in writing and shall be sufficiently given or made
          if:</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
delivered in person during normal
          business hours of the recipient on a Business
          Day and left with a receptionist or other responsible employee of the recipient
          at the applicable address set forth below; or</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt"><a name="_Ref144359239">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          sent by any electronic means of sending messages, including facsimile
          transmission (excluding e-mail), which produces a paper record
          (&#8220;<strong>Transmission</strong>&#8221;) during normal business hours on a Business
          Day;</a></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">in the case of a notice to Licensor,
          addressed to it at:</div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt">MDS Inc.<br>100 International
          Blvd.<br>Toronto, Ontario<br>M9W 6J6</div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt">Attention:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Executive
          Vice-President,<br>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Corporate Development and General Counsel</div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt">Fax No.:&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (416) 213-4222</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">with a copy to (which shall not
          constitute notice):</div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt">Fasken Martineau DuMoulin LLP<br>66
          Wellington Street West<br>Suite 4200, Toronto Dominion Bank Tower<br>Box 20,
          Toronto-Dominion Centre<br>Toronto, Ontario<br>M5K 1N6</div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt">Attention:
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Scott Conover<br>Fax No.:&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (416) 364-7813</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">and in the case of a notice to a
          Licensee, addressed to it at:</div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt">200 Bay Street<br>Royal Bank Plaza,
          South Tower<br>Suite 2100<br>P.O. Box 56<br>Toronto, Ontario<br>M5J 2J2</div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt">Attention:
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; President and Chief Executive
          Officer<br>Fax No.:&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (416)
          361-6075</div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt">with a copy to (which shall not
          constitute notice):</div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt">Ogilvy Renault LLP<br>200 Bay
          Street<br>Royal Bank Plaza, South Tower<br>Suite 3800<br>P.O. Box 84<br>Toronto,
          Ontario<br>M5J 2Z4</div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt">Attention:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Jacques Demers<br>Fax
          No.:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (416)
          216-3930</div>
        <div style="MARGIN: 12pt 0pt 0pt">Each notice sent in accordance with this
          Section shall be deemed to have been received:</div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
on the day it was delivered in person
          as aforesaid;</div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
on the same day that it was sent
          by Transmission, or on the first Business Day
          thereafter if the day on which it was sent by Transmission was not a Business
          Day or if it was sent after normal business hours on a Business Day.</div>
        <div style="MARGIN: 12pt 0pt 0pt">Either Party may change its address for
          notice
          by giving notice to the other Party.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994529"><strong>11.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Waiver of Rights</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Any waiver of, or consent to depart from,
          the
          requirements of any provision of this Agreement shall be effective only
          if it is
          in writing and signed by the Party giving it, and only in the specific
          instance
          and for the specific purpose for which it has been given.&#160; No failure on
          the part of any Party to exercise, and no delay in exercising, any right
          under
          this Agreement shall operate as a waiver of such right.&#160; No single or
          partial exercise of any such right shall preclude any other or further
          exercise
          of such right or the exercise of any other right.&#160; No failure on the part
          of any Party to exercise, and no delay in exercising any right under this
          Agreement shall operate as a waiver of such right; nor shall any single
          or
          partial exercise of any such right preclude any other or further exercise
          of
          such right or the exercise of any other right.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994530"><strong>11.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Amendments</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">This Agreement may only be amended or
          otherwise modified by written agreement executed by Licensor and
          Licensees.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994531"><strong>11.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Governing Law</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">This Agreement shall be governed by, and
          interpreted and enforced in accordance with, the laws in force in the Province
          of Ontario and the federal laws of Canada applicable therein.&#160; Each Party
          irrevocably submits to the non-exclusive jurisdiction of the courts of
          Ontario
          and the Federal Court of Canada with respect to any matter arising hereunder
          or
          related hereto.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994532"><strong>11.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Entire Agreement</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">This Agreement and the Purchase Agreements
          constitute the entire agreement between the Parties pertaining to the subject
          matter hereof and supersede all prior agreements, negotiations, discussions
          and
          understandings, written or oral, between the Parties.&#160; There are no
          representations, warranties, conditions, other agreements or acknowledgements,
          whether direct or collateral, express or implied, that form part of or
          affect
          this Agreement, or which induced any Party to enter into this Agreement
          or on
          which reliance is placed by any Party, except as specifically set forth
          in this
          Agreement and the Purchase Agreements.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994533"><strong>11.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Further Assurances</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Each Licensee and the Licensor shall do
          such
          acts and shall execute such further documents, conveyances, deeds, assignments,
          transfers, elections and the like, and will cause the doing of such acts
          and
          will cause the execution, filing and registration of such further documents
          as
          are within its power, as the Licensor or Licensees, respectively, may in
          writing
          at any time and from time to time reasonably request be done and or executed,
          in
          order to give full effect to the provisions of this Agreement.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994534"><strong>11.7&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Counterparts</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">This Agreement may be executed in
          counterparts.&#160; Each executed counterpart shall be deemed to be an original
          and all such counterparts taken together will constitute one Agreement.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994535"><strong>11.8&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Facsimile Execution</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">To evidence the fact that it has executed
          this
          Agreement, a Party may send a copy of its executed counterpart to the other
          Parties by Transmission.&#160; That Party shall be deemed to have executed this
          Agreement on the date it sent such Transmission.&#160; In such event, such Party
          shall forthwith deliver to the other Parties the counterpart of this Agreement
          executed by such Party.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994536"><strong>11.9&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>Binding Agreement</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Subject to Section 4.1, this Agreement
          shall
          be binding upon and enure to the benefit of the Parties and their respective
          successors and permitted assigns.</div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="_Toc145994537"><strong>11.10&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong><strong>No Partnership</strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt">Nothing contained in this Agreement shall
          be
          deemed in any way or for any purpose to constitute any Party a partner
          or agent
          or legal representative of any other Party in the conduct of any business
          or
          otherwise or a member of a joint venture or joint enterprise with the other,
          or
          to authorize one Party to bind the other or to create any fiduciary relationship
          between them.</div>
        <div style="MARGIN: 18pt 0pt 0pt"><strong>IN WITNESS WHEREOF </strong>the
          Parties have executed this Agreement as of the day and year first above
          written.</div>
        <div style="MARGIN: 0pt">&#160;</div>
        <table border="0" cellpadding="0" cellspacing="0" style="MARGIN-LEFT: 0.4pt; BORDER-COLLAPSE: collapse; mso-table-layout-alt: fixed; mso-padding-alt: 0pt 0pt 0pt 0pt">

            <tr>
              <td valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td colspan="2" valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 233.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt"><strong>MDS INC.</strong></div>
                <div style="MARGIN: 0pt">&#160;</div>
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="bottom" width="26" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 19.35pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">By:</div>
              </td>
              <td valign="bottom" width="286" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 214.55pt; padding-top: 0pt; border-bottom: windowtext 1pt solid;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="26" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 19.35pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="286" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 214.55pt; padding-top: 0pt; border-bottom: #ece9d8; mso-border-top-alt: solid windowtext .5pt;">
                <div style="MARGIN: 0pt">Name:</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="26" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 19.35pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="286" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 214.55pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">Title:</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td colspan="2" valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 233.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
                <div style="MARGIN: 0pt">&#160;</div>
                <div style="MARGIN: 0pt"><strong>BOREALIS INFRASTRUCTURE MANAGEMENT
                  INC.</strong></div>
                <div style="MARGIN: 0pt">&#160;</div>
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="bottom" width="26" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 19.35pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">By:</div>
              </td>
              <td valign="bottom" width="286" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 214.55pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="26" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 19.35pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="286" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: windowtext 1pt solid; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 214.55pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">Name:</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="26" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 19.35pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="286" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 214.55pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">Title:</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="26" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 19.35pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="286" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 214.55pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="bottom" width="26" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 19.35pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">By:</div>
              </td>
              <td valign="bottom" width="286" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 214.55pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="26" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 19.35pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="286" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: windowtext 1pt solid; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 214.55pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">Name:</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="26" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 19.35pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="286" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 214.55pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">Title:</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="26" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 19.35pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="286" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 214.55pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td colspan="2" valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 233.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
                <div style="MARGIN: 0pt">&#160;</div>
                <div style="MARGIN: 0pt"><strong>[DESIGNATED BUYER
                  AFFILIATES]</strong></div>
                <div style="MARGIN: 0pt">&#160;</div>
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="bottom" width="26" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 19.35pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="bottom" width="286" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 214.55pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="26" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 19.35pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="286" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 214.55pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="26" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 19.35pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="286" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 214.55pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
            </tr>

        </table>
      </div><br clear="all">
      <div>
        <div style="MARGIN: 0pt; TEXT-INDENT: 0pt" align="center"><a name="ScheduleA"><strong>SCHEDULE
&#8220;A&#8221;</strong></a><br><strong>MDS
          Marks</strong></div>
        <div style="MARGIN: 0pt">&#160;</div>
        <table border="1" cellpadding="0" cellspacing="0" width="528" style="BORDER-RIGHT: medium none; BORDER-TOP: medium none; MARGIN-LEFT: 41.4pt; BORDER-LEFT: medium none; WIDTH: 396pt; BORDER-BOTTOM: medium none; BORDER-COLLAPSE: collapse; mso-padding-alt: 0pt 5.4pt 0pt 5.4pt; mso-border-alt: solid windowtext .5pt">

            <tr>
              <td valign="top" width="288" bgcolor="transparent" style="border-right: windowtext 0.5pt solid; padding-right: 5.4pt; border-top: windowtext 0.5pt solid; padding-left: 5.4pt; padding-bottom: 0pt; border-left: windowtext 0.5pt solid; width: 216pt; padding-top: 0pt; border-bottom: windowtext 0.5pt solid;">
                <div style="MARGIN: 6pt 0pt 6pt 18pt; TEXT-INDENT: 0pt; TEXT-ALIGN: left" align="left"><strong>Trade-mark</strong></div>
              </td>
              <td valign="top" width="240" bgcolor="transparent" style="border-right: windowtext 0.5pt solid; padding-right: 5.4pt; border-top: windowtext 0.5pt solid; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 180pt; padding-top: 0pt; border-bottom: windowtext 0.5pt solid; mso-border-left-alt: solid windowtext .5pt;">
                <div style="MARGIN: 6pt 0pt 6pt 18pt; TEXT-INDENT: 0pt; TEXT-ALIGN: left" align="left"><strong>Canadian
                  Registration No.</strong></div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="288" bgcolor="transparent" style="border-right: windowtext 0.5pt solid; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: windowtext 0.5pt solid; width: 216pt; padding-top: 0pt; border-bottom: windowtext 0.5pt solid; mso-border-top-alt: solid windowtext .5pt;">
                <div style="MARGIN: 6pt 0pt 6pt 18pt; TEXT-INDENT: 0pt">MDS</div>
              </td>
              <td valign="top" width="240" bgcolor="transparent" style="border-right: windowtext 0.5pt solid; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 180pt; padding-top: 0pt; border-bottom: windowtext 0.5pt solid; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt;">
                <div style="MARGIN: 6pt 0pt 6pt 18pt; TEXT-INDENT: 0pt">TMA
                  407614</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="288" bgcolor="transparent" style="border-right: windowtext 0.5pt solid; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: windowtext 0.5pt solid; width: 216pt; padding-top: 0pt; border-bottom: windowtext 0.5pt solid; mso-border-top-alt: solid windowtext .5pt;">
                <div style="MARGIN: 6pt 0pt 6pt 18pt; TEXT-INDENT: 0pt">MDS and
                  Design</div>
              </td>
              <td valign="top" width="240" bgcolor="transparent" style="border-right: windowtext 0.5pt solid; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 180pt; padding-top: 0pt; border-bottom: windowtext 0.5pt solid; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt;">
                <div style="MARGIN: 6pt 0pt 6pt 18pt; TEXT-INDENT: 0pt">TMA
                  426801</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="288" bgcolor="transparent" style="border-right: windowtext 0.5pt solid; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: windowtext 0.5pt solid; width: 216pt; padding-top: 0pt; border-bottom: windowtext 0.5pt solid; mso-border-top-alt: solid windowtext .5pt;">
                <div style="MARGIN: 6pt 0pt 6pt 18pt; TEXT-INDENT: 0pt">MDS and
                  Design</div>
              </td>
              <td valign="top" width="240" bgcolor="transparent" style="border-right: windowtext 0.5pt solid; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 180pt; padding-top: 0pt; border-bottom: windowtext 0.5pt solid; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt;">
                <div style="MARGIN: 6pt 0pt 6pt 18pt; TEXT-INDENT: 0pt">TMA
                  518767</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="288" bgcolor="transparent" style="border-right: windowtext 0.5pt solid; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: windowtext 0.5pt solid; width: 216pt; padding-top: 0pt; border-bottom: windowtext 0.5pt solid; mso-border-top-alt: solid windowtext .5pt;">
                <div style="MARGIN: 6pt 0pt 6pt 18pt; TEXT-INDENT: 0pt">Science
                  Advancing
                  Health</div>
              </td>
              <td valign="top" width="240" bgcolor="transparent" style="border-right: windowtext 0.5pt solid; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 180pt; padding-top: 0pt; border-bottom: windowtext 0.5pt solid; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt;">
                <div style="MARGIN: 6pt 0pt 6pt 18pt; TEXT-INDENT: 0pt">TMA
                  517829</div>
              </td>
            </tr>

        </table>
        <div style="MARGIN: 0pt">&#160;</div>
      </div><br clear="all">
      <div style="MARGIN: 0pt; TEXT-INDENT: 0pt" align="center"><a name="ScheduleB"><strong>SCHEDULE
&#8220;B&#8221;</strong></a><br><strong>Form
        of
        Sub-License</strong></div>
      <div style="MARGIN: 0pt">&#160;</div>
      <div>
        <hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
        <hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
      </div>
      <div style="MARGIN: 0pt; TEXT-INDENT: 0pt" align="center"><strong>SCHEDULE
        5.7</strong></div>
      <div style="MARGIN: 0pt; TEXT-INDENT: 0pt" align="center">&#160;</div>
    </div>
    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
      <div>
        <div style="MARGIN: 0pt 0pt 12pt; TEXT-INDENT: 0pt" align="center"><a name="DocsID"><strong><u>CBS
          LICENSE AGREEMENT</u></strong></a></div>
        <div style="MARGIN: 0pt 0pt 10pt"><strong>THIS CBS LICENSE AGREEMENT
</strong>(the &#8220;<strong>Agreement</strong>&#8221;)
          is made and effective this &#9679; day of
&#9679;, 2006 (the &#8220;<strong>Effective Date</strong>&#8221;).</div>
        <div style="MARGIN: 0pt 0pt 10pt"><strong>BETWEEN:</strong></div>
        <div style="MARGIN: 0pt; TEXT-ALIGN: center" align="center"><strong>MDS
          INC.</strong>,</div>
        <div style="MARGIN: 0pt; TEXT-INDENT: 36pt; TEXT-ALIGN: center" align="center">&#160;</div>
        <div style="MARGIN: 0pt 0pt 10pt; TEXT-INDENT: 36pt; TEXT-ALIGN: center" align="center">(hereinafter
          referred to as &#8220;<strong>MDS</strong>&#8221;)</div>
        <div style="MARGIN: 0pt 0pt 10pt; TEXT-ALIGN: center; tab-stops: 36.0pt" align="center">-
          and -</div>
        <div style="MARGIN: 0pt 0pt 10pt; TEXT-ALIGN: center" align="center"><strong>BOREALIS
          INFRASTRUCTURE MANAGEMENT INC.,</strong></div>
        <div style="MARGIN: 0pt 0pt 10pt; TEXT-ALIGN: center" align="center">(hereinafter
          referred to as &#8220;<strong>Borealis</strong>&#8221;)</div>
        <div style="MARGIN: 0pt 0pt 10pt">is as follows:</div>
        <div>RECITALS:</div>
        <div style="MARGIN: 0pt 0pt 10pt 36pt; TEXT-INDENT: -36pt; tab-stops: 36.0pt; mso-list: none">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Pursuant
          to the Asset Purchase Agreement dated &#9679; 2006 between MDS as vendor and Borealis
          as purchaser (the &#8220;<strong>Asset Purchase Agreement</strong>&#8221;) and the BC
          Purchase Agreement (as defined in the Asset Purchase Agreement) MDS has
          agreed
          to sell and Borealis has agreed to purchase certain of the assets of the
          MDS
          Diagnostics Division. </div>
        <div style="MARGIN: 0pt 0pt 10pt 36pt; TEXT-INDENT: -36pt; tab-stops: 36.0pt; mso-list: none">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;During
          the period of time commencing on the date of the Asset Purchase Agreement
          and
          continuing until the Closing Date, the Parties have agreed to work together
          pursuant to the terms of the Migration Agreement dated &#9679; 2006 between MDS and
          Borealis (the &#8220;<strong>Migration Agreement</strong>&#8221;) in order to migrate
          certain shared aspects of the MDS Diagnostics Division to Borealis as
          contemplated therein.</div>
        <div style="MARGIN: 0pt 0pt 10pt 36pt; TEXT-INDENT: -36pt; tab-stops: 36.0pt; mso-list: none">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In
          connection with Borealis&#8217; operation of the Diagnostics Operations after the
          Closing Date, Borealis shall require access to and use of the Licensed
          Materials
          and MDS has agreed with Borealis that MDS shall license the Licensed Materials
          to Borealis on the terms and conditions set out in this Agreement.</div>
        <div style="MARGIN: 0pt 0pt 10pt"><strong>NOW THEREFORE</strong>, in
          consideration of the foregoing and the respective covenants set forth herein,
          and for other good and valuable consideration (the receipt and sufficiency
          of
          which are hereby acknowledged by each Party), the Parties agree as
          follows:</div>
        <div style="MARGIN: 6pt 0pt 10pt; mso-list: none"><a name="_Ref435594240"/><a name="_Toc437051924"/><a name="_Toc445193822"><strong><font size="2">1.0&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
DEFINITIONS</font></strong></a></div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><a name="_Toc437051925"/><a name="_Toc445193823"><font size="2">1.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Definitions</strong>:</font></a><font size="2">&#160; All capitalized
          terms used in this Agreement (including the Recitals hereto) shall have
          the
          meanings set forth below (or in the Recitals above).</font></div>
        <div style="MARGIN: 0pt 0pt 10pt">&#8220;<strong>CBS</strong>&#8221; means MDS&#8217; common back
          office system solution known internally by MDS as the &#8220;CBS&#8221; and used to support
          its business operations, including the MDS Diagnostics Division, prior
          to
          Closing.</div>
        <div style="MARGIN: 0pt 0pt 10pt">&#8220;<strong>Claim</strong>&#8221; has the meaning set
          forth in Section 2.9(a).</div>
        <div style="MARGIN: 0pt 0pt 10pt">&#8220;<strong>Closing</strong>&#8221; has the meaning set
          forth in the Asset Purchase Agreement.</div>
        <div style="MARGIN: 0pt 0pt 10pt">&#8220;<strong>Closing Date</strong>&#8221; has the
          meaning set forth in the Asset Purchase Agreement.</div>
        <div style="MARGIN: 0pt 0pt 10pt"><strong>&#8220;Diagnostics Operations&#8221; </strong>has
          the meaning set forth in the Migration Agreement.</div>
        <div style="MARGIN: 0pt 0pt 10pt">&#8220;<strong>Improvements</strong>&#8221; has the
          meaning set forth in Section 2.4.</div>
        <div style="MARGIN: 0pt 0pt 10pt">&#8220;<strong>Licensed Materials</strong>&#8221; means
          the technology and related materials described in Schedule A.</div>
        <div style="MARGIN: 0pt 0pt 10pt">&#8220;<strong>Licensed Rights</strong>&#8221; has the
          meaning set forth in Section 2.1.</div>
        <div style="MARGIN: 0pt 0pt 10pt"><strong>&#8220;MDS Diagnostics Division</strong>&#8221;
has the meaning set
          forth in the Asset Purchase Agreement.</div>
        <div style="MARGIN: 0pt 0pt 10pt">&#8220;<strong>Migrating Assets</strong>&#8221; has the
          meaning set forth in the Migration Agreement.</div>
        <div style="MARGIN: 0pt 0pt 10pt">&#8220;<strong>notice</strong>&#8221; has the meaning set
          forth in Section 4.9.</div>
        <div style="MARGIN: 0pt 0pt 10pt">&#8220;<strong>Party</strong>&#8221; means either MDS or
          Borealis and &#8220;<strong>Parties</strong>&#8221; means both of them.</div>
        <div style="MARGIN: 0pt 0pt 10pt">&#8220;<strong>Permitted Use</strong>&#8221; has the
          meaning set forth in Section 2.2.</div>
        <div style="MARGIN: 0pt 0pt 10pt">&#8220;<strong>Purchased Assets</strong>&#8221; means,
          collectively, the assets identified as &#8220;Purchased Assets&#8221; and &#8220;Replacement
          Contracts&#8221; in the Asset Purchase Agreement and as &#8220;Purchased Assets&#8221;,
&#8220;Replacement Contracts&#8221; and &#8220;Rix Assets&#8221; in the BC Purchase Agreement. </div>
        <div style="MARGIN: 0pt 0pt 10pt">&#8220;<strong>Transmission</strong>&#8221; has the
          meaning set forth in Section 4.9.</div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><a name="_Toc437051927"/><a name="_Toc445193825"><font size="2">1.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Schedules</strong>:</font></a><font size="2">&#160; The Schedules set out
          below are attached to and form an integral part of this Agreement:</font></div>
        <div style="MARGIN: 0pt 0pt 10pt; TEXT-INDENT: 36pt">Schedule A &#8211; Licensed
          Materials Description </div>
        <div style="MARGIN: 6pt 0pt 10pt; mso-list: none"><a name="_Ref435594334"/><a name="_Toc437051928"/><a name="_Toc445193826"><strong><font size="2">2.0&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
LICENSING </font></strong></a><strong><font size="2">AND
          OWNERSHIP</font></strong></div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><a name="_Ref435590560"/><a name="_Ref435591025"/><a name="_Toc437051929"/><a name="_Toc445193827"><font size="2">2.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Licence</strong>:</font></a><font size="2"> MDS hereby grants to Borealis
          as of the Closing Date a perpetual (subject to termination pursuant to
          Section
          3.0), irrevocable, non-exclusive, royalty free, worldwide and non-transferable
          (except as is permitted under Section 4.6) licence to all of its rights,
          inclusive of any intellectual property rights, in and to the Licensed Materials
          for the Permitted Use (the &#8220;<strong>Licensed Rights</strong>&#8221;). </font></div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><a name="_Ref435591375"/><a name="_Toc437051930"/><a name="_Toc445193828"><font size="2">2.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Use of </strong></font></a><font size="2"><strong>Licensed
          Materials</strong>:</font></div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><a name="_Ref435603004">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Permitted Use</strong>:&#160; Pursuant to the Licensed Rights Borealis
          may</a> access, use, copy, reproduce, modify, adapt, change, customize, enhance,
          make derivatives and otherwise use, without limitation or restriction (subject
          to Subsection 2.2(c)), the Licensed Materials as and to the extent required
          by
          Borealis to operate and support the conduct of, and the continued evolution
          of,
          the Diagnostics Operations. The foregoing rights as described in this subsection
          shall be referred to herein as the &#8220;<strong>Permitted Use</strong>&#8221;.</div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Third Parties</strong>:&#160; For certainty, the Licensed Rights include
          the right of Borealis to: (i) sublicense pursuant to a written agreement
          that is
          materially and substantially consistent with the terms and conditions of
          this
          Agreement (but otherwise without limitation or restriction), the access
          to and
          beneficial use of the Licensed Materials to Borealis&#8217; affiliates (including the
          Designated Buyer Affiliates, as defined in the Asset Purchase Agreement)
          and to
          such other persons as Borealis determines is reasonably necessary or required
          or
          desirable in, and solely for the purposes of, the conduct, support and
          continued
          evolution of the Diagnostics Operations (including, for certainty, the
          entity
          that operates and conducts the Diagnostics Operations if different than
          Borealis); and (ii) sublicense pursuant to a written agreement that is
          materially and substantially consistent with the terms and conditions of
          this
          Agreement, the access to and use of the Licensed Materials to third party
          service providers solely for the purposes of and to the extent such third
          party
          service providers are engaged by a permitted user hereunder to assist in
          the
          conduct or support of or the continued evolution of the Diagnostics
          Business.</div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Restricted Use and Provision</strong>: For greater certainty, Borealis
          acknowledges and agrees that it shall: (i) access, use, copy, reproduce,
          modify,
          adapt, change, customize, enhance and make derivatives of, the Licensed
          Materials, solely for the Permitted Use in accordance with this Agreement;
          and
          (ii) not distribute, sell, lease, rent, license, or otherwise make the
          Licensed
          Materials available to any person on a for-profit basis. For certainty,
          nothing
          in this Agreement shall require MDS to provide or make available to Borealis
          any
          employee, contractor, agent or other representative of MDS or any affiliate
          of
          MDS. Borealis also acknowledges and agrees that the license of the Licensed
          Materials hereunder does not obligate MDS to permit Borealis or any authorized
          user to access any computer systems of MDS or any affiliate of MDS.</div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><a name="_Ref435603892"/><a name="_Toc437051933"/><a name="_Toc445193831"><font size="2">2.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Licensed Materials Ownership</strong></font></a><font size="2">: Borealis
          acknowledges and agrees that MDS and its licensors are and shall remain
          the sole
          and exclusive owners of all right, title and interest in and to the Licensed
          Materials, including all copyright, trademarks, patents, trade secrets
          and all
          other intellectual property or proprietary rights therein.</font></div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><font size="2">2.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Improvements Ownership</strong>: MDS acknowledges and agrees that
          ownership of, and all right, title and interest in and to (including all
          copyright, trademarks, patents, trade secrets and all other intellectual
          property rights therein), any modifications, improvements, adaptations,
          changes,
          customizations, enhancements and derivatives to or of the Licensed Materials
          (&#8220;<strong>Improvements</strong>&#8221;) made by Borealis shall be owned solely and
          exclusively by Borealis.</font></div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><font size="2">2.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Confidential Information</strong>: </font></div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          The Licensed Materials are the confidential information of MDS. Borealis
          agrees
          that it shall take reasonable measures to keep secure and protect the Licensed
          Materials from unauthorized access, disclosure, loss and theft and to maintain
          the confidentiality of all Licensed Materials in its possession or control,
          which measures shall in any event be no less than the measures it uses
          to
          maintain the confidentiality of its own confidential information of similar
          importance. Borealis shall not disclose to any person any of the Licensed
          Materials except as expressly permitted in this Agreement. Borealis may
          disclose
          the Licensed Materials (or parts thereof): (i) to the extent required by
          compulsion of law, including by order of a court or other governmental
          authority
          of competent jurisdiction, or otherwise as required by applicable law;
          (ii) to
          its officers, directors, personnel, professional advisors, third parties
          (as is
          permitted under Section 2.2(b) above), provided, however, that prior to
          such
          disclosure, Borealis shall inform such persons of the confidential nature
          of the
          Licensed Materials and shall be responsible to ensure that all persons
          to whom
          it discloses the Licensed Materials comply with the terms hereof; (iii)
          to the
          extent, as established by reliable evidence, that such information is publicly
          available when it was received by or became known to Borealis (including
          because
          and to the extent it had previously been disclosed by MDS in the course
          of the
          conduct of the MDS Diagnostic Division), or which subsequently entered
          the
          public domain, through no fault of or breach of the terms of this Agreement
          by
          Borealis (but only after it enters the public domain); (iv) which, as
          established by reliable evidence, is already known to Borealis at the time
          of
          its disclosure to Borealis by MDS provided that the receipt of such information
          was not made pursuant to an obligation of confidentiality between MDS and
          Borealis or in contravention of this Agreement or was not made by a person
          in
          contravention of an obligation of confidence of any kind that is, or reasonably
          ought to be known, by Borealis.</div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Borealis agrees that in the event it or any person(s) authorized hereunder
          to
          use the Licensed Materials is requested pursuant to, or required by, applicable
          law, regulation or legal process to disclose the Licensed Materials or
          any
          portion thereof, it shall notify MDS promptly in writing so that MDS may
          seek a
          protective order or other appropriate remedy.&#160; Borealis and such authorized
          person(s) shall consent to MDS obtaining any protective order or other
          appropriate remedy that it and/or its affiliates may seek for the purpose
          of
          preventing disclosure of any of the Licensed Materials to the public.&#160; In
          the event that no such protective order or other remedy is obtained, Borealis
          and such authorized person(s) shall furnish only that portion of the Licensed
          Materials which it is advised by legal counsel is legally required and
          shall
          take all commercially reasonable steps, to the extent permitted by law,
          to
          remove from such portion of the Licensed Materials that is required to
          be
          disclosed any information that is commercially sensitive to MDS.</div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Borealis acknowledges that any threatened or actual breach of any of the
          covenants or provisions contained in this Section 2.5 may cause MDS and/or
          its
          affiliates to suffer irreparable harm which could not be adequately compensated
          for by damages.&#160; In such circumstances, Borealis agrees that MDS and/or its
          affiliates shall be entitled to seek to enforce the performance of this
          Agreement by equitable relief (including injunction or specific performance)
          upon application to a court of competent jurisdiction.&#160; Any such relief or
          remedy shall not be exclusive, but shall be in addition to all other available
          legal or equitable remedies.&#160; Borealis agrees that the provisions of this
          Section 2.5 are fair and reasonable in the commercial circumstances of
          this
          Agreement, and that MDS has relied on such provisions in entering into
          this
          Agreement</div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><font size="2">2.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Limited Warranty</strong>. MDS warrants to Borealis that it has full
          power and authority to enter into this Agreement, it has all necessary
          rights to
          perform its obligations herein and to grant the Licensed Rights and that
          the
          execution, delivery and performance of this Agreement are not to any extent
          limited or restricted by, and are not in conflict with, any obligations,
          agreement or instrument to which it is either bound or subject.</font></div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><font size="2">2.7&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Disclaimer Of Warranties</strong>: OTHER THAN THE LIMITED WARRANTIES
          EXPRESSLY SET OUT IN THIS AGREEMENT, MDS MAKES, AND THERE ARE, NO OTHER
          REPRESENTATIONS, WARRANTIES OR CONDITIONS OF ANY KIND WITH RESPECT TO THE
          LICENSED MATERIALS, WHETHER EXPRESS, IMPLIED, STATUTORY, ARISING OUT OF
          A COURSE
          OF DEALING OR USAGE OF TRADE OR OTHERWISE, INCLUDING BUT NOT LIMITED TO,
          ANY
          IMPLIED WARRANTIES OR CONDITIONS OF MERCHANTABILITY, FITNESS OR ADEQUACY
          FOR ANY
          PARTICULAR PURPOSE.</font></div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><font size="2">2.8&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>No Indirect Damages and Limitation</strong>: NEITHER PARTY SHALL BE
          LIABLE TO THE OTHER PARTY FOR ANY INDIRECT, SPECIAL, PUNITIVE, INCIDENTAL
          OR
          CONSEQUENTIAL LOSSES OR DAMAGES ARISING IN ANY MANNER FROM THIS AGREEMENT
          AND
          THE PERFORMANCE OR NON-PERFORMANCE OF OBLIGATIONS HEREUNDER, WHETHER BASED
          IN
          CONTRACT (INCLUDING FUNDAMENTAL BREACH AND BREACH OF A FUNDAMENTAL TERM),
          TORT
          (INCLUDING NEGLIGENCE) OR OTHERWISE, IN LAW OR EQUITY, EVEN IF IT HAS BEEN
          ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. EACH PARTY&#8217;S TOTAL LIABILITY AND
          OBLIGATION TO THE OTHER, IN THE AGGREGATE (INCLUDING CLAIMS MADE UNDER
          SECTION
          2.9) FOR ANY AND ALL CLAIMS ARISING OUT OF OR IN ANY CONNECTION WITH THIS
          AGREEMENT, WITH RESPECT TO ANY EXPENSE, DAMAGE, LOSS, INJURY, OR LIABILITY
          OF
          ANY KIND, REGARDLESS OF THE FORM OF ACTION OR THEORY OF LIABILITY (INCLUDING
          FOR
          BREACH OF CONTRACT (INCLUDING FUNDAMENTAL BREACH AND BREACH OF A FUNDAMENTAL
          TERM), TORT (INCLUDING NEGLIGENCE), BY STATUTE OR OTHERWISE) SHALL NOT
          EXCEED
          ONE HUNDRED THOUSAND DOLLARS ($100,000).</font></div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><font size="2">2.9&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Remedies and Limitation</strong>: </font></div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><font size="2">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Subject
          to Section 2.8, in the event of any claim, suit, action, threat, allegation
          or
          proceeding by any third party ("Claim") against Borealis (and any other
          person
          authorized hereunder to use the Licensed Materials) arising out of, or
          otherwise
          related to the use of the Licensed Materials (or any part thereof) as and
          to the
          extent permitted under this Agreement infringes any patent, trade secret,
          confidentiality, copyright or any other intellectual property rights of
          that
          person, such Claim shall be deemed to be a breach by MDS of this Agreement
          and
          MDS shall indemnify and hold harmless, and at the option of Borealis, defend
          Borealis, its affiliates and any other person authorized hereunder to use
          the
          Licensed Materials and their respective directors, officers and employees
          from
          any and all liabilities, damages, losses and expenses (including legal
          fees and
          expenses) arising out of such Claim, provided that with respect to such
          Claim:
          (i) the indemnity conditions described in Section 2.9(c) below are complied
          with; and (ii) the infringement does not result from any Improvements made
          by
          Borealis (or on its behalf by a third party), or the use or operation of
          the
          Licensed Materials in combination with any Improvements, or other software,
          products, data, apparatus or equipment.</font></div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><font size="2">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Subject
          to Section 2.8, in the event of any Claim against MDS arising out of, or
          otherwise related to, any allegation that the use of the Improvements (or
          any
          part thereof) by Borealis (or any other person authorized hereunder to
          use the
          Licensed Materials) infringes any patent, trade secret, confidentiality,
          copyright or any other intellectual property rights of that person, Borealis
          shall indemnify and hold harmless, and at the option of MDS defend, MDS
          and its
          affiliates and their respective directors, officers and employees from
          any and
          all liabilities, damages, losses and expenses (including legal fees and
          expenses) arising out of such Claim, provided that with respect to such
          Claim
          the indemnity preconditions described in Section 2.9(c) below are complied
          with.</font></div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><font size="2">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
To
          receive the indemnities contained in this Section 2.9, each Party seeking
          indemnification shall provide: (i) prompt written notice of the Claim to
          the
          indemnifying Party; (ii) all reasonable information and assistance which
          the
          indemnifying Party may reasonably require to defend the Claim; and (iii)
          the
          other party with sole control of the defence of the Claim, and all negotiations
          for its settlement or compromise, provided that neither Party may settle
          any
          Claim without the prior written consent of the other Party which consent
          will
          not be unreasonably withheld or delayed; and provided further that the
          failure
          to give such notice, information and assistance or to provide such control shall
          not relieve the indemnifying Party of its indemnification obligations pursuant
          to this Section except to the extent that the indemnifying Party was actually
          prejudiced by such failure.</font></div>
        <div style="MARGIN: 6pt 0pt 10pt; mso-list: none"><a name="_Toc437051948"/><a name="_Ref441561502"/><a name="_Toc445193845"><strong><font size="2">3.0&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
TERMINATION</font></strong></a><a name="_Ref435603669"/><a name="_Toc437051950"/><a name="_Toc445193847"/></div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><a name="_Ref435594417"/><a name="_Toc437051952"/><a name="_Toc445193849"><font size="2">3.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Termination</strong>:&#160; MDS acknowledges and confirms that the use
          by Borealis of the Licensed Materials is required for the ongoing operation
          of
          the Diagnostics Operations and therefore, after Closing, this Agreement
          (including the license granted hereunder) may only be terminated as follows:
          (a)&#160;upon mutual agreement of the Parties set out in writing; and
          (b)&#160;by Borealis at any time on notice to MDS. MDS agrees that the foregoing
          limitation is fair and reasonable in the commercial circumstances of this
          Agreement, the Asset Purchase Agreement and the BC Purchase Agreement and
          agrees
          not to assert any right to, and hereby waives to the maximum extent permitted
          by
          law, its right to terminate this Agreement inclusive of any Licensed Rights.
          For
          certainty, if this Agreement is terminated pursuant to this Section 3.1
          the
          Licensed Rights shall terminate.</font></a></div>
        <div style="MARGIN: 6pt 0pt 10pt; mso-list: none"><a name="_Toc437051956"/><a name="_Toc445193854"><strong><font size="2">4.0&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
GENERAL</font></strong></a></div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><a name="_Ref435594484"/><a name="_Toc437051960"/><a name="_Toc445193858"><font size="2">4.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Governing Law and Jurisdiction</strong>:</font></a><font size="2"> This
          Agreement shall be subject to and governed by the laws of the province
          of
          Ontario, and the laws of Canada applicable therein without regard to the
          conflicts of law principles of such province. The Parties irrevocably attorn
          and
          submit to the non-exclusive jurisdiction of the courts of the Province
          of
          Ontario. The Parties expressly exclude the application of the United Nations
          Convention on Contracts for the International Sale of Goods. </font></div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><a name="_Toc437051962"/><a name="_Toc445193860"><font size="2">4.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Waiver</strong>:</font></a><font size="2"> No waiver of any provision
          of
          this Agreement shall be implied, and no waiver shall be valid unless it
          is in
          writing and signed by the Party waiving its rights.&#160; No waiver of any
          breach of any of the terms, provisions or conditions of this Agreement
          shall be
          construed as or held to be a waiver of any other breach, or a waiver of,
          acquiescence in, or consent to, any further or succeeding breach
          hereof.</font></div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><a name="_Toc437051963"/><a name="_Toc445193861"><font size="2">4.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Entire Agreement</strong>:</font></a><font size="2"> This Agreement
          constitutes the entire agreement between the Parties and contains all agreements
          between the Parties with respect to the subject matter hereof.&#160; All
          Schedules attached hereto are incorporated herein by reference.&#160; This
          Agreement supersedes any and all other agreements, negotiations, discussions
          and
          understandings, either oral or written, between the Parties with respect
          to the
          subject matter hereof.&#160; </font></div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><font size="2">4.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Amendment</strong>: No modification or amendment of this Agreement will
          be binding upon either Party unless in writing, expressly referencing this
          Agreement and duly executed by each Party.</font></div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><a name="_Toc437051964"/><a name="_Toc445193862"><font size="2">4.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Severability</strong>:</font></a><font size="2">&#160; If any provision of
          this Agreement shall be determined by an arbitrator or any court of competent
          jurisdiction to be illegal, invalid or unenforceable, that provision shall
          be
          severed from this Agreement to the extent of its illegality, invalidity
          or
          unenforceability and the remaining provisions of this Agreement shall continue
          in full force and effect.</font></div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><a name="_Toc437051965"/><a name="_Toc445193863"><font size="2">4.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Assignment</strong>:</font></a><font size="2">&#160; This Agreement shall
          be binding upon and shall enure to the benefit of and be enforceable by
          each of
          the Parties, their respective successors and permitted assigns. Neither
          Party
          may assign this Agreement without the prior written consent of the other
          (not to
          be unreasonably withheld) except as is expressly permitted under this Section.
          MDS may assign this Agreement without the consent of Borealis to an affiliate.
          Borealis may assign this Agreement without the consent of MDS to an entity
          that
          operates and conducts any part of the Diagnostics Operations if different
          than
          Borealis. Either Party may assign this Agreement without the consent of
          the
          other Party to a person that purchases or acquires all or substantially
          all of
          that Party&#8217;s assets or the business or portion of the business to which the
          Licensed Material relates (which in the case of Borealis is the Diagnostic
          Operations). Any assignment permitted pursuant to this Section 4.6 shall
          as a
          condition of assignment require: (a)&#160;the assignee or transferee agrees in
          writing with the non-assigning Party to be bound by all the terms and conditions
          of this Agreement; and (b)&#160;the assigning Party provides prior notice of the
          assignment to the other Party.</font></div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><font size="2">4.7&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Counterparts</strong>:&#160; This Agreement may be executed in any
          number of counterparts.&#160; Each executed counterpart shall be deemed to be an
          original.&#160; All executed counterparts taken together shall constitute one
          agreement. To evidence the fact that it has executed this Agreement, a
          Party may
          send a copy of its executed counterpart to the other Party by Transmission.
          In
          such event, such Party shall forthwith deliver to the other Party the
          counterpart of this Agreement executed by such Party.</font></div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><a name="_Toc513624366"/><a name="_Toc513624356"><font size="2">4.8&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Covenant of Further Assurances</strong></font></a><font size="2">:&#160;
MDS agrees that it shall,
          without further consideration, do or cause to be done
          all such further acts and things as may be reasonably necessary or desirable
          to
          give full effect to this Agreement. </font></div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><font size="2">4.9&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Notice</strong>: Any notice, demand or other communication (in this
          Section, a &#8220;<strong>notice</strong>&#8221;) required or permitted to be given or made
          hereunder shall be in writing and shall be sufficiently given or made if:
          (a)&#160;delivered in person during normal business hours of the recipient on a
          business day and left with a receptionist or other responsible employee
          of the
          recipient at the applicable address set forth below; or (b)&#160;sent by
          facsimile transmission (&#8220;<strong>Transmission</strong>&#8221;) during normal business
          hours on a business day;&#160; </font></div>
        <div style="MARGIN: 0pt 0pt 10pt">in the case of a notice to MDS, addressed
          to
          it at:</div>
        <div style="MARGIN: 0pt 0pt 0pt 36pt">MDS Inc.</div>
        <div style="MARGIN: 0pt 0pt 0pt 36pt">100 International Blvd.</div>
        <div style="MARGIN: 0pt 0pt 0pt 36pt">Toronto, ON&#160;&#160; M9W 6J6</div>
        <div style="MARGIN: 0pt 0pt 0pt 36pt">Attention:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Executive Vice-President, Corporate
          Development and General Counsel</div>
        <div style="MARGIN: 0pt 0pt 0pt 36pt">Fax No.:&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
(416) 213-4222</div>
        <div style="MARGIN: 0pt">&#160;</div>
        <div style="MARGIN: 0pt">and in the case of a notice to Borealis, addressed
          to
          it at:</div>
        <div style="MARGIN: 0pt">&#160;</div>
        <div style="MARGIN: 0pt 0pt 0pt 36pt"><font size="2">200 Bay Street</font></div>
        <div style="MARGIN: 0pt 0pt 0pt 36pt"><font size="2">P.O. Box 56</font></div>
        <div style="MARGIN: 0pt 0pt 0pt 36pt"><font size="2">Suite 2100</font></div>
        <div style="MARGIN: 0pt 0pt 0pt 36pt"><font size="2">Royal Bank Plaza,
          South
          Tower</font></div>
        <div style="MARGIN: 0pt 0pt 0pt 36pt"><font size="2">Toronto, ON&#160;&#160; M5J
          2J2</font></div>
        <div style="MARGIN: 0pt 0pt 0pt 36pt"><font size="2">Attention:
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Michael J. Rolland,
          Senior Vice President</font></div>
        <div style="MARGIN: 0pt 0pt 0pt 36pt"><font size="2">Fax No.:&#160;
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
(416) 361-6075</font></div>
        <div style="MARGIN: 0pt">&#160;</div>
        <div style="MARGIN: 0pt"><font size="2">Each notice sent in accordance
          with this
          Section shall be deemed to have been received: (i)&#160;on the day it was
          delivered in person as aforesaid; (ii)&#160;on the same day that it was sent by
          Transmission or on the first (1st) business day thereafter if the day on
          which
          it was sent by Transmission was not a business day or if it was sent after
          normal business hours on a business day. Any Party may change its address
          for
          notice by giving notice to the other Party.</font></div>
        <div style="MARGIN: 0pt">&#160;</div>
        <div style="MARGIN: 0pt 0pt 10pt; tab-stops: 36.0pt; mso-list: none"><font size="2">4.10&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          <strong>Survival</strong>:&#160;&#160; The obligations and covenants of the
          Parties described in Articles 1, 2 (except Sections 2.1 and 2.2), and 4
          and
          Section 3.2 shall survive the termination of this Agreement for any reason
          whatsoever. </font></div>
      </div>
      <div>
        <div style="MARGIN: 0pt 0pt 10pt; TEXT-ALIGN: left; mso-pagination: widow-orphan lines-together" align="left">&#160;</div>
        <div style="MARGIN: 0pt 0pt 10pt; TEXT-INDENT: 36pt; TEXT-ALIGN: left; mso-pagination: widow-orphan lines-together" align="left"><strong>&#160;IN
          WITNESS WHEREOF</strong>, the Parties have executed
          this Agreement as of the Effective Date. </div>
        <table align="left" border="0" cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse; mso-table-layout-alt: fixed; mso-padding-alt: 0pt 5.4pt 0pt 5.4pt; mso-table-lspace: 9.0pt; mso-table-rspace: 9.0pt; mso-table-anchor-vertical: paragraph; mso-table-anchor-horizontal: page; mso-table-left: 79.3pt; mso-table-top: 16.35pt">

            <tr>
              <td colspan="2" valign="top" width="324" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 243pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt; TEXT-ALIGN: left; mso-pagination: widow-orphan lines-together; mso-element: frame; mso-element-frame-hspace: 9.0pt; mso-element-wrap: around; mso-element-anchor-horizontal: page; mso-element-left: 79.35pt; mso-element-top: 16.35pt; mso-height-rule: exactly; mso-element-anchor-vertical: paragraph" align="left"><strong>MDS
                  INC.</strong></div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt; mso-pagination: widow-orphan lines-together; mso-element: frame; mso-element-frame-hspace: 9.0pt; mso-element-wrap: around; mso-element-anchor-horizontal: page; mso-element-left: 79.35pt; mso-element-top: 16.35pt; mso-height-rule: exactly; mso-element-anchor-vertical: paragraph">By:</div>
              </td>
              <td valign="top" width="276" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 207pt; padding-top: 0pt; border-bottom: windowtext 0.5pt solid;">
                <div style="MARGIN: 0pt 0pt 24pt; mso-pagination: widow-orphan lines-together; mso-element: frame; mso-element-frame-hspace: 9.0pt; mso-element-wrap: around; mso-element-anchor-horizontal: page; mso-element-left: 79.35pt; mso-element-top: 16.35pt; mso-height-rule: exactly; mso-element-anchor-vertical: paragraph">&#160;</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt; mso-pagination: widow-orphan lines-together; mso-element: frame; mso-element-frame-hspace: 9.0pt; mso-element-wrap: around; mso-element-anchor-horizontal: page; mso-element-left: 79.35pt; mso-element-top: 16.35pt; mso-height-rule: exactly; mso-element-anchor-vertical: paragraph">&#160;</div>
              </td>
              <td valign="top" width="276" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 207pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt; TEXT-INDENT: -0.9pt; mso-pagination: widow-orphan lines-together; mso-element: frame; mso-element-frame-hspace: 9.0pt; mso-element-wrap: around; mso-element-anchor-horizontal: page; mso-element-left: 79.35pt; mso-element-top: 16.35pt; mso-height-rule: exactly; mso-element-anchor-vertical: paragraph">Name:<br>Title:</div>
              </td>
            </tr>
            <tr>
              <td colspan="2" valign="bottom" width="324" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 243pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt 0pt 10pt; mso-pagination: widow-orphan lines-together; mso-element: frame; mso-element-frame-hspace: 9.0pt; mso-element-wrap: around; mso-element-anchor-horizontal: page; mso-element-left: 79.35pt; mso-element-top: 16.35pt; mso-height-rule: exactly; mso-element-anchor-vertical: paragraph">&#160;</div>
                <div style="MARGIN: 0pt; mso-pagination: widow-orphan lines-together; mso-element: frame; mso-element-frame-hspace: 9.0pt; mso-element-wrap: around; mso-element-anchor-horizontal: page; mso-element-left: 79.35pt; mso-element-top: 16.35pt; mso-height-rule: exactly; mso-element-anchor-vertical: paragraph"><strong>BOREALIS
                  INFRASTRUCTURE MANAGEMENT INC.</strong></div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt; mso-pagination: widow-orphan lines-together; mso-element: frame; mso-element-frame-hspace: 9.0pt; mso-element-wrap: around; mso-element-anchor-horizontal: page; mso-element-left: 79.35pt; mso-element-top: 16.35pt; mso-height-rule: exactly; mso-element-anchor-vertical: paragraph">By:</div>
              </td>
              <td valign="top" width="276" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 207pt; padding-top: 0pt; border-bottom: windowtext 0.5pt solid;">
                <div style="MARGIN: 0pt 0pt 24pt; mso-pagination: widow-orphan lines-together; mso-element: frame; mso-element-frame-hspace: 9.0pt; mso-element-wrap: around; mso-element-anchor-horizontal: page; mso-element-left: 79.35pt; mso-element-top: 16.35pt; mso-height-rule: exactly; mso-element-anchor-vertical: paragraph">&#160;</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt; mso-element: frame; mso-element-frame-hspace: 9.0pt; mso-element-wrap: around; mso-element-anchor-horizontal: page; mso-element-left: 79.35pt; mso-element-top: 16.35pt; mso-height-rule: exactly; mso-element-anchor-vertical: paragraph">&#160;</div>
              </td>
              <td valign="top" width="276" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 207pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt; TEXT-ALIGN: left; mso-element: frame; mso-element-frame-hspace: 9.0pt; mso-element-wrap: around; mso-element-anchor-horizontal: page; mso-element-left: 79.35pt; mso-element-top: 16.35pt; mso-height-rule: exactly; mso-element-anchor-vertical: paragraph" align="left">Name:
<br>Title:
</div>
              </td>
            </tr>

        </table>
        <div style="MARGIN: 0pt 0pt 10pt; mso-pagination: widow-orphan lines-together">&#160;</div>
      </div><br clear="all">
      <div>
      </div><br clear="all">
      <div align="center">SCHEDULE A<br><br><u>LICENSED MATERIALS DESCRIPTION</u></div>
      <div style="MARGIN: 0pt 0pt 10pt">&#160;</div>
      <div style="MARGIN: 0pt 0pt 10pt">&#8220;<strong>Licensed Materials</strong>&#8221; means
        all technology, information, materials, data, components and elements (whether
        in written, graphic, electronic, machine-readable or any other form or medium
        whatsoever)forming part of, or included in, the CBS that are proprietary
        to MDS
        or an affiliate of MDS and reasonably necessary and required to replicate
        the
        CBS and to operate, support and maintain the CBS and that are used by MDS
        in
        connection with the operation of the MDS Diagnostics Division immediately
        prior
        to the Closing Date, but that are not included in the Purchased Assets or
        the
        Migrating Assets, and including without limitation:</div>
      <div style="MARGIN: 0pt 0pt 10pt 36pt; TEXT-INDENT: -36pt">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
all software code
        (in both object code and source code forms and containing no
        passwords or other devices that would prevent, obstruct, limit, restrict
        or
        prohibit the use of the software code) including application programming
        interfaces (APIs), graphic user interfaces (GUI&#8217;s) and screen designs (including
        so-called &#8220;look and feel&#8221; attributes), and other interfaces;</div>
      <div style="MARGIN: 0pt 0pt 10pt 36pt; TEXT-INDENT: -36pt">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
system design attributes,
        methods, file layouts, structures, work flow,
        specifications and requirements, order of operations, methodologies, routines,
        designs, data, trade secrets, processes, procedures, systems, templates,
        formulae, algorithms, inventions, drawings, diagrams, studies, work in progress,
        ideas and concepts; </div>
      <div style="MARGIN: 0pt 0pt 10pt 36pt; TEXT-INDENT: -36pt">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
existing documentation,
        including technical and functional descriptions and
        information, any available general flow-charts, field descriptions, any existing
        programmers&#8217; commentary and instructions, programmer specifications, notes
        (technical or otherwise), manuals, reports, reference guides, explanations,
        annotations and other documentation; and</div>
      <div style="MARGIN: 0pt 0pt 10pt 36pt; TEXT-INDENT: -36pt">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
the whole of the
        ideas, concepts, know-how and techniques contained in any of
        the f<font size="2">oregoing.</font></div>
      <div>
        <hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
        <hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
      </div>
      <div style="MARGIN: 0pt 0pt 10pt 36pt; TEXT-INDENT: -36pt">&#160;</div>
      <div style="MARGIN: 0pt 0pt 10pt 36pt; TEXT-INDENT: -36pt">
        <div>
          <div style="MARGIN: 0pt; PAGE-BREAK-AFTER: auto; TEXT-INDENT: 0pt" align="center"><a name="DocsID"><strong><font size="3">S</font></strong></a><a name="_Ref144362973"><strong><font size="3">chedule</font></strong><strong><font size="3">
            5.8</font></strong></a></div>
          <div style="MARGIN: 50pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong><font size="3">M</font></strong><a name="_Ref127365466"><strong><font size="3">DS
            INC.</font></strong></a></div>
          <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center">&#160;</div>
          <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong><font size="3">-
            AND -</font></strong></div>
          <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center">&#160;</div>
          <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong><font size="3">BOREALIS
            INFRASTRUCTURE MANAGEMENT INC.</font></strong></div>
          <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center">&#160;</div>
          <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center">&#160;</div>
          <table border="1" cellpadding="0" cellspacing="0" style="BORDER-RIGHT: medium none; BORDER-TOP: medium none; MARGIN-LEFT: 88.05pt; BORDER-LEFT: medium none; BORDER-BOTTOM: medium none; BORDER-COLLAPSE: collapse; mso-table-layout-alt: fixed; mso-border-top-alt: solid windowtext .5pt; mso-border-bottom-alt: solid windowtext .5pt; mso-padding-alt: 0pt 5.4pt 0pt 5.4pt">

              <tr>
                <td valign="top" width="418" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: windowtext 0.5pt solid; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 313.5pt; padding-top: 0pt; border-bottom: windowtext 0.5pt solid;">
                  <div style="MARGIN: 12pt 0pt 0pt; TEXT-ALIGN: center" align="center"><strong>NON-COMPETITION
                    AND NON-SOLICITATION
                    AGREEMENT<br><br></strong></div>
                </td>
              </tr>

          </table>
          <div style="MARGIN: 60pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong><font size="3">Dated
            this &lt;*&gt; day of &lt;*&gt;, 2006</font></strong></div>
          <div style="MARGIN: 50pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong><font size="3">Prepared
            by:</font></strong></div>
          <div style="MARGIN: 12pt 0pt 0pt; TEXT-ALIGN: center" align="center"><img src="fasken.jpg" alt=""></div>
          <div style="MARGIN: 12pt 0pt 0pt; TEXT-ALIGN: center" align="center"><font size="3">Fasken
            Martineau DuMoulin LLP</font></div>
          <div style="MARGIN: 0pt; TEXT-ALIGN: center" align="center"><font size="3">Toronto,
            Ontario</font></div>
          <div style="MARGIN: 12pt 0pt 0pt">&#160;</div>
          <div style="MARGIN: 0pt; mso-outline-level: 1">&#160;</div>
        </div><br clear="all">
        <div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><strong><font size="3">Article&#160;1.........
            INTERPRETATION</font></strong></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">1.1..........
            Definitions</font></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">1.2.......... Headings,
            etc.</font></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">1.3.......... Plurality
            and
            Gender</font></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">1.4.......... Including,
            etc.</font></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">1.5..........
            Construction</font></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">1.6..........
            Severability</font></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">1.7.......... Time
            of the
            Essence</font></div>
          <div style="MARGIN: 12pt 36pt 0pt 90pt"><strong><font size="3">Article&#160;2.........
            NON-COMPETITION AND
            NON-SOLICITATION</font></strong></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">2.1..........
            Recitals</font></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">2.2..........
            Non-Compete</font></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">2.3.......... Exclusions
            from Field</font></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">2.4..........
            Non-Solicitation by MDS and Affiliates</font></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">2.5.......... MDS
            Acknowledgement</font></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">2.6..........
            Non-Solicitation by Buyer and Affiliates</font></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">2.7.......... Buyer
            Acknowledgement</font></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">2.8.......... Accounting
            for
            Profits</font></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">2.9.......... Other
            Remedies</font></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">2.10........ Effective
            Time</font></div>
          <div style="MARGIN: 12pt 36pt 0pt 90pt"><strong><font size="3">Article&#160;3.........
            EXCEPTIONS</font></strong></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">3.1.......... Exceptions
            for
            MDS and Affiliates</font></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">3.2.......... Exceptions
            for
            Buyer Entities</font></div>
          <div style="MARGIN: 12pt 36pt 0pt 90pt"><strong><font size="3">Article&#160;4.........
            MISCELLANEOUS</font></strong></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">4.1..........
            Notices</font></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">4.2.......... Waiver
            of
            Rights</font></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">4.3..........
            Amendments</font></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">4.4.......... Governing
            Law</font></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">4.5.......... Entire
            Agreement</font></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">4.6.......... Successors
            and
            Assigns</font></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">4.7..........
            Counterparts</font></div>
          <div style="MARGIN: 0pt 36pt 0pt 90pt"><font size="3">4.8.......... Facsimile
            Execution</font></div>
        </div><br clear="all">
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><font size="3"><strong>NON-COMPETITION
          AND NON-SOLICITATION
          AGREEMENT</strong></font></div>
        <div style="MARGIN: 12pt 0pt 0pt">&#160;</div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3"><strong><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;</font>This
          Non-Competition and
          Non-Solicitation Agreement</strong> (&#8220;<strong>Agreement</strong>&#8221;) is made and
          entered into as of &lt;*&gt;, 2006, by and between MDS Inc., a corporation
          incorporated under the laws of Canada (&#8220;<strong>MDS</strong>&#8221;) and Borealis
          Infrastructure Management Inc., a corporation incorporated under the laws
          of
          Canada (&#8220;<strong>Buyer</strong>&#8221;).</font></div>
        <div style="MARGIN: 12pt 0pt 0pt">&#160;</div>
        <div style="MARGIN: 12pt 0pt 0pt; mso-outline-level: 1"><strong><font size="3">RECITALS:</font></strong></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt"><font size="3"><strong>A.</strong>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          MDS and Buyer have entered into the Ontario Purchase Agreement and the
          BC
          Purchase Agreement (collectively, the &#8220;<strong>Purchase Agreements</strong>&#8221;)
          pursuant to which, among other things, Buyer is purchasing from MDS and
          the
          other Sellers the Purchased Assets on the terms and subject to the conditions
          set forth in the Purchase Agreements.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt"><font size="3"><strong>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong>MDS will derive economic benefits from the transactions contemplated
          in
          the Purchase Agreements.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt"><font size="3"><strong>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong>So that Buyer may realize the full value associated with its purchase
          of the Purchased Assets pursuant to the Purchase Agreements, MDS has agreed
          that
          it will refrain from competing with Buyer, with respect to the Canadian
          Diagnostics Business, all in accordance with the terms of this
          Agreement.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt"><font size="3"><strong>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong>MDS has voluntarily entered into this Agreement and agrees that
          the
          limitations and restrictions set out in this Agreement are reasonable and
          not
          oppressive and are intended to protect Buyer&#8217;s substantial investment and
          legitimate business interests with respect to the Canadian Diagnostics
          Business.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt"><font size="3"><strong>E.</strong>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Buyer has voluntarily entered into this Agreement and agrees that the
          limitations and restrictions set out in this Agreement are reasonable and
          not
          oppressive and are intended to protect MDS&#8217; substantial investment and
          legitimate business interests with respect to its businesses.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt"><font size="3"><strong>F.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          </strong>Buyer has advised MDS that it would not have acquired the Purchased
          Assets and would not have entered into the other transactions and agreements
          contemplated by the Asset Purchase Agreement without a commitment by MDS
          to
          execute and deliver this Agreement.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt"><font size="3"><strong>G.</strong>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          It is a condition of Closing under the Ontario Purchase Agreement that
          the
          Parties enter into this Agreement on the Closing Date.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3"><strong><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;IN
          CONSIDERATION</strong> of the premises, the respective covenants and agreements
          contained herein and of other consideration (the receipt and sufficiency
          of
          which are hereby acknowledged by each Party) the Parties agree as
          follows:</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt; tab-stops: 0pt; mso-list: none" align="center"><a name="_Toc146013330"><strong><font size="3">Article&#160;1</font></strong><br><strong><font size="3">INTERPRETATION</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Toc146013331"><strong><font size="3">1.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Definitions</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">As used in this Agreement,
          unless
          the context otherwise requires capitalized terms not expressly defined
          in this
          Agreement shall have the meanings ascribed thereto in the Ontario Purchase
          Agreement, and the following terms shall have the following
          meanings;</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          &#8220;<strong>Affiliate</strong>&#8221; means, with respect to any Person,</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt; tab-stops: 108.0pt; mso-list: none"><font size="3">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
any
          other Person who
          directly or indirectly controls, is controlled by, or is under direct or
          indirect common control with, such Person; or</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt; tab-stops: 108.0pt; mso-list: none"><font size="3">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
any
          other Person that
          directly or indirectly owns all of the participating equity of such Person
          or
          for which all of the participating equity is directly or indirectly owned
          by
          such Person; and</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; TEXT-INDENT: 0pt; tab-stops: 36.0pt; mso-list: none"><font size="3">a
          Person shall be deemed to &#8220;control&#8221; a Person if such Person possesses
          directly or indirectly the power to direct or cause the direction of the
          management and policies of such Person, whether through the ownership of
          voting
          securities, by contract or otherwise, and &#8220;controlled&#8221; shall have a similar
          meaning;</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          &#8220;<strong>Agreement</strong>&#8221; has the meaning ascribed thereto in the
          recitals;</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Autolabs
          Business</strong>&#8221; means the business carried on by MDS and its Affiliates
          relating to the hardware system and related software known as APX (AutoLab
          Process eXpert) that provides specimen management, storage, results and
          instrument interfacing capabilities at testing locations, consisting of
          the
          licensing, maintenance and support of such system;</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>BC
          Purchase
          Agreement</strong>&#8221; means the asset purchase agreement dated &lt;*&gt;, 2006
          between MDS, Mether Properties Limited Partnership and Buyer;</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          &#8220;<strong>Business</strong><strong>Day</strong>&#8221; means a day other than Saturday
          or Sunday, on which Canadian chartered banks are open for the transaction
          of
          domestic business in the City of Toronto;</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Buyer
          Entity</strong>&#8221; has the meaning ascribed thereto in Section 2.6;</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Canadian
          Diagnostics</strong><strong>Business</strong>&#8221; means the specimen collection and
          diagnostic services businesses carried on in Canada, prior to the date
          hereof,
          by MDS, the Operators, BC Operators and the Non-Controlled Operators (as
          defined
          in both Purchase Agreements) and after Closing by Buyer, Buyer Entities
          and
          their Affiliates, consisting of the provision of clinical laboratory testing
          for
          physicians, hospitals, non-hospital health care institutions, employees
          or
          insurance companies, management of hospital laboratories and other support
          services for clinical diagnostics and the AutoLabs Business;</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Capacity</strong>&#8221;
          has the meaning ascribed thereto in Section 2.2;</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          &#8220;<strong>Employees</strong>&#8221; means, collectively, &#8220;Employees&#8221; as defined in the
          BC Purchase Agreement and &#8220;Employees&#8221; as defined in the Ontario Purchase
          Agreement;</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          &#8220;<strong>Field</strong>&#8221; means the collection, testing, monitoring and/or
          reporting of test results of bodily, cytological and other specimens from
          a
          patient at the request of any other Person, including a patient, health
          care
          professional, employer or insurance company;</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Infringing
          Business</strong>&#8221; has the meaning ascribed thereto in Section 3.1(a)(ii)
          hereof;</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>MDS
          Employee</strong>&#8221; has the meaning ascribed thereto in Section 2.6;</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(m)&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>notice</strong>&#8221;
has
          the
          meaning ascribed thereto in Section 4.1 hereof;</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Ontario
          Purchase
          Agreement</strong>&#8221; means the asset purchase agreement dated &lt;*&gt;, 2006
          between MDS and Buyer;</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Phase
          IV
          Trials</strong>&#8221; means post-marketing studies to delineate additional
          information including a drug&#8217;s risks, benefits and optimal use;</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(p)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Purchase
          Agreements</strong>&#8221; has the meaning ascribed to it in the
          recitals;</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(q)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Purchased
          Assets</strong>&#8221; means, collectively, the &#8220;Purchased Assets&#8221; and &#8220;Regional
          Assets&#8221; as defined in the BC Purchase Agreement (but, for greater certainty,
          excluding any Regional Asset that is an Excluded Asset as defined in the
          BC
          Purchase Agreement) and the &#8220;Purchased Assets&#8221; and &#8220;Regional Assets&#8221; as defined
          in the Ontario Purchase Agreement (but, for greater certainty, excluding
          any
          Regional Asset that is an Excluded Asset as defined in the Ontario Purchase
          Agreement);</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(r)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Regional
          Asset</strong>&#8221; means &#8220;Regional Assets&#8221; as defined in each of the Purchase
          Agreements;</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(s)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          &#8220;<strong>Territory</strong>&#8221; means Canada; </font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(t)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&#8220;<strong>Transferred
          Employee</strong>&#8221; means any Employee or any employee of MDS, in each case, who
          becomes an employee of Buyer, a Buyer Entity or their Affiliates on Closing
          in
          accordance with the Purchase Agreements or after Closing in accordance
          with and
          as contemplated by the Parties in connection with a Migration Project (as
          defined in the Migration Agreement); and</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(u)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          &#8220;<strong>Transmission</strong>&#8221; has the meaning ascribed thereto in Section
          4.1(b) hereof.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Toc146013332"><strong><font size="3">1.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Headings, etc.</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;</font>The
          division of this Agreement into
          articles, sections, subsections and schedules and the insertion of headings
          are
          for convenience of reference only and shall not affect the construction
          or
          interpretation of this Agreement.&#160; The article, section, subsection and
          schedule headings in this Agreement are not intended to be full or precise
          descriptions of the text to which they refer and are not to be considered
          part
          of this Agreement.&#160; All uses of the words &#8220;hereto&#8221;, &#8220;herein&#8221;, &#8220;hereof&#8221;,
&#8220;hereby&#8221; and &#8220;hereunder&#8221; and similar expressions refer to this Agreement and not
          to any particular section or portion of it.&#160; References to an Article,
          Section, Subsection or Schedule refer to the applicable article, section,
          subsection or schedule of this Agreement.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Toc146013333"><strong><font size="3">1.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Plurality and Gender</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">In this Agreement, words
          in the
          singular include the plural and vice-versa and words in one gender include
          all
          genders.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Toc146013334"><strong><font size="3">1.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Including, etc.</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">Reference in this Agreement
          to
          the term &#8220;including&#8221; shall mean &#8220;including without limitation&#8221; and shall not be
          construed to limit any general statement which it follows to the specific
          or
          similar items or matters immediately following it.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Toc146013335"><strong><font size="3">1.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Construction</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">This Agreement is the
          joint
          product of MDS and Buyer, has been subject to mutual consultation, negotiation
          and agreement of the Parties and shall not be construed for or against
          any
          Party.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Toc146013336"><strong><font size="3">1.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Severability</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">If any provision of this
          Agreement is determined by a court of competent jurisdiction to be invalid,
          illegal or unenforceable in any respect, such determination shall not impair
          or
          affect the validity, legality or enforceability of the remaining provisions
          hereof, and each provision is hereby declared to be separate, severable
          and
          distinct.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Toc146013337"><strong><font size="3">1.7&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Time of the Essence</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">Time shall be of the essence
          of
          this Agreement and each provision hereof.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt; tab-stops: 0pt; mso-list: none" align="center"><a name="_Toc146013338"><strong><font size="3">Article&#160;2</font></strong><br><strong><font size="3">NON-COMPETITION
          AND NON-SOLICITATION</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Ref128908022"/><a name="_Toc146013339"><strong><font size="3">2.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Recitals</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">Buyer and MDS represent
          and
          warrant to each other that the recitals set forth above are true in substance
          and in fact and that the purpose of this Agreement is to protect the legitimate
          business interests of Buyer and of MDS, as applicable, by providing, <i>inter
          alia</i>, for the broadest scope, the longest duration and the widest territory
          permitted by law.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Toc146013340"><strong><font size="3">2.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Non-Compete</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">MDS agrees that, for a
          period of
          five (5) years after the Closing neither MDS nor any of its Affiliates
          shall, on
          their own behalf or on behalf of, or together with, any Person, directly
          or
          indirectly, and whether as an owner, operator, manager, employer, principal,
          agent, joint venturer, partner, shareholder or other equity holder, investor,
          independent contractor, licensor, licensee, franchisor, franchisee, distributor,
          consultant, supplier, lender, guarantor, financier, promoter, trustee or
          in any
          other similar capacity whatsoever (collectively, a &#8220;<strong>Capacity</strong>&#8221;),
          carry on, be engaged in, or have any financial interest in any business
          in the
          Field in the Territory.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Ref144364199"/><a name="_Ref144364967"/><a name="_Toc146013341"><strong><font size="3">2.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Exclusions from Field</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">Buyer acknowledges that
          the Field
          does not include (i) central laboratory testing (including bioanalytical
          testing) and/or clinical diagnostic testing (including bioanalytical testing)
          conducted in each case as part of a clinical trial undertaken by MDS or
          its
          Affiliates on behalf of itself and/or its Affiliates and/or on behalf of
          third
          parties (including the use of immune response monitoring services and central
          laboratory esoteric testing (including pharmacogenomic tests)) and all
          other
          research activities (beyond clinical trials) that could be related to any
          previously collected biological fluids or specimen (e.g. tissue) such as
          extended Phase IV Trials, newly available validation using diagnostic tests
          or
          personalized medicine approaches and all physiological testing (including,
          but
          not restricted to, biological samples, genetic analysis, imaging technologies
          and conventional vital indicators) associated with preclinical, clinical
          and
          post-market surveillance studies for pharmaceutical and medical device
          products;
          (ii) molecular imaging services or collaborations with Centres of Excellence
          in
          which a patient may be imaged in whole or part using a variety of techniques
          such as MR, CT, PET, ultrasound and optical and related point-of-care clinical
          diagnostic testing based on bodily or cytological specimens such as P450
          testing, contrast agent interactions and overall patient responses to
          treatments; or (iii) the development, commercialization and support of
          clinical
          diagnostic tests associated with mass spectrometry or cellular analysis
          or a
          clinical diagnostics service using mass spectrometry or cellular analysis
          tools.
</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Ref128914804"/><a name="_Ref144365975"/><a name="_Ref146002358"/><a name="_Toc146013342"><font size="3"><strong>2.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Non-Solicitation</strong><strong> by MDS and
          Affiliates</strong></font></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><a name="_Ref144366022"><font size="3">MDS
          acknowledges that the Transferred Employees are a key component of carrying
          on
          the Canadian Diagnostics Business and therefore agrees to the covenant
          in this
          Section 2.4.&#160; Accordingly, MDS agrees that, for a period of three (3) years
          after the Closing, neither MDS nor any of its Affiliates shall, on their
          own
          behalf or on behalf of, or together with, any Person, directly or indirectly,
          solicit, employ, or offer employment to, any </font></a><font size="3">Transferred
          Employee.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Ref144364207"/><a name="_Toc146013343"><strong><font size="3">2.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          MDS Acknowledgement</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">MDS: (i) acknowledges
          and agrees
          that it has carefully considered with the assistance of its counsel the
          nature
          and extent of the restrictive covenants set forth in this Agreement; (ii)
          acknowledges and agrees that the provisions of Sections 2.2 and 2.4 are
          reasonable and necessary to protect and preserve Buyer&#8217;s interests in and right
          to use the Purchased Assets and the operation of the Canadian Diagnostics
          Business (as such business is carried on as of the date hereof) from and
          after
          Closing; (iii) irrevocably waives (and agrees not to raise) as a defence
          any
          issue of reasonableness (including the reasonableness of the Territory
          or the
          duration and scope of this Agreement) in any proceeding to enforce the
          provisions of Sections 2.2 and 2.4; (iv) acknowledges and agrees that Buyer
          may
          suffer irreparable harm if MDS or its Affiliates breach any of their obligations
          set out in Sections 2.2 and 2.4; and (v) acknowledges and agrees that monetary
          damages may not be a sufficient remedy for a breach by MDS or its Affiliates
          of
          the provisions of Sections 2.2 and 2.4.&#160; Accordingly, in the event of a
          breach or threatened breach by MDS or any of its Affiliates of any of the
          provisions of Sections 2.2 and 2.4, in addition to any remedy provided
          for at
          law or in equity, Buyer shall be entitled to seek equitable relief, including
          an
          interim injunction, interlocutory injunction and permanent injunction or
          specific performance or both.&#160; </font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Ref144366025"/><a name="_Ref146002163"/><a name="_Ref146011015"/><a name="_Toc146013344"><strong><font size="3">2.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Non-Solicitation by Buyer and Affiliates</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">Buyer acknowledges that
          the
          employees of MDS and its Affiliates other than those who from and after
          the date
          of this Agreement become employees of Buyer (in accordance with the Purchase
          Agreements or after Closing in accordance with and as contemplated by the
          Parties in connection with a Migration Project (as defined in the Migration
          Agreement)) (&#8220;<strong>MDS Employees</strong>&#8221;) are a key component of carrying
          on MDS&#8217; businesses and therefore agrees to the covenant in this Section
          2.6.&#160; Accordingly, Buyer agrees that, for a period of three (3) years after
          the Closing, none of Buyer, any Designated Buyer Affiliate (as defined
          in and
          pursuant to the Purchase Agreements), any BC Operator (as defined in the
          Ontario
          Purchase Agreement) excluding Metro GP, Mether LP and Mether GP (as each
          is
          defined in the BC Purchase Agreement) or any of their respective Affiliates
          (other than one which is an Affiliate of OMERS Administration Corporation
          and
          not a Designated Buyer Affiliate or BC Operator) (each a &#8220;<strong>Buyer
          Entity</strong>&#8221;) shall, on their own behalf or on behalf of, or together with,
          any Person, directly or indirectly, solicit, employ, or offer employment
          to any
          MDS Employee.&#160; For avoidance of doubt, this Agreement does not apply in
          respect of OMERS Administration Corporation or any of its Affiliates that
          is not
          a Buyer Entity.&#160; However, Buyer shall not and shall cause the other Buyer
          Entities not to encourage, assist or facilitate the solicitation or hiring
          of
          any MDS Employees by OMERS Administration Corporation or any of its Affiliates
          that is not a Buyer Entity including by disclosing any information about
          any MDS
          Employee.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Toc146013345"><strong><font size="3">2.7&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Buyer Acknowledgement</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">Buyer acknowledges and
          agrees
          that: (i) it has carefully considered with the assistance of its counsel
          the
          nature and extent of the restrictive covenant set forth in Section 2.6;
          (ii)&#160;the provisions of Section 2.6 are reasonable and necessary to protect
          and preserve MDS&#8217; interests in and right to carry on its business from and after
          Closing; (iii) MDS may suffer irreparable harm if Buyer or its Affiliates
          breach
          any of their obligations set out in Section 2.6; and (iv) monetary damages
          may
          not be a sufficient remedy for a breach by Buyer or its Affiliates of the
          provisions of Section 2.6.&#160; Accordingly, in the event of a breach or
          threatened breach by Buyer or any of its Affiliates of any of the provisions
          of
          Section 2.6, in addition to any remedy provided for at law or in equity,
          MDS
          shall be entitled to seek equitable relief, including an interim injunction,
          interlocutory injunction and permanent injunction or specific performance
          or
          both.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Toc146013346"><strong><font size="3">2.8&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Accounting for Profits</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">If either Party or its
          Affiliates
          breaches any of its obligations as set out in this Agreement the other
          Party
          shall be entitled to seek an accounting and repayment of any and all profits,
          compensation, royalties, commissions, remunerations or benefits which the
          breaching Party or its Affiliates, directly or indirectly, shall have realized
          or may realize as a result of, arising out of, or in connection with, any
          such
          breach.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Toc146013347"><strong><font size="3">2.9&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Other Remedies</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">The rights of each Party
          hereunder shall be in addition to any and all other remedies available
          to it and
          shall not be construed to prevent it from pursuing, either consecutively
          or
          concurrently, any and all other legal or equitable remedies available to
          it
          including the recovery of monetary damages.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Toc146013348"><strong><font size="3">2.10&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Effective Time</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">Notwithstanding anything
          in this
          Agreement, the terms and provisions hereof shall take effect from the date
          hereof in relation to activities or transactions undertaken by the parties
          in
          the province of Ontario and from the next day in relation to activities
          or
          transactions undertaken by the parties in the rest of Canada.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt; tab-stops: 0pt; mso-list: none" align="center"><a name="_Toc146013349"><strong><font size="3">Article&#160;3</font></strong><br><strong><font size="3">EXCEPTIONS</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Toc146013350"><strong><font size="3">3.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Exceptions for MDS and Affiliates</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Notwithstanding
          anything
          herein contained, the covenants set forth in Sections 2.2 and 2.4 shall
          not be
          construed so as to:</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt; tab-stops: 108.0pt; mso-list: none"><font size="3">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
prohibit
          MDS or any
          Affiliate of MDS from owning shares or other securities of any Persons
          engaged
          in any business in the Field in the Territory which are listed on a nationally
          recognized stock exchange or on NASDAQ, provided that MDS and its Affiliates,
          in
          the aggregate, do not hold more than five percent (5%) of the outstanding
          shares
          or other securities of such Persons; or</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt; tab-stops: 108.0pt; mso-list: none"><a name="_Ref144362975"><font size="3">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          restrict, limit or preclude MDS and its Affiliates from (A) carrying on
          (x)&#160;its Pharma Services business (including the central laboratory
          operations, the drug development and regulatory services business and the
          bioanalytical operations of its Pharma Services business), its Nordion
          business
          and its Sciex business, in each case as such business is currently carried
          on
          or, provided such business is not conducted in a manner which is competitive
          with the Canadian Diagnostics Business (as such business is carried on
          as of the
          date hereof), as such business may be carried on in the future, or (y)
          any other
          businesses that are not within the Field, including, in the case of both
          (x) and
          (y), acting as a supplier to any Person carrying on business in the Field;
          (B)
          in any Capacity, holding or acquiring any financial interest in any Person
          or
          acquiring more than fifty percent (50%) of the shares or other securities
          of a
          Person (twenty percent (20%) in the event that the Person is a public entity)
          in
          each case where such Person carries on a business within the Field in the
          Territory (an &#8220;<strong>Infringing Business</strong>&#8221;), provided that the
          Infringing Business is a minor and incidental part of its business; (C)
          soliciting or hiring any Transferred Employees after they have ceased to
          be
          employees of Buyer, a Buyer Entity or their Affiliates; (D)&#160;hiring of any
          Transferred Employee who responds to employment advertisements of a general
          nature not targeted to Transferred Employees; (E)&#160;hiring of any Transferred
          Employee who initiates discussions regarding such employment with MDS or
          an
          Affiliate, without any direct or indirect solicitation or inducement by
          MDS or
          any Affiliate; or (F)&#160;any solicitation by an independent third party
          employment agency retained by MDS or an Affiliate that independently (and
          with
          no direct or indirect guidance or direction from MDS or an Affiliate) determines
          to solicit a Transferred Employee.</font></a></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Notwithstanding
          anything
          herein contained, this Agreement shall not apply to MDS or any Person designated
          by MDS to the extent that MDS or any such Person holds a Non-Assignable
          Contract
          on or after the date hereof as contemplated by and in accordance with the
          applicable Purchase Agreement nor shall this Agreement apply to any transferee
          of a Non-Assignable Contract or to the extent that such Non-Assignable
          Contract
          becomes an Excluded Asset under the applicable Purchase Agreement.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Notwithstanding
          anything
          herein contained, this Agreement shall not apply to MDS or any Person designated
          by MDS to the extent that MDS or any such Person holds a Regional Asset
          on or
          after the date hereof as contemplated by and in accordance with the applicable
          Purchase Agreement nor shall this Agreement apply to any transferee of
          a
          Regional Asset to the extent that such Regional Asset becomes an Excluded
          Asset
          under the applicable Purchase Agreement, provided in all cases MDS:&#160; (i) is
          only a passive investor in any such Regional Asset holding no more than
          the
          equity or voting interests in such Regional Asset that is currently held
          by MDS
          or any of its Affiliates; (ii)&#160;uses its commercially reasonable efforts to
          obtain the consent or approval of other holders of equity or voting interests
          in
          the Regional Asset to the sale of such Regional Assets to the Buyer or
          a
          Designated Buyer Affiliate or, if such efforts are not successful, seeks
          to sell
          its interests in any such Regional Assets in an orderly manner; provided
          that
          nothing herein shall require MDS to sell a Regional Asset at a price that
          is
          less than fair value. </font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Toc146013351"><strong><font size="3">3.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Exceptions for Buyer Entities</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">Notwithstanding anything
          herein
          contained, the covenants set forth in Section 2.6 shall not be construed
          so as
          to restrict, limit or preclude Buyer or any other Buyer Entity from
          (i)&#160;soliciting or hiring any MDS Employee after they have ceased to be
          employees of MDS or its Affiliates; (ii) hiring of any MDS Employee who
          responds
          to employment advertisements of a general nature not targeted to MDS Employees;
          (iii)&#160;hiring of any MDS Employee who initiates discussions regarding such
          employment with a Buyer Entity, without any direct or indirect solicitation
          or
          inducement by any Buyer Entity; (iv) any solicitation by an independent
          third
          party employment agency retained by a Buyer Entity that independently (and
          with
          no direct or indirect guidance or direction from a Buyer Entity) determines
          to
          solicit an MDS Employee; or (v) the hiring of any Employee or MDS Employee
          in
          accordance with the terms of a Purchase Agreement or in accordance with
          and as
          contemplated by the Parties in connection with a Migration Project (as
          defined
          in the Migration Agreement).</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt; tab-stops: 0pt; mso-list: none" align="center"><a name="_Toc146013352"><strong><font size="3">Article&#160;4</font></strong><br><strong><font size="3">MISCELLANEOUS</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Ref144363026"/><a name="_Toc146013353"><strong><font size="3">4.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Notices</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">Any notice, demand or
          other
          communication (in this Section, a &#8220;<strong>notice</strong>&#8221;) required or
          permitted to be given or made hereunder shall be in writing and shall be
          sufficiently given or made if:</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><font size="3">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
delivered
          in person during
          normal business hours of the recipient on a Business Day and left with
          a
          receptionist or other responsible employee of the recipient at the applicable
          address set forth below; or</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none"><a name="_Ref144363103"><font size="3">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          sent by any electronic means of sending messages, including facsimile
          transmission (excluding e-mail), which produces a paper record
          (&#8220;<strong>Transmission</strong>&#8221;) during normal business hours on a Business
          Day;</font></a></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt"><font size="3">in the case of a
          notice to
          MDS, addressed to it at:</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt"><font size="3">MDS Inc.<br>100
          International Blvd.<br>Toronto, Ontario<br>M9W 6J6</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt; tab-stops: 171.0pt"><font size="3">Attention:&#160;&#160;&#160;&#160;&#160;&#160;
Executive
          Vice-President,
<br>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Corporate Development and General Counsel<br>Fax No.:&#160;
&#160;&#160;&#160;&#160;&#160; (416) 213-4222</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt; mso-pagination: widow-orphan"><font size="3">with
          a copy to (which shall not constitute notice):</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 108.3pt"><font size="3">Fasken Martineau
          DuMoulin
          LLP <br>66 Wellington Street West<br>Suite 4200, Toronto Dominion Bank
          Tower<br>Box 20, Toronto-Dominion Centre<br>Toronto, Ontario <br>M5K
          1N6</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt; tab-stops: 171.0pt; mso-pagination: widow-orphan"><font size="3">Attention:
&#160;&#160;&#160;&#160;&#160;
Scott
          Conover<br>Fax No.:&#160;
&#160;&#160;&#160;&#160;&#160; (416) 364-7813</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt"><font size="3">and in the case of
          a notice
          to Buyer, addressed to it at:</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt"><font size="3">200 Bay Street<br>P.O. Box
          56<br>Suite 2100<br>Royal Bank Plaza, South Tower<br>Toronto, Ontario<br>M5J
          2J2</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt"><font size="3">Attention:
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; President and Chief
          Executive
          Officer<br>Fax No.:&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (416)
          361-6075</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 72pt"><font size="3">with a copy to (which
          shall
          not constitute notice):</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt"><font size="3">200 Bay Street<br>P.O. Box
          84<br>Suite 3800<br>Royal Bank Plaza, South Tower<br>Toronto, Ontario<br>M5J
          2Z4</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt"><font size="3">Attention:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Jacques
          Demers<br>Fax No.:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
(416) 216-3930</font></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">Each notice sent in accordance
          with this Section shall be deemed to have been received:</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt; tab-stops: 108.0pt; mso-list: none"><font size="3">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
on
          the day it was
          delivered in person as aforesaid;</font></div>
        <div style="MARGIN: 12pt 0pt 0pt 108pt; tab-stops: 108.0pt; mso-list: none"><font size="3">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
on
          the same day that it
          was sent by Transmission, or on the first Business Day thereafter if the
          day on
          which it was sent by Transmission was not a Business Day or if it was sent
          after
          normal business hours on a Business Day.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">Either Party may change
          its
          address for notice by giving notice to the other Party.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Toc146013354"><strong><font size="3">4.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Waiver of Rights</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">Any waiver of, or consent
          to
          depart from, the requirements of any provision of this Agreement shall
          be
          effective only if it is in writing and signed by the Party giving it, and
          only
          in the specific instance and for the specific purpose for which it has
          been
          given.&#160; No failure on the part of any Party to exercise, and no delay in
          exercising, any right under this Agreement shall operate as a waiver of
          such
          right.&#160; No single or partial exercise of any such right shall preclude any
          other or further exercise of such right or the exercise of any other
          right.&#160; No failure on the part of either party to exercise, and no delay in
          exercising any right under this Agreement shall operate as a waiver of
          such
          right; nor shall any single or partial exercise of any such right preclude
          any
          other or further exercise of such right or the exercise of any other
          right.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Toc146013355"><strong><font size="3">4.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Amendments</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">This Agreement may only
          be
          amended or otherwise modified by written agreement executed by Buyer and
          MDS.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Toc146013356"><strong><font size="3">4.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Governing Law</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">This Agreement shall be
          governed
          by, and interpreted and enforced in accordance with, the laws in force
          in the
          Province of Ontario and the federal laws of Canada applicable therein.&#160;
Each Party irrevocably submits to the non-exclusive jurisdiction of the
          courts
          of Ontario with respect to any matter arising hereunder or related
          hereto.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Toc146013357"><strong><font size="3">4.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Entire Agreement</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">This Agreement and the
          Purchase
          Agreements constitute the entire agreement between the Parties pertaining
          to the
          subject matter hereof and supersede all prior agreements, negotiations,
          discussions and understandings, written or oral, between the Parties.&#160;
There are no representations, warranties, conditions, other agreements
          or
          acknowledgements, whether direct or collateral, express or implied, that
          form
          part of or affect this Agreement, or which induced either Party to enter
          into
          this Agreement or on which reliance is placed by either Party, except as
          specifically set forth in this Agreement and the Purchase
          Agreements.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Toc146013358"><strong><font size="3">4.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Successors and Assigns</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">This Agreement shall be
          binding
          upon and enure to the benefit of the Parties and their respective successors
          and
          permitted assigns.&#160; This Agreement shall not be assignable by MDS or Buyer,
          other than in the same manner assignment is permitted under Section 10.4
          of the
          Ontario Purchase Agreement (and for such purposes, the term &#8220;Affiliate&#8221; shall
          include an Affiliate of OMERS Administration Corporation).</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Toc146013359"><strong><font size="3">4.7&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Counterparts</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">This Agreement may be
          executed in
          any number of counterparts.&#160; Each executed counterpart shall be deemed to
          be an original.&#160; All executed counterparts taken together shall constitute
          one agreement.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none"><a name="_Toc146013360"><strong><font size="3">4.8&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
          Facsimile Execution</font></strong></a></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3">To evidence the fact that
          it has
          executed this Agreement, a Party may send a copy of its executed counterpart
          to
          the other Party by Transmission.&#160; That Party shall be deemed to have
          executed this Agreement on the date it sent such Transmission.&#160; In such
          event, such Party shall forthwith deliver to the other Party the counterpart
          of
          this Agreement executed by such Party.</font></div>
        <div style="MARGIN: 12pt 0pt 0pt"><font size="3"><strong>IN WITNESS
          WHEREOF</strong> the parties executed this Agreement as of the day and year
          first above written.</font></div>
        <div style="MARGIN: 0pt">&#160;</div>
        <table border="0" cellpadding="0" cellspacing="0" style="MARGIN-LEFT: 0.4pt; BORDER-COLLAPSE: collapse; mso-table-layout-alt: fixed; mso-padding-alt: 0pt 0pt 0pt 0pt">

            <tr>
              <td valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td colspan="2" valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 233.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt"><strong>MDS INC.</strong></div>
                <div style="MARGIN: 0pt">&#160;</div>
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="bottom" width="26" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 19.35pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">By:</div>
              </td>
              <td valign="bottom" width="286" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 214.55pt; padding-top: 0pt; border-bottom: windowtext 1pt solid;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="26" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 19.35pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="286" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 214.55pt; padding-top: 0pt; border-bottom: #ece9d8; mso-border-top-alt: solid windowtext .5pt;">
                <div style="MARGIN: 0pt">Name:</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="26" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 19.35pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="286" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 214.55pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">Title:</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td colspan="2" valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 233.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
                <div style="MARGIN: 0pt">&#160;</div>
                <div style="MARGIN: 0pt"><strong>BOREALIS INFRASTRUCTURE MANAGEMENT
                  INC.</strong></div>
                <div style="MARGIN: 0pt">&#160;</div>
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="bottom" width="26" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 19.35pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">By:</div>
              </td>
              <td valign="bottom" width="286" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 214.55pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="26" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 19.35pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="286" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: windowtext 1pt solid; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 214.55pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">Name:</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="26" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 19.35pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="286" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 214.55pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">Title:</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td colspan="2" valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 233.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="bottom" width="26" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 19.35pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">By:</div>
              </td>
              <td valign="bottom" width="286" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 214.55pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="26" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 19.35pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="286" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: windowtext 1pt solid; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 214.55pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">Name:</div>
              </td>
            </tr>
            <tr>
              <td valign="top" width="312" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 234pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="26" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 19.35pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">&#160;</div>
              </td>
              <td valign="top" width="286" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 214.55pt; padding-top: 0pt; border-bottom: #ece9d8;">
                <div style="MARGIN: 0pt">Title:</div>
              </td>
            </tr>

        </table>
        <div style="MARGIN: 0pt">&#160;</div>
      </div>
      <div>
        <hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
        <hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
      </div>
      <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><strong>SCHEDULE
        5.9</strong></div>
      <div style="MARGIN: 0pt 0pt 10pt 36pt; TEXT-INDENT: -36pt" align="center">
        <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">
          <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt"><a name="DocsID"><strong>SUPPORT
            SERVICES AGREEMENT<br>TERM SHEET</strong></a></div>
          <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="justify">
            <div>
              <div style="MARGIN: 12pt 0pt 0pt"><strong>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Remaining AutoLabs Contracts</strong></div>
              <div style="MARGIN: 12pt 0pt 0pt"><strong>Purpose</strong></div>
              <div style="MARGIN: 12pt 0pt 0pt">To the extent that any of the contracts
                listed
                on Schedule &#8220;A&#8221; hereto (the <strong>&#8220;AutoLabs Contracts&#8221;</strong>) have not been
                validly assigned to the Buyer or an applicable Designated Buyer Affiliate
                (a
&#8220;<strong>Buyer Entity</strong>&#8221;) on the Closing Date (such non-assigned AutoLabs
                Contracts, the <strong>&#8220;Remaining AutoLabs Contracts&#8221;</strong>), notwithstanding
                Section 2.3 of the Agreement, then under the terms of the Support
                Services
                Agreement, a Buyer Entity will assume responsibility for the performance
                of all
                services, covenants and obligations under such contracts.</div>
              <div style="MARGIN: 12pt 0pt 0pt"><strong>Performance of
                Obligations</strong></div>
              <div style="MARGIN: 12pt 0pt 0pt">Pursuant to the Support Services
                Agreement,
                from and after the Closing Date, MDS or the MDS entity party to the
                applicable
                contract (the &#8220;<strong>MDS Contracting Party</strong>&#8221;) will hold the Remaining
                AutoLabs Contracts in trust for the applicable Buyer Entity, and
                the Buyer
                Entity will be required to assume and perform all of the covenants
                and
                obligations of the MDS Contracting Parties under the Remaining AutoLabs
                Contracts under such trust arrangement until the earliest of: (i)
                such contract
                being validly assigned to a Buyer Entity; (ii) such contract being
                validly
                assigned to a service provider (e.g. [REDACTED]), provided that the
                MDS
                Contracting Party is released from any obligations or liabilities
                in respect of
                future performance under the contract; (iii) the expiration or termination
                of
                such contract, or (iv) the extension, amendment or renewal of such
                contract to
                remove the MDS Contracting Party as a party to the contract.&#160; The
                performance by the Buyer Entity will be in accordance with the terms
                of the
                applicable Remaining AutoLabs Contract.&#160; For certainty, the MDS Contracting
                Party shall not, without the written consent of Buyer, have the right
                to
                terminate or refuse to extend or renew a Remaining AutoLabs Contract
                if such
                termination, non-extension or non-renewal could, pursuant to the
                terms of the
                applicable AutoLabs Contract, result in the right of the applicable
                third party
                to obtain the source code for the software licensed to such person
                pursuant to
                the applicable AutoLabs Contract.</div>
              <div style="MARGIN: 12pt 0pt 0pt">The applicable Buyer Entity will
                grant the
                applicable MDS Contracting Party a limited, non-exclusive and non-transferable
                license to the AutoLabs Assets to extent required to effect the license
                of the
                AutoLabs Assets to the applicable third party. Each applicable MDS
                Contracting
                Party shall indemnify Buyer and the applicable Buyer Entity from
                any breach of
                such license.</div>
              <div style="MARGIN: 12pt 0pt 0pt">Each applicable MDS Contracting
                Party shall
                take or provide such reasonable action, assistance and/or information
                so as to
                provide the applicable Buyer Entity with the benefits of and to allow
                the
                applicable Buyer Entity to comply with the obligations under the
                Remaining
                AutoLabs Contracts, and each applicable MDS Contracting Party shall
                pay over to
                Buyer all money received by such MDS Contracting Party in respect
                of services
                performed by a Buyer Entity under each Remaining AutoLabs Contract
                within a ten
                (10) business days<strong>)</strong> following receipt of such money.</div>
              <div style="MARGIN: 12pt 0pt 0pt">Buyer shall be responsible for any
                failure to
                perform the services, covenants and obligations under the Remaining
                AutoLabs
                Contracts, except to the extent caused by MDS.</div>
              <div style="MARGIN: 12pt 0pt 0pt"><strong>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;
U.S. Transition Services
                Contracts</strong></div>
              <div style="MARGIN: 12pt 0pt 0pt"><strong>&#8220;U.S. Transition Services
                Contracts&#8221;
</strong>means the U.S. Support Services Contracts relating to the
                provision of
                transition services in connection with the sale of the diagnostics
                business in
                the U.S. to (i) [REDACTED], as are more particularly set out and
                described in
                Schedule &#8220;B&#8221; hereto.</div>
              <div style="MARGIN: 12pt 0pt 0pt">Pursuant to the Support Services
                Agreement,
                from and after the Closing Date, the applicable Buyer Entity will
                use
                commercially reasonable efforts to provide the applicable MDS Contracting
                Party
                with services, on a sub-contract basis, as may be required to enable
                such MDS
                Contracting Party to fulfill its obligations under the U.S. Transition
                Services
                Contracts (the <strong>&#8220;Transition Support Services&#8221;</strong>). Buyer and MDS
                acknowledge that the performance of any such sub-contracting arrangement
                shall
                be on terms and conditions that provide for the ownership and licensing
                of work
                product, the protection of confidential information and privacy related
                obligations in a manner consistent with the applicable U.S. Transition
                Services
                Contracts.</div>
              <div style="MARGIN: 12pt 0pt 0pt">The Transition Support Services
                shall be
                provided on a cost-recovery basis, with customary provisions for
                verification of
                such costs by MDS. Each applicable MDS Contracting Party shall pay
                to Buyer the
                costs incurred by applicable Buyer Entity in respect of services
                performed by
                such Buyer Entity within a ten (10) business days) following receipt
                of the
                applicable Buyer Entity invoice.</div>
              <div style="MARGIN: 12pt 0pt 0pt">The liability of the Buyer Entity
                in
                connection with its performance of the Transition Support Services
                will be
                subject to a customary limitation of liability. The Buyer Entity
                will only be
                liable for direct damages (and not any indirect damages of any kind
                or nature
                whatsoever).</div>
              <div style="MARGIN: 12pt 0pt 0pt">&#160;</div>
            </div><br clear="all">
            <div>
              <div style="MARGIN: 12pt 0pt 0pt; TEXT-ALIGN: center" align="center"><strong>SCHEDULE
&#8220;A&#8221;</strong></div>
              <div style="MARGIN: 12pt 0pt 0pt; TEXT-ALIGN: center" align="center"><strong>AutoLabs
                Contracts</strong></div>
              <div style="MARGIN: 12pt 0pt 0pt">[REDACTED]</div>
            </div><br clear="all">
            <div style="MARGIN: 12pt 0pt 0pt; TEXT-ALIGN: center" align="center"><strong>SCHEDULE
&#8220;B&#8221;</strong></div>
            <div style="MARGIN: 12pt 0pt 0pt; TEXT-ALIGN: center" align="center"><strong>U.S.
              Transition Services Contracts</strong></div>
            <div style="MARGIN: 12pt 0pt 0pt; TEXT-ALIGN: center" align="center">&#160;</div>
            <div style="MARGIN: 12pt 0pt 0pt">[REDACTED]</div>
            <div style="MARGIN: 12pt 0pt 0pt">&#160;</div>
          </div>
          <div>
            <hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
            <hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
          </div>
          <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="justify">
            <div style="MARGIN: 0pt 0pt 12pt; TEXT-INDENT: 0pt; mso-outline-level: 1" align="center"><a name="draftnum"/><a name="DocsID"><strong>SCHEDULE&#160;
              5.12</strong></a></div>
            <div style="MARGIN: 0pt 0pt 12pt; TEXT-INDENT: 0pt; mso-outline-level: 1" align="center"><strong>C</strong><a name="_Ref119387825"><strong>ONFIDENTIALITY
              AGREEMENT</strong></a></div>
            <div style="MARGIN: 12pt 0pt; TEXT-INDENT: 0pt" align="center">This
              Confidentiality Agreement (the &#8220;<strong>Agreement</strong>&#8221;) entered into and
              made effective <strong>[</strong>l<strong>]</strong>, 2006 is between:</div>
            <div style="MARGIN: 6pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong>MDS
              INC</strong>. <br>(&#8220;<strong>MDS</strong>&#8221;) </div>
            <div style="MARGIN: 12pt 0pt; TEXT-INDENT: 0pt" align="center">- and
              -</div>
            <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong>MDS
              LABORATORY SERVICES LIMITED PARTNERSHIP <br></strong>(&#8220;<strong>MDS ONT
              LP</strong>&#8221;) </div>
            <div style="MARGIN: 12pt 0pt; TEXT-INDENT: 0pt" align="center">- and
              -</div>
            <div style="MARGIN: 12pt 0pt; TEXT-INDENT: 0pt" align="center"><strong>LABORATOIRES
              MDS QU&#201;BEC LT&#201;E. <br></strong>(&#8220;<strong>MDS
              Quebec</strong>&#8221;)</div>
            <div style="MARGIN: 12pt 0pt; TEXT-INDENT: 0pt" align="center">- and
              -</div>
            <div style="MARGIN: 6pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong>METRO
              MCNAIR CLINICAL LABORATORIES LTD.<br>(&#8220;Metro GP&#8221;)</strong></div>
            <div style="MARGIN: 12pt 0pt; TEXT-INDENT: 0pt" align="center">- and
              -</div>
            <div style="MARGIN: 6pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong>METHER
              PROPERTIES LIMITED PARTNERSHIP<br>(&#8220;Mether LP&#8221;)</strong></div>
            <div style="MARGIN: 12pt 0pt; TEXT-INDENT: 0pt" align="center">- and
              -</div>
            <div style="MARGIN: 6pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong>METHER
              MANAGEMENT LTD.<br>(&#8220;Mether GP&#8221;)</strong></div>
            <div style="MARGIN: 12pt 0pt; TEXT-INDENT: 0pt" align="center">- and
              -</div>
            <div style="MARGIN: 6pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong>BOREALIS
              INFRASTRUCTURE MANAGEMENT INC.</strong><br>(&#8220;<strong>Buyer</strong>&#8221;)</div>
            <div style="MARGIN: 6pt 0pt 0pt"><strong>[<i>NTD&#160;: Designated Buyer
              Affiliates to be added as parties to this agreement and all defined
              as
&#171;&#160;Buyer Entities&#160;&#187;</i><i>.</i>]</strong></div>
            <div style="MARGIN: 6pt 0pt 0pt; TEXT-INDENT: 0pt">&#160;</div>
            <div style="MARGIN: 0pt"><strong>WHEREAS </strong>MDS and Buyer have entered
              into an asset purchase agreement with respect to the Ontario Diagnostics
              Business dated <strong>[</strong>l<strong>]</strong>, 2006 (as such agreement
              may be amended from time to time, the &#8220;<strong>Ontario Purchase
              Agreement</strong>&#8221;), as well as an asset purchase agreement with respect to
              the
              BC Diagnostics Business dated <strong>[</strong>l<strong>]</strong>, 2006 (as
              such agreement may be amended from time to time, the &#8220;<strong>BC Purchase
              Agreement</strong>&#8221; and, together with the Ontario Purchase Agreement, the
&#8220;<strong>Purchase Agreements</strong>&#8221;) pursuant to which, among other things,
              MDS has agreed to sell and, subject to receipt of all necessary consents,
              to
              cause various Affiliates of MDS to sell, and Mether LP has agreed to
              sell, to
              the Buyer Entities, and the Buyer Entities have agreed to purchase,
              certain
              assets relating to the MDS Diagnostics Division;&#160; </div>
            <div style="MARGIN: 0pt">&#160;</div>
            <div style="MARGIN: 0pt"><strong>AND WHEREAS</strong> pursuant to the Purchase
              Agreements, MDS and Buyer agreed that, prior to the Closing Time, MDS,
              MDS ONT
              LP, MDS Quebec, Metro GP, Mether LP and Mether GP (collectively, the
              &#8220;<strong>MDS Entities</strong>&#8221;) and the Buyer Entities would enter into a
              confidentiality agreement for the purpose of ensuring the confidentiality
              post-Closing of all Information in the possession or control of the
              other;</div>
            <div style="MARGIN: 0pt">&#160;</div>
            <div style="MARGIN: 0pt"><strong>AND WHEREAS</strong> Buyer and MDS are also
              parties to a migration agreement dated <strong>[</strong>l<strong>]</strong>,
              2006 (the &#8220;<strong>Migration Agreement</strong>&#8221;), pursuant to which, during the
              period of time commencing on the date of the Ontario Purchase Agreement
              and
              continuing until the Closing Date unless extended as necessary to complete
              the
              projects contemplated therein, the Parties have agreed to cooperate
              and work
              together to transition certain aspects of the MDS Diagnostics Division
              to the
              Buyer Entities;</div>
            <div style="MARGIN: 0pt">&#160;</div>
            <div style="MARGIN: 0pt"><strong>AND WHEREAS</strong> pursuant to the Migration
              Agreement, Buyer and MDS agreed, in respect of the mutual exchange
              of
              confidential information required in connection with the Migration
              Agreement, to
              enter into a confidentiality agreement for the purpose of ensuring
              the
              confidentiality from and after the date of this Agreement of all information
              exchanged between such parties pursuant to the Migration Agreement;</div>
            <div style="MARGIN: 0pt">&#160;</div>
            <div style="MARGIN: 0pt"><strong>AND WHEREAS </strong>the MDS Entitieshave
              voluntarily entered into this Agreement and agree that the limitations
              and
              restrictions set out in this Agreement are reasonable and not oppressive
              and are
              intended to protect the Buyer Entities&#8217; substantial investment and legitimate
              business interests under the Purchase Agreements;</div>
            <div style="MARGIN: 0pt">&#160;</div>
            <div style="MARGIN: 0pt"><strong>AND WHEREAS</strong> the Buyer Entities
              voluntarily entered into this Agreement and agree that the limitations
              and
              restrictions set out in this Agreement are reasonable and not oppressive
              and are
              intended to protect the MDS Entities&#8217; substantial investment and legitimate
              business interests in their respective on-going business operations
              that do not
              comprise the MDS Diagnostics Division;</div>
            <div style="MARGIN: 0pt">&#160;</div>
            <div style="MARGIN: 0pt"><strong>AND WHEREAS</strong> the Parties acknowledge
              that the Information of the other is highly sensitive;</div>
            <div style="MARGIN: 0pt">&#160;</div>
            <div style="MARGIN: 0pt"><strong>NOW THEREFORE </strong>in considerationof the
              premises and the respective agreements in this Agreement, and of other
              consideration (the receipt and sufficiency of which are acknowledged
              by each
              Party hereto), the Parties hereto agree as follows:</div>
            <div style="MARGIN: 6pt 0pt 6pt 36pt; tab-stops: 36.0pt; mso-list: none; mso-pagination: widow-orphan lines-together">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              <strong>Definitions</strong></div>
            <div style="MARGIN: 0pt 0pt 12pt; mso-pagination: widow-orphan lines-together">As
              used in this Agreement, unless the context otherwise requires, capitalized
              terms
              not expressly defined in this Agreement shall have the meanings ascribed
              thereto
              in the Ontario Purchase Agreement, and the following terms shall have
              the
              following meanings:</div>
            <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              &#8220;<strong>Affiliate</strong>&#8221; means, with respect to any Person,</div>
            <div style="MARGIN: 12pt 0pt 0pt 108pt; tab-stops: 108.0pt; mso-list: none">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              any other Person who directly or indirectly controls, is controlled
              by, or is
              under direct or indirect common control with, such Person; or</div>
            <div style="MARGIN: 12pt 0pt 0pt 108pt; tab-stops: 108.0pt; mso-list: none">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              any other Person that directly or indirectly owns all of the participating
              equity of such Person or for which all of the participating equity
              is directly
              or indirectly owned by such Person; and</div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 36.0pt; mso-list: none">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              a Person shall be deemed to &#8220;control&#8221; a Person if such Person possesses directly
              or indirectly the power to direct or cause the direction of the management
              and
              policies of such Person, whether through the ownership of voting securities,
              by
              contract or otherwise, and &#8220;controlled&#8221; shall have a similar meaning;</div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              &#8220;<strong>Agreement</strong>&#8221; has the meaning set forth in the preamble
              hereof;</div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              &#8220;<strong>BC Diagnostics Business</strong>&#8221; means the specimen collection and
              diagnostic services businesses carried on, prior to the date hereof,
              by MDS, in
              British Columbia, and the BC Operators consisting of the provision
              of clinical
              laboratory testing for physicians, hospitals, non-hospital health care
              institutions, employers or insurance companies, management of hospital
              laboratories and other support services for clinical diagnostics;</div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              &#8220;<strong>BC Purchase Agreement</strong>&#8221; has the meaning set forth in the
              recitals to this Agreement;</div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              &#8220;<strong>Business Day</strong>&#8221; means any day, other than a Saturday or Sunday,
              on which Canadian chartered banks are open for the transaction of business
              in
              the City of Toronto;</div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              &#8220;<strong>Buyer Confidential Information</strong>&#8221; means all information,
              knowledge and data (regardless of form) concerning or related to: (i)&#160;the
              MDS Diagnostics Division, the Purchased Assets, the BC Purchased Assets,
              the
              Replacement Contracts and the Migrating Assets; (ii)&#160;the business and
              affairs of Buyer (other than pertaining to the MDS Diagnostics Division,
              the
              Purchased Assets, the BC Purchased Assets, the Replacement Contracts
              and the
              Migrating Assets) disclosed by Buyer to the MDS Entities prior to or
              after the
              date of this Agreement; (iii)&#160;the migration of the MDS Diagnostics Division
              (inclusive of Buyer&#8217;s proposed or actual changes and plans related thereto) in
              connection with the performance of the Migration Agreement; and (iv)
              the
              business and affairs of the MDS Diagnostics Division as carried on
              by the Buyer
              Entities after the Closing Date; including without limitation, in each
              of the
              foregoing cases, trade secrets, processes, practices, ideas, concepts,
              know-how,
              formulas, assays, recipes, and all other information, knowledge and
              data of an
              intellectual, proprietary, technical, scientific, commercial, financial
              or
              industrial nature provided that Buyer Confidential Information does
              not include
              any information, knowledge or data concerning any Regional Asset that
              is an
              Excluded Asset under the applicable Purchase Agreement;</div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              &#8220;<strong>Buyer Entities</strong>&#8221; has the meaning set forth in the recitals to
              this Agreement;</div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              &#8220;<strong>Governmental Authority</strong>&#8221; means any domestic or foreign
              government whether federal, provincial, state or municipal and any
              governmental
              agency, governmental authority, governmental tribunal or governmental
              commission
              of any kind whatever;</div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              &#8220;<strong>Information</strong>&#8221; means either Buyer Confidential Information or
              MDS Confidential Information, as the case may be;</div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              &#8220;<strong>MDS Confidential Information</strong>&#8221; means all information, knowledge
              and data (regardless of form) concerning or related to the business
              and affairs
              of the MDS Entities, or the business and affairs of an Affiliate of
              MDS (but in
              each case excluding information, knowledge and data (regardless of
              form)
              relating Primarily (as such term is defined and interpreted under the
              Purchase
              Agreements) to the MDS Diagnostics Division), including without limitation,
              trade secrets, processes, practices, ideas, concepts, know-how, formulas,
              assays, recipes, and all other information, knowledge and data of an
              intellectual, proprietary, technical, scientific, commercial, financial
              or
              industrial nature disclosed (i) by or on behalf of the MDS Entities
              or any
              Affiliate of MDS to Buyer or employees of the MDS Entities that are
              employed by
              Buyer after Closing prior to or after the date of this Agreement, including,
              without limitation, in connection with the performance of the Migration
              Agreement, or (ii) that is or has been disclosed by, or is within the
              knowledge
              or possession of, employees of the MDS Entities that are employed by
              Buyer after
              Closing; </div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              &#8220;<strong>MDS Diagnostics Division</strong>&#8221; means the Ontario Diagnostics
              Business and BC Diagnostics Business carried on by MDS up to the Closing
              Date,
              the Operators and the BC Operators and including the businesses carried
              on by
              Toronto Labs, Windsor Labs, Trainor Laboratories Limited Partnership,
              Dynacare
              Kasper Medical Laboratories Partnership, Excelleris Technologies Inc.
              and
              Excelleris Technologies LP; </div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              &#8220;<strong>MDS Entities</strong>&#8221; has the meaning set forth in the recitals to
              this Agreement;</div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              &#8220;<strong>notice</strong>&#8221; has the meaning set forth in Section 14 hereof;</div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt 171.0pt; mso-list: none">(m)&#160;&#160;&#160;&#160;&#160;&#160;
              &#8220;<strong>Ontario Diagnostics Business</strong>&#8221; means the specimen collection
              and diagnostic services businesses carried on, prior to the date hereof,
              by MDS
              and the Operators in Ontario and Quebec consisting of the provision
              of clinical
              laboratory testing for physicians, hospitals, non-hospital health care
              institutions, employers or insurance companies, management of hospital
              laboratories and other support services for clinical diagnostics and
              the
              AutoLabs Business;</div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt 171.0pt; mso-list: none">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              &#8220;<strong>Ontario Purchase Agreement</strong>&#8221; has the meaning set forth in the
              recitals to this Agreement;</div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              &#8220;<strong>Parties</strong>&#8221; means the MDS Entities and the Buyer Entities,
              collectively, and &#8220;<strong>Party</strong>&#8221; means any one of them;</div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none">(p)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              &#8220;<strong>Person</strong>&#8221; shall be broadly interpreted and includes an
              individual, body corporate, partnership, joint venture, trust, association,
              unincorporated organization, the Crown, any Governmental Authority
              or any other
              entity recognized by law;</div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none">(q)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              &#8220;<strong>Purchase Agreements</strong>&#8221; has the meaning set forth in the recitals
              to this Agreement;</div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none">(r)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              &#8220;<strong>Representatives</strong>&#8221; means the directors, officers, employees,
              agents, solicitors, accountants, consultants, financial or legal advisors
              and
              all other representatives of the Party being referred to; and</div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none">(s)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              &#8220;<strong>Transmission</strong>&#8221; has the meaning set forth in Subsection 14(b)
              hereof.</div>
            <div style="MARGIN: 6pt 0pt 6pt 36pt; tab-stops: 36.0pt; mso-list: none">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              Subject to the provisions of this Agreement, neither the MDS Entities
              nor the
              Buyer Entities shall, at any time, use or disclose to any Person, directly
              or
              indirectly, the Information of the other except as otherwise provided
              herein.
              The MDS Entities and Buyer Entities acknowledge that (i) the Information
              of the
              other is vital, sensitive, confidential and proprietary to, in the
              case of
              Buyer, the specimen collection and diagnostic services business carried
              on by
              the Buyer after the date of this Agreement and, in the case of the
              MDS Entities,
              MDS&#8217; businesses and the businesses of its Affiliates, other than the MDS
              Diagnostics Division, and (ii) use by, or unauthorized disclosure of,
              the
              others&#8217; Information would be materially prejudicial and detrimental to the
              interests and business of the Buyer Entities or the MDS Entities, as
              the case
              may be.</div>
            <div style="MARGIN: 6pt 0pt 6pt 36pt; tab-stops: 36.0pt; mso-list: none"><a name="_Ref143069962">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Neither
              the MDS Entities nor the Buyer Entities shall disclose the Information
              of the
              other to any Person other than to those of its Representatives who
              have a need
              to know and who have agreed to maintain such Information in the strictest
              confidence. The MDS Entities, on the one hand, and the Buyer Entities,
              on the
              other hand, shall protect, to the same extent and in the same manner
              as it
              protects its own confidential information (provided that such standard
              is not
              less than commercially reasonable efforts), all Information of the
              other that it
              retains in its respective possession or under its respective control
              from all
              harm, loss, theft, reproduction and unauthorized access and shall ensure
              that
              such Information is not disclosed, published, released, transferred
              or otherwise
              made available in any form to, for the use or benefit of, any Person
              except as
              provided in this Agreement, without the prior written approval of Buyer
              or MDS,
              as applicable. The MDS Entities shall be jointly and severally liable
              for
              breaches hereunder and shall be responsible for any breach of this
              Agreement by
              their Representatives (or any other Person to whom the MDS Entities
              disclose
              Buyer Confidential Information), whether or not such Representatives
              (or other
              Persons) have agreed to maintain such confidentiality, other than for
              any
              breaches hereunder caused by an employee of an MDS Entity provided
              that the MDS
              Entities have taken all commercially reasonable steps to protect the
              Buyer
              Confidential Information to the same extent and in the same manner
              as it
              protects its own confidential information and further provided it takes
              all
              reasonable steps to prevent any further breaches of this Agreement
              by such
              employee which may include, without limitation, appropriate disciplinary
              measures for the employee who caused the breach of this Agreement.</a>&#160; The
              Buyer Entities shall be jointly and severally liable for breaches hereunder
              and
              shall be responsible for any breach of this Agreement by their Representatives
              (or any other Person to whom the Buyer Entities disclose Buyer Confidential
              Information), whether or not such Representatives (or other Persons)
              have agreed
              to maintain such confidentiality, other than for any breaches hereunder
              caused
              by an employee of a Buyer Entity provided that the Buyer Entities have
              taken all
              commercially reasonable steps to protect the MDS Confidential Information
              to the
              same extent and in the same manner as it protects its own confidential
              information and further provided it takes all reasonable steps to prevent
              any
              further breaches of this Agreement by such employee which may include,
              without
              limitation, appropriate disciplinary measures for the employee who
              caused the
              breach of this Agreement.</div>
            <div style="MARGIN: 6pt 0pt 6pt 36pt; tab-stops: 36.0pt; mso-list: none"><a name="_Ref119387829">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
The
              non-disclosure obligations in this Agreement shall not restrict disclosure
              of
              Information by a Party where: </a></div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              the disclosure is required by law (including, in the case of MDS, any
              published
              policies of applicable securities regulators and applicable stock exchange
              rules); </div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              the disclosure is required to defend any claim or other proceeding
              as
              contemplated in Section 7.2 (Litigation) of the Purchase Agreements,
              the filing
              of Tax Returns or dealing with any matters contemplated in Section
              7.5 (Tax
              Matters) of the Purchase Agreements;</div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              in the case of the MDS Entities, the disclosure is required by the
              MDS
              Entities&#160; relating to the MDS Diagnostics Division (as defined in the
              Ontario Purchase Agreement) to the extent required to address financial
              reporting requirements; or</div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              such information has been, or at any time is, made available to the
              public
              through no fault of the applicable Parties or their Representatives;</div>
            <div style="MARGIN: 6pt 0pt 6pt 36pt; TEXT-INDENT: 0pt; tab-stops: 36.0pt; mso-list: none">provided
              in each case, that the applicable disclosing Party has provided the
              other Party
              with at least three (3) Business Days notice prior to such disclosure,
              other
              than in the case of paragraph (d) or if disclosure is required pursuant
              to
              applicable securities laws, published policies of applicable securities
              regulators or any applicable stock exchange rules.</div>
            <div style="MARGIN: 6pt 0pt 6pt 36pt; tab-stops: 36.0pt; mso-list: none">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              Each Party acknowledges and agrees that the obligations of confidentiality
              and
              trust in this Agreement are in addition to and not in substitution
              for any
              duties or obligations of secrecy, confidence or trust arising from
              or implied by
              any statute or rule of law.</div>
            <div style="MARGIN: 6pt 0pt 6pt 36pt; tab-stops: 36.0pt; mso-list: none"><a name="_Ref144101698">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Each
              Party
              acknowledges that any threatened or actual breach of any of the covenants
              or
              provisions contained herein would cause the other Party and/or any
              of the other
              Party&#8217;s Affiliates to suffer irreparable harm which could not be adequately
              compensated for by damages.&#160; In such circumstances, subject to Section 3,
              each Party agrees that the other Party and/or its Affiliates shall,
              in addition
              to any other remedy or relief, be entitled to seek to enforce the performance
              of
              this Agreement by equitable relief (including injunction or specific
              performance) upon application to a court of competent jurisdiction
              without proof
              of actual damage to such Party or its Affiliates and notwithstanding
              that
              damages may be readily quantifiable, and each Party agrees not to contest,
              object to, or otherwise delay, obstruct or oppose (including by pleading
              sufficiency of damages as a defence) an application for equitable relief
              by any
              other Party in the circumstances of such threatened or actual breach,
              on notice
              or <i>ex parte</i>, and hereby waive any and all immunities from injunctive or
              other equitable relief to which they may be entitled.&#160; Any such relief or
              remedy shall not be exclusive, but shall be in addition to all other
              available
              legal or equitable remedies.&#160; Each Party agrees that the provisions of this
              Section 6 are fair and reasonable in the commercial circumstances of
              this
              Agreement, and that it has relied on such provisions in entering into
              this
              Agreement, the Migration Agreement and each of the Purchase
              Agreements.</a>&#160; </div>
            <div style="MARGIN: 6pt 0pt 6pt 36pt; tab-stops: 36.0pt; mso-list: none">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              In the event of litigation relating to this Agreement, if a court of
              competent
              jurisdiction determines that a Party or any of itsRepresentatives have
              breached
              this Agreement, the breaching Party shall be liable and pay to the
              other Party
              the reasonable legal fees incurred by the other Party in connection
              with such
              litigation, including without limitation any appeals therefrom.</div>
            <div style="MARGIN: 6pt 0pt 6pt 36pt; tab-stops: 36.0pt; mso-list: none">8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              Each Party agrees that in the event it or any of its Representatives
              are
              requested pursuant to, or required by, applicable law, regulation or
              legal
              process (other than under applicable securities laws, published policies
              of
              applicable securities regulators or any applicable stock exchange rules)
              to
              disclose any Information of the other Party, it shall notify the other
              Party
              promptly in writing so that the other Party may seek a protective order
              or other
              appropriate remedy.&#160; The notifying Party shall consent to the other
              obtaining any protective order or other appropriate remedy that it
              and/or its
              Affiliates may seek for the purpose of preventing disclosure of any
              of the
              Information to the public.&#160; In the event that no such protective order or
              other remedy is obtained, such Party shall furnish only that portion
              of the
              other Party&#8217;s Information which it is advised by legal counsel is legally
              required and shall take all commercially reasonable steps, to the extent
              permitted by law, to remove from such Information that is required
              to be
              disclosed any information that is commercially sensitive to the other.
</div>
            <div style="MARGIN: 6pt 0pt 6pt 36pt; tab-stops: 36.0pt; mso-list: none">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              Each Party agrees that all of the terms, conditions and restrictions
              in this
              Agreement are reasonable in the circumstances and are intended to protect,
              in
              the case of Buyer, Buyer&#8217;s substantial investment and legitimate business
              interests in carrying on the specimen collection and diagnostic services
              business carried on by the Buyer after the date of this Agreement,
              and, in the
              case of MDS, MDS&#8217; businesses and the businesses of its Affiliates, other than
              the MDS Diagnostics Division.&#160; Nevertheless, if any such restrictions shall
              be held invalid, the remaining restrictions shall not be so affected.
              In
              addition, if any amendment to any restriction would be necessary in
              order to
              ensure its validity, such restriction shall apply with such amendment
              or
              modification as may be necessary to make it valid and effective.</div>
            <div style="MARGIN: 6pt 0pt 6pt 36pt; tab-stops: 36.0pt; mso-list: none">10.&#160;&#160;&#160;&#160;&#160;&#160;
              Nothing contained in this Agreement shall be construed, by implication,
              estoppel
              or otherwise, as a grant of a licence to use any of the Information
              of the other
              Party.</div>
            <div style="MARGIN: 6pt 0pt 6pt 36pt; tab-stops: 36.0pt; mso-list: none">11.&#160;&#160;&#160;&#160;&#160;&#160;
              A Party&#8217;s obligation of confidentiality under this Agreement survives
              indefinitely. </div>
            <div style="MARGIN: 6pt 0pt 6pt 36pt; tab-stops: 36.0pt; mso-list: none">12.&#160;&#160;&#160;&#160;&#160;&#160;
              This Agreement sets out the entire agreement between the Parties pertaining
              to
              the subject matter hereof and supersedes all prior agreements, understandings,
              negotiations and discussions, whether oral or written.</div>
            <div style="MARGIN: 6pt 0pt 6pt 36pt; tab-stops: 36.0pt; mso-list: none">13.&#160;&#160;&#160;&#160;&#160;&#160;
              No waiver of or consent to depart from the requirements of any provision
              of this
              Agreement shall be binding on a Party and/or its Affiliates unless
              it is in
              writing and is signed by such Party.&#160; Such waiver or consent shall be
              effective only in the specific instance and for the specific purpose
              for which
              it has been given.&#160; No failure on the part of a Party to exercise, and no
              delay in exercising, any right under this Agreement shall operate as
              a waiver of
              such right.&#160; No single or partial exercise of any such right shall preclude
              any other or further exercise of such right or the exercise of any
              other
              right.</div>
            <div style="MARGIN: 6pt 0pt 6pt 36pt; tab-stops: 36.0pt; mso-list: none"><a name="_Ref143485739">14.&#160;&#160;&#160;&#160;&#160;&#160;
Any
              notice, demand or
              other communication (a &#8220;<strong>notice</strong>&#8221;) required or permitted to be
              given or made hereunder shall be in writing and shall be sufficiently
              given or
              made if:</a></div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              delivered in Person during normal business hours on a Business Day
              and left with
              a receptionist or other responsible employee at the applicable address
              set forth
              below; or</div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none"><a name="_Ref143487438">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
sent
              by any
              electronic means of sending messages, including facsimile transmission
              (excluding e-mail), which produces a paper record
              (&#8220;<strong>Transmission</strong>&#8221;) during normal business hours on a Business
              Day.</a></div>
            <div style="MARGIN: 6pt 0pt 0pt 36pt">In the case of a notice to <strong>Buyer
              Entity</strong>:</div>
            <div style="MARGIN: 6pt 0pt 0pt 72pt">200 Bay Street,<br>P.O. Box 56, Suite
              2100<br>Toronto, Ontario<br>M5J 2J2</div>
            <div style="MARGIN: 6pt 0pt 0pt 72pt">Attention:&#160; President and Chief
              Executive Officer<br>Facsimile Number:&#160; (416) 361-6075</div>
            <div style="MARGIN: 6pt 0pt 0pt 36pt; TEXT-ALIGN: justify">and in the
              case of a
              notice to <strong>MDS</strong>:</div>
            <div style="MARGIN: 6pt 0pt 0pt 72pt">75 International Boulevard<br>Toronto,
              Ontario<br>M9W 6J6</div>
            <div style="MARGIN: 6pt 0pt 0pt 72pt">Attention:&#160; <strong><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">[</font></strong><font style="DISPLAY: inline; FONT-FAMILY: Wingdings">l<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">]</font></font><br>Facsimile
              Number:&#160; <strong>[<font style="DISPLAY: inline; FONT-FAMILY: Wingdings">l</font></strong><strong>]</strong></div>
            <div style="MARGIN: 6pt 0pt 0pt 36pt; TEXT-ALIGN: justify; mso-pagination: widow-orphan">and
              in the case of a notice to <strong>MDS LP ONT</strong>:</div>
            <div style="MARGIN: 12pt 0pt 0pt 72pt"><strong>[<font style="DISPLAY: inline; FONT-FAMILY: Wingdings">l</font></strong><strong>]<br><br></strong></div>
            <div style="MARGIN: 0pt 0pt 0pt 72pt; TEXT-ALIGN: left" align="left">Attention:
              <strong>[<font style="DISPLAY: inline; FONT-FAMILY: Wingdings">l</font></strong><strong>]
              </strong></div>
            <div style="MARGIN: 0pt 0pt 0pt 72pt; TEXT-ALIGN: left" align="left">Facsimile
              Number:&#160; <strong>[<font style="DISPLAY: inline; FONT-FAMILY: Wingdings">l</font></strong><strong>]</strong></div>
            <div style="MARGIN: 12pt 0pt 0pt 36pt; TEXT-ALIGN: justify">and in the
              case of a
              notice to <strong>MDS Quebec</strong>:</div>
            <div style="MARGIN: 12pt 0pt 0pt 72pt"><strong>[<font style="DISPLAY: inline; FONT-FAMILY: Wingdings">l</font></strong><strong>]</strong></div>
            <div style="MARGIN: 12pt 0pt 0pt 72pt">Attention: <strong>[<font style="DISPLAY: inline; FONT-FAMILY: Wingdings">l</font></strong><strong>]
              <br></strong>Facsimile Number:&#160; <strong>[<font style="DISPLAY: inline; FONT-FAMILY: Wingdings">l</font></strong><strong>]</strong></div>
            <div style="MARGIN: 12pt 0pt 0pt 36pt; TEXT-ALIGN: justify">and in the
              case of a
              notice to <strong>Metro GP</strong>:</div>
            <div style="MARGIN: 12pt 0pt 0pt 72pt"><strong>[<font style="DISPLAY: inline; FONT-FAMILY: Wingdings">l</font></strong><strong>]</strong></div>
            <div style="MARGIN: 12pt 0pt 0pt 72pt">Attention: <strong>[<font style="DISPLAY: inline; FONT-FAMILY: Wingdings">l</font></strong><strong>]
              <br></strong>Facsimile Number:&#160; <strong>[<font style="DISPLAY: inline; FONT-FAMILY: Wingdings">l</font></strong><strong>]</strong></div>
            <div style="MARGIN: 12pt 0pt 0pt 36pt; TEXT-ALIGN: justify">and in the
              case of a
              notice to <strong>Mether LP</strong>:</div>
            <div style="MARGIN: 12pt 0pt 0pt 72pt"><strong>[<font style="DISPLAY: inline; FONT-FAMILY: Wingdings">l</font></strong><strong>]</strong></div>
            <div style="MARGIN: 12pt 0pt 0pt 72pt">Attention: <strong>[<font style="DISPLAY: inline; FONT-FAMILY: Wingdings">l</font></strong><strong>]
              <br></strong>Facsimile Number:&#160; <strong>[<font style="DISPLAY: inline; FONT-FAMILY: Wingdings">l</font></strong><strong>]</strong></div>
            <div style="MARGIN: 12pt 0pt 0pt 36pt; TEXT-ALIGN: justify">and in the
              case of a
              notice to <strong>Mether GP</strong>:</div>
            <div style="MARGIN: 12pt 0pt 0pt 72pt"><strong>[<font style="DISPLAY: inline; FONT-FAMILY: Wingdings">l</font></strong><strong>]</strong></div>
            <div style="MARGIN: 12pt 0pt 12pt 72pt">Attention: <strong>[<font style="DISPLAY: inline; FONT-FAMILY: Wingdings">l</font></strong><strong>]
              <br></strong>Facsimile Number:&#160; <strong>[<font style="DISPLAY: inline; FONT-FAMILY: Wingdings">l</font></strong><strong>]</strong></div>
            <div style="MARGIN: 12pt 0pt 6pt 36pt; TEXT-ALIGN: justify">Each notice
              sent in
              accordance with this Section shall be deemed to have been received:</div>
            <div style="MARGIN: 6pt 0pt 6pt 72pt; tab-stops: 72.0pt; mso-list: none">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              if delivered in Person, on the day of delivery;</div>
            <div style="MARGIN: 6pt 0pt 0pt 72pt; tab-stops: 72.0pt; mso-list: none">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
              on the same day that it was sent by Transmission, or on the first Business
              Day
              thereafter if the day on which it was sent by Transmission was not
              a Business
              Day or if it was sent after normal business hours on a Business Day.</div>
            <div style="MARGIN: 12pt 0pt 6pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Any Party may change its address for
              notice by giving notice to the other
              Parties.</div>
            <div style="MARGIN: 6pt 0pt 6pt 36pt; tab-stops: 36.0pt; mso-list: none">15.&#160;&#160;&#160;&#160;&#160;&#160;
              Each Party represents and warrants to the other that the execution
              and delivery
              of this Agreement has been duly authorized by all necessary corporate
              action on
              their respective parts and that the Person signing this Agreement on
              behalf of
              it is duly authorized to do so.</div>
            <div style="MARGIN: 6pt 0pt 6pt 36pt; tab-stops: 36.0pt; mso-list: none">16.&#160;&#160;&#160;&#160;&#160;&#160;
              This Agreement is personal to the Parties and may not be assigned without
              the
              prior written consent of the other Parties.</div>
            <div style="MARGIN: 6pt 0pt 6pt 36pt; tab-stops: 36.0pt; mso-list: none">17.&#160;&#160;&#160;&#160;&#160;&#160;
              Any amendments to this Agreement must be made in writing and signed
              by all of
              the Parties.</div>
            <div style="MARGIN: 6pt 0pt 6pt 36pt; tab-stops: 36.0pt; mso-list: none"><a name="_Ref143487301">18.&#160;&#160;&#160;&#160;&#160;&#160;
This
              Agreement shall
              be governed by and construed in accordance with the laws of the Province
              of
              Ontario and the Parties hereby attorn and submit to the non-exclusive
              jurisdiction of the courts of the Province of Ontario with respect
              to any
              dispute arising under this Agreement.</a></div>
            <div style="MARGIN: 6pt 0pt 6pt 36pt; tab-stops: 36.0pt; mso-list: none">19.&#160;&#160;&#160;&#160;&#160;&#160;
              This Agreement shall enure to the benefit of and be binding upon the
              Parties and
              their respective successors and permitted assigns.</div>
            <div style="MARGIN: 6pt 0pt 6pt 36pt; tab-stops: 36.0pt; mso-list: none">20.&#160;&#160;&#160;&#160;&#160;&#160;
              The parties have agreed that this Agreement be drawn up in the English
              language.&#160; Les parties aux pr&#233;sentes ont convenu que le pr&#233;sent contrat
              soit r&#233;dig&#233; en anglais. </div>
            <div style="MARGIN: 12pt 0pt 0pt"><strong>IN WITNESS WHEREOF</strong>, the
              Parties hereto have executed this Agreement as of the date first written
              above.</div>
            <div style="MARGIN: 0pt">&#160;</div>
            <div style="MARGIN: 0pt">&#160;</div>
            <table border="0" cellpadding="0" cellspacing="0" style="MARGIN-LEFT: 0.4pt; BORDER-COLLAPSE: collapse; mso-table-layout-alt: fixed; mso-padding-alt: 0pt 0pt 0pt 0pt">

                <tr>
                  <td valign="top" width="299" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 224.6pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                  <td colspan="2" valign="top" width="324" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 243.3pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt"><strong>MDS INC.</strong></div>
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td valign="bottom" width="299" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 224.6pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                  <td valign="bottom" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">By:</div>
                  </td>
                  <td valign="bottom" width="276" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 207.3pt; padding-top: 0pt; border-bottom: windowtext 1pt solid;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="299" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 224.6pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                  <td valign="top" width="276" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 207.3pt; padding-top: 0pt; border-bottom: #ece9d8; mso-border-top-alt: solid windowtext .5pt;">
                    <div style="MARGIN: 0pt">Name: </div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="299" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 224.6pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                  <td valign="top" width="276" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 207.3pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">Title: </div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="299" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 224.6pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                  <td valign="top" width="276" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 207.3pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">I have the authority to bind the
                      Corporation</div>
                  </td>
                </tr>

            </table>
            <div style="MARGIN: 0pt">&#160;</div>
            <table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse; mso-table-layout-alt: fixed; mso-padding-alt: 0pt 5.4pt 0pt 5.4pt">

                <tr style="height: 40pt;">
                  <td colspan="2" valign="bottom" width="259" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 194.4pt; padding-top: 0pt; border-bottom: #ece9d8; height: 40pt;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td rowspan="4" valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8; height: 40pt;">
                    <div style="MARGIN: 2pt 0pt; TEXT-ALIGN: center; mso-pagination: widow-orphan lines-together" align="center">&#160;</div>
                  </td>
                  <td colspan="2" valign="bottom" width="330" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 247.5pt; padding-top: 0pt; border-bottom: #ece9d8; height: 40pt;">
                    <div style="MARGIN: 2pt 0pt 12pt; mso-pagination: widow-orphan lines-together"><strong>MDS
                      LABORATORY SERVICES LIMITED PARTNERSHIP</strong></div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">By:</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: windowtext 0.5pt solid;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">Name:
                      </div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">Title:
                      </div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">I
                      have the authority to bind the Partnership</div>
                  </td>
                </tr>

            </table>
            <div style="MARGIN: 0pt">&#160;</div>
            <table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse; mso-table-layout-alt: fixed; mso-padding-alt: 0pt 5.4pt 0pt 5.4pt">

                <tr style="height: 40pt;">
                  <td colspan="2" valign="bottom" width="259" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 194.4pt; padding-top: 0pt; border-bottom: #ece9d8; height: 40pt;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td rowspan="4" valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8; height: 40pt;">
                    <div style="MARGIN: 2pt 0pt; TEXT-ALIGN: center; mso-pagination: widow-orphan lines-together" align="center">&#160;</div>
                  </td>
                  <td colspan="2" valign="bottom" width="330" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 247.5pt; padding-top: 0pt; border-bottom: #ece9d8; height: 40pt;">
                    <div style="MARGIN: 2pt 0pt 12pt; mso-pagination: widow-orphan lines-together"><strong>LABORATOIRES
                      MDS QU&#201;BEC LT&#201;<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#201;</font></strong></div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">By:</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: windowtext 0.5pt solid;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">Name:
                      </div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">Title:
                      </div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">I
                      have the authority to bind the Corporation</div>
                  </td>
                </tr>

            </table>
            <div style="MARGIN: 0pt">&#160;</div>
            <div style="MARGIN: 0pt">&#160;</div>
            <table border="0" cellpadding="0" cellspacing="0" style="MARGIN-LEFT: 0.4pt; BORDER-COLLAPSE: collapse; mso-table-layout-alt: fixed; mso-padding-alt: 0pt 0pt 0pt 0pt">

                <tr>
                  <td valign="top" width="299" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 224.6pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                  <td colspan="2" valign="top" width="324" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 243.3pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt"><strong>BOREALIS INFRASTRUCTURE MANAGEMENT
                      INC.</strong></div>
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td valign="bottom" width="299" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 224.6pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                  <td valign="bottom" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">By:</div>
                  </td>
                  <td valign="bottom" width="276" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 207.3pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="299" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 224.6pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                  <td valign="top" width="276" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: windowtext 1pt solid; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 207.3pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt">Name: </div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="299" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 224.6pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                  <td valign="top" width="276" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 207.3pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt">Title: </div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="299" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 224.6pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                  <td colspan="2" valign="top" width="324" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 243.3pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td valign="bottom" width="299" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 224.6pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                  <td valign="bottom" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">By:</div>
                  </td>
                  <td valign="bottom" width="276" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 207.3pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="299" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 224.6pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                  <td valign="top" width="276" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: windowtext 1pt solid; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 207.3pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">Name:</div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="299" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 224.6pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                  <td valign="top" width="276" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 207.3pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt">Title: </div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="299" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 224.6pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">&#160;</div>
                  </td>
                  <td valign="top" width="276" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 0pt; border-top: #ece9d8; padding-left: 0pt; padding-bottom: 0pt; border-left: #ece9d8; width: 207.3pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 0pt">We have the authority to bind the
                      Corporation</div>
                  </td>
                </tr>

            </table>
            <div style="MARGIN: 12pt 0pt 0pt">&#160;</div>
            <table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse; mso-table-layout-alt: fixed; mso-padding-alt: 0pt 5.4pt 0pt 5.4pt">

                <tr style="height: 40pt;">
                  <td colspan="2" valign="bottom" width="259" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 194.4pt; padding-top: 0pt; border-bottom: #ece9d8; height: 40pt;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td rowspan="4" valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8; height: 40pt;">
                    <div style="MARGIN: 2pt 0pt; TEXT-ALIGN: center; mso-pagination: widow-orphan lines-together" align="center">&#160;</div>
                  </td>
                  <td colspan="2" valign="bottom" width="330" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 247.5pt; padding-top: 0pt; border-bottom: #ece9d8; height: 40pt;">
                    <div style="MARGIN: 2pt 0pt 12pt; mso-pagination: widow-orphan lines-together"><strong>METRO
                      MCNAIR CLINICAL LABORATORIES LTD.</strong></div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">By:</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: windowtext 0.5pt solid;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">Name:
                      </div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">Title:
                      </div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">I
                      have the authority to bind the Corporation</div>
                  </td>
                </tr>

            </table>
            <div style="MARGIN: 12pt 0pt 0pt">&#160;</div>
            <table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse; mso-table-layout-alt: fixed; mso-padding-alt: 0pt 5.4pt 0pt 5.4pt">

                <tr style="height: 40pt;">
                  <td colspan="2" valign="bottom" width="259" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 194.4pt; padding-top: 0pt; border-bottom: #ece9d8; height: 40pt;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td rowspan="4" valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8; height: 40pt;">
                    <div style="MARGIN: 2pt 0pt; TEXT-ALIGN: center; mso-pagination: widow-orphan lines-together" align="center">&#160;</div>
                  </td>
                  <td colspan="2" valign="bottom" width="330" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 247.5pt; padding-top: 0pt; border-bottom: #ece9d8; height: 40pt;">
                    <div style="MARGIN: 2pt 0pt 12pt; mso-pagination: widow-orphan lines-together"><strong>METHER
                      PROPERTIES LIMITED PARTNERSHIP</strong></div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">By:</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: windowtext 0.5pt solid;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">Name:
                      </div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">Title:
                      </div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">I
                      have the authority to bind the Corporation</div>
                  </td>
                </tr>

            </table>
            <div style="MARGIN: 12pt 0pt 0pt">&#160;</div>
            <table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse; mso-table-layout-alt: fixed; mso-padding-alt: 0pt 5.4pt 0pt 5.4pt">

                <tr style="height: 40pt;">
                  <td colspan="2" valign="bottom" width="259" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 194.4pt; padding-top: 0pt; border-bottom: #ece9d8; height: 40pt;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td rowspan="4" valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8; height: 40pt;">
                    <div style="MARGIN: 2pt 0pt; TEXT-ALIGN: center; mso-pagination: widow-orphan lines-together" align="center">&#160;</div>
                  </td>
                  <td colspan="2" valign="bottom" width="330" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 247.5pt; padding-top: 0pt; border-bottom: #ece9d8; height: 40pt;">
                    <div style="MARGIN: 2pt 0pt 12pt; mso-pagination: widow-orphan lines-together"><strong>METHER
                      MANAGEMENT LTD.</strong></div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">By:</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: windowtext 0.5pt solid;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">Name:
                      </div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">Title:
                      </div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">I
                      have the authority to bind the Corporation</div>
                  </td>
                </tr>
                <tr style="height: 40pt;">
                  <td colspan="2" valign="bottom" width="259" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 194.4pt; padding-top: 0pt; border-bottom: #ece9d8; height: 40pt;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td rowspan="4" valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8; height: 40pt;">
                    <div style="MARGIN: 2pt 0pt; TEXT-ALIGN: center; mso-pagination: widow-orphan lines-together" align="center">&#160;</div>
                  </td>
                  <td colspan="2" valign="bottom" width="330" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 247.5pt; padding-top: 0pt; border-bottom: #ece9d8; height: 40pt;">
                    <div style="MARGIN: 2pt 0pt 12pt; mso-pagination: widow-orphan lines-together"><strong>[designated
                      buyer affiliates]</strong></div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td valign="top" width="49" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36.9pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="210" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 157.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="48" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 36pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                  <td valign="top" width="282" bgcolor="transparent" style="border-right: #ece9d8; padding-right: 5.4pt; border-top: #ece9d8; padding-left: 5.4pt; padding-bottom: 0pt; border-left: #ece9d8; width: 211.5pt; padding-top: 0pt; border-bottom: #ece9d8;">
                    <div style="MARGIN: 2pt 0pt; mso-pagination: widow-orphan lines-together">&#160;</div>
                  </td>
                </tr>

            </table>
            <div>
              <hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
              <hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
            </div>
            <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong>SCHEDULE
              6.1.5(B)</strong></div>
            <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center">Closing
              Conditions in Favour of Buyer</div>
            <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center">&#160;</div>
            <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center">[REDACTED]</div>
            <div style="MARGIN: 12pt 0pt 0pt">&#160;</div>
            <div style="MARGIN: 12pt 0pt 0pt">&#160;</div>
            <div style="MARGIN: 12pt 0pt 0pt"><br>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><strong>SCHEDULE
                6.2.4(B)</strong></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">Closing
                Conditions in Favour of MDS</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">[REDACTED]</div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
            </div>
            <div>
              <hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
              <hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
            </div>
            <div style="MARGIN: 12pt 0pt 0pt">
              <div style="MARGIN: 12pt 0pt 0pt; TEXT-INDENT: 0pt" align="center"><strong>Schedule
                9.3<br>Rules of Procedure for
                Arbitration</strong></div>
              <div style="MARGIN: 12pt 0pt 0pt">The following rules and procedures
                shall apply
                with respect to any matter to be arbitrated by the Parties under
                the terms of
                the Agreement.</div>
              <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                INITIATION OF ARBITRATION PROCEEDINGS</div>
              <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 18.0pt; mso-list: none">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                If any Party to this Agreement wishes to have any dispute under Sections
                3.4,
                3.5 and 3.6 and Schedule 3.1 arbitrated in accordance with the provisions
                of
                this Agreement, it shall give notice to the other Party hereto specifying
                particulars of the matter or matters in dispute and proposing the
                name of the
                person it wishes to be the single arbitrator.&#160; Within 15 days after receipt
                of such notice, the other Party to this Agreement shall give notice
                to the first
                Party advising whether such Party accepts the arbitrator proposed
                by the first
                Party.&#160; If such notice is not given within such 15 day period, the other
                Party shall be deemed to have accepted the arbitrator proposed by
                the first
                Party.&#160; If the Parties do not agree upon a single arbitrator within such
                15
                day period, either party may request that the ADR Institute of Canada,
                Inc.
                select a single arbitrator (the &#8220;<strong>Arbitrator</strong>&#8221;).</div>
              <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 18.0pt; mso-list: none">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                The individual selected as Arbitrator shall be qualified by education
                and
                experience to decide the matter in dispute.&#160; The Arbitrator shall be at
                arm&#8217;s length from both Parties and shall not be a member of the audit
                or legal
                firm or firms who advise either Party, nor shall the Arbitrator be
                an individual
                who is, or is a member of a firm, otherwise regularly retained by
                either of the
                Parties.</div>
              <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                SUBMISSION OF WRITTEN STATEMENTS</div>
              <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 18.0pt; mso-list: none">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                Within 30 days of the appointment of the Arbitrator, the Party initiating
                the
                arbitration (the &#8220;<strong>Claimant</strong>&#8221;) shall send the other Party (the
&#8220;<strong>Respondent</strong>&#8221;) a Statement of Claim setting
                out in sufficient
                detail the facts and any contentions of law on which it relies, and
                the relief
                that it claims.</div>
              <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 18.0pt; mso-list: none">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                Within 30 days of the receipt of the Statement of Claim, the Respondent
                shall
                send the Claimant a Statement of Defence stating in sufficient detail
                which of
                the facts and contentions of law in the Statement of Claim it admits
                or denies,
                on what grounds, and on what other facts and contentions of law it
                relies.</div>
              <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 18.0pt; mso-list: none">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                Within 15 days of receipt of the Statement of Defence, the Claimant
                may send the
                Respondent a Statement of Reply.</div>
              <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 18.0pt; mso-list: none">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                All Statements of Claim, Defence and Reply shall be accompanied by
                copies (or,
                if they are especially voluminous, lists) of all essential documents
                on which
                the Party concerned relies and which have not previously been submitted
                by any
                Party.</div>
              <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 18.0pt; mso-list: none">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                After submission of all the Statements, the Arbitrator will give
                directions for
                the further conduct of the arbitration.</div>
              <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                MEETINGS AND HEARINGS</div>
              <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 18.0pt; mso-list: none">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                The arbitration shall take place in the City of Toronto, Ontario
                or in such
                other place as the Claimant and the Respondent shall agree upon in
                writing
                within 5 days after the Statements of Claim, Defence and Reply have
                been
                delivered.&#160; The arbitration shall be conducted in English unless otherwise
                agreed by such Parties and the Arbitrator.&#160; Subject to any adjournments
                which the Arbitrator allows, the final hearing will be continued
                on successive
                working days until it is concluded.</div>
              <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 18.0pt; mso-list: none">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                All meetings and hearings will be in private unless the Parties otherwise
                agree.</div>
              <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 18.0pt; mso-list: none">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                Any Party may be represented at any meetings or hearings by legal
                counsel.</div>
              <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 18.0pt; mso-list: none">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                Each Party may examine, cross-examine and re-examine all witnesses
                at the
                arbitration.</div>
              <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                THE DECISION</div>
              <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 18.0pt; mso-list: none">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                The Arbitrator will make a decision in writing and, unless the Parties
                otherwise
                agree, will set out reasons for the decision in the decision.</div>
              <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 18.0pt; mso-list: none">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                The Arbitrator will send the decision to the Parties as soon as practicable
                after the conclusion of the final hearing, but in any event no later
                than 45
                days thereafter, unless that time period is extended for a fixed
                period by the
                Arbitrator on written notice to each Party because of illness or
                other cause
                beyond the Arbitrator&#8217;s control.</div>
              <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 18.0pt; mso-list: none">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                The provisions of this Agreement and this Schedule requiring the
                determination
                of certain disputes of arbitration shall not operate to prevent recourse
                to the
                court by any Party as permitted by the Arbitration Act, 1991 (Ontario)
                with
                respect to injunctions, receiving orders and orders regarding the
                detention,
                preservation and inspection of property, or whenever enforcement
                of an award by
                the sole arbitrator reasonably requires access to any remedy which
                an arbitrator
                has no power to award or enforce.</div>
              <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 18.0pt; mso-list: none">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                The decision of the Arbitrator shall be conclusive, final and binding
                on the
                Parties and no appeal shall lie therefrom.</div>
              <div style="MARGIN: 12pt 0pt 0pt; tab-stops: 72.0pt; mso-list: none">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                JURISDICTION AND POWERS OF THE ARBITRATOR</div>
              <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 18.0pt; mso-list: none">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                By submitting to arbitration under these Rules, the Parties shall
                be taken to
                have conferred on the Arbitrator the following jurisdiction and powers,
                to be
                exercised at the Arbitrator&#8217;s discretion subject only to these Rules and the
                relevant law with the object of ensuring the just, expeditious, economical
                and
                final determination of the dispute referred to arbitration.</div>
              <div style="MARGIN: 12pt 0pt 0pt 72pt; tab-stops: 18.0pt; mso-list: none">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                Without limiting the jurisdiction of the Arbitrator at law, the Parties
                agree
                that the Arbitrator shall have jurisdiction to:</div>
              <div style="MARGIN: 12pt 0pt 0pt 108pt; tab-stops: 18.0pt; mso-list: none">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                determine any question of law arising in the arbitration including
                claims in
                tort, contract or relating to the validity of the Agreement or any
                Closing
                Document;</div>
              <div style="MARGIN: 12pt 0pt 0pt 108pt; tab-stops: 18.0pt; mso-list: none">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                determine any question as to the Arbitrator&#8217;s jurisdiction;</div>
              <div style="MARGIN: 12pt 0pt 0pt 108pt; tab-stops: 18.0pt; mso-list: none">(iii)&#160;&#160;&#160;&#160;&#160;&#160;
                determine any question of good faith, dishonesty or fraud arising
                in the
                dispute;</div>
              <div style="MARGIN: 12pt 0pt 0pt 108pt; tab-stops: 18.0pt; mso-list: none">(iv)&#160;&#160;&#160;&#160;&#160;&#160;
                order any Party to furnish further details of that Party&#8217;s case, in fact or in
                law;</div>
              <div style="MARGIN: 12pt 0pt 0pt 108pt; tab-stops: 18.0pt; mso-list: none">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                proceed in the arbitration notwithstanding the failure or refusal
                of any Party
                to comply with these Rules or with the Arbitrator&#8217;s orders or directions, or to
                attend any meeting or hearing, but only after giving that Party written
                notice
                that the Arbitrator intends to do so;</div>
              <div style="MARGIN: 12pt 0pt 0pt 108pt; tab-stops: 18.0pt; mso-list: none">(vi)&#160;&#160;&#160;&#160;&#160;&#160;
                receive and take into account such written or oral evidence tendered
                by the
                Parties as the Arbitrator determines is relevant, whether or not
                strictly
                admissible in law;</div>
              <div style="MARGIN: 12pt 0pt 0pt 108pt; tab-stops: 18.0pt; mso-list: none">(vii)&#160;&#160;&#160;&#160;&#160;
                make one or more interim awards;</div>
              <div style="MARGIN: 12pt 0pt 0pt 108pt; tab-stops: 18.0pt; mso-list: none">(viii)&#160;&#160;&#160;&#160;&#160;
                hold meetings and hearings, and make a decision (including a final
                decision) in
                Ontario or elsewhere with the concurrence of the Parties thereto;</div>
              <div style="MARGIN: 12pt 0pt 0pt 108pt; tab-stops: 18.0pt; mso-list: none">(ix)&#160;&#160;&#160;&#160;&#160;&#160;
                order the Parties to produce to the Arbitrator, and to each other
                for
                inspection, and to supply copies of, any documents or classes of
                documents in
                their possession or power which the Arbitrator determines to be relevant;</div>
              <div style="MARGIN: 12pt 0pt 0pt 108pt; tab-stops: 18.0pt; mso-list: none">(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                order the preservation, storage, sale or other disposal of any property
                or thing
                under the control of any of the Parties;</div>
              <div style="MARGIN: 12pt 0pt 0pt 108pt; tab-stops: 18.0pt; mso-list: none">(xi)&#160;&#160;&#160;&#160;&#160;&#160;
                make interim orders to secure all or part of any amount in dispute
                in the
                arbitration; and</div>
              <div style="MARGIN: 12pt 0pt 0pt 108pt; tab-stops: 18.0pt; mso-list: none">(xii)&#160;&#160;&#160;&#160;&#160;
                make an award of interest in respect of any amount determined to
                be owing and
                make an award as to costs of the arbitration.</div>
              <div style="MARGIN: 12pt 0pt 0pt">&#160;</div><br>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
              <div align="center">
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </body>
</html>

</TEXT>
</DOCUMENT>
